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1 
Introduction 
 
1.1. Supercritical Fluids 
Supercritical fluids (SCFs) are pure substances or mixtures at a temperature and pressure 
higher than their critical coordinates. The main distinctive characteristic of a supercritical 
fluid is its density that is very sensitive to small changes in temperature and pressure; the 
fluid behavior may be tuned from that of a liquid at a high pressure to that of a gas at low 
pressure.  
 
Carbon dioxide is the most commonly used supercritical fluid because it is nontoxic, 
nonflammable, and has a moderate critical temperature and pressure. Fig. 1.1 shows the 
pressure-temperature phase diagram of carbon dioxide.  
 
Fig.1.1 Pressure- temperature phase diagram of carbon dioxide [1]. 
 
 
 
Fig. 1.1 presents conditions where the two phases coexist along with the areas where the 
single phases exist, and also the point where the three phases coexist at the triple point. The 
diagram shows the critical pressure (Pc) and the critical temperature (Tc). The supercritical 
fluid region extends above both Pc and Tc. In this area, lowering the pressure or the 
temperature will bring the substance into the vapor or the liquid region, respectively, without 
any phase change occurring. Carbon dioxide has a critical temperature of 304.12 K and a 
critical pressure of 7.37 MPa [2].  
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Table 1.1 lists values for the molar masses and the critical temperature, pressure and 
density of some compounds commonly used as supercritical fluids.  
 
Table 1.1 The critical properties of selected compounds [2]. 
Component 
Molecular 
Weight (g/mol) 
Tc (K) Pc (MPa) ρc (g/mL) 
Carbon dioxide  44.01 304.1 7.37 0.469 
Water  18.02 647.3 22.12 0.348 
Methane 16.04 190.4 4.60 0.162 
Ethane 30.07 305.3 4.87 0.203 
Propane 44.09 369.8 4.25 0.217 
Ethylene 28.05 282.4 5.04 0.215 
Propylene 42.08 364.9 4.60 0.323 
Methanol 32.04 512.6 8.09 0.272 
Ethanol 46.07 513.9 6.14 0.276 
Acetone 58.08 508.1 4.70 0.278 
 
As shown, light molecules tend to have lower critical temperatures and higher critical 
densities than those of larger molecular weight. The critical pressures of most substances 
range from 3 to 6 MPa. The presence of hydrogen bonds or the polarity of the molecules tend 
to increase the critical temperature or pressure of the compound. Although a variety of 
components can be utilized in supercritical fluid processing, common substances such as light 
hydrocarbons, water and carbon dioxide have received the greatest attention. 
 
1.1.1. Properties of Supercritical Fluids 
The distinctive properties of a supercritical fluid in comparison with those typical of gases 
and liquids are shown in table 1.2. The thermophysical properties of SCF include liquid-like 
densities, gas-like viscosities and diffusivities much higher than those of liquids. 
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  Table 1.2 Comparison of gases, supercritical fluids and liquids [3]. 
Property Gas SCF Liquid 
Density 
 (kg/m3 ) 
1 100-800 1000 
Viscosity  
(cP) 
0.01 0.05-0.1 0.5-1.0 
Diffusivity 
 (mm2 /s) 
1-10 0.01-0.1 0.001 
Thermal conductivity  
(10-3W/mK) 
1 1-100 100 
 
Density is a very important factor in determining the solubility of different compounds. A 
high-density SCF exhibits a high solvent power similar to that of liquid solvents. On the 
contrary, in comparison to liquid solvents SCFs have relatively low viscosity and diffusivity 
values which provide appreciable penetrating power into a solid matrix. These properties give 
rise to higher rates of mass transfer of solutes into a SCF than into a liquid. On the other 
hand, heat transfer is favored in a SCF because SCFs have high values of the thermal 
conductivity in comparison to gases although still lower than those of liquids. Additionally, 
the low surface tension of SCF allows the fluid to penetrate inside porous materials. 
 
As a result of this combination of properties, SCFs are very interesting substances for 
different technological applications such as supercritical fluid extraction, material treatment 
and fabrication, material micronization and reaction media. Supercritical fluid science and 
technology is a growing field with a wide variety of applications ranging from the extraction 
of pharmaceutical active ingredients to the synthesis of advantage materials.  
 
One of the most important properties is the solubility of the different materials in the 
fluid. The solubility in the supercritical fluid tends to increase with an increase of the fluid 
density at a constant temperature. Fig. 1.2 shows the density of carbon dioxide as a function 
of pressure and temperature. 
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Fig.1.2 Density- pressure phase diagram of carbon dioxide [1]. 
 
At a temperature below the critical temperature (T < Tc), e.g. at 280 K, as the pressure 
increases, the density of gaseous carbon dioxide increases. Further increase in pressure 
results in phase splitting, vapor-liquid equilibrium that is represented as a discontinuous 
line. By increasing temperature to 300 K, the CO2 compresses and condenses into a less 
dense liquid; however, the vapor-liquid equilibrium still exists.  At the critical point the 
two phases become one supercritical fluid phase. At temperatures below Tc, it is required 
a great increase of pressure in order to slightly increase the density. However, in the 
supercritical region close to the critical point, small changes in pressure result in large 
changes in density allowing many properties to be tuned. For carbon dioxide at 310 K (T 
> Tc) a small increase in pressure causes a large increase in the density of the supercritical 
phase. At higher temperatures, the fluid starts to behave like a gas. 
 
Many pressurized gases are actually supercritical fluids. For example, nitrogen has a 
critical point of 126.2 K and 3.4 MPa. Therefore, nitrogen (or compressed air) in a gas 
cylinder above this pressure is actually a supercritical fluid. At room temperature, it 
behaves as a gas, similar to CO2 at 400 K and above.  
 
1.1.2. Phase Diagrams of Mixtures Involving Supercritical Fluids 
We have defined a supercritical fluid as a substance under a temperature and pressure 
above their critical coordinates. The same definition may be used for a pure compound and a 
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mixture. Binary mixtures are usually studied in the first place, then ternary and high order 
mixtures. This strategy allows us to use our knowledge of mixtures with two or three 
components in the analysis of multi-component mixtures. 
 
At conditions of temperature or pressure away from the critical point, the P-x and T-x 
diagrams for a binary mixture are easily understood. However, when we approach the critical 
point of one of the components, the phase diagram is similar to that shown in Fig. 1.3 for the 
CO2 + pentane system at 344 K [4].  
 
Fig.1.3 Phase diagram of carbon dioxide + pentane at 344 K [4]. 
 
For a value of pressure of 5 MPa, the intersection of a parallel to the composition axis 
with the upper curve provides the CO2 mole fraction value in the pentane-rich liquid phase 
(x1) while the intersection of this line with the lower curve provides the CO2 mole fraction 
value in the CO2-rich vapor phase (y1). These are the compositions of the liquid and vapor 
mixtures in equilibrium at 344 K and 5 MPa. Each pair of composition values thus obtained 
for a given pressure describes possible liquid-vapor equilibrium states for this system. As the 
pressure goes up, the values of x1 and y1 become more similar. At a pressure of 9.5 MPa, the 
two curves come together, the coincident value of x1 and y1 is the composition of the mixture 
with critical coordinates 344 K and 9.5 MPa. To obtain other critical P, T, x coordinates for 
this system it is necessary to plot diagrams similar to that of Fig. 1.3 at other temperatures. 
The set of critical P, T, x coordinates thus obtained defines the so-called critical locus for this 
particular system. Therefore, a three-dimensional P-T-x plot is necessary in order to analyze 
the critical behavior of a binary system. Fig. 1.4 shows this plot for a system such as CO2 + 
pentane. This is the simplest critical behavior. C1 and C2 represent the CO2 and pentane 
critical points, respectively.  
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Fig.1.4 Left: The three-dimensional P-T-x diagram for the CO2 + pentane system. Right: P-x and T-x 
projections. 
 
The full lines A-C1 and B-C2 represent the vapor pressure curves of both pure 
components. The dash line connecting C1 and C2 is the critical locus for the CO2 + pentane 
system. The two surfaces describing the liquid and vapor phase are confined within the 
curves A-C1, B-C2 and C1-C2. Fig. 1.4 also shows some isotherm and isobar sections 
comprised between the liquid and vapor phase surfaces. These sections give rise to the 
bidimensional P-x and T-x plots shown separately in Fig. 1.4. The P-T diagrams at constant 
composition for the ethane + heptane system (isoplets, left) together with the projection of the 
three-dimensional phase diagram on the PT plane (right) are shown in Fig. 1.5.  
 
          
Fig.1.5 Left: Isoplets and critical locus for the ethane + heptane system. Right: P-T projection. 
 
A 
B 
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Usually, only the information given in the P-T projection is given. This projection also 
represents the behavior of the CO2 + pentane system. In this case, the points of the critical 
locus close to C1 would correspond to critical coordinates of CO2-rich mixtures while those 
close to C2 would correspond to pentane-rich mixtures. This simplified representation is the 
basis of the Scott and van Konynenburg classification [5] of the binary system phase 
diagrams shown in Fig. 1.6.  
 
Fig.1.6 Six types of phase behavior in binary fluid systems, points C1 and C2 are the critical points of pure 
components; L = liquid; V = vapor; UCEP = upper critical end point; LCEP = lower critical end point.  
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Scott and van Konynenburg showed that almost all known types of binary fluid-phase 
equilibria (vapor-liquid, liquid-liquid and gas-gas equilibria) could be qualitatively predicted 
using the van der Waals equation of state and the quadratic mixing rules. Using this equation, 
they were able to generate five types. A type VI phase diagram was added to complete this 
description by Street [6] but it is much less common. Phase behavior is classified in these six 
types according to the shape of the critical line and the absence or presence of three-phase 
equilibrium lines. The appearance and explanation of the various P-T-x diagrams for the all 
six types are given in details by Mc Hugh and Krukonis [7]. The CO2 + pentane phase 
diagram belongs to the type I diagram is characterized for a continuous critical line 
connecting the critical points of the pure components C1 and C2 and the complete miscibility 
in the liquid phase. 
 
In the type II diagram the two components are not completely miscible and a three-phase 
equilibrium is possible at temperatures below the critical points of both components. This is 
the situation along the liquid-liquid-gas line (LLV). The point UCEP indicates the upper 
consolute temperature for the liquid-liquid equilibrium (L-L) more commonly known as the 
upper critical end point. At pressures above this point the vapor phase condenses and a 
dashed line represents the L-L equilibrium. 
When the immiscibility extends to temperatures close to the critical temperature of one of 
the components, the phase diagram may be a type III. In this case the critical line has two 
sections. The section starting in the critical point of the less volatile component (C2) reaches 
high pressures and may exhibit a maximum or a minimum in temperature and/or pressure. 
When the temperatures in this critical line are higher than that of the component 2, the line is 
described as a gas-gas critical line (b). The other section of the critical locus is found at lower 
temperatures and connects the critical point of the more volatile component (C1) and the 
upper critical end point (UCEP) that intersects the three-phase equilibrium line (LLV). 
 
In the type IV and V phase diagrams the gas-liquid critical line starts in C2 and ends in the 
lower critical end point usually denoted by the acronym LCEP. This point intersects with the 
three-phase equilibrium line LLV. This line ends in the upper critical end point (UCEP) and 
is connected to the critical point of the other component through the critical line VL. In the 
type IV diagram at low temperatures appears a liquid-liquid equilibrium (LL) similar to that 
exhibited in the type II diagram. 
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Usually when the two components of the binary system have a similar chemical nature the 
phase behavior is a type I. When the two components differ, the phase behavior becomes 
more complicate and type II, III, etc. are observed [8]. For instance, in the CO2 + alkane 
series, the phase behavior evolves as the hydrocarbon chain becomes larger. Type I is 
observed for the systems CO2 + methane to CO2 + pentane, type II for CO2 + octane to CO2 + 
undecane, type III for CO2+ hexadecane and type IV for CO2 + tridecane [9]. 
 
Finally, for some binary systems where one or the two components are self-associated 
through hydrogen bonding the phase behavior is a type VI. In this case two critical lines are 
present: a continuous critical line similar to that of types I and II and a LLV equilibrium line 
at lower temperatures limited by an upper critical end point (UCEP) and a lower critical end 
point (LCEP). This LCEP distinguishes type VI from type II systems.  
 
The description of high-pressure phase equilibria is not limited to fluid phases. In many 
SCF applications a solid phase is involved. In this thesis, binary and ternary diagrams without 
solid interference are involved. For the sake of brevity, the diagrams with solid interference 
are not described in this introduction.  
 
The critical locus in a ternary system is a surface stretching from the locus of the three 
related binary systems involved. In the case of type I binary systems the surface will be 
continuous. In other cases, the critical locus surface presents discontinuities and may become 
extremely complicate. The analysis of the locus may be simplified if the ternary system is 
considered as a set of pseudobinary systems. The critical locus for the ternary system CO2 + 
hexane + methanol based on this simplification is shown in Fig. 1.7 [10]. 
 
 
 
Fig. 1.7 Critical locus of CO2 (x1) + hexane (x2) + methanol (x3) ternary system. ():  x2 /x3 = 1/3; ():  x2 /x3 = 
1; ():  x2 /x3 = 3; ():  x2 /x3 = 5. 
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The critical full lines correspond to the three binary systems involved. The symbols 
connected by dashed lines are critical data obtained for mixtures of CO2 and a methanol + 
hexane mixture of fixed composition. In this diagram the pseudobinary component is the 
hexane + methanol mixture. Each pseudobinary locus (dash lines) will start in the common 
component CO2 and will end in a point of the hexane + methanol locus. CO2 + hexane and 
CO2 + methanol are type I systems; methanol + hexane is a type II system. 
 
In the SCF processes involved in this thesis two kinds of ternary systems appear. In the 
first kind CO2 is one component and two organic solvents are the second and third 
components; these are systems that can be treated in a similar way to that above described for 
the CO2 + hexane + methanol. In the second kind of systems, the first component is CO2, the 
second component is an organic solvent and the third component is a solid that has been 
previously dissolved in the organic solvent. The nature of this solid is diverse: it may be a 
drug such as cefonicid or a polymer such as dextran or polyvinylpyrrolidone. 
 
Reverchon et al. [11] have studied the effect of cefonicid on the binary phase diagram of 
carbon dioxide + dimethylsulfoxide (DMSO). In Fig. 1.8, the P-x diagram for carbon dioxide 
+ DMSO binary system at 60 ºC is represented along with the experimental data obtained in 
presence of cefonicid.  
 
Fig.1.8 The P-x diagram and experimental data for the binary system for CO2 + DMSO system and the 
ternary system CO2 + DMSO + cefonicid [8]. 
 
In that study, a view cell was used to analyze the effect that the presence of cefonicid has 
on the binary CO2 + DMSO system. They found that at low concentration of cefonicid (30 
mg/mL) the experimental vapor-liquid equilibrium (VLE) data for the ternary CO2 + DMSO 
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+ cefonicid system is close to the VLE data for the binary CO2 + DMSO system. On the other 
hand, at a higher concentration of cefonicid (50 mg/mL) the experimental VLE data for the 
ternary CO2 + DMSO + cefonicid system differs from the binary system data at the CO2-poor 
region while at the CO2-rich region the VLE data for the ternary system become almost 
coincident with the binary data. Differences between the VLE of the binary and ternary 
systems decrease as the concentration of the solute diminishes and the CO2 mole fraction 
increases. Generally, the mixture critical point (MCP) of the ternary system is not coincident 
with that of the binary system [11]. The binary system MCP is coincident with that of the 
ternary system when the amount of the third component (cefonicid) is small. 
 
Diego et al. [12] have used a view cell to study the phase behavior of the CO2 + DMSO + 
dextran system at pressures up to 8-12 MPa and temperatures ranging from 283.69 to 363.66 
K. Phase transition measurements were performed keeping the concentration of CO2 constant 
at 20 wt. %. They found that at very low concentrations of dextran polymer (0.1 wt. %) no 
liquid–liquid phase splitting was observed. When the concentration of dextran is increased to 
0.85 wt. %, vapor-liquid, liquid-liquid and the vapor-liquid-liquid splitting were observed. 
Further increase in concentration of dextran to 8 wt. % made the liquid-liquid splitting occurs 
at a lower temperature. In the case of dextran that interacts with carbon dioxide the pseudo 
binary phase diagram, the ternary phase diagram at low concentration of the solute, differs to 
a great extent from the binary phase diagram [12]. On the contrary, for solutes such as 
cefonicid that interact weakly with carbon dioxide the ternary phase diagram for the low 
solute concentration is coincident with the binary one at least in the CO2-rich region [11].  
 
The knowledge of the phase diagram is a key factor to analyze the phase behavior of 
systems involved in SCFs applications. For instance, the solubility of a solid or a liquid in a 
supercritical fluid as a function of pressure at a given temperature is obtained from P-x 
diagrams such as that shown in Fig. 1.3. The phase diagrams such as that shown in Fig. 1.5 
will help us to find the critical temperature and pressure for a given binary mixture. From this 
information the state of the mixture (liquid, supercritical, vapor-liquid equilibrium) will be 
established. In the following chapters we will see that phase diagrams are necessary both to 
understand the fundamentals and to optimize the operating condition in SCF processes. 
Unfortunately, although data for many binary systems involving a supercritical fluid are 
available in the literature, data for ternary and higher-order systems are scarce. 
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1.2. Supercritical Fluid Technology 
The environmentally friendly nature of supercritical fluids such as supercritical carbon 
dioxide (SC-CO2) has led to the exploration of their use in a range of applications in various 
fields such as food industry, chemical processing, pharmaceutical industry, textile industry 
and cleaning of precious components [13-16]. 
 
• Supercritical Fluid Extraction  
Supercritical Fluid Extraction (SFE) is extremely used in industries such as petroleum, 
chemical and textile industries and to produce high quality extracts from natural raw 
materials in the food industry. In the pharmaceutical industry this is more challenging 
because the standards for recovery and reproducibility are more rigorous than for other 
applications [13]. SFE can be used as a sample preparation step for analytical purposes, or on 
a larger scale to either strip unwanted component from a product (e.g. decaffeination) [17] or 
to collect a desired product (e.g. essential oils) [18]. 
 
• Supercritical Fluid Chromatography  
Supercritical fluid chromatography (SFC) is an analytical technique used for the separation 
of complex chemical mixtures into individual components using a supercritical fluid as a 
carrier. In SFC the sample is carried through a separating column by a supercritical fluid 
(typically carbon dioxide) where the mixture is divided into unique bands based on the 
different interaction between the individual analytes and the stationary phase in the column. 
As these bands leave the column their identities and quantities are determined by a detector 
[19]. Preparative SFC can be used for separation of high pressure extracts or for cleaning of 
product mixtures from reactions. It is also possible to concentrate an extract by removing 
impurities or unwanted by-products. Preparative SFC is a technically feasible process for 
purifying a polypeptide from other peptides and from other constituents obtained from 
fermentation. For example, cyclosporine A can be separated from mycelial extracts by SFC 
and purified by subsequent crystallization [20]. 
 
• Supercritical Fluid Fractionation  
Fractional separation of the extracts is another well-known concept that can be useful to 
improve the SFE process selectivity. In several cases, it is not possible to avoid the co-
extraction of some compound families (with different solubilities, but also with different 
mass transfer resistances in the raw matter). In these cases, it is possible to perform an 
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extraction in successive steps at increasing pressures to obtain the fractional extraction of the 
soluble compounds contained in the organic matrix, selected by decreasing solubilities in the 
supercritical solvent. Fractional separation allows the fractionation of the SCF extracts, 
operating the plant with some separators in series at different pressures and temperatures. The 
scope of this operation is to induce the selective precipitation of different compound families 
as a function of their different saturation conditions in the supercritical fluid. Industrial 
supercritical fluid fractionation generally operates in continuous mode with carbon dioxide as 
solvent, possibly added with a co-solvent (ethanol most often) to increase its polarity. The 
equipment mainly consists in a fractionation column through which the supercritical solvent 
and the raw material flow counter-currently, and separations sections. In contrast to SFE, this 
process is easy to operate with full automation, leading to very limited manpower expenses 
and resulting in low operating costs [21]. 
 
• Chemical Reactions 
The use of supercritical fluids as a reaction media offers the chemical and pharmaceutical 
industries the opportunity to replace conventional hazardous organic solvents and 
simultaneously optimize and control more precisely the effect of the solvent on reactions. 
This is related to the unique properties of SCFs in comparison to those of liquids and gases. 
The reactants and the SCF frequently form a single supercritical fluid phase. SCFs share 
many of the advantages of gas phase reactions including miscibility with other gases, low 
viscosity, and high diffusivities providing enhanced mass and heat transfer and the potential 
for fast reactions. Several chemical reactions, such as oxygenation, hydrogenation and 
alkylation have been studied in supercritical fluids [22-23].  
 
• Polymer Processing 
In some applications it is difficult to produce polymers with narrow molecular weight 
distributions by traditional methods. The solubility parameter of supercritical fluids can be 
varied carefully and systematically by pressure and temperature to fractionate materials 
according to molecular weight, because the solubility varies according to the molecular 
weight or chain length. Therefore, selective extraction and fractionation are possible from a 
multi-component mixture [13]. Also polymeric foams and the polymer impregnation can be 
achieved with good control of both processes using SCFs. 
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• Particle Coating and Encapsulation 
Drug release profile is an important aspect in pharmaceutical applications. Most of the 
active pharmaceutical ingredients have a low solubility in aqueous media. Therefore, in the 
last years the attention of many researches was focused on biodegradable polymeric systems 
for drug delivery to enhance the therapeutic properties of drugs and patient compliance [24]. 
Conventional pharmaceuticals methods for the production of protein-loaded microparticles 
include emulsion or double-emulsion and solvent extraction, spray drying and freeze-drying. 
Often these techniques use organic solvent, which may cause the drug inactivation, lead to 
high residual contents of them in the final product and low drugs encapsulation efficiencies 
[25]. Supercritical fluids can be used to coat tablets and particles of active substance, which 
have the desired size, with a coating agent [26]. 
 
• Material Micronization  
Fine particles with defined grain size distribution are of interest for many fields of 
applications. For example, particle size is a  critical parameter that determines the rate of 
dissolution of a drug in biological fluids and thus has significant effect on bioavailability. 
Particle design is presently a major development of supercritical fluids applications, mainly in 
the pharmaceutical, nutraceutical, cosmetic and specialty chemistry industries [26, 27]. Next 
section discusses in more detail particle production using SCFs and in particular the 
supercritical antisolvent technique. 
 
1.3. Production of Microparticles using Supercritical Fluids  
The morphology, size and size distribution of particles are key properties that must meet 
requirements connected to the subsequent use of these materials. Micro and nanoparticles are 
increasingly important in the manufacture of advanced ceramic materials, dyes, explosives, 
catalysts, coating materials, microsensors, polymers, food ingredients and pharmaceuticals. 
Several conventional micronization techniques are currently used: milling, crystallization, 
spray drying, spray freezing and recrystallization using solvent evaporation or liquid anti-
solvent. This latter technique is based on the use of two liquid solvents that are completely 
miscible. The solute to be micronized is soluble in the first solvent, but not soluble in the 
second. Consequently, the addition of the second solvent (antisolvent) induces the formation 
of a solution formed by the two liquids and the supersaturation and precipitation of the solute. 
However, liquid antisolvent and solvent evaporation recrystallizations require complex post-
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processing treatments for the complete elimination of solvent residues. The other techniques 
present their own specific disadvantages. For example, spray-drying usually requires high 
operation temperatures that may lead to thermal degradation of sensitive materials such as 
pharmaceuticals. Furthermore, all the conventional techniques share the disadvantage of poor 
control of size and size distribution; usually a wide range of particle sizes is obtained [28]. 
 
In the last years, many researchers have successfully tried to overcome the limitations of 
conventional techniques by exploring the unique properties of supercritical fluids. Processing 
with supercritical fluids in general and with carbon dioxide in particular has several 
advantages: non-toxicity and easy removal of the solvent, operation at moderate temperatures 
in an inert atmosphere thus avoiding the product degradation and the possibility of tuning the 
fluid properties with changes in temperature and pressure that enables us to control the 
particle size and/or morphology. Jung and Perrut [26] reviewed in 2001 the different 
techniques available for particle design using supercritical fluids. Two years before 
Reverchon [29] reviewed those based on the use of supercritical carbon dioxide as antisolvent 
agent. In 2003 Shariati and Peters [30] updated these reviews. Later on, other authors 
reviewed the developments concerning several types of materials: explosives (Pourmortazavi 
and Hajimirsadeghi, 2005) [31]; polymers (Yeo and Kiran, 2005 [32] and Reverchon et al., 
2009 [33]); inorganic materials (Aymonier et al., 2006 [34]); biomedical materials (Byrappa 
et al., 2008 [35] and Okamoto and Danjo, 2008 [36]); food ingredients (Weidner, 2009 [37]). 
The techniques can be classified into two groups; the non reactive techniques only involve 
physical transformations while other techniques use a supercritical fluid as medium (or both 
solvent and reactant) to carry out a reaction leading to particle formation. Both pure material 
microparticles and composite microparticles can be obtained using these techniques. 
Composite microparticles are very important in areas such as pharmaceuticals, 
agrochemicals, cosmetics or food ingredients and will be introduced in the next section. Next, 
the non reactive techniques most frequently used will be briefly described.  
 
1.3.1. Composite Microparticles 
Many formulations of pharmaceuticals, agrochemicals or cosmetics consist in an active 
substance encapsulated or embedded in a coating or carrier material that confers additional 
properties to them. Although composite microparticles have a variety of structures, they are 
usually classified into microspheres and microcapsules. Microspheres are particles with 
irregular geometry, composed of an active substance in form of aggregates or molecularly 
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dispersed solids embedded into a matrix. Microcapsules have spherical geometry; they are 
composed of a core of active substance surrounded by a solid polymeric or proteic shell. 
According to their size, microparticles may be classified into nano-spheres/capsules if they 
are smaller than 1 µm, macro-spheres/capsules if they are larger than 1000 µm and micro-
spheres/capsules if they present an intermediate size. 
 
A wide range of materials including pharmaceuticals, flavors, enzymes, and agrochemicals 
has been embedded/encapsulated. The carrier/shell materials are usually natural or synthetic 
polymers but fats, sugar and waxes may be also used.  
 
Composite microparticles present several advantages, in the first place, they are easier to 
handle and dose than the pure particles of an active substance. The material chosen as 
shell/carrier depends on the intended use of the composite microparticles and improves its 
properties. A biodegradable carrier is used to achieve a controlled delivery of the active 
ingredient into the targeted media (the organism of a patient, the soil in agriculture, etc.). If 
the active substance is susceptible of degradation, the carrier acts a protection against 
aggressive agents. If the active substance is poorly soluble in the targeted media, the carrier 
facilitates solubilization. This is the case of a number of poorly water soluble drugs. For 
drugs with low solubility in the crystalline state, the possibility of improving their solubility, 
dissolution rate and bioavailability due to the formation of an amorphous form in the 
composite material presents additional advantages. 
 
As was already mentioned, several conventional techniques to obtain composite materials 
are available. Cocero et al. [38] have recently reviewed these methods and those resulting 
from the application of supercritical technologies. The latter have been the subject of 
numerous investigations during the last years; essentially they are modifications of techniques 
used to obtain pure particles. The advantages already mentioned for pure material processing 
using supercritical fluids are also applicable in the case of composites. Furthermore, the 
supercritical fluid may be used to modify the properties of the carrier (plasticizing, swelling, 
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or reducing the melting temperature, in the case of a polymer) or the interactions between the 
carrier and the active substance. These interactions are not fully understood and composite 
production is still a matter of empirical knowledge.  
 
1.3.2. Rapid Expansion of Supercritical Solutions (RESS)  
Val Kukronis [39] was the first scientist who ever tried to apply supercritical fluids for 
recrystallizing solid materials with the intention of producing fine particles with narrow size 
distributions. The technique proposed by him was named Rapid Expansion of Supercritical 
Solutions (RESS) and is based on the supercritical fluid acting as the solvent. The solid 
material to be micronized is first solubilized in the fluid using an extractor (Fig. 1.9). This is 
followed by a rapid depressurization of the solution through a nozzle into an expansion vessel 
where the nucleation of the product leads to a highly dispersed material. Fine particles with a 
narrow size distribution can be produced at relatively low temperatures using RESS.  
 
 
Fig.1.9 Schematic illustration of the Rapid Expansion of Supercritical Solutions (RESS) technique. 
 
Turk [40] has recently reviewed this technique. RESS has the advantage of the absence of 
organic solvents but its application is restricted to solids that present a good solubility in pure 
carbon dioxide which is the fluid most frequently used. The low solubility of big and polar 
molecules such as pharmaceuticals in CO2 limits RESS application. Otherwise, RESS would 
be the first choice for particle design. Co-precipitation is also possible but both the carrier and 
the active substance have to be soluble in CO2. Since RESS is a very fast process, it is also 
difficult to control the morphology and loading of the composites. An alternative is the 
precipitation of the carrier over previously formed microparticles of the active substance.  
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1.3.3. Particles from Gas-Saturated Solutions (or Suspensions) (PGSS) and Related 
Processes 
Another supercritical fluid process for particle design is the Particles from Gas-saturated 
Solutions (or Suspensions) (PGSS). In this process the supercritical fluid is dissolved into a 
liquid substrate, or a solution of the substrate(s) in a solvent, or a suspension of the 
substrate(s) in a solvent (Fig. 1.10). Next, the liquid mixture is rapidly depressurized through 
a nozzle causing the formation of solid particles or liquid droplets depending on the mixture 
and the conditions. This process is based on the high solubilities of compressed gases in 
liquids and solids such as polymers in comparison with the low solubilities of such liquids 
and solids in the compressed phase and allows the formation of particles from a variety of 
substances that do not need to be soluble in the supercritical fluid. PGSS can also be used 
with suspensions of active substrate(s) in a polymer or other carrier substance leading to 
composite microspheres.  
 
Fig.1.10 Schematic illustration of the Particles from Gas Saturated Solutions (PGSS) technique. 
Also, PGSS has been used to apply paintings or other type of coatings such as adhesives. 
The main drawback of this process is the difficulty to produce submicronic particle and to 
control particle size distributions. Co-precipitation is possible; the plasticizing and swelling 
effect caused by CO2 dissolution in polymers can enhance the incorporation of the active 
substance. However, if the carrier material has to be used in molten form, high temperatures 
may be required to melt substances like the semicrystalline polymers that are used for some 
applications. 
 
Related to the PGSS process is the Depressurization of an Expanded Liquid Organic 
Solution (DELOS) process proposed by Ventosa et al. [41]. In this process, a compressed gas 
in an autoclave expands the liquid solution consisting of the solute to be micronized and a 
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conventional solvent. At this point, the compressed gas acts as a cosolvent, not as an 
antisolvent. The expanded solution of the ternary mixture of solute-solvent-compressed gas is 
depressurized by rapid reduction of the system pressure to atmospheric pressure in an 
expansion chamber. As a consequence, the solution evaporates and its temperature sharply 
decreases, supersaturation takes place over all the solution and the solute precipitates as fine 
particles with a narrow size distribution. 
 
1.3.4. Supercritical Antisolvent (SAS) Precipitation  
Krukonis et al. [42] were the first to propose the use of supercritical carbon dioxide as an 
antisolvent to induce controlled precipitation of various solutes from organic solvent 
solutions. This approach is based on the relatively low solvent power of CO2 for solutes such 
as polymers or pharmaceutical products and its good miscibility with many organic solvents. 
This is the so-called supercritical antisolvent (SAS) precipitation. Different process 
arrangements, apparatuses and acronyms have been used: GAS (gas antisolvent), PCA 
(precipitation by compressed antisolvent), ASES (aerosol solvent extraction), SEDS (solution 
enhanced dispersion by supercritical fluid) and SAS (supercritical antisolvent). The acronym 
GAS is usually employed for the batch process while SAS provides a good description of the 
continuous processes. Batch or continuous operation antisolvent techniques are based on the 
same concept illustrated in Fig. 1.11.  
 
 
Fig.1.11 Schematic illustration of a supercritical antisolvent micronization. 
 
The compound to precipitate is dissolved in an organic solvent and the solution is mixed in 
the precipitation chamber with CO2. When the supercritical CO2 dissolves in the organic 
solvent, the liquid experiences a volumetric expansion and becomes a bad solvent for the 
solute that precipitates from the solution in micro and nanoparticles. The particle size may be 
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tuned by varying the process parameters such as pressure, temperature, solute concentration, 
etc. CO2 accessible critical parameters allow operation at moderate temperatures. 
Furthermore, these are solvent-free particles exhibiting a narrow size distribution. From the 
point of view of Sustainable Chemistry, the only disadvantage of SAS is the use of organic 
solvents but the pressure of operation is much lower than in the RESS technique. In some 
cases agglomeration retardants or crystal habit modifiers have been used in SAS. As in the 
RESS process, it is possible to produce composites by simultaneously co-precipitating the 
active substance and the carrier or by encapsulation of previously formed particles. In the 
latter case, particles are suspended in a solution of the carrier in the organic solvent and the 
carrier is precipitated by SAS. In the case of co-precipitation of a drug and a polymer 
excipient, drug-polymer ratios can be easily modified by varying their relative amounts in the 
organic solvent solution. 
 
1.3.5. Reactions in Supercritical Media Leading to Particle Formation 
Reactions in supercritical media leading to particle formation have also received 
considerable attention as a mean to synthesize ceramics or oxide materials powders. Contrary 
to the RESS, SAS, and PGSS processes, the supercritical fluid is used to carry out a chemical 
reaction. For instance, precursors are dissolved in the fluid and thermally decomposed. Upon 
depressurization in CO2, the solvent turns to the gas phase and separates from the particles 
that are obtained in a highly divided state. Also, a sol-gel reaction may be carried out at high 
pressure and high temperature. In the hydrothermal synthesis, a supercritical fluid is used 
both as solvent and reactant. For oxide powders formation, precursors (inorganic salts) are 
first dissolved in water and the solution is introduced into a reactor operated at supercritical 
conditions. The crystal growth, morphology, particle size and distribution can be controlled 
by modifying the thermodynamic and transport properties through changes in pressure and 
temperature. This technique avoids the crushing and calcination steps used in conventional 
processes but filtration, washing and drying are still necessary. Unfortunately, corrosion 
problems associated to the use of supercritical water have to be addressed. 
 
1.4. Fundamentals of Supercritical Antisolvent (SAS) Precipitation  
The general applicability of SAS has contributed to its increasing use. In the last years, a 
variety of compounds including explosives, polymers, pharmaceutical compounds, colorants, 
catalysts and inorganic compounds has been successfully micronized. As to the particle 
morphology, different amorphous particle morphologies have been obtained: nanoparticles 
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with mean diameters in the 30-200 nm range, microparticles in the 0,25-20 µm range and 
expanded (hollow) microparticles with diameters between 10 and 200 µm. Crystals with 
various habits and dimensions have been also obtained. Based on these characteristics, SAS 
has been chosen as the technique to be used in this study. 
 
SAS precipitation consists of several steps: 
• Supercritical carbon dioxide is introduced in the precipitation chamber using a high-
pressure pump at constant flow rate. Then the solvent or directly the solution is fed 
also at a constant flow rate reaching steady state operating conditions and an adequate 
supercritical fluid/solvent ratio. The chamber is heated and both temperature and 
pressure are controlled. 
• The fluid dissolves in the solution formed by the solid and a polar organic solvent 
such as dimethylsulfoxide (DMSO) or N-methyl-2-pyrrolidone (NMP). The liquid 
expands, the mixture becomes supersaturated and precipitation starts. The solute is 
collected at the precipitation chamber. 
• At the end of the precipitation process, the chamber is washed with the antisolvent to 
eliminate the liquid solvent. The mixture CO2 + organic solvent passes to a separation 
chamber where the solvent is recovered. 
The volumetric expansion of the liquid solvent is the result of the massive dissolution of 
the supercritical antisolvent into the liquid phase. The percentage volume expansion ΔV % is 
defined as 
ΔV % =                                       (1.1) 
where V (P, T) is the volume of the liquid phase loaded with the antisolvent and V0 is the 
volume of the pure liquid phase at atmospheric conditions. 
 
Many authors have studied the volumetric expansion isotherms for various CO2 + solvent 
systems [29, 43]. However, the effect of the solute on the volume expansion at different 
solution concentrations should be also taken into account. This type of studies is rare. 
Reverchon et al. [44] have studied this effect in the case of the CO2 + DMSO + dextran 
ternary system at 30 °C. Fig. 1.12 shows the expansion curves obtained for the CO2 + DMSO 
and CO2 + DMSO + dextran.  
Chapter 1 - Introduction 
 
 
 
22 
 
 
 
 
 
 
 
 
 
 
Fig.1.12 Expansion curves for the system CO2 + DMSO + dextran at 30°C and at increasing dextran 
contents,  , 0%, □, 0.05%, ○, 0.5% and ,  5% [44]. 
 
Dextran percentages vary from 0.05 to 5 %. The presence of dextran does not modify the 
expansion behavior. Values of ΔV % for the ternary mixtures follow the same isotherm of the 
binary CO2 + solvent system. Although these data correspond to a temperature lower than 
those usually employed in SAS, they point out that for the low solute concentration used in 
this technique volume expansion may be described using the binary data.  
 
The feasibility of SAS and the particle morphology, size and size distribution depend on a 
large number of process parameters: temperature, pressure, solute concentration, choice of 
the solvent, injection mode of the antisolvent, etc. These parameters simultaneously influence 
high-pressure phase equilibria, hydrodynamics, mass transfer and particle formation and 
growth. All these influences must be taken into account and their interrelation has to be 
elucidated for a better understanding of SAS. Experimental studies usually explore different 
combinations of the process parameters and the optimum values are selected after 
considerable work. Sometimes, a design of experiment strategy is followed to minimize the 
number of micronization experiments. Nevertheless, it is difficult to extract general 
conclusions from this type of studies or to obtain information about the scale-up necessary for 
commercial applications. This has prompted many authors to carry out experimental and 
theoretical studies aimed to a more detailed understanding of the fundamentals and 
mechanisms of SAS. Interactions between high-pressure vapor-liquid equilibria, surface 
tension variations, jet fluid dynamics, mass transfer, nucleation and growth have to be taken 
into account to establish the mechanisms of particle precipitation. A detailed review of all 
these contributions is beyond the scope of this introduction. 
Chapter 1 - Introduction 
 
 
 
23 
Prof. E. Reverchon and Prof. M. J. Cocero, and their groups at the University of Salerno 
(Italy) and Universidad de Valladolid (Spain), respectively, have contributed to a large extent 
both to SAS experimental studies and to the analysis of the precipitation mechanisms. Martín 
and Cocero [45] reviewed in 2008 the contributions to SAS fundamentals and mechanisms. 
Attention was paid to the fluid mechanics, the transport and thermodynamic properties, mass 
transfer and particle formation and growth. As shown by Reverchon, Brauer and coworkers 
using light and laser scattering techniques [46, 47], SAS mechanisms result from an interplay 
of these phenomena. In two recently published papers, De Marco and Reverchon [48, 49] 
summarized these contributions and the most important conclusions. 
 
Some authors attempted an explanation of SAS mechanisms, starting from the analysis of 
the fluid dynamic behavior of the solution injected into the pressurized antisolvent. Lengsfeld 
et al. [50] indicated that gas-like jet mixing is the characteristic mechanism when completely 
miscible conditions for the system solvent–antisolvent are set in the precipitator, and is due to 
the disappearance of the dynamic surface tension, related to the formation of a supercritical 
solution. Successively, Dukhin et al. [51], Sarkari et al. [52], Badens et al. [53], Gokhale et al. 
[54] and Obrzut et al. [55] studied the jet atomization in pressurized gases. Two process 
characteristic times were observed: a relaxation time τ and a jet break-up time t. If t < τ, a real 
interface exists between the liquid and the fluid phase, and jet break-up prevails transforming 
the liquid jet in droplets. If τ < t, near the nozzle orifice a short jet is present, then, gas-like jet 
mixing is obtained in the absence of any interface. Dukhin et al. [51] also discussed the 
existence of a different dynamic interfacial tension (DIT) mechanism driven by enthalpy 
gradients. A new nonisothermic DIT mode was introduced and shown to contribute to the jet 
stability in the case of exothermic mixing. Debenedetti and Werling [56, 57] introduced 
mathematical models of the mass transfer. Baldyga et al. [58] and Martín and Cocero [59] 
proposed models for the precipitation process above and below the critical point for the CO2 
+ solvent mixture, MCP. 
 
In agreement with this description of the different fluid mechanic mechanisms, Reverchon 
et al. [60] found that when operating at pressures above the mixture critical point, the 
parameters which affect the mixing between the two streams, as the design of the nozzle and 
the precipitator, or the Reynolds number in the nozzle, have a negligible effect on the 
precipitation. This indicates that, in these conditions, the mixing between solution and CO2 
occurs faster than the precipitation, and thus the mixing parameters cannot influence the 
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precipitation. However, at pressures below the mixture critical point, there was a significant 
effect of these parameters. Moreover, a change in particle morphology was frequently 
observed when pressure was reduced below this point, and sometimes, the particles were 
agglomerated forming empty spheres, which could indicate that the atomization and 
precipitation occurs through the formation of droplets. A correlation between SAS particles 
dimension and the position of the SAS operating point in the vapor–liquid equilibrium (VLE) 
diagram has been established. At pressures far above the MCP nanoparticles can be 
precipitated [11, 61, 62]; near above the MCP, microparticles can be obtained [63]. In some 
cases nanoparticles and microparticles can coexist. The uniformity of the resulting products 
becomes worse when the precipitation conditions approach the critical locus. Irregular micro-
scale aggregated particles are formed in the vapor region and both dense cake and spherical 
clusters are produced in the vapor-liquid region. This is illustrated by the relationship 
between particle morphology and the phase equilibria for the CO2 + DMSO in the 
micronization of α-chymotrypsin studied by Chang et al. [61]. Their findings are summarized 
in Fig. 1.13. 
 
 
 
 
Fig. 1.13 Scanning electron microscopy images of micronized α-chymotrypsin prepared from different CO2 + 
DMSO phase regions [61]. 
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An interpretation of the results obtained operating at different pressures has been proposed 
[46, 48, 63] showing that the switch between nanoparticles and microparticles production is 
related to the competition between the jet break-up of the liquid injected in the precipitator 
and gas mixing. When jet break-up prevails, liquid droplets are formed that can produce 
micrometric particles by liquid solvent extraction; when gas mixing develops in the 
precipitator without jet break-up, nanoparticles are produced by precipitation from the fluid 
phase. The competition between these two processes can be explained taking into account 
their characteristic times: when the time for jet break-up is shorter than the time occurring for 
the vanishing of the dynamic surface tension, droplets are formed; in the opposite case, gas 
mixing prevails [46, 63, 64]. Nanoparticles differ from microparticles not only for their 
diameter but also for the fact that are irregularly spherical as a consequence of the gas-to-
solid precipitation in absence of surface tension. De Marco and Reverchon [48] also showed 
that these precipitation mechanisms can be modulated either by varying the pressure, 
temperature or solute concentration, thus selecting the range of particle sizes required for a 
given application. 
 
Mechanisms differ when the compound precipitates as crystals [49]. In this case two 
possible mechanisms are involved. Crystals with a spherical predominant shape are formed 
when the droplets drying is followed by a fast crystallization kinetics. When precipitation 
takes place in an expanded liquid phase, crystals of various habits and dimensions are 
obtained depending on the interactions with the liquid solvent used.  
 
Since the phase behavior is one of the crucial factors governing the morphology and the 
mean size of particles obtained in the SAS process, the high-pressure phase equilibria of 
binary mixtures formed by CO2 and the organic solvents usually employed in SAS have 
received considerable attention in the last years. The presence of solutes such polymers can 
induce modifications in the phase diagram. Unfortunately, data for the ternary systems 
including the solute are scarce. However, when the solute has little interaction with carbon 
dioxide the ternary phase diagram for the low solute concentrations usually employed in SAS 
is coincident with the binary one in the CO2-rich region which is the region for mixtures 
involved in SAS. As previously mentioned in section 1.1.2., this is the case for the CO2 + 
DMSO + cefonicid systems. Therefore, in many cases the mixtures formed in the 
precipitation chamber may be treated as binary CO2 + organic solvent systems. Volumetric 
properties, densities and critical parameters for this type of binary systems have been the 
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subject of numerous studies. However, with the exception of Dukhin et al. [51], no attention 
has been paid to the heat evolved when supercritical CO2 dissolves into the organic solvent. 
The heat of mixing (excess enthalpy) at these conditions can be quite high. Thus, thermal 
effects during this process may have an effect on the phase separation path and must be 
considered in order to fully understand SAS micronization. The contribution to this 
magnitude due to solute interactions may be neglected: thermal effects can be analyzed by 
measuring the excess enthalpies for the CO2 + organic solvent mixtures formed in SAS 
precipitation chamber. 
 
By measuring the heat of mixing supercritical CO2 and N-methyl-2-pyrrolidone at the 
conditions of temperature and pressure used in SAS experiments, our group has shown in a 
previous study [65] that thermal effects have an important role on SAS and seem to be related 
to marked coalescence phenomena reported for antibiotic particles obtained using NMP. The 
conditions of temperature and pressure leading to this undesirable coalescence are coincident 
with those for extremely exothermic heats of mixing. A systematic study of excess enthalpies 
for these CO2 + organic solvent mixtures and parallel CO2 micronizations should be carried 
out in order to elucidate the effect of temperature, pressure and the interactions between 
phase equilibria and the heat evolved when the supercritical fluid and the solution are mixed. 
The heat of mixing supercritical CO2 and methanol and ethanol has been previously studied 
[66-68]. However, this magnitude is not known for other solvents widely used in SAS such as 
DMSO and acetone.  
 
1.5. Application of Supercritical Antisolvent Precipitation in the Field of 
Pharmaceuticals 
In addition to the interest in SAS fundamentals, the application of SAS in the field of 
pharmaceuticals is a very active field of research [33, 35, 36]. In the case of pure substances, 
SAS allows a good control of size and morphology. Crystals, nanoparticles and 
microparticles for improved drug delivery of many pharmaceuticals have been produced. All 
the studies mentioned in the previous section can be applied in this case. 
 
The formation of composite microparticles is less understood [33, 38]. In the precipitation 
over a suspension of particles, the particles behave as nuclei for the precipitation of the 
polymer and a polymer matrix of encapsulated particles is produced by agglomeration. This 
procedure is especially suitable for organic insoluble materials such as proteins. Co-
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precipitation is preferred for organic soluble drugs. Nanoparticles precipitation does not give 
co-precipitation due to the gas-to-particle mechanism that governs this process. Polymer-drug 
composite microparticles seem to be formed by the solvent elimination from liquid droplets. 
The process is more complicate than that for pure drugs. New parameters such as the polymer 
mass or the polymer to drug ratio have to be considered.  
 
In contrast to pure material micronization, co-precipitation is still a matter of empirical 
knowledge. As Reverchon et al. pointed out [33], although a polymer such as poly(L-lactide) 
(PLLA) has been used in many studies, no systematic investigation on how composite 
properties are influenced by the SAS process parameters has been undertaken. Polymer-drug 
interactions need to be studied in order to obtain information about what one can expect for 
the same polymer in combination with a different drug.  
 
The selection of the carrier or coating material is crucial. Several requisites must be 
fulfilled: biocompatibility, lack of toxicity, preservation of the properties and activity of the 
drug, and affinity between both substances. Thanks to this affinity, the drug is included in the 
carrier in the amorphous state. The coating or carrier material should be also easy to process 
with the SAS technique. The incorporation of the drug in its amorphous state leads to 
composite particles much smaller than the size of pure material precipitated under the same 
conditions. This is an additional advantage to be added to the improved solubility, dissolution 
rate and bioavailability of the amorphous pharmaceutical.  
 
Several polymers have been used in SAS co-precipitation: PLLA, polyethylene glycol 
(PEG), polyvinylpyrrolidone (PVP), lactide glycolide copolymer (PLGA), poly-DL-lactide 
acid (PLA), eudragit. In this study, PVP has been chosen because this polymeric lactam is 
one of the major additives in pharmaceutical preparations. Its inclusion in dry form 
pharmaceuticals improves the dissolution rates and bioavailability of drugs with low 
solubility. 
 
Poly[1-(2-oxo-1-pyrrolidinyl)ethylene], IUPAC name of PVP. 
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Enhancement of dissolution rates is caused by the inhibition of crystallization of drugs. 
This is mostly due to the plasticizing effect of PVP and its surface adsorption and efficient 
steric hindrance for nucleation and crystal growth [69-70]. Furthermore, PVP is a synthetic 
water-soluble linear polymer that is also able to dissolve in a variety of organic solvent. The 
properties of PVP and the analytical techniques used to characterize drug-PVP systems in 
solid and liquid states have been reviewed by Chadha et al. [71]. Depending on the conditions 
of polymerization, PVP can be prepared in a variety of molecular weights expressed by the so 
called K-values. 
 
K-value =  
                               (1.2) 
where Z is the viscosity of PVP at concentration C relative to water. 
 
From the following equations the number average ( ), the weight average ( ) and the 
viscosity average molecular weight ( ) may be determined: 
 
 = 24* K2,  = 15* K2.3,  = 22.22 (K + 0.0075 K2)1.65               (1.3) 
  
The glass transition temperature (Tg) of linear PVP increases with increasing molecular 
weight and is calculated according to the following equation: 
 
Tg [○C] = 175 - (9685/K2)                         (1.4) 
 
Recently, PVP has been used in combination with SAS micronization as a carrier or 
excipient for several pharmaceuticals. Lim et al. [72] obtained amorphous indomethacin 
composite microparticles by co-precipitation with PVP K-90. Indomethacin is a crystalline 
non-steroidal anti-inflammatory drug. Uzun et al. [73] also obtained composite microparticles 
formed by the antibiotic cefuroxime axetil and PVP K -30. Badens and coworkers [74, 75] 
prepared solid dispersions of oxeglitazar in PVP K-17. Oxeglitar is a new drug used in the 
treatment of type II diabetes. Composite microparticles formed by piroxicam and PVP K-25 
were obtained by Wu et al. [76] by PCA. Processes related to SAS have been also used. 
Hydrocortisone-PVP composite microparticles were successfully prepared by Corrigan and 
Crean [77] using GAS. Good morphologies and improved dissolution rates were obtained in 
most cases. 
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PVP interacts with the drug molecule by electrostatic bonds (ion to ion, ion to dipole, 
dipole to dipole), van der Waals forces and H-bonds. A number of physicochemical 
techniques provide information about the interactions drug-PVP: X-ray diffraction (XRD), 
differential scanning calorimetry (DSC) and infrared spectroscopy (IR) are the most used 
ones. XRD also provides information about changes in the crystallinity and polymorphic 
form of the drug as a consequence of SAS micronization. DSC may be used to establish the 
glass transition temperatures. IR is used to detect hydrogen bonding between the drug and 
PVP through the nitrogen or the carbonyl group in the pyrole ring. Scanning electron 
microscopy provides information about the morphology of the pure drug, PVP and the 
composites. The solubility and dissolution rate of the drug-PVP combination or composite is 
another key aspect. Dissolution tests are carried out in simulated intestinal fluid (pH = 7.4) 
and results are compared to those obtained for the pure drug. 
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Objectives 
 
This thesis deals with the micronization of compounds using supercritical fluids. Among 
the different techniques the SAS method was chosen because of the unique properties of 
materials micronized using supercritical carbon dioxide as an antisolvent. 
 
The reasons for this study are twofold: the need for further study of SAS processes in 
order to correctly design and scale-up them and the need for further development of 
pharmaceuticals micronizations. 
 
Our preliminary study about the role of thermal effects in the SAS precipitation of 
antibiotics using NMP as solvent has been extended obtaining heat of mixing (excess 
enthalpy) data for CO2 + organic solvent systems typically used in these micronizations. The 
interaction between the excess enthalpies and phase equilibria in the SAS precipitation 
chamber has been elucidated. Pharmaceuticals micronizations using these solvents and CO2 
as antisolvent have been carried out and the role of SAS parameters has been analyzed paying 
special attention to the temperature and pressure conditions, phase equilibria and the heat 
evolved when the supercritical fluid and the solution are mixed. Two pharmaceuticals have 
been micronized as pure substances forming micro and nanoparticles and as composite 
microparticles.  
 
The specific objectives of this study were: 
 
1. Measurement of Excess Enthalpy Data for Supercritical CO2 + Organic Solvent 
Systems 
Excess enthalpies were measured using a high-pressure isothermal flow calorimeter 
available at our laboratory under the conditions of temperature and pressure usually 
employed in SAS micronizations. Since these data are already available for the solvents N-
methyl-2-pyrrolidone, ethanol and methanol, the solvents dimethylsulfoxide (DMSO), 
acetone, N,N-dimethylformamide (DMF) and ethyl acetate (EA) were studied. The excess 
enthalpy data obtained were correlated using cubic equations of state. 
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2. Study of High-Pressure Phase Behavior and Critical Data for Supercritical CO2 + 
Organic Solvent Systems. Interaction between Phase Equilibria and Excess Enthalpies 
during SAS Experiments 
The isothermal vapor-liquid equilibrium (VLE) and critical data for the CO2 + organic 
solvent mixtures involved in this study are available in the literature. Nevertheless, critical 
data are scarce. For each system a literature review was carried out. If necessary, critical 
locus and VLE data were predicted or calculated using cubic equations of state. Data gathered 
in objectives 1 and 2 were used to discuss the thermodynamic behavior of the mixtures 
formed in SAS precipitation chamber and the influence of thermal effects on phase equilibria 
and the particles morphology.  
 
3. Assembly of a SAS Apparatus 
A SAS apparatus was built at our laboratory. Validation was carried out by micronizing 
yttrium acetate using DMSO as a solvent. This is a micronization well described in the 
literature. 
 
4. Micronization of Pharmaceuticals 
Precipitation experiments were performed in order to determine the optimum condition 
for these processes taking into account the requirements on particle size and morphology of 
the precipitates. A design of experiment strategy was followed in order to minimize the 
number of experiments. The relation between temperature and pressure conditions, phase 
equilibria and excess enthalpy was discussed. The optimal conditions of precipitation were 
established. Drugs to be micronized were selected after a literature survey. 5-fluorouracil, a 
drug widely used in the treatment of different types of cancer is one of the candidates. The 
second candidate is diflunisal, a salicylic acid derivative with analgesic and anti-
inflammatory activity. Both drugs have a low solubility in supercritical CO2. 5-fluorouracil 
has been previously micronized using methanol or mixtures formed by methanol and a 
second solvent. Diflunisal has not been micronized using any supercritical technique. SAS 
processed particles were studied using scanning electron microscope (SEM) and particle size 
and particle size distribution were established. X-ray diffraction (XRD) was used as a tool to 
detect changes in the crystallinity and polymorphic form of the drug as a consequence of SAS 
micronization. 
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5. Co-precipitation of pharmaceuticals and PVP 
Diflunisal was co-precipitated using PVP K-15 and K-30 as a carrier or coating material. 
The solvent or solvent combination was chosen taking into account the pure pharmaceutical 
experiments and PVP solubility. The optimal conditions of precipitation were established. 
Different drug to polymer ratios have been used. Microparticles were studied using SEM, 
XRD, infrared spectroscopy (IR), differential scanning calorimetry (DSC), and thermal 
gravimetric analysis (TGA). The solubility and dissolution rate of the drug-PVP composite 
were measured. Polymer-drug interactions were studied. A systematic comparison with 
previous drug-PVP composites obtained by SAS was carried out. 
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Methodology 
 
The experimental and theoretical methods used in this study are described in this chapter. 
In the first place, the excess molar enthalpy, and the isothermal high-pressure flow 
calorimeter used to perform the  measurements are introduced. Next, the equations of 
state and procedures used to analyze the  data, and the related phase equilibrium and 
critical data are given. Finally, the SAS apparatus and the method used to design the 
precipitation experiments and to characterize the particles are described.  
 
3.1. Residual and Excess Molar Enthalpies 
Energy is interchanged in any chemical or physical process. This interchange involves 
different types of energy such as electrical energy in galvanic cells, work in engines and heat 
in reactions and mixing processes. Enthalpy is a thermodynamic property very often used to 
evaluate the heat involved in a process because the enthalpy variation equals the heat evolved 
or absorbed at constant pressure: 
 
 =                        (3.1) 
 
In particular, for a mixing process at constant pressure the heat absorbed or released upon 
mixing corresponds to the excess enthalpy, . An excess property is defined as the 
difference between the value of a magnitude for the mixture and that for an ideal mixture at 
the same conditions of temperature, pressure and composition. For 1 mole of mixture the 
excess molar enthalpy is given by: 
 
 =  (real mixture)  (ideal mixture)               (3.2) 
 
This magnitude is coincident with the molar enthalpy of mixing  which is given by 
 
  =  (real mixture)                 (3.3) 
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where is the mole fraction for each component and is the molar enthalpy for each pure 
component at a given P and T.  may be evaluated in terms of the residual molar enthalpy, 
, which is defined as  
 
 =  (real system)  (ideal gas)               (3.4) 
 
Residual molar enthalpies will be used to calculate  by means of equations of state. The 
experimental device used for measurements is the isothermal flow calorimeter described 
next. 
 
3.1.1. Isothermal Flow Calorimeter 
An isothermal high-pressure flow calorimeter (Hart Scientific model 7501) [1] was used 
to perform the excess molar enthalpies measurements. With this device we can measure 
excess enthalpies, heats of solution and enthalpies of reaction. The isothermal flow 
calorimeter operates at pressures between 2 and 30 MPa and temperatures between 273 and 
473 K. This device allows to measure the energy required to keep constant the temperature of 
the system located in the cell during the mixing, reaction or dilution process. 
 
The reactants are pumped into the calorimetric cell by two thermostated pumps (ISCO, 
model LC-2600) at constant flow rates. Volume flow rates are selected to cover the entire 
concentration range. Temperature of the pumps is controlled within ± 0.02 K. The 
calorimetric cell is located into a silicon bath in which temperature is controlled within ± 
0.001 K. A Peltier cooling device and a pulsed heater keep the cell under isothermal 
conditions. The pulse energy is determined by a heater calibration. The pressure is measured 
using a calibrated pressure transducer (Lucas Schaevitz, model P721-0001). A back-pressure 
regulator located outside the calorimeter keeps the pressure within ± 0.01 MPa. 
 
A schematic diagram of the isothermal flow calorimeter, details of the flow cell and the 
control units are shown in Fig. 3.1.  
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Two commercial three-way Swagelok valves have been installed to select the filling or 
the output of the reactants to the calorimetric cell. The valves are attached to each of the 
pumps and to the calorimeter by 1/8" and 1/16" stainless steel tubes, respectively. 
 
3.1.3. Calorimetric Flow Cell 
The calorimetric flow cell (see Figs. 3.1 and 3.3) is the core of the calorimeter, and it is 
responsible for perceiving heat changes that occur as a result of the mixing of the reactants. 
The calorimetric cell is immersed in a silicone bath whose temperature is kept constant (± 
0.001 K) with a temperature controller (Hart Scientific model 2100). The controller operates 
correctly between 273 and 473 K. The cell is coupled to the junction box that houses the 
electronic connections and insulates the top of the silicon bath. 
 
For a proper control of the temperature, the silicone bath is refrigerated using another 
water bath outside that has a thermostatic head (SELECTA, TECTRON BIO MEDIC 60) and 
is kept between 5 and 10 degrees below the temperature fixed in the calorimeter. 
 
The calorimetric cell is cylindrical, 5/8" in diameter and 3½" long. The cell assembly 
comprises eleven main parts that are shown in detail in Fig. 3.3. 
 
The reactants enter the cell through two 1/16" tubes and are mixed in a T-shaped piece. 
The fluids exit through a tube of the same size that is wound around a copper cylinder that 
serves as conductor of heat, plus support of the output tube. Welded to this block are 
calibrating and heating resistors. The heating resistance is 100 ± 10 Ω and is used together 
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Fig. 3.3  Details of the calorimetric flow cell. 
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with the refrigeration unit to regulate the heat absorbed or released by the mixture by means 
of heat pulses. 
 
The cooling unit is a Peltier device, a thermoelectric heat pump that operates by pumping 
heat from a cold to a hot reservoir. It is used to extract heat from the calorimetric cell to the 
silicon bath. It consists of two parallel thin ceramic plates bonded together by two columns of 
a semiconductor material. The refrigeration unit is located at the top of the copper block. 
When heat is released or absorbed upon a reaction or mixing process, the number of pulses is 
decreased or increased, respectively, to compensate this heat difference. The magnitude of the 
pulse is established in a previous heater calibration. 
 
Control sensors and a temperature sensor are used to monitor and measure the 
temperature. Control sensors are two 10 and 100 kW thermistors that are used in temperature 
ranges between 273 and 373 K and between 373 and 473 K, respectively. The choice of the 
thermistor is important for the proper functioning of the equipment, and is selected with a 
knob on the junction box. The thermistors are located between the cooling device and the 
heating element. The temperature sensor measures the magnitude at that point, an area very 
close to the outlet pipe of the mixture. The temperature measured by the sensor is recorded on 
the front panel of the 1701 unit. 
 
3.1.4. Control Units and Data Collection 
• Digital Control 1701 Unit 
This device controls the circuits of the calibration resistor and monitors the temperature of 
the calorimetric cell. It comprises four subsystems: a preamplifier, a temperature monitor, the 
circuits of calibration resistors and a digital multimeter. Calibration resistor circuits control 
the heating power. Calibration resistance at a given temperature is constant, but varying the 
amount of current passing through it, with a selector provided on the front panel, the power 
dissipated can be regulated. Since the calibration resistance located in the calorimetric cell 
varies with temperature, its exact value is determined with a standard resistor of 1000 Ω 
connected in series with the calibration resistor. Knowing the potential difference that exists 
on both sides of the calibration resistor and the standard resistor value, the heating power by 
Joule effect may be established. 
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3.1.6. Experimental Procedure 
• Establishment of Working Conditions 
The pressure is fixed by introducing nitrogen into the upper section of the pressure 
regulator. A fine adjustment is achieved using the manual piston connected in line with the 
regulator. Since the regulator is located at the end of the calorimeter circuit, the pressure is 
maintained throughout the system.  
 
The measurement temperature is set by selecting the controller of the silicone bath that 
contains the calorimetric cell. For proper control of temperature, the temperature in the 
external bath that cools the silicon bath is set to a value between 5 and 10 degrees below the 
calorimeter temperature measurement. Two to three days are necessary to get a steady 
temperature. Once the temperature is stabilized, the calorimeter is set to zero by balancing the 
Wheatstone bridge in the isothermal controller 3704.  
 
To balance the bridge, heating and cooling selectors are set to zero, and the gain is set at 
the desired value for the measurements. Under these conditions the device is manipulated to 
balance the Wheatstone bridge in order to get in the frequency counter a constant value 
around 44.5 ± 0.5.This value corresponds to a balanced bridge.  
 
In addition, pumps should also be kept at a constant temperature in order to transform 
subsequently volumetric flow into mass flow. The temperature of the pumps is set at a value 
at which the density of the pumped fluid is known and that temperature can be different to the 
temperature of the measurements as reactants are thermostated in the silicon bath prior to 
mixing. 
 
Once the pressure and temperature are fixed, the heating power and the intensity of cooling 
in the 3704 unit are set through the dials and selectors on the front panel of this device. Both 
values are set depending on the amount of heat to be measured, so that before and after 
mixing the number of pulses is within the range of the equipment (0 to 100000 pulses/s). If 
the magnitude of the heating resistance is too low, it would take too many pulses to 
compensate for the heat absorbed by the mixture. Conversely, if it is too high, a few pulses 
will suffice and consequently the accuracy will be low. 
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The choice of flow must be conditioned mainly by the diffusivity of the mixture 
components. For compounds that are diffused in each other easily, flow rates between 5 and 
10 mL/h are enough. However, if the diffusivity is not high, higher flow rates are required. 
Values between 40 and 70 mL/h are required to promote turbulent flow. In this study we have 
used flow rates between 5 and 10 mL/h, temperature conditions of 313.15, 323.15 and 333.15 
K and pressures of 9.00, 12.00, 15.00 and 18.00 MPa. 
 
• Calibration and Implementation of Measurements 
The first step before carrying out the measurements in the calorimeter is to clean the lines 
and fill the pumps. A small amount of cleaning fluid, acetone, in 3 portions is used to clean 
the pumps and the lines by introducing the liquid at the empty pump and discarding it by the 
line repeatedly. The same operation is repeated with the liquid or fluid to be used in each 
pump. Then pumps are filled. Liquids are degasified by pressurizing and depressurizing at the 
atmospheric pressure several times. To fill a pump with pressurized fluids such as CO2, the 
pump is first cooled at a temperature between 278 and 288 K, thus the fluid from the cylinder 
that contains the gas condenses within the pump and this serves to increase the amount of 
fluid in it. 
 
The pumps are thermostated at a temperature for which the density of the components 
they contain is known. In our case, we selected a temperature of 303 K. To drive components 
inside the calorimeter, we raise the pump pressure slightly above the working pressure then 
the valve is open. 
 
The next step to take is the calibration, to know the exact value of the energy equivalent to 
a pulse. This calibration simulates an exothermic mixing through a calibration resistor. The 
calibration consists of the following stages: 
1) Measure the frequency of the baseline for 20 minutes. 
2) Connect the calibration resistor to simulate the exothermic reaction. The heating 
frequency decreases to maintain constant temperature. At this stage the potential 
differences for the calibration and the standard resistors are measured. This will help us 
to determine the calibration power.  
3) Calculate the frequency difference observed between these first two steps of calibration 
(Δfc). 
4) Switch off the calibration power and recover the frequency of the baseline. 
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The heating power of the heating resistor is produced by Joule effect. Through a dial on the 
front panel of the 1701 unit , the intensity of current passing through it can be controlled and 
therefore, different heats to calibrate the different values of the pulse can be generated. 
 
The power of the calibration resistor is determined using a calibrated standard resistor of 
1000 Ω connected in series with it. By measuring the potential difference with the standard 
resistor, V1, we can know the current, using Ohm's law. Once the intensity and potential 
difference of the calibration resistance V2 are known, we can determine the calibration power 
 using the following expression: 
 
                                        (3.6) 
where is the heat dissipated by pulse whose value may be obtained from the above equation. 
 
Once the device is calibrated, we can start with the implementation of the measurements. 
The baseline measurement takes place by pushing one of the reactants, the high viscous one, 
at the total flow to be used during the measurements. Under these conditions, the pulsed 
heater frequency compensates for the removal of heat through the Peltier device and the 
temperature of the calorimetric cell is kept constant. The frequency of the baseline should be 
high if the mixing is exothermic because the pulsed heater frequency decreases to maintain 
constant temperature. Otherwise, the baseline should be low to maintain isothermal conditions 
by increasing the frequency of the pulses. During the recording of the baseline, the heating 
power counteracts the Peltier cooling power to maintain constant temperature. Then the 
reagents are pumped in the right proportion to the calorimetric cell. The heat absorbed or 
released upon mixing causes an increase or decrease in frequency with respect to that of the 
baseline. Therefore, temperature is kept constant. The frequency variations are collected in the 
computer through a program and displayed on the screen. The average frequency is taken 
when this magnitude stabilizes, which usually occurs between 45 and 60 minutes, depending 
on the studied mixture. 
 
The power generated by the mixture, , and the power of the heating resistance, , 
compensate the Peltier cooling power, , and the temperature is kept constant. 
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                                        (3.7) 
 
By measuring the variation of the heating power, which is associated with the frequency 
difference between the baseline and mixing, , we can determine the amount of power 
generated by mixing in a precise manner. Knowing the total molar flow, , we can obtain 
the excess molar enthalpy, by the following expression: 
 
                                          (3.8) 
where  is the constant for the heat dissipated per pulse (in µJ/pulse). This value has been 
estimated in the calibration process. 
 
3.1.7. Uncertainties 
The molar flow rate is calculated using the volume flow rate , the density  of the 
mixture component at the temperature and pressure of the pumps and the molar mass : 
   =                        (3.9) 
The mole fraction of each component is given by:  
   =                         (3.10) 
For each pump the uncertainty in was obtained by a previous calibration. Since 
densities are affected by temperature and pressure changes, the uncertainty in molar flow rates 
was derived taking into account contributions from variations in volume flow rates, pressure, 
and pumps temperature. The mole fraction uncertainty is based on the molar flow rates 
uncertainty and was estimated to be better than ± 0.001. The uncertainty in HmE was obtained 
taking into account contributions from molar flow rates, pulse energy and frequency and was 
estimated to be ± 1 % or at least ± 1 J mol-1.The uncertainties in T and P, ± 0.001 K and 0.01 
MPa, respectively, were already given. More details about the error treatment are given in 
reference [2]. 
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3.2. Equations of State Calculations 
The data obtained in this study for the mixtures formed by carbon dioxide and organic 
polar solvents in supercritical antisolvent micronizations together with related phase equilibria 
and critical data taken from the literature have been modeled using equations of state (EOS). 
 
3.2.1 Equations of State and their Application to Mixtures 
 
An analytical equation of state describes the relationship between temperature, pressure 
and volume for a given substance, f (P,V, T) = 0. In the case of a mixture of substances the 
composition variable has to be included through the mixing rules that allow the calculation of 
the mixture parameters from those of the pure components. From this equation of state all the 
thermodynamic properties of the system such as phase equilibria or excess enthalpies may be 
obtained. Many analytical EOS of varying complexity are available in the literature; 
unfortunately, none of them may be applied for any type of system in the whole range of 
experimental conditions. For mixtures involving supercritical fluids and short chain 
molecules, equations derived from the van der Waals EOS are the most widely used. 
 
The van der Waals equation was the first EOS that provided a qualitative description of 
the liquid and vapor phases and critical phenomena. Van der Waals proposed this pressure-
explicit equation in 1873. 
 
                  (3.11) 
 
The first term in this equation accounts for the short range repulsive forces and depends 
on a parameter  describing a correction for the volume occupied by the molecules 
themselves. is the molar volume. The second term accounts for the attractive forces and 
depends on the parameter  that reflects the strength of attraction between two molecules. 
This equation is cubic in . At temperatures below the critical, there are three real roots but 
only two values correspond to stable states. The van der Waals equation roughly 
approximates fluid behavior in the two-phase region. At the critical temperature where liquid 
and vapor become indistinguishable the following conditions have to be met: 
 
                 (3.12) 
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                 (3.13) 
 
where is the Helmholtz energy. Evaluating these derivatives and equation (3.11) at the 
critical point results in three equations involving ,  and the critical parameters Tc, Pc and 
Vc. Because Vc is not always available, it can be eliminated and the remaining equations 
solved for and in terms of Tc and Pc. For the van der Waals equation this results in  
 
                (3.14) 
 
Thus, and are independent of temperature for this EOS and can be easily calculated 
from the critical parameters Pc and Tc. 
 
The van der Waals equation is the starting point for other cubic EOS able to represent 
PVT data in the two-phase region. Many modifications have been proposed; in this study the 
Peng-Robinson and the Soave-Redlich-Kwong equations have been used [3, 4]. These EOS 
retain the repulsive term and introduce temperature dependence in the attractive term of the 
van der Waals equation. 
 
• Peng-Robinson Equation of State 
The Peng-Robinson EOS is given by 
 
              (3.15) 
 
The volume dependence of the attractive term provides a better description of liquid 
volumes. The parameters and are calculated according to the procedure used for the van 
der Waals EOS. The temperature dependence of and  leads to a better description of vapor 
pressures. 
                   (3.16) 
                  (3.17) 
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where  
 
 ;                 (3.18) 
                 (3.19) 
               (3.20) 
 
where is the reduced temperature (  = T/Tc) and  is the acentric factor introduced by 
Pitzer [5] in order to describe deviations in pressure with respect to values observed for fluids 
formed by spherical molecules. Pitzer defined the acentric factor as  
 
                 (3.21) 
where  is the saturation pressure. The coefficients in equation (3.20) are obtained from a 
correlation of vapor pressure taken at temperatures ranging from the boiling to the critical 
temperature.  
 
• Soave-Redlich-Kwong Equation of State 
Redlich and Kwong [6] proposed in 1949 the following EOS: 
 
                 (3.22) 
 
the parameters and are calculated in terms of the critical parameters using equations 
(3.16) and (3.17) where = 1/ ,  = 0.42784 and  = 0.08664. Values for  
and  are obtained by applying equation (3.12) and (3.13) to the Redlich-Kwong EOS. 
 
In order to improve the description of vapor pressures and liquid densities Soave modified 
the expression of in the Redlich-Kwong EOS: 
              (3.23) 
 
The coefficients in equation (3.23) are obtained by applying the condition of equal 
fugacities at the reduced saturation pressure. When this modification is used, the EOS is 
known as the Soave-Redlich-Kwong equation. 
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• Application to Mixtures and Mixing Rules 
The EOS described in equations (3.11) to (3.23) are defined for pure substances. In order 
to extend them to mixtures, it is necessary to introduce a mixing rule. A mixing rule is an 
expression that relates the and  parameters of the mixture to those of the pure components 
and the composition. A large variety of mixing rules are found in the literature. The simplest 
one is the classical mixing rule that has been used in this study: 
 
                  (3.24)  
                  (3.25)  
Parameters  and  are calculated from the pure component parameters using the 
combination rules given by 
 
                  (3.26)  
                  (3.27)  
 
where  =  and = are binary interaction parameters obtained by correlation of 
vapor-liquid equilibrium or excess enthalpy data. The absolute values adopted by and 
are usually much smaller than one.  is related to molecular interactions between two 
unlike molecules. is related to the free volume and the fluid compressibility. 
 
3.2.2. Phase Equilibria Calculations 
 
Phase equilibrium is characterized by temperature, pressure and the composition of each 
phase. For two phases  and in equilibrium the fugacity of each component must satisfy 
the condition: 
 
                    (3.28) 
 
In order to solve this equation, fugacities are evaluated from an EOS using the following 
expression for the fugacity coefficient of each component [7] 
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             (3.29) 
 
where is the mole fraction and is the compressibility factor of the mixture. 
For the Peng-Robinson EOS the fugacity coefficient is given by 
 
             (3.30) 
where  
 ;                   (3.31) 
 
, ,  and are calculated using equations (3.24)-(3.27). A similar equation is obtained 
for the Soave-Redlich-Kwong EOS.  
 
Different algorithms may be used to solve equation (3.28) depending on the type of phase 
equilibrium. In this study, calculations involve a liquid and a vapor phase for a binary system 
at constant temperature. This is the so-called bubble point calculation: T and (composition 
of the liquid phase) are known and P and  (composition of the vapor phase) are calculated. 
Equations (3.28) and (3.30) must be applied to each component. The liquid and vapor molar 
volumes required in equation (3.30) are calculated using the EOS twice. The PE 2000 
program developed by G. Brunner and coworkers was used in this calculation [8]. The binary 
interaction parameters and  may be set equal to zero in equations (3.26) and (3.27). In 
this case, binary phase equilibria data are predicted using only pure component data: critical 
parameters, acentric factors and vapor pressures at a given temperature. Usually, values of 
and  are determined by correlation of VLE data at a given temperature. Then binary 
interaction parameters can be used for calculations in multicomponent behavior assuming that 
the binary interactions add up to the multicomponent behavior. Assuming that and  
obtained from VLE data taken at a given temperature ought to be temperature-independent, 
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values for and obtained from VLE data taken at a given temperature may be used to 
predict VLE at a different temperature, the critical locus or binary excess enthalpy data for the 
same binary system. 
 
3.2.3 Excess Enthalpy Calculations 
 
The excess molar enthalpy, , for a binary mixture may be calculated in terms of the 
residual enthalpies 
 
 
             (3.32) 
where  is the residual molar enthalpy of the mixture and is that for pure components. 
 
The residual molar enthalpy is given by 
 
               (3.33) 
 
For a pressureـexplicit EOS, the integral appearing in equation (3.33) can be solved 
analytically. Thus, for the Soave-Redlich-Kwong EOS the following expression is obtained 
 
              (3.34) 
  
 
 
If the Peng-Robinson EOS is used in equation (3.33), the residual molar enthalpy of the 
mixture is given by  
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             (3.35) 
 
 
In equations (3.34) and (3.35) the expressions of and for mixtures have to be obtained 
using the mixing rules described by equation (3.24)-(3.27). Usually, values for the binary 
interaction parameters and  are determined by a correlation of data taken at 
different pressures and a given temperature. 
 
3.2.4. Critical Locus Calculations 
 
There are several methods to estimate the mixture critical locus using an equation of state. 
They differ in the formulation of the stability criteria and critical point conditions. For 
pressure-explicit EOS it is convenient to use a formulation based on the Helmholtz 
function . Heidemann and Khalil have developed a procedure based on  that has been 
used in this study [9]. The independent variables are the compositions expressed as amount of 
substance . The critical point first condition is expressed in matricial form 
 
                 (3.36) 
where the elements of  are given by 
 
                  (3.37) 
 
The condition expressed by equation (3.36) is met if the vector 
satisfies the equation 
 
                   (3.38) 
 
This leads to the second critical condition 
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             (3.39) 
 
The second and third derivatives of  are obtained using the EOS and thermodynamic 
relationships: 
 
               (3.40) 
                         (3.41) 
 
Fugacity coefficients are evaluated using equation (3.29). When this procedure is applied 
to a gas-liquid critical line, the root providing the largest volume is selected. However, in the 
case of a liquid-liquid critical line the root providing the smallest volume is selected. 
 
The Heidemann and Khalil procedure has been used to calculate the critical locus of the 
CO2 + organic solvent systems involved in this study which exhibit type I critical behavior 
according to the Scott and van Konynenburg classification [10]. The critical locus may be 
predicted from pure component data if the binary interaction parameters and involved 
in the calculations of fugacity coefficients are set equal to zero. Otherwise, the critical locus 
may be determined from a correlation of the critical data available for the binary system. In 
this case, values for and are required to draw the gas-liquid critical line.  
 
3.3. Supercritical Antisolvent Micronizations 
Liquid antisolvent processes are largely used in micronizations. They are based on the use 
of two liquid solvents that are completely miscible. The solute to be micronized is soluble in 
the first solvent, but not soluble in the second. Consequently, the addition of the second 
solvent (antisolvent) induces the formation of a solution formed by the two liquids and the 
supersaturation and precipitation of the solute. 
 
Supercritical fluid antisolvent micronizations have been used in the last years as 
alternatives to liquid antisolvent processes [11-13]. Thanks to the relatively low solvent power 
of supercritical CO2 for solutes such as polymers or pharmaceutical products and its good 
miscibility with many polar organic solvents, the controlled micronization of the solid from 
an organic solvent solution may be achieved at moderate temperatures. As previously 
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described in the introduction, different process arrangements, apparatuses and acronyms have 
been used: GAS (gas antisolvent), PCA (precipitation by compressed antisolvent), ASES 
(aerosol solvent extraction), SEDS (solution enhanced dispersion by supercritical fluid) and 
SAS (supercritical antisolvent), among others. 
 
The higher diffusivities of supercritical fluids with respect to those of liquids lead to its 
very fast diffusion into the liquid solvent and the supersaturation and precipitation in particles 
much smaller than those obtained using liquid antisolvents. Carbon dioxide is the most 
frequently used supercritical fluid used as an antisolvent. Its accessible critical parameters (Tc 
= 304.1 K, Pc = 7.38 MPa) allow operation at moderate temperatures. The particle size may 
be tuned by varying the process parameters such as pressure, temperature, solute 
concentration, etc. Furthermore, these are solvent-free particles exhibiting a narrow size 
distribution.  
 
• Batch Operation 
The precipitation vessel is loaded with a given quantity of the liquid solution and then the 
supercritical antisolvent is added until the final pressure is reached. Typically, moderate 
pressures are used (5-8 MPa). In this mode of operation, the rate of the supercritical 
antisolvent addition can be an important parameter in controlling the morphology and the size 
of the solid particles. The antisolvent can be added from the bottom or from the top of the 
chamber. It is also possible to charge the precipitation chamber with the antisolvent and then 
to perform a discontinuous injection of the liquid solution. The difference between these two 
operational modes is that in the first case the precipitation occurs in a liquid rich phase, 
whereas, in the second case it occurs in a supercritical fluid rich phase. The results can be 
very different. In both cases the operation performed is not at the steady state; therefore, it is 
difficult to analyze the effect of the process parameters on the final characteristics of the 
powders. Moreover, batch operation is usually not suitable for industrial production. When 
relatively large volumes of solution are processed, a stirrer may be necessary to improve the 
mixing between the solution and the CO2. 
 
At the end of the precipitation process, the vessel is washed with the antisolvent to 
eliminate the liquid. This operation is very important. If the washing is not performed or the 
washing time is not sufficient, the liquid solvent may be released from the supercritical 
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solution during the depressurization of the apparatus and may resolubilize the solute. The 
acronym commonly used for batch processes is GAS. 
 
• Continuous Operation  
In the SAS, ASES, PCA and SED processes the liquid solution and the supercritical 
antisolvent are continuously delivered to the precipitation vessel in co-current or counter-
current mode. As their titles indicate, there are differences between these processes. For 
example, in the SED process an aqueous solution containing biomaterials is dispersed using 
CO2 and a polar organic solvent in a coaxial nozzle. Supercritical CO2 is used to extract the 
aqueous phase from the product. The organic solvent acts both as precipitating agent and as 
modifier, enabling the non-polar CO2 to remove the water. The following discussion is mainly 
centered in ASES, SAS and PCA, and the acronym most frequently used, SAS, will be our 
choice to refer to them. In the continuous mode of operation the flow rates and their ratio are 
important for the precipitation process. The pressure, at which the operation is performed, and 
the liquid solution injection device are also relevant process parameters. This is the mode of 
operation chosen in this study. A schematic representation of the continuous supercritical 
antisolvent apparatus used in this thesis is shown in Fig. 3.6.  
 
Fig. 3.6 Schematic diagram of the laboratory scale SAS apparatus. 
 
The injector is designed to produce liquid-jet break-up and the formation of small 
micronic droplets that expand in the precipitator. The solid solute is released when its local 
Chapter 3 - Methodology 
 
 
 
62 
concentration exceeds the saturation limit. Particles are collected on a filter (frit) at the bottom 
of the basket installed inside the precipitation chamber. The solution formed by the 
supercritical fluid and the organic solvent passes through this filter and after depressurizing at 
the BPR it is introduced in a separator where the organic solvent is recovered. Various 
injection devices have been proposed in the literature. A nozzle is a very common choice; 
capillary tubes or vibrating orifices are also used. Coaxial devices use two capillary tubes to 
deliver continuously the liquid solution and the supercritical antisolvent. In the SAS apparatus 
built up in this study, the liquid solution is introduced separately from the supercritical 
antisolvent using a nozzle. In order to obtain a good mixing between the two streams without 
the aid of a mechanical device, this process operates at higher pressures than the GAS 
process, typically in the range 9-15 MPa. The washing step with pure supercritical antisolvent 
at the end of the precipitation process is also very important in continuous operation to avoid 
the condensation of the liquid phase and the solute resolubilization. Although smaller than in 
batch processes, the length of washing has to be carefully estimated.  
 
The SAS production capacity is much larger than that of GAS. Therefore, SAS processes 
are preferred; a large number of solutes have been micronized using this procedure in the last 
years [14-15]. Co-precipitation of natural substances or pharmaceuticals with a biocompatible 
or biodegradable carrier material is also possible [16]. On the other hand, fundamental studies 
aimed at understanding the role of phase equilibria, hydrodynamics and mass transfer in SAS 
have been carried out [17-23]. 
 
3.3.1. Description of SAS Apparatus 
The schematic diagram and image for our laboratory scale SAS apparatus are shown in 
Figs. 3.6 and 3.7, respectively. In this apparatus, an HPLC pump (Series III Pump, 10 mL 
head) is used for solution delivery; it can produce flow rates from 0.01 to 10.00 mL/min, these 
flow rates can be set in 0.01 mL increments. A high pressure pump (Thar-SCF CO2 Pump P-
50) is used to deliver carbon dioxide; it can produce flow rates from 1 to 50 g/min, these flow 
rates can be set in 1 g increments. Prior to mixing, CO2 is heated in the heat exchanger at the 
precipitation temperature. The desired mole fraction required for SAS precipitation is 
obtained by combining adequate values for the flow rate of both pumps. Both the solution and 
CO2 are pumped separately into the precipitation chamber where they contact with each other 
producing the microparticles.  
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Fig. 3.7 SAS apparatus used for micronization. 
 
 
A stainless steel cylinder vessel of 500 mL (THAR-SCF) is used as a precipitation 
chamber. Sealing is made using a spring-energized O-ring made out of polyimide. The 
solution is sprayed in the precipitation chamber through a thin stainless steel nozzle of 
diameter 100 µm. Supercritical CO2 is pumped through another inlet port located on the top of 
the chamber.  
 
A stainless steel basket with a removable filter (frit, 2 µm) is installed inside the 
precipitation chamber to collect the microparticles, allowing the CO2 + organic solvent 
mixture to pass through. A cylinder piece of aluminum of dimension 4.5 cm x 2.5 cm x 0.2 
cm was used to keep a suitable distance between the basket and the bottom of the cylinder 
vessel. A schematic diagram for the precipitation chamber is shown in Fig. 3.8. 
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Fig. 3.8 Schematic diagram of the precipitation chamber, dimensions in inches. 
 
 
Several types of nozzles can be used in the SAS system, specifically a single nozzle, a 
coaxial nozzle, capillary tubing, a laser-drilled orifice and a valve nozzle. A nozzle of 
internal diameter of 100 µm was used in this study. Fig 3.9 shows the schematic diagram 
of the nebulizer. The nozzle is drilled in the sapphire plate. 
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Fig. 3.9 Schematic diagram of the nebulizer utilized with a sapphire plate; outside diameter (A) = 2210 µm; 
inside diameter (B) =100 µm; thickness (C) = 1194 µm; length of the hole (D) = 254 µm. 
 
 
Then a back pressure regulator (TESCOM, Pressure Reducer Series 26-1700) located after 
the precipitation chamber allows keeping constant pressure in the system, Fig 3.10. 
 
 
Fig. 3.10 TESCOM BPR. 
 
 
 
Another stainless steel cylinder vessel of 500 mL (THAR-SCF) (Fig. 3.11) with the same 
sealing mechanism as the precipitation chamber is used as the cyclone separator where the 
mixture is introduced tangentially at a high velocity. Centrifugal forces act on the liquid 
droplets forcing them to the bottom of the separator and allowing the light gases to exit 
through a port at the top.  
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Fig. 3.11 Schematic diagram of the cyclone separator chamber. 
 
The temperature of the precipitation chamber and the separator is controlled using 
temperature controllers (CAL 9400) and two electrical heating jackets. For further accurate 
temperature reading an additional digital thermocouple is installed to read the temperature 
inside the precipitation chamber (see Fig. 3.8 for localization of the thermocouple in the 
precipitation chamber). Usually in SAS experiments temperatures are expressed in celsius. 
For this reason, this unit will be used in this section and in chapter five.  
 
The CO2 line passes through two heat exchangers as a helix coil of length 3 m and 5 m, 
respectively. The first one is a chiller operated at 3°C located just before the high pressure 
pump to liquefy the CO2. This allows filling the pump with liquid CO2 thus increasing pump 
efficiency and preventing pump cavitation. The other heat exchanger is a water bath operated 
at temperatures ranging from 40-60°C that is located just before the precipitation chamber to 
achieve the supercritical temperature condition for CO2. Loss of pressure upstream of the 
point where the supercritical mixture is depressurized is compensated by using the back 
pressure regulator. Joule-Thompson cooling as a result of the large volumetric expansion 
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across the BPR leads to a drop in temperature of the supercritical mixture and precipitation of 
the solution and/or CO2 dry ice. This leads to inconsistent flow rates and plugging on the 
lines. So an independent electrical heating coil is installed to maintain the BPR at a 
temperature higher than that of the precipitation chamber.  
 
The equipment contains auxiliary components: safety elements such as two relieve valves 
(Swagelok, model SS-4R3A), three check valves (Parker, model 25-BN-SS) and four two-
way valves (Swagelok, model SS-OVS2) to protect the system from backward flow and 
pressure increases. In addition, two manometers P1 and P2 are used to measure the pressure at 
different points; P1 is a pressure gauge used to measure the pressure inside the CO2 tank to be 
sure that the cylinder is full during the experiment while P2 is a pressure transducer (Gems 
Sensors & Controls, 2800 CVD series, model, 2800BGC4001D3003A001) used to measure 
the pressure inside the precipitation chamber. Furthermore, two stainless steel filters of 5 
micron (Parker, model 2A-FT4-5-BN-SS) and 15 micron (Swagelok, model SS-4TF-15) are 
installed before the CO2 pump and BPR, respectively, to trap any impurities that may lead to 
malfunction of the pump or the BPR. The different components are connected to each other 
by 1/8" chemically cleaned and passivated stainless steel tubing (Autoclave Engineers, model 
MS 15-200 316 SS) of 0.05 " wall thickness and 0.052 " inside diameter. 
 
The main units (solvent pump, high pressure CO2 pump, precipitation chamber and 
separation chamber) have been purchased from THAR-SCF. Tubing and valves were supplied 
from Swagelok and Parker companies.  Pressure control units and temperature controllers 
were supplied from TESCOM and RS Co. High purity (99.98 mol % pure) CO2 tank was 
supplied from Air Liquide Co. All those units have been integrated together to build up our 
laboratory scale SAS apparatus. 
 
The SAS apparatus can be divided into hot regions and cold regions. The hot regions 
include the precipitation chamber and the BPR unit. The rest of the components belong to the 
cold region, not heated units. Table 3.1 shows the limiting pressure and temperature for the 
essential SAS components. 
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Table 3.1 Rating of the essential SAS components. 
Component Max. Pressure 
(MPa) 
Max.Temperature 
(°C) 
Precipitation Chamber 69 90 
Separator Chamber 40 150 
BPR 69 70 
Tubing 103 93 
Pressure Sensor 30 125 
CO2 Pump 65 5 - cold region 
Solvent Pump 41 30 - cold region 
Relief Valve 27 300 - cold region 
Pressure Gauge 25 120 - cold region 
Swagelok Valves 34 35 - cold region 
 
 
According to the data shown in table 3.1 the precipitator in our SAS apparatus is rated up to 
69 MPa and 90 °C but because of the pressure and temperature limits of the pressure gauge, 
valves and the BPR used, our SAS apparatus is rated up to 25 MPa and 70 °C, which is 
enough for micronization of pharmaceutical active ingredients. Further improvement of the 
SAS equipment would include the replacement of the current BPR for one rated at a higher 
temperature as well as using pressure gauges and valves working at a higher pressure. 
 
3.3.2. Experimental Procedure  
All the experiments were performed following the same procedure: first of all, the nozzle 
and the frit are ultrasonicated for 30 min in acetone to dissolve any residuals or impurities that 
may accumulate at the orifice or the frit, then left to be dried at air. Once the precipitator is 
closed and put in place, the heat exchangers are switched on: when the desired temperatures 
are achieved, the CO2 is pumped into the precipitation vessel at low flow rate (10 g/min). In 
parallel, the BPR is used to adjust the pressure inside the precipitation chamber. The time 
required to fill the precipitation chamber ranges from 30-45 min depending on the working 
pressure and temperature. Once the supercritical conditions (temperature and pressure) are 
obtained, at the precipitation chamber an excess of CO2 is flushed for 20-30 min through the 
system at the selected flow rate (15-20 g/min) to clean the lines and obtain steady conditions. 
Meanwhile, the solution pump is primed and filled with the liquid solution. In the next step, 
the solution is pumped to the chamber at 1-3 mL/min depending on the working conditions 
and sprayed inside the vessel itself by means of the nozzle. To minimize the amount of 
solvent during the process, pure solvent is not pumped into the chamber prior to the liquid 
solution. The small drops of solvent are dissolved by supercritical CO2 causing 
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supersaturation of the liquid solution and the consequent precipitation of the solute in the 
form of a powder that accumulates on the frit located at the bottom of the vessel, as well as 
being deposited on the internal wall of the vessel. The precipitation process finishes when the 
desired amount of liquid solution has been fed into the system, then the liquid pump is turned 
off and the supercritical CO2 continues flowing through the precipitator vessel. The 
precipitate is washed by excess CO2 to remove the residual content of the liquid solvent 
solubilized into the supercritical CO2 antisolvent. The washing time is assumed to be 3 times 
the time required to fill the precipitation chamber with CO2 and it is estimated using the 
following expressions:  
 
                 (3.42) 
 
                 (3.43) 
 
where  is the washing time,  is the time required to fill the precipitation chamber, 
 is the volume of the precipitation chamber,  is the CO2  mass flow rate and is the 
density of CO2 at the working pressure and temperature. 
 
The washing stage lasts approximately 60-120 min. After that the supercritical CO2 flow is 
stopped and the system is depressurized down to atmospheric pressure. Finally, all the 
precipitate is recovered from both the wall and the frit of the precipitator vessel; the analyses 
required, such as scanning electron microscope (SEM) and X-ray diffraction (XRD), are then 
carried out. 
 
 Most SAS experiments were carried out at flow rates of 1mL/min and 15-20 g/min for 
solution and CO2, respectively. These values were chosen to obtain mole fractions ≥ 0.96 by 
combining adequate values for the flow rates of the two pumps. 
 
3.3.3. Design of Experiments (DOE) 
The ''one-factor-at-a-time'' has been a common route for investigating the effects of 
parameters on a process. By this method the effect of one variable or factor is examined by 
running all the factors at one condition and then repeating and changing the condition of one 
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factor. Continuing to hold that factor at that condition, the experiment is repeated with another 
factor at its second condition, etc.  This process is repeated until all factors become at their 
optimum conditions. Nevertheless, this method is slow, expensive and requires many tests for 
a few factors. 
Design of Experiments (DOE) is a statistics-based approach and powerful technique used 
for exploring new processes, gaining increased knowledge of the existing ones and optimizing 
theses processes for achieving high performance. DOE is aimed to reduce the number of 
factors to be studied by identifying the key ones that affect product quality or process 
performance and allowing us to focus our efforts on the few really important factors, or the 
'vital few' [24-25]. In particular, applying the factorial design at two levels for each factor 
allows us to focus on the important factors, with only a few trials. In general, for K factors, 
the one-factor-at-a-time method would require K times more trials to be performed than the 
factorial design approach (2K). However, the number of trials required in a factorial design at 
two levels (2K) increases with the number of factors K. As a consequence, the costs of 
resources needed to conduct experiments of a full factorial design can quickly become 
prohibitive. Fortunately, in most cases, when K is too high, the desired information can be 
obtained using only a fraction of the full factorial design. A fractional factorial design is 
normally used for the early stages of an investigation where the study of the approximate 
influence of a large number of factors is more advisable than an accurate study of a few 
factors that could prove to be relatively unimportant. 
 
In general, a fractional factorial design is created from the full factorial design at two 
levels. Some of the high-order interaction terms of the full factorial design are associated with 
additional experimental factors. Each pair of associated factors is called an alias, so the 
fractional factorial design is denoted as 2k-p, where p is the number of aliases (pairs of allied 
factors). 
 
The factors that could have effects on the performance of the SAS process are: the initial 
concentration of the solution (C), the temperature (T), the pressure (P), the liquid flow rate 
(QL), the supercritical CO2 flow rate (QCO2), the drying time (t), and the nozzle diameter (Øn).  
In our study, the drying time and the nozzle diameter are kept constant at 3 times the time 
required to fill the precipitation chamber and 100 µm, respectively. Consequently, we have 
five factors to be studied.  
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The coding scheme used to describe the factor levels is based on the + and - signs, where 
+ and - denote the high and low levels, respectively, of a factor. The full matrix 25 design and 
the magnitude assigned to each factor are shown in table 3.2.  
 
Table 3.2 The full matrix 25 design. 
Run C (1) T (2) P(3) QL(4) QCO2 (5) 
1 - - - - - 
2 + - - - - 
3 - + - - - 
4 + + - - - 
5 - - + - - 
6 + - + - - 
7 - + + - - 
8 + + + - - 
9 - - - + - 
10 + - - + - 
11 - + - + - 
12 + + - + - 
13 - - + + - 
14 + - + + - 
15 - + + + - 
16 + + + + - 
17 - - - - + 
18 + - - - + 
19 - + - - + 
20 + + - - + 
21 - - + - + 
22 + - + - + 
23 - + + - + 
24 + + + - + 
25 - - - + + 
26 + - - + + 
27 - + - + + 
28 + + - + + 
29 - - + + + 
30 + - + + + 
31 - + + + + 
32 + + + + + 
 
 
To further reduce in the large number of experiments (32), factors QL(4) and QCO2 (5) 
were thought to have the less influence on the process performance, and therefore they are 
considered as allied factors. 
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Among all possible fractional factorial designs for five factors at two levels, the design  
25-2  was selected. The fractional factorial 25-2 design was obtained as follows: 
1. The full factorial design at two levels for concentration (1), temperature (2), and 
pressure (3) was built following Yates standard order [24]. 
2. Two pairs of allied factors (p = 2), liquid flow rate (4) and supercritical CO2 flow rate 
(5) were associated with concentration/temperature interaction (12) and concentration 
/pressure interaction (13), respectively. This association was obtained using  
MINITAB 15 SOFTWARE [26]. 
3. The signs of the new columns of allied factors (QL(4) and QCO2 (5)) were obtained by 
multiplying the signs of the interaction variables. For example, the signs of the liquid 
flow rate (4 = 12) column were obtained by multiplying the signs of the concentration 
(1) column by the signs of the temperature (2) column. 
 
As a result, we generated eight different combinations of signs for the five factors as 
shown in table 3.3. The generated combinations are eight different trails (25, 2, 19, 12, 13, 22, 
7 and 32) out of the full factorial design at two levels 25. Thus, the design is a fraction of ¼ of 
the full 25 design. 
Table 3.3 The fractional factorial 25-2 design. 
Run Run No. in the 
Full 25 Matrix 
C (1) T (2) P(3) QL 
(4=12) 
QCO2 
 (5=13) 
Response  
1 25 - - - + +  
2 2 + - - - -  
3 19 - + - - +  
4 12 + + - + -  
5 13 - - + + -  
6 22 + - + - +  
7 7 - + + - -  
8 32 + + + + +  
Contrast        
 
To determine the complete meaning of each column, a simple procedure involving the 
response, contrast calculations and alias generators was performed. 
 
• Response and Contrast Calculation 
The dimensional properties of the final product are the most important characteristics 
because they define the processing behavior. In the case of pharmaceuticals, particle 
morphology and size are key parameters that determine the drug rate of dissolution in the 
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biological fluid and the bioavailability of poorly water-soluble drugs. Therefore, the mean 
particle size (PS) and the particle morphology were used as a response to evaluate the process 
performance.  
 
 Which main factors or interactions might affect the response? What is the optimum 
process condition? To answer these questions we need to calculate the mean effect (contrast) 
of each factor. The mean effect (contrast) can be calculated using the following equation:  
 
                 (3.44) 
where ,  are the number of runs with high and low levels for each factor, respectively. 
And ,  are the response of each run at the high and low levels, respectively. 
  
The order of importance of the factors for particle size and morphology can be summarized in 
view of their mean effect. 
 
• Alias Structure  
A fractional factorial design is generated from a full factorial design by choosing an alias 
structure. The alias structure determines which effects are confounded with each other. 
MINITAB 15 SOFTWARE [26] was used also to generate the alias structure and simplified 
alias structure that are shown in tables 3.4 and 3.5, respectively. 
 
Table 3.4 The alias structure. 
Concentration Effect l1 = 1 + 24 + 35 + 12345 
Temperature Effect l2  = 2 + 14 + 345 + 1235 
Pressure Effect l3  = 3 + 15 + 245 + 1234 
Liquid flow rate Effect l4  = 4 + 12 + 235 + 1345 
Supercritical CO2 flow rate Effect l5  = 5 + 13 + 234 + 1245 
 
LI is calculated by adding the li values obtained using Eq. (3.44) for the products of factors 
specified in table 3.4. 
 
 
The simplified structure obtained by neglecting three order and higher interactions [24] is 
given in the following table. 
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Table 3.5 The simplified alias structure. 
Concentration Effect l1 = 1 + 24 + 35  
Temperature Effect l2  = 2 + 14  
Pressure Effect l3  = 3 + 15  
Liquid flow rate Effect l4  = 4 + 12  
Supercritical CO2 flow rate Effect l5  = 5 + 13  
 
In table 3.3 the effect (contrast) in each column is due to both the main variables (C, T, P, 
QL and QCO2) and the effects of the interactions are shown in table 3.5. For screening 
purposes, the interactions between two factors were also considered negligible [25], so the 
effect value li is caused only by the main factor, by other words, concentration for column 1, 
temperature for column 2, and so on. 
 
• Level Identification 
As mentioned before the code used to describe the factor levels is based on the + and - 
signs, the high and low levels, respectively. The two levels were chosen mainly on the basis 
of phase diagrams and previous studies on SAS precipitation. 
 
The low level of concentration was set to obtain a sufficient amount of precipitate for 
subsequent analysis; the high level was limited by the saturation of the solution at room 
temperature. 
 
The lower temperature and pressure limits were determined by the phase diagram of the 
CO2 + binary solvent system aiming to stay within the one phase supercritical region; the 
superior limits were based on reducing energy costs and previous studies. 
 
Flow rate limits were chosen to obtain CO2 mole fractions ≥ 0.96, in the carbon dioxide- 
rich region taking into account the equipment limitations. 
 
3.3.4. Characterization of the Particles 
The solid state properties and characteristics of the precipitated particles have been 
evaluated using scanning electron microscopy (SEM), powder X-ray diffraction, Infrared 
spectroscopy (IR) and differential scanning calorimetry (DSC). 
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• Scanning Electron Microscopy 
Scanning electron microscopy (SEM) is a type of electron microscopy that images a 
sample by scanning it with a high-energy beam of electrons in a raster scan pattern. The 
electrons interact with the atoms that make up the sample producing signals that contain 
information about the sample's surface topography, composition, and other properties such as 
electrical conductivity. A JEOL-6400 electron microscope working at 10 kV was used to 
characterize the microparticles obtained in SAS experiments. Prior to analysis, samples were 
gold coated. This study was carried out in the National Center of Electron Microscopy located 
at the Universidad Complutense de Madrid.  
 
• Particle Size and Particle Size Distribution Analysis 
The size and size distribution of the precipitated particles are important characteristics 
because they define processing behavior, particle solubility and bioavailability. The particle 
size may vary over a wide range. This range is called the particle size distribution (PSD), and 
it can be represented in the form of a table or a histogram (see Fig. 3.12). 
 
 
 
Fig. 3.12 Typical PSD in the form of a histogram.  
 
A PSD such as that shown in Fig. 3.12 is obtained by counting the particles of different 
sizes in an electron microscope image using SEMAFORCE program [27] and the frequency 
using STATEXT program [28].  
 
Another feature to describe the variation in particle size is the normal distribution curve; 
the Normal curve is a symmetrical curve with a single central peak at the mean (average) µ of 
the data.  The shape of the curve is described as a bell-shaped with the graph falling off 
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evenly on either side of the mean.  Fifty percent of the distribution lies to the left of the mean 
and fifty percent lies to the right of the mean. The spread of a normal distribution is controlled 
by the standard deviation σ  of the data; the smaller the standard deviation the more 
concentrated in the data (see Fig. 3.13). 
 
Fig. 3.13 Probability density as a function of particle size.  
 
A normal distribution curve such as that shown in Fig. 3.13 is obtained also by counting 
the particles of different sizes and calculating the normal distribution using the following 
equation: 
                         (3.45) 
where x is a normal random variable (size), µ is the mean and σ is the standard deviation 
 
• Powder X-ray Diffraction  
Powder X-ray diffraction (XRD) is a scientific technique using X-ray diffraction on 
powder or microcrystalline samples for structural characterization of materials. XRD patterns 
of the solids prior and after micronization were obtained using (Philips X’pert, model MPD) 
powder diffraction system. The X-ray source was nickel-filtered Kα emission of copper 
(1.541837Å). Samples were scanned over the range of 5-50 2θ degrees using the Bragg-
Brentano geometry. 
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• Infrared Spectroscopy (IR)  
Infrared spectroscopy (IR spectroscopy) deals with the infrared region of the 
electromagnetic spectrum. Molecules absorb specific frequencies that are characteristic of 
their structure. These absorptions are resonant frequencies, i.e. the frequency of the absorbed 
radiation matches the frequency of the bond or group that vibrates. The energies are 
determined by the shape of the molecular potential energy surfaces, the masses of the atoms, 
and the associated vibronic coupling. Nowadays most common laboratory instruments are 
Fourier transform infrared (FTIR) spectrometers. FTIR is used to obtain an infrared spectrum 
of absorption, emission, photoconductivity or Raman scattering of a solid, liquid or gas. An 
FTIR spectrometer simultaneously collects spectral data in a wide spectral range.  
 
Solid samples were prepared by crushing the sample with purified potassium bromide to 
remove scattering effects from large crystals. This powder mixture was then pressed in a 
mechanical press to form a translucent pellet through which the beam of the spectrometer can 
pass. IR spectra of the solids prior and after micronization were obtained in the 4000–400 
cm−1 frequency range. Spectra were collected using a Perkin-Elmer model Spectrum 100 
FTIR spectrophotometer. 
 
• Differential Scanning Calorimetry (DSC)  
A differential scanning calorimeter or DSC is a thermoanalytical apparatus in which the 
difference in the amount of heat required to increase the temperature of a sample and the 
reference is measured as a function of temperature. Both the sample and reference are 
maintained at nearly the same temperature throughout the experiment. DSC curves of the 
solids prior and after micronization were obtained using a TA Instruments DSC model Q10, 
connected to a RCS cooling unit. Tightly sealed aluminum volatile pans were used, in dry 
nitrogen, flowing at 50.0 mL min-1. A MT5 Mettler microbalance was used to weigh the 
samples, ranging between 3 and 10 mg (with an error of ± 0.001 mg). The calorimeter was 
calibrated in temperature using standard samples of In and Sn, supplied by TA Instruments 
(purity > 99.999% and > 99.9%, respectively), and of benzoic acid (purity > 99.97%), 
supplied by the former NBS (lot 39i), and in enthalpy with the In and Sn standards already 
described. 
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• Thermogravimetric Analysis (TGA) 
Thermogravimetric Analysis measures the amount and rate of change in the weight of a 
material as a function of temperature or time in a controlled atmosphere. Measurements are 
used primarily to determine the composition of materials and to predict their thermal stability 
at temperatures up to 1000°C. The technique can characterize materials that exhibit weight 
loss or gain due to decomposition, oxidation, or dehydration. TGA can tell us about: the 
composition of multicomponent systems, thermal stability of materials, oxidative stability of 
materials, estimated lifetime of a product, decomposition kinetics of materials, the effect of 
reactive or corrosive atmospheres on materials, moisture and volatiles content of materials. 
DSC and TGA studies of SAS co-precipitated diflunisal + PVP K-30 from acetone/DCM 
(80:20, v/v %) as well as the pure materials were performed using a Delta Series TA-SDT 
(Simultaneous DSC and TGA) Model Q-600 in nitrogen atmosphere using open aluminum 
crucibles. 
 
• Dissolution Test   
Dissolution tests were carried out in pH 7.4 phosphate buffer medium (0.01 M phosphate 
buffer) using phosphate buffer saline supplied from Sigma-Aldrich. A hydraulic press at 5000 
kg/cm2 was used to prepare compressed disks in similar fashion to those used for IR 
spectroscopy by the conventional procedure; 100 mg of the diflunisal powder were used in 
each case. Bath temperature and paddle speed were set at 100 rpm and 37 °C. Aliquots of 5 
mL were taken at 5, 10, 20, 30, 45, 60, 90, up to 480 min time intervals and analyzed using a 
Perkin-Elmer spectrophotometer  model Lambda 35 at λmax = 275 nm. The volume of the 
solution kept constant by adding 5 mL of the phosphate buffer to solution each time.  
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Thermal Effects in Supercritical Antisolvent Micronizations 
 
4.1 Discussion of Results Already Published for the Solvents Acetone, N,N-
Dimethylformamide, Dimethylsulfoxide and Ethyl Acetate 
As indicated in chapter two of this thesis, the role of thermal effects in SAS 
micronizations has been studied. Since CO2 is fed into the precipitation chamber at a flow rate 
much higher than that of the solution and the solute concentration is very low, the 
contribution to the excess enthalpy due to solute interactions may be neglected and the 
thermal effects in SAS experiments can be considered mainly due to the formation of [CO2 (x) 
+ organic solvent (1-x)] mixtures very rich in carbon dioxide (x ≥ 0.95). In the first step, we 
determined the excess enthalpy data for the CO2 + organic solvent systems typically used in 
these micronizations. In a second step, the interaction between the excess enthalpies and 
phase equilibria in the SAS precipitation chamber has been elucidated. Therefore, the specific 
objectives of this thesis covered in this chapter are: 
 
1. Measurement of Excess Enthalpy Data for Supercritical CO2 + Organic Solvent 
Systems 
Heats of mixing were measured using a high-pressure isothermal flow calorimeter available at 
our laboratory under the conditions of temperature and pressure usually employed in SAS 
micronizations. Since these data are already available for the solvents N-methyl-2-pyrrolidone 
(NMP), ethanol and methanol, the solvents acetone (Ac), N,N-dimethylformamide (DMF), 
dimethylsulfoxide (DMSO) and ethyl acetate (EA) were studied. The excess enthalpy data 
obtained were correlated using cubic equations of state. 
 
    
Ac  DMF  DMSO  EA 
    
C3H6O C3H7NO C2H6OS C4H8O2 
58.08 g/mol 73.09 g/mol  78.13 g/mol    88.105 g/mol 
    
 
Fig. 4.1 Solvents included in this study 
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2. Study of High-Pressure Phase Behavior and Critical Data for Supercritical CO2 + 
Organic Solvent Systems. Interaction between Phase Equilibria and Excess Enthalpies 
during SAS Experiments 
 
The isothermal vapor-liquid equilibrium (VLE) and critical data for the CO2 + organic 
solvent mixtures involved in this study are available in the literature. Nevertheless, critical 
data are scarce. For each system a bibliographic review was carried out. If necessary, critical 
locus and VLE were predicted or calculated using cubic equations of state. Data gathered in 
objectives 1 and 2 were used to discuss the thermodynamic behavior of the mixtures formed 
in the SAS precipitation chamber and the influence of thermal effects on phase equilibria and 
the particles morphology.  
 
This part of the thesis has been already published in references [1-4]. The publications are 
included after this comprehensive discussion. 
 
The high-pressure isothermal flow calorimeter used for these measurements was described 
in detail in chapter three. The conditions for temperature and pressure were 313.15 and 323.15 
K and 9.00, 12.00, 15.00 and 18.00 MPa as well as 333.15 K and 9.00 and 15.00 MPa. By 
combining adequate values for the flow rates of the two pumps the entire mole fraction range 
was covered. Details about the experimental procedure, the source of the densities required to 
convert volume flow rates into molar flow rates and values for the excess molar enthalpy 
( ) can be found in references [1-4]. It is necessary to know the CO2 and organic liquid 
densities at the temperature of the pumps and the pressure of each experiment. Plots of  vs 
CO2 mole fraction (x) are also included in references [1-4]. For the sake of comparison, all the 
results have been combined in Figs. 4.2 - 4.6 together with those obtained for CO2 + NMP at 
the same conditions of temperature and pressure [5]. At each temperature and pressure  
data have been correlated using the Padé functions described in reference [1]. Results from 
these correlations are also shown in Figs. 4.2 - 4.6.  
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Fig. 4.2 Excess molar enthalpies at 313.15 K for the binary systems [CO2(x) + organic solvent (1 − x)] at 9.00 
MPa (blue) and 12.00 MPa (red) for NMP (), Ac (■), DMF (♦), DMSO (●) and EA (★). 
 
Fig. 4.3 Excess molar enthalpies at 313.15 K for the binary systems [CO2(x) + organic solvent (1 − x)] at 15.00 
MPa (green) and 18.00 MPa (orange) for NMP (), Ac (■), DMF (♦), DMSO (●) and EA (★). 
 
Similar trends for the variation of  with mole fraction, temperature and pressure were 
observed for all the CO2 + organic solvent systems studied. In most cases, mixtures showed 
very exothermic mixing.  minimum values may be as low as –4500 J mol-1. For most 
conditions of temperature and pressure, excess molar enthalpies exhibit this minimum in the 
CO2 rich region. For CO2 + DMSO at 333.15 K and 9.00 MPa the minimum appears for x ≈ 
0.5 due to the beginning of a two-phase region in which  varies linearly with x because a 
gaseous and a liquid mixture of fixed composition are at equilibrium. These linear sections 
appear for several conditions of temperature and pressure, and are explained in detail in 
Chapter 4 - Thermal Effects in Supercritical Antisolvent Micronizations 
 
 84 
reference [1]. The liquid and vapor-phase compositions are shown to correspond to the x 
coordinates of the beginning and end of the linear sections. Usually, the CO2 vapor-phase 
composition is very close to one and cannot be established from the calorimetric 
measurements. The liquid phase composition is determined as the intersection of the two Padé 
functions describing the two-phase and the one-phase sections of the isotherm-isobar. The 
values thus obtained are in agreement with vapor-liquid equilibrium data described in the 
literature. Two phase regions have been observed for every system at different T and P 
conditions. 
 
Fig. 4.4 Excess molar enthalpies at 323.15 K for the binary systems [CO2(x) + organic solvent (1 − x)] at 9.00 
MPa (blue) and 12.00 MPa (red) for Ac (■), DMF (♦), DMSO (●) and EA (★). 
 
The effects of temperature and pressure on  are large. For a given system and mole 
fraction, in general, mixtures become less exothermic as pressure increases or temperature 
decreases. The effect of the nature of the organic solvent depends on the conditions of 
temperature and pressure. For instance CO2 + EA mixtures are the most exothermic ones at 
the three temperatures studied and 9.00 MPa. However, at the other pressures studied they 
exhibit values intermediate between those observed for the other systems studied. 
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Fig. 4.5 Excess molar enthalpies at 323.15 K for the binary systems [CO2(x) + organic solvent (1 − x)] at 15.00 
MPa (green) and 18.00 MPa (orange) for Ac (■), DMF (♦), DMSO (●) and EA (★). 
 
Fig. 4.6 Excess molar enthalpies at 333.15 K for the binary systems [CO2(x) + organic solvent (1 − x)] at 9.00 
MPa (blue) and 15.00 MPa (green) for Ac (■), DMF (♦), DMSO (●) and EA (★). 
 
Excess molar enthalpies for CO2 + acetone, DMF, EA or NMP were accurately correlated 
using the Peng-Robinson [6] and Soave-Redlich-Kwong [7] equations of state (EOS), and the 
classical mixing rule with two adjustable binary parameters for each temperature. The 
equations of state and the excess enthalpy calculations are described in detail in sections 3.2.1 
and 3.2.3 of this thesis. As was already discussed in section 3.1.7, the uncertainties in 
temperature, pressure and composition are smaller than those of the excess molar enthalpies 
and a least square-procedure was used to minimize relative deviations between experimental 
and calculated . The source of the critical constants and acentric factors required in this 
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calculation, the values adopted by the binary interaction parameters k12 and δ12, and values for 
the standard deviation between experimental and calculated binary excess enthalpies, σ, for 
each condition of temperature and pressure can be found in references [1, 2, 4 and 5]. These 
parameter values may be used to predict enthalpies in the temperature and pressure intervals 
considered in this study. For the sake of simplicity, results from these calculations are not 
shown in Figs. 4.2 - 4.6; plots including calculated enthalpies can be examined in references 
[1, 2, 4 and 5]. Excess molar enthalpies could not be correlated for the CO2 + DMSO system; 
this could be related to the complex critical behavior exhibited by this system that is discussed 
next in this chapter.  
 
In the case of the CO2 + DMF system, the Peng-Robinson and the Soave-Redlich-Kwong 
EOS were used in conjunction with the classical mixing rules to correlate VLE data for CO2 + 
DMF at 293.95, 313.05 and 338.05 K available in the literature. Phase equilibria calculations 
are described in section 3.2.2. Best results were obtained for the Peng-Robinson EOS. Using 
the 313.05 K set of parameters, this equation was shown to provide a simultaneous and 
accurate description of VLE and critical data for the CO2 + DMF system. On the other hand, 
predictions of excess molar enthalpies using the Peng-Robinson EOS and the 313.05 K set of 
parameters were considerably more accurate than those obtained using the Soave-Redlich-
Kwong EOS. 
 
The trends of the excess enthalpies with temperature and pressure may be analyzed in 
terms of molecular interactions, phase equilibria, density and critical parameters previously 
reported for these systems. A literature search has been carried out and all the available 
information for CO2 + acetone, DMF, DMSO or EA is gathered in references [1-4]. These 
systems have been the subject of numerous investigations due to their relation to supercritical 
fluid applications. The excess molar enthalpy is shown to be the sum of two contributions: 
one contribution is associated to changes in molecular interactions due to the disruption of the 
organic solvent liquid structure by carbon dioxide and the formation of complexes among 
CO2 and the organic solvent molecules. The second contribution to  is due to the carbon 
dioxide change of state from that of a gas-like or liquid-like fluid to that of a liquid mixture 
component. We will refer to these two contributions as the molecular interactions contribution 
and the change of state contribution, respectively.  
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Table 4.1 shows values for the dipole moment of the organic solvents involved in this study at 
ambient temperature. These organic solvents are unassociated but all of them present high 
dipolar moments and solvent structures dominated by dipole-dipole interactions. However, 
carbon dioxide does not have a dipole moment although it does have a relatively large 
quadrupole moment. Table 4.1 also summarizes studies carried out either on the pure liquid 
structure or about the interactions between CO2 and the organic solvent molecules. The high 
dipolar moments lead to highly structured liquids with relatively high densities. In the case of 
NMP, the ring enables an efficient packing and as shown in table 3 of reference [5] NMP 
densities reach a value of 1.02 g mL-1 at 313.15 K and pressures in the 9.00-20.00 MPa range. 
The solvent structure is disrupted upon mixing with carbon dioxide leading to an endothermic 
contribution to . Moderately exothermic enthalpies are the result of a balance between the 
endothermic contribution and an exothermic one due to strong organic solvent- CO2 
interactions. This is the molecular interaction contribution to  that may be expected to 
change only slightly with temperature and pressure. The organic solvent- CO2 interactions 
have been so far studied for acetone, DMSO and EA but similar results may be expected for 
DMF and NMP. 
 
Table 4.1 Dipole moment of the solvents involved in this study and interactions between CO2 
and the organic solvent molecules. 
Solvent Dipole 
momenta /D 
Type of study Main conclusion Reference 
acetone 2.9b 
 
IR spectroscopy and 
ab initio calculations 
Molecular dynamics 
calculation 
Acetone carbonyl atom 
attracts very strongly CO2 
molecules 
Sala et al. [12] 
Aida et al. [13] 
 
DMF 3.9c - -  
DMSO 4.1d Ab initio 
calculations 
S=O bond is involved in 
the CO2-DMSO complex 
Raveendran 
and Wallen 
[14] 
EA 1.9b Molecular dynamics 
calculation 
EA carbonyl atom attracts 
very strongly CO2 
molecules 
Aida et al. [15] 
 
NMP 4.1e 
(303.15 K) 
Pure solvent PVT 
measurements 
NMP presents high 
density because the NMP 
ring enables efficient 
packing 
García et al. 
[16] 
a Dipole moment at 298.15 K, unless otherwise indicated. 
b Poling et al. [8]. 
c Marcus [9].  
d McClellan [10]. 
e Lee and Kumler [11]. 
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In order to analyze the change of state contribution to  we need to consider the state and 
densities of the pure components and those of the mixtures formed in the calorimeter. The 
organic solvents are liquid at the conditions of temperature and pressure of the experiments. 
Their densities have been measured in the intervals of T and P considered in this study. For a 
given solvent, density values vary slightly with temperature and pressure and can be found in 
references [1-4]. However the state and density of carbon dioxide differ to a great extent from 
one (P,T) coordinate to another. Carbon dioxide is a supercritical fluid that may be either a 
high-density (liquid-like) fluid or a low-density (gas-like) fluid. Carbon dioxide densities at 
the P, T conditions of  measurements are listed in table 4.2. For instance, at 323.15 K 
carbon dioxide is a gas-like fluid at 9.00 MPa (ρ = 0.2850 g mL-1) and a liquid-like fluid at 
18.00 MPa (ρ = 0.7571 g mL-1). 
 
Table 4.2 Densities of carbon dioxide at the P and T conditions of  measurements [17]. 
T (K) P (MPa) ρ  (g mL−
1) 
313.15 9 
12 
15 
18 
0.4855 
0.7178 
0.7802 
0.8195 
323.15 9 
12 
15 
18 
0.2850 
0.5847 
0.6998 
0.7571 
333.15 9 
15 
0.2354 
0.6041 
 
 
The state of the mixtures formed in the calorimeter (liquid, fluid, two-phase) may be 
established by examining the situation of the (P, T) coordinate with respect to the system 
critical locus and taking into account the critical composition and the vapor-liquid equilibrium 
data. The CO2 + NMP, CO2 + acetone, CO2 + DMF and CO2 + EA systems exhibit type I 
critical behavior in the classification of Scott and van Konynenburg [18]. Several authors 
have reported critical data for CO2 + acetone in the 304 to 350 K interval and Ziegler et al. 
[19] also reported data covering the entire composition range. There is a good agreement 
between the different sets of data. In Fig. 4 (a) of ref. [1] the complete P-T projection of the 
critical locus is shown for this system; in Fig. 4 (b) the locus obtained by a linear regression of 
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data available in the 304 to 350 K interval is shown together with the temperature and 
pressure coordinates where experimental  data were taken. 
 
For the systems CO2 + NMP, CO2 + DMF and CO2 + EA there is only one set of critical 
data. In these cases, the P-T projections of the critical locus were calculated using these data 
and the Peng-Robinson equation of state. The critical locus calculation is described in section 
3.2.3. P-T projections are shown in Fig. 4 of reference [2] and [3] and Fig. 5 of reference [5]. 
In all these plots the (P, T) coordinates for  measurements are indicated so that the state of 
the mixtures formed in the calorimeter may be established. As discussed in detail in reference 
[3], the critical behavior of the CO2 + DMSO system is more complicate; it belongs either to 
type III or IV in the Scott and van Konynenburg classification; more data in the lower 
temperature range are required to reach a definitive conclusion. Equation-of-state calculations 
for this system do not lead to a good agreement with experimental data. However, the gas-
liquid critical data taken by González et al. [20] and Chiu et al. [21] shown in Fig. 2 of 
reference [3] may be used to establish the state of the mixtures formed in the calorimeter.  
 
It turns out that most mixtures formed in the calorimeter are either liquid or a gaseous and 
a liquid mixture in equilibrium. Only mixtures very rich in CO2 are fluid; this type of 
mixtures are confined to such a narrow mole fraction range that very few experimental  
data could have been taken in this region. In most cases, the fluid carbon dioxide mixes with 
the liquid solvent forming a liquid mixture or the gaseous and liquid mixtures in equilibrium. 
As a consequence of the CO2 change of state, this contribution to the excess enthalpy is 
exothermic and becomes increasingly exothermic when low-density CO2 is mixed. This effect 
is sometimes called the fluid condensation effect. When carbon dioxide enters the calorimeter 
as a liquid-like fluid, the change-of-state contribution to  is small and excess molar 
enthalpy values may be considered mainly the result of the molecular interactions 
contribution to . When carbon dioxide enters the calorimeter as a gas-like fluid, the fluid 
condensation effect is very pronounced and the change-of-state contribution to  is 
extremely exothermic. As a result, the excess molar enthalpy may reach values of – 4500 J 
mol–1. A detailed discussion for each binary system studied may be found in references [1-4]. 
 
For a given temperature, pressure and mole fraction the variations due to the organic 
solvent nature observed may be attributed to the type of critical diagram and differences in 
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intermolecular interactions in the pure liquid and the mixtures. These differences lead to 
varying values for the molecular interactions contribution to . However, the magnitude of 
the change-of-state contribution may be expected to be rather similar for the different solvents 
at a given temperature, pressure and mole fraction when no phase equilibria are involved. 
 
Mixtures formed by supercritical CO2 and an organic polar solvent are involved in several 
supercritical applications. Their role in supercritical antisolvent precipitation (SAS) was 
already explained in the introduction chapter. They are also involved in other supercritical or 
near critical crystallization processes such as the Gas antisolvent (GAS) and the 
Depressurization of an Expanded Liquid Organic Solution (DELOS) techniques described in 
chapter one. Organic polar solvents such as NMP or DMF are used in polymer solutions when 
membranes are formed using supercritical carbon dioxide to induce the phase separation. On 
the other hand, CO2-expanded using these solvents is also used as reaction media. Examples 
of these applications are found in references [1-4]. The excess enthalpy data reported in this 
thesis may be used to model or optimize these processes. However, the aim of this study is to 
understand the interaction between phase equilibria and excess enthalpies during SAS 
experiments. The extremely exothermic values obtained at many of the P, T conditions 
studied are likely to influence other magnitudes of the system.  
 
As was already pointed out in chapter one, the phase behavior of the CO2 + organic 
solvent is one of the crucial factors governing the morphology and the mean size of particles 
obtained in the SAS process. The presence of the solute can induce modifications in the phase 
diagram. This is the case of polymers; however, when the solute has little interaction with 
carbon dioxide the ternary phase diagram for the low solute concentrations usually employed 
in SAS is coincident with the binary one in the CO2-rich region which is the region for 
mixtures involved in SAS. Therefore, the mixtures formed in the precipitation chamber may 
be treated as binary CO2 + organic solvent systems. The heat evolved when the supercritical 
CO2 dissolves into the organic solution has an important role in the phase behavior. The 
temperature control in the precipitation chamber is not very precise and the local temperature 
increase may lead to T and P conditions where phase splitting takes place. 
 
Since CO2 is fed into the chamber at a flow rate much higher than that of the solution and 
the solute concentration is very low, the contribution to  due to solute interactions may be 
neglected and the thermal effects in SAS experiments can be considered mainly due to the 
Chapter 4 - Thermal Effects in Supercritical Antisolvent Micronizations 
 
 91 
formation of CO2 + organic solvent mixtures very rich in carbon dioxide (x ≥ 0.95). 
Consequently, the temperature increase ΔT may be estimated using the  data reported in 
this thesis. Since carbon dioxide is the predominant component in these mixtures, its isobaric 
heat capacity [22] was used to calculate the local temperature increase assuming an adiabatic 
process and using  correlation equations to evaluate the heat evolved when a mol of 
mixture is formed. Values for ΔT thus obtained are shown in table 3 of reference [1] for x = 
0.95, in table 3 of reference [3] for the x interval 0.95-0.98 and in table 3 of reference [4] for x 
= 0.95. An examination of these values together with literature vapor-liquid equilibrium data 
indicates how the heat evolved upon mixing affects the phase behavior. For instance, at x = 
0.95, P = 9.00 MPa and T = 313.15 or 323.15 K carbon dioxide and EA are completely 
miscible (see Fig. 4.7) and the values estimated for the temperature increase are 7.1 and 8.3 K, 
respectively. A 8.3 K local temperature increase at 323.15 K and 9.00 MPa would induce 
immiscibility because the new isotherm is close to that shown in Fig. 4.7 at T = 333.15 K. The 
7.1 K local temperature increase at 313.15 K and 9.00 MPa would approach precipitation 
conditions to the critical locus or even induce immiscibility for the CO2-rich mixtures formed 
in the SAS experiments. In both cases the particle morphology would not correspond to that 
expected in a supercritical phase. This effect is a consequence of the enlargement of the 
immiscibility window as the temperature increases. 
 
Fig. 4.7 Isothermal vapor-liquid equilibrium for the binary system [CO2 (x) + EA (1-x)] reported by Byun et al. 
[23] (Δ, 313.15 K; □, 333.15 K) and Borges et al. [24] (▲, 313.15 K; , 323.15 K; , 333.15 K), pressure 
condition of  measurements (⋅ ⋅ ⋅ ⋅), and critical line (- - -) based on critical data reported by Byun et al. [23] 
(). 
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The enthalpy effect on the phase equilibria has been clearly shown in SAS micronizations 
using DMSO as the polar solvent. Reverchon et al. [25] precipitated YAc from its DMSO 
solutions using CO2 as the antisolvent agent at 313.15, 323.15 and 333.15 K, x = 0.98 and 
pressures up to 16.0 MPa. A windowed vessel was used to observe the phase behavior of the 
[CO2 (x) + DMSO (1-x)] mixtures formed in the precipitation chamber. Immiscibility was 
observed for initial temperature and pressure conditions where one supercritical phase was 
expected according to the phase equilibria data available for this system. By measuring the 
excess molar enthalpies for CO2 + DMSO mixtures at these T and P conditions and carrying 
out ΔT calculations similar to those above described, we have shown that Reverchon et al. 
phase equilibria observations may be a consequence of temperature increases due to the 
enthalpy effect. Fig. 4.8 shows VLE and critical data for the CO2 + DMSO system in the 
temperature interval 309.41 - 348.15 K. 
 
Fig. 4.8 (Fig. 2 in ref. [3]). Isothermal vapor-liquid equilibrium and critical data for the binary system [CO2(x) + 
dimethylsulfoxide (1–x)] reported by González et al. [20]: (), 309.41 K; () 314.49 K; (), 321.28 K; () 
328.94 K, and Chiu et al. [21]: () 318.15 K; () 328.95 K; () 338.15 K; () 348.15 K, critical line (− − −), 
and pressure conditions of SAS experiments carried out by Reverchon et al. [25] at 313.15 K using DMSO (⋅ ⋅ ⋅). 
 
According to González et al. [20] the critical temperature and pressure for x = 0.98 are 
314.9 K and 8.65 MPa. At 313.15 K and 1.36 wt% of YAc in DMSO, Reverchon et al. 
reported two phases and agglomerated nanoparticles at 7.5 MPa, two phases and a mixture of 
nanoparticles and microparticles at 9.0 MPa, one phase and balloon-like particles at 9.5 MPa 
and one phase and uniform nanoparticles from 10 to 15 MPa. An inspection of Fig. 4.7 
indicates that one phase should have been observed already at 9.00 MPa. However, the 
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temperature increase of 2.9 K calculated for these x, P and T conditions explains the 
immiscibility observed for mixtures formed in the SAS experiments and a particle 
morphology that does not correspond to the uniform nanoparticles expected in a supercritical 
phase. As the pressure rises for this condition of temperature, the heat evolved upon mixing 
and the local temperature increase are of smaller magnitude and the phase behavior is not 
affected. Similar effects are observed for experiments carried out by Reverchon et al. at 
323.15 and 333.15 K.  
 
Chang et al. used DMSO as a solvent in the SAS precipitation of α-chymotrypsin [26] and 
lysozyme [27] at 308.15, 318.15, 328.15 and 338.15 K and pressures up to 20 MPa (see Fig. 
1.13). In both cases agglomerated or irregular particles are obtained at pressures below 10 
MPa when the considerable heat evolved may lead to a local temperature increase in the 
precipitator. The very exothermic  values correlate with T and P conditions where 
micronization is less successful. The solubility of both proteins in CO2 and its concentration 
in the solution are very low and the binary phase diagram shown in Fig. 4.8 may be used to 
discuss results. For instance, in the case of lysozyme at 308.15 K for identical values of 
lysozyme concentration, capillary size, and CO2 and solution flow rates, irregular 
nanoparticles are obtained at 8.5, 10, and 12 MPa and uniform nanoparticles are obtained at 
15 and 20 MPa. At this temperature one phase is already expected at 8.5 MPa and at 10 and 
12 MPa particle morphologies should correspond to the uniform nanoparticles expected for 
the supercritical region well above the critical boundary. As mentioned in chapter one, there 
are other factors that may simultaneously influence the particle morphology but the heat 
evolved upon mixing CO2 and the polar solvent is shown to play an important role. By 
modifying the phase equilibria, excess molar enthalpies will affect the particle precipitation 
mechanism. 
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Excess Molar Enthalpies of CO2 + Acetone at Pressures from (9.00 to 18.00) MPa
and Temperatures from (313.15 to 333.15) K
Fouad Zahran, Concepcio´n Pando,* Juan A. R. Renuncio, and Albertina Caban˜as
Departamento de Quı´mica Fı´sica I, Universidad Complutense, E-28040 Madrid, Spain
Mixtures of supercritical CO2 and acetone are very often involved in supercritical fluid applications, and
their thermodynamic properties are required to understand and design these processes. Excess molar enthalpies
(HmE ) for CO2 + acetone mixtures were measured using an isothermal high-pressure flow calorimeter under
conditions of temperature and pressure typically used in supercritical processes: pressures from (9.00 to
18.00) MPa and temperatures from (313.15 to 333.15) K. Mixtures showed exothermic mixing; excess
molar enthalpies exhibited a minimum in the CO2-rich region. The effects of pressure and temperature on
the excess molar enthalpy of CO2 + acetone are large. The most exothermic HmE values were observed for
a coincident CO2 mole fraction value of 0.771 at (323.15 and 333.15) K and 9.00 MPa: (-4176 and -4366)
J ·mol-1, respectively. Two-phase vapor-liquid CO2-rich regions are observed at (323.15 and 333.15) K
and 9.00 MPa where HmE linearly varies with CO2 mole fraction. For a given mole fraction and temperature,
mixtures become more exothermic as pressure decreases. These trends were analyzed in terms of molecular
interactions, phase equilibria, density, and critical parameters previously reported for CO2 + acetone. Excess
molar enthalpies here reported were correlated using the Peng-Robinson equation of state and the classical
mixing rule with two binary interaction parameters. The influence of the thermal effects on the phase behavior
of CO2 + acetone mixtures formed in supercritical antisolvent precipitation experiments was discussed.
Introduction
The mixtures formed by supercritical carbon dioxide and
organic solvents such as acetone have received considerable
attention in the recent past due to the advantages of CO2 over
conventional organic solvents and its numerous applications in
sustainable chemistry.1 Supercritical carbon dioxide is often
promoted as a green solvent since it is nontoxic, has low cost,
is nonflammable, and allows operation at low temperatures and
moderate pressures (Tc ) 304.1 K, Pc ) 7.38 MPa).2 Carbon
dioxide physical properties such as density, viscosity, and
diffusion coefficient may be varied continuously from liquid-
like to gas-like values by simply changing pressure and
temperature conditions. Furthermore, a small amount of an
organic polar solvent such as acetone may be added to the pure
supercritical fluid to increase the solute solubility and/or
selectivity in extraction applications.
Mixtures formed by supercritical CO2 and acetone are also
used in the micronization of solutes such as polymers, phar-
maceutical compounds, explosives, and colorants. The so-called
supercritical antisolvent precipitation (SAS) is based on using
supercritical carbon dioxide as an antisolvent to induce con-
trolled precipitation of solutes from their organic solvent
solutions thanks to the relatively low solvent power of CO2 for
these solutes and its good miscibility with many organic
solvents. SAS precipitation has been extensively used during
the last years, and several reviews are available.3-6 When the
supercritical antisolvent dissolves in the organic solvent, the
liquid experiences a volumetric expansion and becomes a bad
solvent for the solute that precipitates from the solution in micro-
and nanoparticles. Other typical polar organic solvents used are
dimethylsulfoxide, N,N-dimethylformamide, dichloromethane,
and N-methyl-2-pyrrolidone. On the other hand, CO2-expanded
solvents may also be used as reaction media.7
The numerous applications of mixtures formed by supercriti-
cal carbon dioxide and acetone have prompted researchers like
Sala et al.8 to undertake their study from a fundamental point
of view. On the other hand, the physical and thermodynamic
properties of the CO2 + organic polar solvent mixtures are also
required to understand and design supercritical fluid applications.
Consequently, the high-pressure density and phase behavior and
the volumetric expansion of CO2 + acetone mixtures have
received considerable attention in the last years.9-23 However,
not much attention has been paid to the heat evolved when
supercritical CO2 dissolves into the organic solvent. The excess
molar enthalpies (HmE ) at these conditions can be quite high.
Thus, thermal effects during this process have an effect on the
phase separation path and must be considered to optimize
precipitation and reaction conditions. In a previous study,24 HmE
values for CO2 + N-methyl-2-pyrrolidone mixtures were
reported at (313.15 and 338.15) K and (9.48, 15.00, and 20.00)
MPa. Furthermore, the relationship between thermal effects and
phase behavior and coalescence phenomena observed in SAS
micronization of several antibiotics was discussed. In this paper,
we report excess molar enthalpies for the binary system CO2 +
acetone under conditions of temperature and pressure typically
used in supercritical CO2 applications: (313.15 and 323.15) K
and (9.00, 12.00, 15.00, and 18.00) MPa and 333.15 K and (9.00
and 15.00) MPa. The excess enthalpy data for mixtures of
CO2 and acetone will be analyzed in terms of molecular
interactions, phase equilibria, and density data and critical
parameters. The influence of these thermal effects on the phase
behavior of mixtures formed in the precipitation chamber in
SAS experiments will be examined.
* Corresponding author. Phone: +34 91394 4304. Fax: +34 91394 4135.
E-mail: pando@ quim.ucm.es.
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Experimental Section
The materials employed were CO2 (Air Liquide, 99.98 % in
mole) and acetone (Sigma-Aldrich, 99.9 % in mole). Com-
mercial materials were used without further purification.
An isothermal high-pressure flow calorimeter (Hart Sci-
entific model 7501) was used to perform HmE measurements.
The calorimeter was first described by Christensen et al.,25
and the experimental procedure is described elsewhere.24 The
reactants were pumped into the calorimetric cell by two
thermostatted syringe pumps (model: LC-2600, ISCO) at
constant flow rates. The temperature of the pumps was
controlled within ( 0.02 K. Volume flow rates were selected
to cover the entire concentration range. For each pump, the
uncertainty in the volume flow rate was obtained by a
previous calibration. The flow rate stability was ( 1 % over
the total volume of the cylinder. The calorimetric cell was
located in a silicon bath in which temperature was controlled
within ( 0.001 K. A Peltier cooling device and a pulsed
heater kept the cell under isothermal conditions. The pulse
energy was determined by a previous heater calibration based
on the Joule effect. The pressure was measured using a
calibrated pressure transducer (Lucas Schaevitz, model P721-
0001). A back-pressure regulator located outside the calo-
rimeter kept the pressure within ( 0.01 MPa.
All runs were made in the steady-state fixed composition
mode. Measurements at all the P and T conditions studied
were carried out at total volume flow rates of (0.0014 and
0.0028) cm3 · s-1. The CO2 mole fraction range is covered
by combining adequate values for the flow rates of the two
pumps at these total volume flow rates. Also, the coincidence
within the experimental error of results obtained using
different total flow rates is an indication of equilibrium
conditions in the calorimeter. The volume flow rates were
converted to molar flow rates using the densities and molar
masses. CO2 densities at the temperature and pressure of the
pumps were obtained from NIST webbook.26 Acetone densi-
ties were obtained from the Tait equation provided by Adams
and Laidler.27 Since densities are affected by temperature
and pressure changes, the error in molar flow rates was
derived taking into account contributions from variations in
volume flow rates, pressure, and pumps temperature. The
mole fraction precision is based on the error in molar flow
rates and was estimated to be better than ( 0.001. The error
in HmE was obtained taking into account contributions from
molar flow rates, pulse energy, and frequency and was
estimated to be ( 1 % or at least ( 1 J ·mol-1. Periodically,
HmE values obtained using this calorimeter for the ethanol +
H2O system at 323.15 K and 15.00 MPa were compared to
those previously reported by Ott et al.28 This set of data has
been proposed as a reference for isothermal dilution and flow
calorimeters.29
Results and Discussion
HmE data for the binary system [CO2(x) + acetone(1 - x)]
were determined at (313.15 and 323.15) K and (9.00, 12.00,
15.00, and 18.00) MPa as well as at 333.15 K and (9.00 and
15.00) MPa over the entire composition range and are given
in Table 1. Figures 1 to 3 show plots of HmE vs CO2 mole
fraction at (313.15, 323.15, and 333.15) K, respectively. For
comparison purposes, the same scale has been used for HmE
in Figures 1 to 3.
Similar trends are observed for the variation of HmE with
mole fraction and pressure. For a given mole fraction and
temperature, mixtures become increasingly exothermic as the
pressure decreases. At each condition of temperature and
pressure, excess molar enthalpies exhibit a minimum in the
CO2-rich region. As the temperature increases for a given
mole fraction and pressure, mixtures show more exothermic
mixing. The most exothermic HmE values were observed at
9.00 MPa and (323.15 and 333.15) K. Minimum values of
Table 1. Excess Molar Enthalpy, HmE , for the Binary System
[CO2(x) + Acetone(1 - x)]
HmE HmE HmE
x J ·mol-1 x J ·mol-1 x J ·mol-1
T/K ) 313.15; P/MPa ) 9.00
0.095 -454 0.507 -2023 0.900 -2038
0.180 -935 0.586 -2226 0.938 -1736
0.246 -1202 0.662 -2288 0.969 -1202
0.337 -1494 0.771 -2366
0.432 -1864 0.840 -2234
T/K ) 313.15, P/MPa ) 12.00
0.108 -323 0.395 -1049 0.781 -1201
0.189 -574 0.464 -1167 0.847 -1025
0.258 -732 0.562 -1284 0.911 -736
0.332 -922 0.675 -1321 0.971 -256
T/K ) 313.15, P/MPa ) 15.00
0.111 -277 0.530 -1000 0.852 -724
0.194 -457 0.586 -1021 0.913 -499
0.264 -621 0.647 -1019 0.943 -364
0.340 -760 0.719 -980 0.972 -191
0.456 -906 0.787 -887
T/K ) 313.15, P/MPa ) 18.00
0.114 -264 0.479 -846 0.855 -569
0.198 -417 0.577 -898 0.915 -383
0.269 -541 0.652 -919 0.956 -218
0.346 -672 0.724 -857
0.410 -781 0.791 -722
T/K ) 323.15, P/MPa ) 9.00
0.102 -728 0.507 -3132 0.840 -4050
0.158 -1096 0.586 -3491 0.906 -3434
0.246 -1699 0.699 -4003 0.938 -2609
0.319 -2142 0.771 -4176 0.969 -1132
0.424 -2689 0.805 -4174
T/K ) 323.15, P/MPa ) 12.00
0.108 -403 0.438 -1471 0.801 -1719
0.209 -761 0.562 -1687 0.879 -1389
0.305 -1062 0.646 -1771 0.941 -933
0.351 -1213 0.747 -1796 0.971 -553
T/K ) 323.15, P/MPa ) 15.00
0.111 -308 0.530 -1186 0.913 -651
0.194 -531 0.609 -1244 0.943 -490
0.264 -714 0.683 -1240 0.972 -265
0.359 -905 0.787 -1122
0.473 -1118 0.852 -932
T/K ) 323.15, P/MPa ) 18.00
0.114 -271 0.577 -1039 0.915 -453
0.219 -518 0.652 -1025 0.944 -324
0.318 -729 0.724 -967 0.973 -186
0.410 -883 0.791 -857
0.479 -974 0.855 -698
T/K ) 333.15, P/MPa ) 9.00
0.102 -753 0.424 -2938 0.771 -4366
0.180 -1309 0.507 -3347 0.807 -4196
0.246 -1776 0.625 -4010 0.906 -2031
0.337 -2389 0.699 -4272 0.938 -1210
T/K ) 333.15, P/MPa ) 15.00
0.111 -371 0.609 -1524 0.915 -844
0.215 -677 0.683 -1558 0.943 -653
0.312 -941 0.753 -1505 0.972 -342
0.404 -1191 0.820 -1296
0.489 -1363 0.883 -1039
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(-4176 and -4366) J ·mol-1 are reached, respectively, at
these two temperatures for mixtures with a coincident CO2
mole fraction value of 0.771. On the other hand, a linear
section is observed in the HmE vs CO2 mole fraction plot at
these conditions of temperature and pressure. At 9.00 MPa
and 323.15 K, this linear section is confined in the CO2-rich
region (x > 0.931). However, at 9.00 MPa and 333.15 K the
linear section includes mixtures with x > 0.788. HmE varies
linearly with CO2 mole fraction due to the appearance of a
two-phase region where a gaseous and a liquid mixture of
fixed compositions, for a given condition of temperature and
pressure, are in equilibrium. For a mixture of global
composition x, the enthalpy effect in the two-phase region
is the sum of two contributions due to the nl moles of liquid
mixture of composition xl and nv moles of vapor mixture of
composition xv
where Hm,lE is the excess molar enthalpy of the liquid mixture
and Hm,vE is the excess molar enthalpy of the vapor mixture.
Equation 1 may rewritten as24
Since Hm,lE , Hm,vE , xl, and xV have constant values for each
isotherm, the second member of eq 2 is a first-degree
polynomial in x. When x ) xl, HmE ) Hm,lE , and when x ) xv,
HmE ) Hm,vE . Therefore, the liquid- and vapor-phase composi-
tions are shown to correspond to the x coordinates of the
beginning and the end of the linear sections shown in Figures
2 and 3. A considerable amount of acetone may be present
in the liquid mixture, but only a very small amount is
dissolved in the vapor phase; in both linear sections, the CO2
vapor-phase composition is very close to one and cannot be
established from the calorimetric measurements. Two-phase
regions do not appear for the other conditions of temperature and
pressure studied in this paper. This is in agreement with high-
pressure phase equilibria data previously reported for CO2 +
acetone at the same or similar temperatures.9,13,16-19,21,23 The
only exception is the data reported by Han et al. at 333.15
K.20
HmE data for [CO2 (x) + acetone (1 - x)] were fitted to an (n,
m) Pade´ function given by
where Ai and Bj are adjustable coefficients. A least-squares
procedure was used to minimize deviations between experi-
mental and calculated excess molar enthalpies. For those
conditions of temperature and pressure where phase-splitting
occurs, two different sets of coefficients are used to represent
data in the two-phase and one-phase region, respectively. In
the linear section, a (1, 2) Pade´ function with fixed values for
the denominator coefficients, B1 ) 0 and B2 ) -1, may be
used to keep the weight factor x (1 - x). This results in a first-
degree polynomial in the composition variable: the slope is A1/
2, and the zero intercept is (A0 - A1)/4. The HmE representation
using eq 3 is shown in Figures 1 to 3. Table 2 lists values for
the coefficients Ai and Bj and the standard deviation between
experimental and calculated HmE values. The beginning of the
linear section shown in Table 2 at (323.15 and 333.15) K and
9.00 MPa provides the value for the liquid-phase composition
in the two-phase region.
The excess molar enthalpies of CO2 + acetone were also
calculated using the Peng-Robinson (PR) equation of state.30
Figure 1. Excess molar enthalpies, HmE , for the binary system [CO2(x) +
acetone(1 - x)] at 313.15 K and: 9, 9.00 MPa; b, 12.00 MPa; 2, 15.00
MPa; f, 18.00 MPa; s, calculated using eq 3 and coefficients given in
Table 2; - - -, calculated using the Peng-Robinson equation of state.30
Figure 2. Excess molar enthalpies, HmE , for the binary system [CO2(x) +
acetone(1 - x)] at 323.15 K and: 9, 9.00 MPa; b, 12.00 MPa; 2, 15.00
MPa; f, 18.00 MPa; s, calculated using eq 3 and coefficients given in
Table 2; - - -, calculated using the Peng-Robinson equation of state.30
Figure 3. Excess molar enthalpies, HmE , for the binary system [CO2(x) +
acetone(1 - x)] at 333.15 K and: 9, 9.00 MPa; 2 15.00 MPa;s, calculated
using eq 3 and coefficients given in Table 2; - - -, calculated using the
Peng-Robinson equation of state.30
Hm
E ) Hm,l
E
nl + Hm,v
E
nV (1)
Hm
E ) Hm,v
E +
x - xv
xl - xv
(Hm,lE - Hm,vE ) (2)
Hm
E ) x(1 - x)
∑
i)0
n
Ai(2x - 1)i
1 + ∑
j)1
m
Bj(2x - 1)j
(3)
Journal of Chemical & Engineering Data, Vol. 55, No. 9, 2010 3651
99
The excess molar enthalpy for a binary mixture is given
by
where HmR is the residual molar enthalpy of the mixture and
Hm,iR is that of pure components. The residual molar enthalpy
is given by
where z is the compressibility factor. The equation-of-state
parameters a and b were evaluated for the mixtures using
the classical mixing rule given by the equations
where kij ) kji and δij ) δij are binary interaction parameters.
Values for the pure component parameters a and b were
calculated using the acentric factor and the critical constants
values given by Poling et al.2 HmE data taken in the one-phase
region at each of the three temperatures considered were
simultaneously correlated using eqs 4 to 6. As was already
discussed in the Experimental Section, the uncertainties in
temperature, pressure, and composition are smaller than those
of the excess molar enthalpies, and a least-squares-procedure
was used to minimize relative deviations between experi-
mental and calculated HmE . Table 3 lists values adopted by
the binary interaction parameters k12 and δ12 and values for
the standard deviation between experimental and calculated
binary excess enthalpies, σ, for each condition of temperature
and pressure. Results from the PR correlations are shown in
Figures 1 to 3. A comparison of values for σ and the
maximum absolute value of HmE for each condition of
temperature and pressure indicates that relative deviations
are larger for the 313.15 K correlation. The correlations are
accurate at the higher temperatures of (323.15 and 333.15)
K, thus allowing the prediction of excess molar enthalpies
at temperatures and pressures in the T ) (323.15 to 333.15)
K and P ) (9.00 to 18.00) MPa intervals.
The large effects of pressure and temperature on the excess
molar enthalpy values are related to changes in the state and
densities of the pure components and their mixtures. The CO2
+ acetone system presents a liquid-gas type I diagram in the
classification of Scott and van Konynenburg.31 Figure 4 shows
the P, T projection of CO2 + acetone critical locus and the
conditions of temperature and pressure for the experimental HmE
data reported in this paper. The curve shown in Figure 4a
covering the entire composition range was reported by Ziegler
et al.10 Several other authors reported critical data for CO2-rich
mixtures. In the T ) (304 to 350) K interval, Pc varies linearly
with Tc, and there is good agreement between literature critical
data. The line shown in Figure 4b was obtained by a linear
regression of data reported by Ziegler et al.,10 Adrian and
Maurer,13 Reaves et al.,15 Chen et al.,18 and Chiu et al.23 in
this temperature interval. The state of the mixtures formed in
the calorimeter (liquid, fluid, two-phase) may be established
using Figure 4b and taking into account the critical composition
and vapor-liquid equilibrium data.9,13,16,9,21,23 At the conditions
of HmE measurements, acetone is a liquid (Tc ) 508.1 K, Pc )
4.70 MPa),2 and its density does not change to a great extent
with temperature and pressure.27 However, carbon dioxide may
be either a high-density (liquid-like) fluid or a low-density (gas-
like) fluid. Densities of carbon dioxide are listed in Table 3.
When carbon dioxide and acetone are mixed at 313.15 K and
pressures greater than 9.00 MPa, carbon dioxide is a liquid-
like fluid, and the resulting mixtures are mostly liquid. Critical
data indicate that fluid mixtures are confined to a very narrow
mole fraction range where x > 0.975. HmE values are moderately
exothermic. The change-of-state contribution to HmE is small,
and excess molar enthalpy values may be considered mainly
the result of the molecular interaction contribution to HmE .
Acetone presents a solvent structure dominated by dipole-dipole
Table 2. Coefficients Ai and Bj and Standard Deviation, σ, for Least-Squares Representation of HmE (J ·mol-1) for [CO2 (x) + Acetone (1 - x)]
at (313.15, 323.15, and 333.15) K using Equation 3
T P
K MPa interval A0 A1 A2 A3 A4 B1 B2 σ
313.15 9.00 0 e x e 1 -8088.28 2551.90 98.842 0 -26.213 -0.92178 0 7.3
12.00 0 e x e 1 -4857.29 -2573.23 -1795.62 -1155.02 0 0 0 3.0
15.00 0 e x e 1 -3858.17 -1754.55 -929.53 -659.27 0 0 0 1.8
18.00 0 e x e 1 -3464.80 -1695.88 -296.08 441.31 0 0 0 2.7
323.15 9.00 0 e x e 0.938 -12389.48 -9127.38 -9809.38 -15590.29 -11435.57 0 0 9.7
0.938e x e 1 -83430.12 83644.97 0 0 0 0 -1 6.6
12.00 0 e x e 1 -6385.06 -3743.81 -1717.40 -4039.31 -4543.33 0 0 5.5
15.00 0 e x e 1 -4587.26 -2440.15 -1537.87 -1157.72 0 0 0 2.5
18.00 0 e x e 1 -3951.52 -1883.26 -493.40 0 0 0 0 2.6
333.15 9.00 0 e x e 0.807 -13340.27 -11369.69 -12569.90 -8530.71 0 0 0 8.1
0.807e x e 1 -43631.78 43866.78 0 0 0 0 -1 4.6
15.00 0 e x e 1 -5504.58 -3473.48 -2375.90 -1348.43 0 0 0 5.3
Hm
E ) Hm
R(mixture) - ∑
i
xiHm,i
R (4)
Hm
R ) RT(z - 1) + ∫
∞
V [T(∂P∂T )V - P]dV (5)
a ) ∑
i
∑
j
xixjaij; aij ) (aiiajj)1/2(1 - kij)
b ) ∑
i
∑
j
xixjbij; bij )
(bii + bjj)
2 (1 - δij)
(6)
Table 3. Densities of Carbon Dioxide,26 Estimated Temperature
Increments at Mixing, and Correlation of HmE Data for Carbon
Dioxide + Acetone Binary Mixtures at (313.15, 323.15, and 333.15)
K Using the PR Equation of State: Binary Parameters k12 and δ12
and Standard Deviation Between Experimental and Calculated
Excess Enthalpies, σ
T P FCO2 ∆T PR
K MPa g · cm-3 K k12 δ12 σ/J ·mol-1
313.15 9.00 0.4855 6.1 0.1127 0.0862 260
12.00 0.7178 2.4 55
15.00 0.7802 2.7 110
18.00 0.8195 2.2 160
323.15 9.00 0.2850 11 0.0644 0.0478 78
12.00 0.5847 5.1 110
15.00 0.6998 3.1 36
18.00 0.7571 2.5 62
333.15 9.00 0.2354 9.4 0.0405 0.0312 140
15.00 0.6041 3.6 88
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interactions that is disrupted upon mixing with carbon dioxide
leading to an endothermic contribution to HmE . Moderately
exothermic enthalpies are the result of a balance between the
endothermic contribution and an exothermic one due to strong
DMF-CO2 interactions. This molecular interaction contribution
may be expected to change only slightly with temperature and
pressure in the intervals considered in this study. Mixing at
313.15 K and 9.00 MPa becomes considerably more exothermic
as a result of combining a gas-like carbon dioxide with a liquid
acetone to obtain liquid mixtures. The contribution to HmE due
to intermolecular interactions is combined with another exo-
thermic contribution due to the CO2 change of state from that
of a gas-like fluid to that of a liquid mixture component. This
fluid condensation effect is even more pronounced at (323.15
or 333.15) K and 9.00 MPa when acetone is mixed with a fluid
of very low density, and the resulting mixtures are a liquid or
a gaseous and a liquid mixture in equilibrium. Fluid mixtures
are also confined to a narrow mole fraction range at these
conditions of temperature and pressure. Minimum values of
(-4176 and -4366) J ·mol-1 are reached for x ≈ 0.8 at 9.00
MPa and (323.15 and 333.15) K, respectively. As the pressure
is increased from (9.00 to 18.00) MPa at (323.15 or 333.15) K,
carbon dioxide density increases, reaching values typical of a
liquid at (15.00 or 18.00) MPa, and mixing becomes much less
exothermic than that observed at the same temperature and 9.00
MPa.
Several authors32-37 have pointed out that the phase behavior
of CO2 + organic solvent is one of the crucial factors governing
the morphology and the mean size of particles obtained in the
SAS process. The presence of the solute can induce modifica-
tions in the phase diagram. This is the case of polymers;
however, when the solute has little interaction with carbon
dioxide, the ternary phase diagram for the low solute concentra-
tions usually employed in SAS is coincident with the binary
one in the CO2-rich region which is the region for mixtures
involved in SAS.33 Therefore, the mixtures formed in the
precipitation chamber may be treated as binary CO2 + organic
solvent systems. In general, nanoparticles are obtained when
the precipitation is carried out in the supercritical region. The
uniformity of the resulting products becomes worse when the
precipitation conditions approach the critical locus. Irregular
microscale aggregated particles are formed in the vapor region,
and both dense cake and spherical clusters are produced in the
vapor-liquid region. The heat evolved when the supercritical
CO2 dissolves into the organic solution has an important role
in the phase behavior. The temperature control in the precipita-
tion chamber is not very precise, and the local temperature
increase may lead to T and P conditions where phase splitting
takes place. Since CO2 is fed into the chamber at a flow rate
much higher than that of the solution and the solute concentra-
tion is very low, the contribution to HmE due to solute interactions
may be neglected, and the thermal effect in SAS experiments
can be considered mainly due to the formation of CO2 + acetone
mixtures very rich in carbon dioxide (x g 0.95). Consequently,
the temperature increase ∆T may be estimated using the HmE
data reported in this paper. Since carbon dioxide is the
predominant component in these mixtures, its isobaric heat
capacity38 was used to calculate the local temperature increase
assuming an adiabatic process and using eq 3 to evaluate the
heat evolved when a mole of mixture of composition x ) 0.95
is formed. Values for ∆T thus obtained are shown in Table 3.
An examination of these values together with literature
vapor-liquid equilibrium data indicates how the heat evolved
upon mixing affects the phase behavior. For instance, at 313.15
K and 9.00 MPa or at 323.15 K and 12.00 MPa carbon dioxide
and acetone are completely miscible. However, a (6.1 or 5.1)
K local temperature increase would approach precipitation
conditions to the critical locus or even induce immiscibility for
CO2-rich mixtures formed in the SAS experiments, and the
particle morphology would not correspond to that expected in
a supercritical phase.
Conclusions
Excess molar enthalpies for mixtures of supercritical CO2 and
acetone were measured at (313.15 and 323.15) K and (9.00,
12.00, 15.00, and 18.00) MPa and 333.15 K and (9.00 and
15.00) MPa. The CO2 + acetone system presents immiscibility
at (323.15 and 333.15) K and 9.00 MPa; in this range, HmE varies
linearly with mole fraction due to vapor-liquid equilibria.
The effects of pressure and temperature on the excess molar
enthalpy are large. HmE values are exothermic at all the conditions
of temperature and pressure studied and become extremely
exothermic when low-density supercritical carbon dioxide is
mixed with the liquid acetone and the resulting mixture is a
liquid or a gaseous and a liquid mixture in equilibrium.
Excess molar enthalpies for CO2 + acetone can be correlated
using the PR equation of state and the classical mixing rule
with two adjustable binary parameters for each temperature (T
) (313.15, 323.15, and 333.15) K) in the P ) (9.00 to 18.00)
MPa interval.
Thermal effects in SAS experiments are shown to modify
the phase behavior of CO2 + acetone mixtures formed in the
precipitation chamber thus affecting the morphology of the
particles.
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a b s t r a c t
Mixtures of supercritical CO2 and N,N-dimethylformamide (DMF) are very often involved in supercriti-
cal ﬂuid applications and their thermodynamic properties are required to understand and design these
processes. Excess molar enthalpies (HEm) for CO2 +DMF mixtures were measured using an isothermal
high-pressure ﬂow calorimeter under conditions of temperature and pressure typically used in super-
critical processes: 313.15 and 323.15K at 9.00, 12.00, 15.00 and 18.00MPa and 333.15K at 9.00 and
15.00MPa. The Peng–Robinson and the Soave–Redlich–Kwong equations of state were used in conjunc-
tion with the classical mixing rules to model the literature vapor–liquid equilibrium and critical data and
the excess enthalpy data. In most cases, CO2 +DMF mixtures showed very exothermic mixing and excess
molar enthalpies exhibited a minimum in the CO2-rich region. The lowest HEm value (−4526 Jmol−1)
was observed for a CO2 mole fraction value of 0.713 at 9.00MPa and 333.15K. On the other hand, HEm
at 9.00MPa and 323.15 and 333.15K varies linearly with CO2 mole fraction in the two-phase region
where a gaseous and a liquid mixture of ﬁxed composition are in equilibrium. The effects of pressure
and temperature on the excess molar enthalpy are large. For a given mole fraction, mixtures become less
exothermic as pressure increases or temperature decreases. These excess enthalpy data were analyzed
in terms of molecular interactions, phase equilibria, density and critical parameters previously reported
for CO2 +DMF. All throughout this paper, the key concepts and modeling tools originate from the work
of van der Waals: the paper is intended as a small piece of recognition of van der Waals overwhelming
ynamcontributions to thermod
. Introduction
The mixtures formed by supercritical carbon dioxide and
rganic solvents have received considerable attention in the recent
ast due to the advantages of CO2 over conventional organic sol-
ents and its numerous technological applications [1]. Supercritical
arbon dioxide is a non toxic, low cost, non ﬂammable solvent
hat allows operation at low temperatures and moderate pressures
Tc = 304.1K, Pc = 7.38MPa [2]). Carbon dioxide physical properties
uch as density, viscosity, and diffusion coefﬁcient may be varied
ontinuously from liquid-like to gas-like values by simply changing
ressure and temperature conditions. Furthermore, a small amount
f an organic polar solvent may be added to the pure supercriti-
∗ Corresponding author at: Departamento de Química Física I, Facultad C. Quími-
as, Universidad Complutense, E-28040 Madrid, Spain. Tel.: +34 91394 4304;
ax: +34 91394 4135.
E-mail addresses: pando@quim.ucm.es (C. Pando), renuncio@quim.ucm.es
J.A.R. Renuncio).
896-8446/$ – see front matter © 2010 Elsevier B.V. All rights reserved.
oi:10.1016/j.supﬂu.2010.09.020
103ics.
© 2010 Elsevier B.V. All rights reserved.
cal ﬂuid to increase the solute solubility and/or selectivity. These
compounds are referred to as cosolvents, modiﬁers or entrainers
and their mixtures with CO2 are of interest in applications such as
extraction or chromatography.
N,N-dimethylformamide (DMF) is a dipolar aprotic and unasso-
ciated solvent. Thanks to its high dipolar moment and moderately
high dielectric constant (=3.8D, ε=36.76 at 298.15K [3]), DMF is
a powerful organic solvent that may be used in combination with
carbon dioxide in a variety of processes. CO2 +DMF mixtures are
involved in the micronization of solutes such as polymers, phar-
maceutical compounds, explosives and colorants. The so-called
gas antisolvent (GAS) or supercritical antisolvent (SAS) precipita-
tion is based on the relatively low solvent power of CO2 for these
solutes and its good miscibility with many organic solvents such
as DMF [4,5]. When the supercritical antisolvent dissolves in the
organic solvent, the liquid experiences a volumetric expansion and
becomesabad solvent for the solute thatprecipitates fromthe solu-
tion in micro and nanoparticles. There are many examples of DMF
use in GAS or SAS micronization and in other material process-
ing [4–8]. Charoenchaitrakool et al. recently proposed to extract an
ritical Fluids 55 (2010) 566–572 567
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Fig. 1. Excess molar enthalpies, HEm , for the binary system [CO2 (x) +N,N-F. Zahran et al. / J. of Superc
ctive ingredient found in vegetable leaves using DMF followed by
GAS precipitation to isolate the natural product [9]. DMF is also
sedasa solvent inpolymer solutionswhenmembranesare formed
sing supercritical carbon dioxide to induce the phase separation
10]. The mutual afﬁnity between the solvent and the antisolvent is
key factor in this application. On the other hand, CO2-expanded
MF has been also used as reaction media [11,12]. In order to
ully understand and design these processes, themeasurement and
odeling of properties for the CO2 +organic polar solventmixtures
re required
The physical and thermodynamic properties of CO2 +DMF mix-
ures have been the subject of several investigations. Chang et
l. [13] measured solubilities of CO2 in DMF and liquid densities
rom 290.8 to 310.1K at pressures up to 7.82MPa. Kordikowski et
l. [14] reported isothermal vapor–liquid equilibria (VLE, bubble
oints), liquid densities and volume expansions at 298.15, 303.15
nd 313.15K. Duran-Valencia et al. [15] measured the isothermal
LE data (bubble and dew points) at 293.95, 313.05 and 338.05K.
yunet al. [16] reported isothermalVLEdata (mostlybubblepoints)
nd values for the mixture critical parameters in the 318.2–398.2K
emperature interval and found that the critical locus is a type I
n the Scott and van Konynenburg classiﬁcation [17]. The phase
iagrams in the critical region were ﬁrst predicted by van der
aals using his equation of state. Zún˜iga-Moreno and Galicia-Luna
18] measured compressed liquid densities and excess volumes in
he 313.2–362.7K interval at pressures up to 25MPa. Modeling of
hese VLE data has been carried out using cubic equations of state
EOS) that are derived directly from the van der Waals equation.
hang et al. used the Patel–Teja EOS [19] and Kordikowski et al.,
uran-Valencia et al. and Byun et al. used the Peng–Robinson EOS
20].
To the best of our knowledge, no attention has been paid to
he heat evolved when supercritical CO2 dissolves into the liq-
id DMF. The excess molar enthalpies (HEm) at these conditions
an be quite high and must be considered in order to under-
tand and optimize supercritical ﬂuid applications. In a previous
tudy [21], HEm values for CO2 +N-methyl-2-pyrrolidone (NMP)
ixtures were reported at 313.15 and 338.15K and 9.48, 15.00 and
0.00MPa. NMP is another organic polar solvent frequently used
n the SAS and GAS micronizations and in the formation of poly-
eric membranes. Exothermic HEm values were observed at all the
onditions of temperature andpressure studied. The lowestHEm val-
es (≈−4500 Jmol−1) were observed for mixtures at 338.15K and
.48MPa. These thermal effects were shown to play an important
ole in supercritical antisolvent micronizations using NMP.
In this paper, we report excess molar enthalpies for the binary
ystem CO2 +DMF under conditions of temperature and pres-
ure typically used in supercritical CO2 applications: 313.15 and
23.15K and 9.00, 12.00, 15.00 and 18.00MPa as well as 333.15K
nd 9.00 and 15.00MPa. Using concepts introduced and devel-
ped by van der Waals, these HEm data will be analyzed taking into
ccount molecular interactions, phase equilibria and density data,
nd critical properties. On the other hand, the Peng–Robinson and
he Soave–Redlich–Kwong EOS [20,22] will be used to model the
iterature VLE and critical data together with the excess enthalpy
ata. The extension of these equations of state to mixtures will be
arried out by means of the classical mixing rules ﬁrst proposed
y van der Waals to evaluate the parameters a and b. Both in the
alculations and discussion, the key concepts and modeling tools
sed in this paper originate from the ideas of van der Waals. As
very worker in the ﬁeld of thermodynamics, we feel very much
ndebted to his pioneering work and breakthrough contributions.
t is an honor for us to participate in this issue commemorating
he 100 year anniversary of Johannes Diderik van der Waals Nobel
rize for Physics and to join other colleagues in the homage to this
xtraordinary scientist.
104dimethylformamide (1− x)] versus CO2 mole fraction at 313.15K and: () 9.00MPa;
() 12.00MPa; () 15.00MPa; () 18.00MPa; (—), calculated using Eq. (4) and coef-
ﬁcients given in Table 2; (- - -), calculated using the Peng–Robinson EOS [20] and
values for the binary parameters k12 and ı12 given in Table 4.
2. Experimental
Thematerials employedwere CO2 (Air Liquide 99.98mol% pure)
and DMF (Sigma–Aldrich, 99.8mol% pure). Commercial materials
were used without further puriﬁcation.
An isothermal high-pressure ﬂow calorimeter (Hart Scien-
tiﬁc model 7501) was used to perform HEm measurements. The
calorimeter was ﬁrst described by Christensen et al. [23] and the
experimental procedure is described elsewhere [21]. The reac-
tants were pumped into the calorimetric cell by two thermostatted
pumps (ISCO, model LC-2600) at constant ﬂow rates. The tem-
perature of the pumps, 313.15K, was controlled within ±0.02K.
Volume ﬂow rates were selected to cover the entire concentration
range. For each pump, the uncertainty in the volume ﬂow rate was
obtainedbyaprevious calibration. The calorimetric cellwas located
into a silicon bath in which temperature was controlled within
±0.001K. A Peltier cooling device and a pulsed heater kept the
cell under isothermal conditions. The pulse energywas determined
by a heater calibration. The pressure was measured using a cali-
brated pressure transducer (Lucas Schaevitz, model P721-0001). A
back-pressure regulator located outside the calorimeter kept the
pressure within ±0.01MPa.
All runs were made in the steady-state ﬁxed composition mode.
Measurementswere carriedout at total volumeﬂowrates of 0.0014
and0.0028 cm3 s−1. The volumeﬂowrateswere converted tomolar
ﬂow rates using the densities and molar masses. CO2 densities at
the temperature and pressure of the pumps were obtained from
NIST [24]. DMF densities were obtained from data reported by
Zún˜iga-Moreno and Galicia-Luna [18]. Since densities are affected
by temperature and pressure changes, the error in molar ﬂow
rates was derived taking into account contributions from varia-
tions in volume ﬂow rates, pressure, and pumps temperature. The
mole fraction precision is based on the error in molar ﬂow rates
and was estimated to be better than ±0.001. The error in HEm was
obtained taking into account contributions from molar ﬂow rates,
pulse energy and frequency andwas estimated to be ±1% or at least
±1 Jmol−1.
3. Experimental results
HEm data for thebinary system [CO2 (x) +DMF (1− x)]weredeter-
mined at 313.15 and 323.15K and 9.00, 12.00, 15.00 and 18.00MPa
aswell at 333.15K and9.00 and15.00MPaover the entire composi-
tion rangeandaregiven inTable1. Figs. 1–3 showplots ofHEm versus
CO2 mole fraction at 313.15, 323.15 and 333.15K, respectively.
For comparison purposes the same scale has been used for HEm in
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Table 1
Excess molar enthalpy, HEm , for the binary system [CO2 (x) +DMF (1− x)].
x HEm (Jmol
−1) x HEm (Jmol
−1) x HEm (Jmol
−1)
313.15K and 9.00MPa
0.108 −465 0.564 −2390 0.848 −2643
0.259 −1209 0.640 −2586 0.911 −2284
0.352 −1622 0.713 −2719 0.942 −2028
0.483 −2181 0.782 −2779 0.968 −1587
313.15K and 12.00MPa
0.114 −368 0.577 −1520 0.855 −1287
0.219 −716 0.689 −1597 0.915 −991
0.365 −1094 0.758 −1542 0.944 −771
0.479 −1380 0.791 −1478 0.973 −443
313.15K and 15.00MPa
0.117 −303 0.545 −1285 0.859 −985
0.225 −583 0.623 −1329 0.918 −690
0.325 −839 0.696 −1290 0.946 −512
0.418 −1066 0.731 −1265 0.973 −259
0.504 −1228 0.797 −1152
313.15K and 18.00MPa
0.120 −294 0.511 −1086 0.862 −824
0.230 −554 0.629 −1154 0.906 −644
0.331 −763 0.701 −1116 0.950 −405
0.424 −958 0.801 −1002 0.974 −223
323.15K and 9.00MPa
0.108 −789 0.564 −3592 0.911 −2592
0.210 −1535 0.640 −3935 0.942 −1817
0.306 −2163 0.713 −4106 0.971 −940
0.397 −2756 0.782 −4185
0.483 −3241 0.848 −4158
323.15K and 12.00MPa
0.114 −408 0.577 −2026 0.915 −1543
0.219 −812 0.653 −2126 0.944 −1274
0.318 −1175 0.724 −2161 0.973 −769
0.410 −1551 0.791 −2100
0.496 −1831 0.855 −1898
323.15K and 15.00MPa
0.117 −361 0.545 −1468 0.918 −906
0.225 −684 0.660 −1551 0.946 −674
0.325 −980 0.731 −1527 0.973 −388
0.418 −1177 0.797 −1431
0.488 −1372 0.859 −1248
323.15K and 18.00MPa
0.120 −313 0.591 −1270 0.920 −638
0.230 −606 0.666 −1299 0.950 −462
0.331 −833 0.736 −1252 0.974 −248
0.424 −1018 0.801 −1121
0.494 −1151 0.862 −939
333.15K and 9.00MPa
0.108 −881 0.483 −3566 0.782 −3478
0.210 −1672 0.564 −3996 0.848 −2383
0.306 −2427 0.640 −4315 0.911 −1365
0.397 −3039 0.713 −4526 0.942 −893
333.15K and 15.00MPa
0.117 −487 0.585 −1877 0.918 −1203
0.225 −864 0.696 −1955 0.946 −928
0.325 −1189 0.764 −1909 0.973 −512
0.418 −1468 0.810 −1789
t
m
r
a
g
i
t
a
i
ﬁ
s
c
t0.504 −1717 0.859
hese plots. At each condition of temperature and pressure, excess
olar enthalpies are exothermic and exhibit minima in the CO2-
ich region. Minima values range from −1154 Jmol−1 at 313.15K
nd 18.00MPa to −4526 Jmol−1 at 333.15K and 9.00MPa. For a
iven mole fraction, mixtures become less exothermic as pressure
ncreases or temperature decreases. On the other hand, a linear sec-
ion is observed in the HEm versus CO2 mole fraction plot at 9.00MPa
nd 323.15 and 333.15K. HEm varies linearly with CO2 mole fraction
n the two-phase region where a gaseous and a liquid mixture of
xed compositions, for a given condition of temperature and pres-
ure, are in equilibrium. Since a mixture of global composition x
onsists of amounts of substance nl of liquid mixture of composi-
ion xl and nv of vapor mixture of composition xv, the excess molar
105−1586
enthalpy in the two-phase region may be expressed as
HEm = HEm,l nl + HEm,v nv (1)
where HE
m,l is the excess molar enthalpy of the liquid mixture, and
HEm,v is the excess molar enthalpy of the vapor mixture. Both H
E
m,l
and HEm,v have as initial states the carbon dioxide and DMF entering
the calorimeter. Therefore, the contributions to the enthalpy due to
changes of state are included in HE
m,l and H
E
m,v. Values of nl and nv
are related to the mole fractions xl, xv and x by the relations:
xl nl + xv nv = x(nl + nv)
(1 − xl)nl + (1 − xv)nv = (1 − x)(nl + nv)
(2)
F. Zahran et al. / J. of Supercritical
0.0 0.2 0.4 0.6 0.8 1.0
-5000
-4000
-3000
-2000
-1000
0
X
H
E m
(J
m
o
l-
1
)
Fig. 2. Excess molar enthalpies, HEm , for the binary system [CO2 (x) +N,N-
dimethylformamide (1− x)] versus CO2 mole fraction at 323.15K and: () 9.00MPa;
() 12.00MPa; () 15.00MPa; () 18.00MPa; (—), calculated using Eq. (4) and coef-
ﬁcients given in Table 2; (- - -), calculated using the Peng–Robinson EOS [20] and
values for the binary parameters k12 and ı12 given in Table 4.
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Fig. 3. Excess molar enthalpies, HEm , for the binary system [CO2 (x) +N,N-
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Cimethylformamide (1− x)] versus CO2 mole fraction at 333.15K and: () 9.00MPa;
) 15.00MPa; (—), calculated using Eq. (4) and coefﬁcients given in Table 2; (- - -),
alculated using the Peng–Robinson EOS [20] and values for the binary parameters
12 and ı12 given in Table 4.
Based on Eqs. (1) and (2) and taking into account that for 1mol
f mixture nl +nv = 1, the excess molar enthalpy may be expressed
s
E
m = HEm,v +
x − xv
xl − xv
(HEm,l − HEm,v) (3)
Since HE
m,l, H
E
m,v, xl and xv have constant values for each
sotherm, the secondmember of Eq. (3) is a ﬁrst-degree polynomial
n x. When x= xl, HEm = HEm,l and when x= xv, HEm = HEm,v. Therefore,
he liquid and vapor-phase compositions are shown to correspond
o the x coordinates of the beginning and the end of the linear
ections shown in Figs. 2 and 3. A considerable amount of DMF
able 2
oefﬁcients Ai and Bj and standard deviation, , for least-squares representation of HEm (J
T (K) P (MPa) Interval A0 A1
313.15 9.00 0≤ x≤1 −8871.76 1313
12.00 0≤ x≤1 −5652.54 1102
15.00 0≤ x≤1 −4842.21 976
18.00 0≤ x≤1 −4246.99 738
323.15 9.00 0≤ x≤0.848 −13368.24 2973
0.848≤ x≤1 −52953.53 51970
12.00 0≤ x≤1 −7318.19 426
15.00 0≤ x≤1 −5516.23 539
18.00 0≤ x≤1 −4635.05 −730
333.15 9.00 0≤ x≤0.713 −14660.71 614
0.713≤ x≤1 −32248.60 32535
15.00 0≤ x≤1 −6765.07 −284
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is present in the liquid mixture but only a very small amount is
dissolved in the vapor phase; the CO2 vapor-phase composition is
very close to one and cannot be established from the calorimet-
ric measurements. The linear sections at 323.15 and 333.15K and
9.00MPa are in agreement with isothermal VLE data previously
reported for CO2 +DMF by Kordikowski et al., Duran-Valencia et al.
and Byun et al. [14–16]. As could be expected from the phase equi-
libria data and may be observed in Figs. 1–3, two-phase regions do
not appear when the pressure is raised from 9.00 to 12.00, 15.00 or
18.00MPa at the three temperatures studied. Similar trends in the
variation of HEm with temperature and pressure were observed for
the CO2 +N-methyl-2-pyrrolidonemixtures at 313.15 and 338.15K
in the 9.48–20.00MPa pressure range [21].
HEm data for [CO2 (x) +DMF (1− x)] were ﬁtted to a (n, m) Padé
function given by
HEm = x(1 − x)
∑n
i=0Ai(2x − 1)
i
1 +∑mj=1Bj(2x − 1)j (4)
where Ai and Bj are adjustable coefﬁcients. A least-square proce-
dure was used to minimize deviations between experimental and
calculated excess molar enthalpies. For those conditions of tem-
perature and pressure where phase-splitting occurs, two different
sets of coefﬁcients are used to represent data in the two-phase
and one-phase region, respectively. In the linear section, a (1, 2)
Padé function with ﬁxed values for the denominator coefﬁcients,
B1 = 0 and B2 =−1, may be used in order to keep the weight factor
x (1− x). This results in a ﬁrst-degree polynomial in the composi-
tion variable; the slope is A1/2 and the zero intercept is (A0 −A1)/4.
The HEm representation using Eq. (4) is shown in Figs. 1–3. Table 2
lists values for the coefﬁcients Ai and Bj and the standard devia-
tion between experimental and calculated HEm values at 313.15 and
323.15K and 9.00, 12.00, 15.00 and 18.00MPa and 333.15K and
9.00 and 15.00MPa. The beginning of the linear sections shown in
Table 2 at 9.00MPa and 323.15 and 333.15K provides the value for
the liquid-phase composition in the two-phase region.
4. Calculation of the phase equilibria and the critical locus
using a cubic equation of state
The Peng–Robinson and the Soave–Redlich–Kwong EOS [20,22]
were used to correlate the isothermal VLE data reported by Duran-
Valencia et al. at 293.95, 313.05 and 338.05K [15]. These are the
most comprehensive sets of VLE data found in the literature for
this system and include a good description of both liquid and vapor
phase compositions. The equation-of state parameters a and bwere
evaluated for the mixtures using the classical mixing rules given by
mol−1) for [CO2 (x) +DMF (1− x)] at 313.15, 323.15K and 333.15K using Eq. (4).
A2 A3 B1 B2 
.48 1998.24 – −0.94369 – 7.6
.22 945.15 – −0.81944 – 3.1
.61 1617.01 – −0.81600 – 3.4
.28 937.22 5.70 −0.73901 – 2.5
.08 2268.22 – −0.98209 – 4.6
.61 – – 0 −1 23
.10 2210.92 – −0.83108 −0.05328 4.3
.98 855.15 – −0.75408 – 3.3
.27 – – −0.47876 – 2.4
.57 – – −0.81603 – 5.2
.42 – – 0 −1 5.9
.02 – – −0.70723 – 4.6
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Table 3
Correlation and prediction of VLE data for the CO2 +DMF system at 293.95, 313.05 and 338.05K [15] using the Peng–Robinson and the Soave–Redlich–Kwong EOS: binary
parameters k12 and ı12, standard deviation between experimental and calculated CO2 compositions, , and standard deviation between experimental and calculated total
pressure, P.
T (K) Peng–Robinson correlation Soave–Redlich–Kwong correlation
k12 ı12  P (MPa) k12 ı12  P (MPa)
293.95 0.0470 0.0025 0.012 0.042 0.0412 −0.0013 0.014 0.053
313.05 0.0228 −0.0269 0.024 0.20 0.0004 0.0196 0.062 0.60
338.05 0.0473 −0.0102 0.006 0.071 0.0471 −0.0086 0.006 0.077
Prediction using the 313.05 K set of parameters
Peng–Robinson Soave–Redlich–Kwong
(MPa
13
37
t
w
c
g
P
b
T
i
a
a
c
3
u
d
l
E
e
s
u
s
t
i
e
c
F
(
wk12 ı12  P
293.95 0.0228 −0.0269 0.026 0.
338.05 0.0228 −0.0269 0.027 0.
he equations:
a =
∑
i
∑
j
xixjaij; aij = (aiiajj)1/2(1 − kij)
b =
∑
i
∑
j
xixjbij; bij =
(bii + bjj)
2
(1 − ıij)
(5)
here kij = kji and ıij = ıij are binary interaction parameters.
Values for the pure component parameters a and b were cal-
ulated using the acentric factor and the critical constants values
iven by Poling et al. [2] for carbon dioxide and those given by
erry and Green for DMF [25]. The PE 2000 program developed
y G. Brunner and coworkers was used in this calculation [26].
able 3 lists for each temperature values adopted by the binary
nteraction parameters k12 and ı12, values for the standard devi-
tion between experimental and calculated CO2 compositions, ,
nd values for the standard deviation between experimental and
alculated total pressures, P. Maximum total pressures at 293.95,
13.05 and338.05K are 5.13, 7.51 and11.51MPa, respectively. Val-
es of k12 and ı12 obtained at 313.05Kwere alsoused topredict VLE
ata at 293.05 and 338.05K. For both correlations and predictions,
ower deviations were obtained by means of the Peng–Robinson
OS. This equation together with the 313.05K set of binary param-
ters provides a good description of VLE at the three temperatures
tudied and was also used to predict the CO2 +DMF critical locus
sing the procedure described by Heidemann and Khalil [27]. Fig. 4
hows the P, T projection of the critical locus, the conditions of
emperature and pressure for the experimental HEm data reported
n this paper and the experimental critical points reported by Byun
t al. [16] for the mixture. CO2 mole fraction values for the criti-
al data range from 0.994 at 318.2K to 0.898 at 398.2K. The type
300 400 500 600 700
0
3
6
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12
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21
24
(a)
DMFCO2
T (K)
P(
M
P
a
)
ig. 4. P, T projection of the CO2 +DMF critical locus showing (a) the CO2 and DMF critic
), the critical line calculated by means of the Peng–Robinson EOS [20] and the 313.05K
here experimental HEm data were taken in this study ().
10) k12 ı12  P (MPa)
0.0004 0.0196 0.061 0.39
0.0004 0.0196 0.061 0.93
I critical curve was obtained by means of the Peng–Robinson EOS
[20] used in conjunction with the classical mixing rules and the
313.05K set of binary parameters given in Table 3. This EOS pro-
vided a better description of the mixture critical data than that of
the Soave–Redlich–Kwong EOS [22].
5. Calculation and discussion of the excess molar enthalpies
The large effects of pressure and temperature on the excess
molar enthalpy values are related to changes in molecular inter-
actions and the state and densities of the pure components and
their mixtures. At the conditions of HEm measurements, DMF is a
liquid and its density does not change to a great extent with tem-
perature and pressure in the intervals considered in this paper.
However, carbon dioxide is a supercritical ﬂuid that may be either
a high-density (liquid-like) ﬂuid or a low-density (gas-like) ﬂuid.
Table 4 lists the densities of the pure components obtained from
the sources described in Section 2. The state of themixturesmay be
established using Fig. 4 and Byun et al. critical data [16]. When car-
bon dioxide and DMF are mixed at 313.15K and 9.00MPa, carbon
dioxide is a gas-like ﬂuid and the resulting mixtures are mostly
liquid. Byun et al. data indicate that ﬂuid mixtures are conﬁned
to a very narrow mole fraction range in the carbon dioxide rich
region. These negative HEm values are a consequence of two contri-
butions: (a) changes inmolecular interactions due to the disruption
of the DMF structure by the carbon dioxide and the new DMF–CO2
interactions, and (b) the CO2 change of state from that of a gas-like
ﬂuid to that of liquidmixture component. The latter is the so-called
ﬂuid condensation effect that has been reported for other similar
mixtures [21]. When the pressure is increased at this temperature,
CO2 density rises considerably and the ﬂuid condensation effect
300 310 320 330 340 350
6
9
12
15
18
(b)
CO2
P
(M
P
a
)
T (K)
al points (©), the critical temperatures and pressures reported by Byun et al. [16]
binary interaction parameters given in Table 3 (- - -) and (b) the (P, T) coordinates
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Table 4
Carbon dioxide and N,N-dimethylformamide experimental densities [18,24] and prediction and correlation of HEm data for their binary mixtures at 313.15, 323.15 and
333.15K using the Peng–Robinson and the Soave–Redlich–Kwong EOS: binary parameters k12 and ı12, standard deviation between experimental and correlated binary
excess enthalpies, cor (Jmol−1), and standard deviation between experimental and predicted binary excess enthalpies, pre (Jmol−1).
T (K) P (MPa) CO2 (g cm
−3) DMF (g cm−3) Soave–Redlich–Kwong Peng–Robinson
k12 ı12 cor pre k12 ı12 cor pre
313.15 9.00 0.4855 0.9356 0.1150 0.0656 350 910 0.1206 0.0693 360 420
12.00 0.7178 0.9375 70 550 70 260
15.00 0.7802 0.9394 150 420 160 350
18.00 0.8195 0.9412 190 330 200 370
323.15 9.00 0.2850 0.9263 0.1017 0.0531 140 690 0.1057 0.0554 120 280
12.00 0.5847 0.9283 110 630 120 240
0.
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a15.00 0.6998 0.9303
18.00 0.7571 0.9322
333.15 9.00 0.2354 0.9171 0.0992
15.00 0.6041 0.9212
ecomes negligible. The intermolecular-interactions contribution
o HEm may be expected to remain approximately the same at a
iven temperature in this range of pressure. As a consequence, val-
es of HEm at 313.15K become much less exothermic as pressures
ises.
When carbon dioxide and DMF are mixed at 323.15 or 333.15K
nd 9.00MPa, carbon dioxide is a gas-like ﬂuid and its density is
uch lower than that at 313.15K and 9.00MPa. The resulting mix-
ures are liquid or a gaseous and a liquid mixture in equilibrium.
heﬂuidcondensationeffectbecomesvery important andmixtures
howextremely exothermicmixing:minimum HEm values of−4185
nd−4526 Jmol−1 are reachedat 323.15and333.15K, respectively.
s the pressure is increased at 323.15 or 333.15K, CO2 densities
harply increase and HEm values become less exothermic.
The excess molar enthalpies of CO2 +DMF were also calculated
sing Peng–Robinson and the Soave–Redlich–Kwong EOS [20,22]
nd the classical mixing rules. The excess molar enthalpy for a
inary mixture is given by
E
m = HRm(mixture) −
∑
i
xi H
R
m,i (6)
here HRm is the residual molar enthalpy of the mixture and H
R
m,i
is
hat of pure components. The residual molar enthalpy is given by
R
m = RT(z − 1) +
∫ V
∞
[
T
(
∂P
∂T
)
V
− P
]
dV (7)
here z is the compressibility factor. HEm data taken in the one-
hase region at 313.15, 323.15 and 333.15K were predicted using
he binary interactions parameters obtained from VLE data taken
t 313.05K. HEm data were also simultaneously correlated using
qs. (5)–(7). As was already discussed in Section 2, the uncertain-
ies in temperature, pressure and composition are smaller than
hose of the excess molar enthalpies and a least square-procedure
as used to minimize relative deviations between experimen-
al and calculated HEm. Table 4 lists values adopted by the binary
nteraction parameters k12 and ı12 and values for the standard
eviation between experimental and correlated binary excess
nthalpies, cor, and the standard deviation between experimen-
al and predicted binary excess enthalpies, pre, for each condition
f temperature and pressure. Values for k12 and ı12 are higher
han those obtained in VLE data correlations. Values for cor are
f similar magnitude for the two equations of state used. How-
ver, values obtained for pre are considerable smaller when the
eng–Robinson EOS is used. A comparison of values for cor and
pre and the maximum absolute value of HEm for each condition
f temperature and pressure indicates that relative deviations are
arger at 313.15K. Both predictions and correlations become more
ccurate as temperature increases. This may be also observed in
10878 490 74 270
130 420 130 300
0547 32 450 0.1040 0.0577 38 340
55 520 53 260
Figs. 1–3where results fromthePeng–RobinsonEOScorrelationare
shown. Values for k12 and ı12 reported in Table 4 at 313.15, 323.15
and 333.15K may be used to calculate HEm at each temperature in
the 9.00–18.00MPa or 9.00–15.00MPa pressure intervals.
6. Conclusions
Excess molar enthalpies for mixtures of supercritical CO2
and DMF were measured at T=313.15, 323.15 and 333.15K in
the 9.00–18.00MPa pressure range over the entire composition
range. The CO2 +DMF system presents immiscibility at 323.15 and
333.15K and 9.00MPa; in this range HEm varies linearly with mole
fraction due to vapor–liquid equilibria. The effects of pressure and
temperature on the excess molar enthalpy are large. Excess molar
enthalpies are exothermic at all the conditions of temperature and
pressure studied and become extremely exothermic (minimum HEm
values of −4185 and −4526 Jmol−1) when low-density supercriti-
cal carbon dioxide is mixed with the liquid DMF and the resulting
mixture is a liquid or a gaseous and a liquid mixture in equilibrium.
The Peng–Robinson and the Soave–Redlich–Kwong EOS [20,22]
were used in conjunction with the classical mixing rules to corre-
late VLE data for CO2 +DMF at 293.95, 313.05 and 338.05K [15].
The best results were obtained for the Peng–Robinson EOS. Using
the 313.05K set of parameters, this equation was shown to provide
a simultaneous and accurate description of VLE and critical data
for the CO2 +DMF system. On the other hand, predictions of excess
molar enthalpiesusing thePeng–RobinsonEOSand the313.05K set
of parameters are considerably more accurate than those obtained
using the Soave–Redlich–Kwong EOS. HEm data may be also cor-
related by means of the cubic EOS. Using the higher values thus
obtained for the k12 and ı12 interaction parameters, excess molar
enthalpies may be calculated at temperatures and pressures in the
T= (313.15–333.15)K and P= (9.00–18.00)MPa intervals. As tem-
perature increases both predictions and correlations become more
accurate.
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The  role  of  excess  molar  enthalpies  (HEm)  in the  supercritical  antisolvent  (SAS)  micronizations  using
dimethylsulfoxide  (DMSO)  as  the  polar  solvent  was  investigated.  Excess  molar  enthalpies  for  CO2 +  DMSO
mixtures  were  measured  using  an isothermal  high-pressure  ﬂow  calorimeter  under  conditions  of temper-eywords:
upercritical carbon dioxide
imethylsulfoxide
xcess molar enthalpies
upercritical antisolvent precipitation
ature  and  pressure  typically  used  in SAS  micronizations.  In most  cases,  mixtures  showed  very exothermic
mixing.  A  local  temperature  increase  can be expected  in  the  precipitation  chamber  as a consequence  of the
heat  evolved  when  CO2 dissolves  in  DMSO.  Based  on  the  HEm measurements,  local  temperature  increases
were  calculated  and  shown  to explain  immiscibility  of CO2 and  DMSO  and  agglomerated  or  irregular
particles  for  average  temperature  and  pressure  conditions  where  complete  miscibility  and  uniform  par-
ticles  could  have  been  expected.  HEm data  were  also  discussed  in terms  of  molecular  interactions,  phase
itical  hase equilibria equilibria,  density  and  cr
. Introduction
Supercritical antisolvent (SAS) micronization has been exten-
ively used during the last years to obtain micro and nanoparticles
ith controlled particle size and morphology [1–4]. This approach
s based on the relatively low solvent power of CO2 for solutes
uch as polymers, pharmaceutical compounds, explosives or
olorants and its good miscibility with many polar organic
olvents. Typical solvents used are acetone, dimethylsulfox-
de,  N,N-dimethylformamide, dichloromethane and N-methyl-2-
yrrolidone. Supercritical carbon dioxide is used as an antisolvent:
pon CO2 solution, the liquid experiences a volumetric expan-
ion and becomes a bad solvent for the solute that precipitates
rom the organic solution. The role of phase equilibria, jet mix-
ng and mass transfer in these micronizations has been analyzed
nd several authors have pointed out that the phase behavior of
O2 + organic solvent is one of the crucial factors governing the
orphology and the mean size of particles obtained in the SAS pro-
ess [5–10]. Consequently, the high-pressure phase behavior and
olumetric expansion of these mixtures have received considerable
ttention. However, no much attention has been paid to the heat
volved when supercritical CO2 dissolves into the organic solvent.
o the best of our knowledge, only Dukhin et al. [11,12] have taken
∗ Corresponding author at: Departamento de Química Física I, Facultad C. Quími-
as,  Universidad Complutense, E-28040 Madrid, Spain. Tel.: +34 91394 4304;
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11parameters  previously  reported  for CO2 + DMSO.
© 2011 Elsevier B.V. All rights reserved.
into account these heats or mixing or excess molar enthalpies (HEm)
that can be quite high at these conditions. Thus, thermal effects
during this process have an effect on the phase separation path
and must be considered in order to fully understand SAS processes
and optimize micronization conditions. Since CO2 is fed into the
precipitation chamber at a ﬂow rate much higher than that of the
solution and the solute concentration is very low, the contribution
to HEm due to solute interactions may  be neglected and the ther-
mal effect in SAS experiments can be considered mainly due to
the formation of CO2 + organic solvent mixtures very rich in carbon
dioxide (x ≥ 0.95). In a previous study [13], HEm values for CO2 + N-
methyl-2-pyrrolidone mixtures were measured at our laboratory
at 313.15 and 338.15 K and 9.48, 15.00 and 20.00 MPa  and the rela-
tion between thermal effects and phase behavior and coalescence
phenomena observed in SAS micronization of several antibiotics
was discussed. More recently, similar effects were observed for
CO2 + acetone and CO2 + N,N-dimethylformamide mixtures [14,15].
In this paper, we  report excess molar enthalpies for the binary
system CO2 + DMSO under conditions of temperature and pres-
sure typically used in supercritical CO2 applications: 313.15 and
323.15 K and 9.00, 12.00, 15.00 and 18.00 MPa  as well as 333.15 K
and 9.00 and 15.00 MPa. These data will be analyzed in terms of
molecular interactions, phase equilibria and density data, and their
role in the supercritical antisolvent micronization will be discussed.Dimethylsulfoxide (DMSO) is an organic solvent with a rela-
tively high dipolar moment (3.8 D [16]) that is able to dissolve
a large variety of products. DMSO has been frequently used as a
solvent in SAS precipitation [1–5] and as a cosolvent to improve
CO2 solution of drugs such as eﬂucimibe [17]. Raveendran and
1
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Table 1
Excess molar enthalpy, HEm, for the binary system [CO2 (x) + DMSO (1 − x)].
x HEm (J mol
−1) x HEm (J mol
−1) x HEm (J mol
−1)
313.15 K and 9.00 MPa
0.151 −407 0.516 −1376 0.828 −1974
0.220  −570 0.567 −1444 0.901 −1712
0.286  −829 0.616 −1582 0.968 −1083
0.348 −936 0.706 −1774
0.407 −1127 0.748 −1876
313.15 K and 12.00 MPa
0.156  −241 0.557 −946 0.740 −1113
0.286  −451 0.597 −1002 0.773 −1109
0.384 −653 0.634 −1059 0.865 −934
0.430 −772 0.671 −1095 0.933 −662
313.15  K and 15.00 MPa
0.063  −78 0.474 −614 0.740 −921
0.156 −221 0.516 −675 0.773 −905
0.286  −415 0.557 −759 0.865 −626
0.384 −516 0.671 −900 0.933 −374
313.15  K and 18.00 MPa
0.063  −182 0.421 −755 0.805 −856
0.122 −303 0.483 −825 0.865 −709
0.156  −346 0.597 −890 0.949 −406
0.212  −408 0.634 −914
0.306 −589 0.706 −952
323.15 K and 9.00 MPa
0.095 −473 0.429 −2885 0.682 −3658
0.168  −968 0.567 −3709 0.720 −3292
0.302  −2077 0.606 −3905 0.828 −2067
0.362 −2453 0.644 −3765 0.913 −1007
323.15  K and 12.00 MPa
0.102  −287 0.381 −1169 0.700 −1997
0.180  −517 0.433 −1325 0.771 −1912
0.247  −769 0.547 −1659 0.840 −1782
0.320  −1005 0.625 −1852 0.919 −1159
323.15 K and 15.00 MPa
0.115  −262 0.392 −1015 0.709 −1468
0.187  −469 0.477 −1167 0.779 −1321
0.255  −616 0.558 −1367 0.846 −1208
0.329 −774 0.635 −1410 0.922 −757
323.15  K and 18.00 MPa
0.109  −163 0.399 −752 0.715 −1088
0.191 −348 0.468 −849 0.784 −1060
0.261  −457 0.566 −996 0.850 −873
0.336 −681 0.643 −1098 0.924 −538
333.15  K and 9.00 MPa
0.095 −720 0.426 −3366 0.756 −1860
0.168 −1370 0.487 −3755 0.828 −1306
0.232 −2428 0.527 −3576 0.913 −660
0.308  −2077 0.606 −2979
0.362 −2858 0.682 −2339
333.15 K and 15.00 MPa
0.106  −387 0.392 −1124 0.709 −17806 F.  Zahran et al. / J. of Supe
allen [18] have chosen CO2 + DMSO as a model system to study
O2–Lewis base complexes and solvation in supercritical CO2 for
he sulfonyl group. Ab initio calculations were performed and the
nteraction energy, geometry and other molecular properties of
he CO2–DMSO complex were calculated and compared to those
f complexes formed by formaldehyde, acetaldehyde, acetic acid
nd methyl acetate. Results indicate that the S O bond plays a key
ole in the CO2–DMSO complex and explain the high miscibility of
MSO in CO2. On the other hand, the physical and thermodynamic
roperties of CO2 + DMSO mixtures have been the subject of numer-
us investigations and densities, viscosities, critical parameters and
hase equilibria and volumetric expansion data are available in
he literature [19–28]. Andreatta et al. [26] discussed the type of
ritical locus in the Scott and van Konynenburg classiﬁcation [29].
ccording to them CO2 + DMSO belongs either to type III or IV
n this classiﬁcation; more data in the lower temperature range
re required to reach a deﬁnitive conclusion. Other investigations
ere carried out for ternary mixtures formed by CO2, DMSO and
2O [22,26], dextran [30], yttrium acetate [5] or cefonicid [6]. The
resence of a third component such as water or dextran that inter-
cts with carbon dioxide modiﬁes the phase diagram. In the case
f solutes such as yttrium acetate or the antibiotic cefonicid that
nteract weakly with carbon dioxide the ternary phase diagram
or the low solute concentration usually employed in SAS is coin-
ident with the binary one in the CO2-rich region which is the
egion for mixtures involved in SAS. These phase equilibria data for
he CO2 + DMSO system will be used to interpret the excess molar
nthalpies reported in this paper, and their relevance in morpholo-
ies observed in some supercritical antisolvent micronizations will
e analyzed.
.  Experimental
The materials employed were CO2 (Air Liquide 99.98 mol% pure)
nd DMSO (Fluka, ≥99.9 mol% pure). Commercial materials were
sed without further puriﬁcation.
An  isothermal high-pressure ﬂow calorimeter (Hart Scien-
iﬁc model 7501) was used to perform HEm measurements. The
alorimeter was ﬁrst described by Christensen et al. [31] and the
xperimental procedure is described elsewhere [13]. The reactants
ere pumped into the calorimetric cell by two thermostated pumps
ISCO, model LC-2600) at constant ﬂow rates. Volume ﬂow rates
ere selected to cover the entire concentration range. Tempera-
ure of the pumps was controlled within ±0.02 K. For each pump,
he uncertainty in the volume ﬂow rate was obtained by a previ-
us calibration. The calorimetric cell was located into a silicon bath
n which temperature was  controlled within ±0.001 K. A Peltier
ooling device and a pulsed heater kept the cell under isothermal
onditions. The pulse energy was determined by a heater cali-
ration. The pressure was measured using a calibrated pressure
ransducer (Lucas Schaevitz, model P721-0001). A back-pressure
egulator located outside the calorimeter kept the pressure within
0.01 MPa.
All runs were made in the steady-state ﬁxed composition mode.
easurements were carried out at total volume ﬂow rates of 0.0014
nd 0.0028 cm3 s−1. These values were chosen to cover the entire
ole fraction range by combining adequate values for the ﬂow rates
f the two pumps. Also, the coincidence of the experimental results
btained using different total ﬂow rates is an indication of equi-
ibrium conditions in the calorimeter. The volume ﬂow rates were
onverted to molar ﬂow rates using the densities and molar masses.
O2 densities at the temperature and pressure of the pumps were
btained from NIST [32]. DMSO densities were obtained from the
ait equation provided by Czeslik and Jonas [33]. Since densities
re affected by temperature and pressure changes, the uncertainty
1120.187 −565 0.461 −1276 0.779 −1680
0.255 −801 0.558 −1535 0.846 −1478
0.329  −956 0.635 −1712 0.922 −1060
in molar ﬂow rates was  derived taking into account contributions
from variations in volume ﬂow rates, pressure, and pumps temper-
ature. The mole fraction uncertainty is based on the molar ﬂow rates
uncertainty and was estimated to be better than ±0.001. The uncer-
tainty in HEm was  obtained taking into account contributions from
molar ﬂow rates, pulse energy and frequency and was estimated to
be ±1%.
3.  Results and discussion
HEm data for the binary system [CO2 (x) + DMSO (1–x)] were
determined at 313.15 and 323.15 K and 9.00, 12.00, 15.00 and
18.00 MPa  as well at 333.15 K and 9.00 and 15.00 MPa over the
entire composition range and are given in Table 1. Fig. 1(a–d) shows
plots of HEm vs CO2 mole fraction at 9.00, 12.00, 15.00 and 18.00 MPa,
respectively. At each condition of temperature and pressure in
the 12.00–18.00 MPa  pressure range, excess molar enthalpies are
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The linear sections at 323.15 and 333.15 K and 9.00 MPa  are in
agreement with the isothermal vapor–liquid equilibrium and criti-
cal data previously reported for CO2 + DMSO by González et al. and
Chiu et al. [21,27] shown in Fig. 2. As could be expected from the
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ig. 1. Excess molar enthalpies, HEm, for the binary system [CO2(x) + dimethylsulfoxid
nd: () 313.15 K; () 323.15 K; () 333.15 K; (—), calculated using Eq. (3) and coef
xothermic and exhibit minima in the CO2-rich region. For a
iven mole fraction and pressure, most mixtures become increas-
ngly exothermic as the temperature increases. Minimum values
ange from −900 J mol−1 to −2000 J mol−1. The effect of temper-
ture becomes less pronounced when the pressure is increased
o 18.00 MPa: HEm values obtained at this pressure and 313.15 or
23.15 K are very similar.
At 9.00 MPa  mixtures show very exothermic mixing: a mini-
um of −2000 J mol−1 is already observed at 313.15 K and minima
f approximately −4000 J mol−1 are observed at the higher temper-
tures of 323.15 and 333.15 K. On the other hand, a linear section
s observed in the HEm vs CO2 mole fraction plot at 9.00 MPa  and
23.15 and 333.15 K. HEm varies linearly with CO2 mole fraction
n the two-phase region where a gaseous and a liquid mixture of
xed compositions, for a given condition of temperature and pres-
ure, are in equilibrium. For a mixture of global composition x, the
nthalpy effect in the two-phase region is the sum of two contri-
utions due to the nl mol  of liquid mixture of composition xl and
v mol  of vapor mixture of composition xv,
E
m = HEm,l nl + HEm,v nv (1)
here  HE
m,l
is the excess molar enthalpy of the liquid mixture, and
E
m,v is the excess molar enthalpy of the vapor mixture. Based on
he relations among nl, nv, x, xl and xv [13], Eq. (1) may  be rewritten
s:
E
m = HEm,v +
x  − xv
xl − xv
(HEm,l − HEm,v) (2)
Since  HE
m,l
, HEm,v, xl and xv have constant values for each
sotherm/isobar, the second member of Eq. (2) is a ﬁrst-degree
olynomial in x. When x = xl, HEm = HEm,l and when x = xv, HEm = HEm,v.
herefore, the liquid and vapor-phase compositions are shown to
orrespond to the x coordinates of the beginning and the end of the
inear sections shown in Fig. 1(a). A considerable amount of DMSO
s present in the liquid mixture but only a very small amount is
113X
 x)] vs CO2 mole fraction at (a) 9.00 MPa, (b) 12.00 MPa, (c) 15.00 MPa, (d) 18.00 MPa
s given in Table 2.
dissolved in the vapor phase; the CO2 vapor-phase composition is
very close to one and cannot be established from the calorimetric
measurements.Fig. 2. Isothermal vapor–liquid equilibrium and critical data for the binary system
[CO2(x) + dimethylsulfoxide (1 − x)] reported by González et al. [21]: (), 309.41 K;
() 314.49 K; (), 321.28 K; ( ) 328.94 K, and Chiu et al. [27]: () 318.15 K; ()
328.95 K; () 338.15 K; () 348.15 K, critical line (−− −), and pressure conditions of
SAS  experiments carried out by Reverchon et al. [5] at 313.15 K using DMSO (· · · ·).
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Table 2
Coefﬁcients Ai and Bj and standard deviation, , for least-squares representation of HEm (J mol
−1) for [CO2(x) + DMSO (1 − x)] at 313.15, 323.15 and 333.15 K using Eq. (3).
T (K) P (MPa) Interval A0 A1 A2 A3 A4 B1 B2  (J mol−1)
313.15 9.00 0 ≤ x ≤ 1 −5312.55 −207.75 −382.21 −278.96 − −0.88 – 14
12.00  0 ≤ x ≤ 1 −3446.04 −1094.14 – – – −0.65 – 5.4
15.00  0 ≤ x ≤ 1 −2590.39 2702.41 −8778.49 −5693.33 919.34 −1.97 3.28 36
18.00  0 ≤ x ≤ 1 −3283.77 −1956.63 −2161.30 −926.08 – – – 8.3
323.15 9.00  0 ≤ x ≤ 0.644 −13580.0  −10768.6 −1231.86 – – – – 23
0.644 ≤ x ≤ 1 −23178.3  23026.0 − – – 0 −1 21
12.00  0 ≤ x ≤ 1 −6139.87 −5765.40 −4605.59 −2682.20 – – – 5.9
15.00  0 ≤ x ≤ 1 −4897.54 −4061.67 −2098.72 −957.17 – – – 8.5
18.00  0 ≤ x ≤ 1 −3700.18 −3029.32 −1524.31 −981.35 – – – 6.3
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9.00 MPa. However, the temperature increase of 2.9 K shown in
Table 3 for these x, P and T conditions explains the immiscibility
observed for mixtures formed in the SAS experiments and a particle
morphology that does not correspond to the uniform nanoparti-
cles expected in a supercritical phase. As the pressure rises for this
Table 3
Carbon dioxide and dimethylsulfoxide experimental densitiesa,b and estimated
temperature  increments at mixing in the x interval 0.95–0.98.
T (K) P (MPa) CO2 (g cm
−3) DMSO (g cm−3) T (K)
313.15 9.00 0.4855 1.0851 5.2–2.9
12.00 0.7178 1.0867 2.7–1.3
15.00 0.7802 1.0882 2.3–1.0
18.00 0.8195 1.0898 3.1–1.5
323.15 9.00 0.2850 1.0753 3.3–1.4
12.00 0.5847 1.0769 5.1–2.2
15.00 0.6998 1.0786 3.9–1.7333.15  9.00 0 ≤ x ≤ 0.487 −15482.3 −14968.4 
0.487 ≤ x ≤ 1 −15060.2  15043.7 
15.00  0 ≤ x ≤ 1 −5568.42  −4929.65 
hase equilibria data and may  be observed in Fig. 1(b)–(d), two-
hase regions do not appear when the pressure is raised from 9.00
o 12.00, 15.00 or 18.00 MPa  at the three temperatures studied.
HEm data for [CO2 (x) + DMSO (1–x)] were ﬁtted to a (n, m) Padé
unction given by
E
m = x(1 − x)
∑n
i=0Ai(2x − 1)
i
1 +
∑m
j=1Bj(2x − 1)
j
(3)
here  Ai and Bj are adjustable coefﬁcients. A least-square proce-
ure was used to minimize deviations between experimental and
alculated excess molar enthalpies. For those conditions of tem-
erature and pressure where phase-splitting occurs, two different
ets of coefﬁcients are used to represent data in the two-phase and
ne-phase region, respectively. In the linear section, a (1, 2) Padé
unction with ﬁxed values for the denominator coefﬁcients, B1 = 0
nd B2 = −1, may  be used in order to keep the weight factor x (1 − x).
his results in a ﬁrst-degree polynomial in the composition vari-
ble; the slope is A1/2 and the zero intercept is (A0 − A1)/4. The HEm
epresentation using Eq. (3) is shown in Fig. 1. Table 2 lists values for
he coefﬁcients Ai and Bj and the standard deviation between exper-
mental and calculated HEm values at 313.15 and 323.15 K and 9.00,
2.00, 15.00 and 18.00 MPa  and 333.15 K and 9.00 and 15.00 MPa.
he beginning of the linear sections shown in Table 2 at 9.00 MPa
nd 323.15 and 333.15 K provides the value for the liquid-phase
omposition in the two-phase region.
In a typical SAS experiment supercritical CO2 is preliminarily
ed to the precipitation chamber at constant ﬂow rate. Then the
iquid solvent is fed also at constant ﬂow rate in order to obtain
teady state operating conditions. Afterwards, DMSO is replaced
y the liquid solution and precipitation starts. The concentra-
ion of solutes in the DMSO solution is low and the CO2/solution
ow ratio is very high. As has been already pointed out, when
he solute has little interaction with carbon dioxide the ternary
hase diagram for the low solute concentrations usually employed
n SAS is coincident with the binary one in the CO2-rich region
hich is the region for mixtures involved in SAS. Therefore, the
ixtures formed in the precipitation chamber may  be treated as
inary CO2 + organic solvent systems. In general, nanoparticles are
btained when the precipitation is carried out in the supercriti-
al region. The uniformity of the resulting products becomes worse
hen the precipitation conditions approach the critical locus. Irreg-
lar micro-scale aggregated particles are formed in the vapor region
nd both dense cake and spherical clusters are produced in the
apor–liquid region [5–10]. The heat evolved when the supercrit-
cal CO2 dissolves into the organic solution has an important role
n the phase behavior. The temperature control in the precipitation
hamber is not very precise and the local temperature increase may
ead to T and P conditions where phase splitting takes place. Since
O2 is fed into the chamber at a ﬂow rate much higher than that
11416795.0 −10968.9 – – – 13
– – – 0 −1 11
4592.05 −1418.29 – – – 9.0
of  the solution and the solute concentration is very low, the contri-
bution to HEm due to solute interactions may  be neglected and the
thermal effect in SAS experiments can be considered mainly due
to the formation of CO2 + DMSO mixtures very rich in carbon diox-
ide (x ≥ 0.95). Consequently, the temperature increase T may  be
estimated using the HEm data reported in this paper. Since carbon
dioxide is the predominant component in these mixtures, its iso-
baric heat capacity [34] was  used to calculate the local temperature
increase assuming an adiabatic process and using Eq. (3) to evaluate
the heat evolved when a mol  of mixture is formed for two com-
position values: x = 0.95 and 0.98. Values for T thus obtained are
shown in Table 3 and they help to explain immiscibility observed in
SAS micronizations for temperature and pressure conditions where
complete miscibility could have been expected for CO2 and DMSO.
As a consequence the particles morphologies do not correspond to
those expected in a supercritical phase.
Reverchon et al. [5] used DMSO as a solvent in the SAS precipita-
tion of yttrium acetate at 313.15, 323.15 and 333.15 K, pressures up
to 16.0 MPa  and x = 0.98. A windowed vessel was used to observe
the phase behavior of the CO2 + DMSO mixtures and the liquid jet
formation and evolution. According to González et al. [21] the criti-
cal temperature and pressure for x = 0.98 are 314.9 K and 8.65 MPa.
At 313.15 K and 1.36 wt%  of YAc in DMSO, Reverchon et al. reported
two phases and agglomerated nanoparticles at 7.5 MPa, two  phases
and a mixture of nanoparticles and microparticles at 9.0 MPa, one
phase and balloon-like particles at 9.5 MPa  and one phase and
uniform nanoparticles from 10 to 15 MPa. An inspection of Fig. 2
indicates that one phase should have been observed already at18.00 0.7571 1.0801 3.4–1.5
333.15 9.00 0.2354 1.0658 3.5–1.4
15.00 0.6041 1.0695 4.7–2.0
a Ref. [32].
b Ref. [33].
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ondition of temperature, the heat evolved upon mixing and the
ocal temperature increase are of smaller magnitude and the phase
ehavior is not affected. Similar effects are observed for experi-
ents carried out by Reverchon et al. at 323.15 and 333.15 K [5].
Chang et al. used DMSO as a solvent in the SAS precipitation
f -chymotrypsin [7] and lysozyme [8] at 308.15, 318.15, 328.15
nd 338.15 K and pressures up to 20 MPa. In both cases agglomer-
ted or irregular particles are obtained at pressures below 10 MPa
hen the considerable heat evolved may  lead to a local temper-
ture increase in the precipitator. The very exothermic HEm values
orrelate with T and P conditions where micronization is less suc-
essful. The solubility of both proteins in CO2 and its concentration
n the solution are very low and the binary phase diagram shown
n Fig. 2 may  be used to discuss results. For instance, in the case
f lysozyme at 308.15 K for identical values of lysozyme concen-
ration, capillary size, and CO2 and solution ﬂow rates irregular
anoparticles are obtained at 8.5, 10, and 12 MPa  and uniform
anoparticles are obtained at 15 and 20 MPa. At this temperature
ne phase is already expected at 8.5 MPa  and at 10 and 12 MPa
article morphologies should correspond to the uniform nanopar-
icles expected for the supercritical region well above the critical
oundary. Of course, there are other factors that may  simultane-
usly inﬂuence the particle morphology but the heat evolved upon
ixing CO2 and the polar solvent is shown to play an important
ole. As was already mentioned, the effect of the heat of mixing
n SAS was ﬁrst introduced by Dukhin et al. [11,12] in their study
f the dynamic interfacial tension (DIT) near a critical point of the
O2 + polar solvent mixtures. A new nonisothermic DIT mode was
ntroduced and shown to contribute to the jet stability in the case
f exothermic mixing. There are several studies such as those of
ukhin et al. [12], Reverchon et al. [10], Petit-Gas et al. [35] or
enorio et al. [36] aimed at the understanding of SAS fundamen-
al mechanisms. High-pressure phase equilibria, hydrodynamics
nd mass transfer must be simultaneously taken into account and
heir interrelation has to be elucidated. In these studies, the differ-
nt regimes are classiﬁed according to the experimental conditions
ocation with respect to the mixture critical point (MCP): subcritical
onditions, near above the MCP  and far above the MCP. Two  time
cales, one for the complete disappearance of the interfacial tension
nd another for the time of the jet break-up were shown to compete
10]. In this paper, the heat evolved upon mixing is shown to mod-
fy the experimental conditions location with respect to the MCP
ausing a change of regime. Thus, these HEm data for CO2 + DMSO and
hose previously obtained for binary mixtures formed by CO2 and
-methyl-2-pyrrolidone, acetone or N,N-dimethylformamide may
ontribute to a better understanding of the fundamental aspects of
AS micronizations. On the other hand, excess enthalpy data could
e also useful when CO2-expanded solvents are used as reaction
edia [37,38].
The  large effects of pressure and temperature on the excess
olar enthalpy values are related to changes in molecular inter-
ctions and the state and densities of the pure components and
heir mixtures. Table 3 lists the densities of the pure components
btained from the sources described in Section 2. At the condi-
ions of HEm measurements, DMSO is a liquid and its density does
ot change to a great extent with temperature and pressure in the
ntervals considered in this paper. However, carbon dioxide is a
upercritical ﬂuid that may  be either a high-density (liquid-like)
uid or a low-density (gas-like) ﬂuid. When carbon dioxide and
MSO are mixed at 313.15 K and 9.00 MPa, carbon dioxide is a gas-
ike ﬂuid and the resulting mixtures are mostly liquid. González
t al. and Chiu et al. critical data [21,27] indicate that ﬂuid mix-
ures are conﬁned to a very narrow mole fraction range in the
arbon dioxide rich region. These negative HEm values are a conse-
uence of two contributions: (a) changes in molecular interactions
ue to the disruption of the DMSO structure by carbon dioxide
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and  the formation of the DMSO–CO2 complexes, and (b) the CO2
change of state from that of a gas-like ﬂuid to that of liquid mix-
ture component. The latter is the so-called ﬂuid condensation effect
that has been reported for other similar mixtures [13–15]. When
the pressure is increased at 313.15 K, CO2 density rises consid-
erably and the ﬂuid condensation effect becomes negligible. The
intermolecular-interactions contribution to HEm may  be expected to
remain approximately the same at a given temperature in this range
of pressure. As a consequence, values of HEm at 313.15 K become
much less exothermic as pressures rises.
When carbon dioxide and DMSO are mixed at 323.15 or 333.15 K
and 9.00 MPa, carbon dioxide is a gas-like ﬂuid; its density is much
lower than that at 313.15 K and 9.00 MPa. The resulting mixtures
are liquid or a gaseous and a liquid mixture in equilibrium. The
ﬂuid condensation effect becomes very important and mixtures
show extremely exothermic mixing: minimum HEm values of −3905
and −3755 J mol−1 are reached at 323.15 and 333.15 K, respectively.
As the pressure is increased at 323.15 or 333.15 K, CO2 densities
sharply increase and HEm values become less exothermic.
4.  Conclusions
Excess molar enthalpies for mixtures of supercritical CO2 and
DMSO were measured at T = 313.15, 323.15 and 333.15 K in the
9.00–18.00 MPa  pressure range over the entire composition range.
The CO2 + DMSO system presents immiscibility at 323.15 and
333.15 K and 9.00 MPa; in this range HEm varies linearly with mole
fraction due to vapor–liquid equilibria. The effects of pressure and
temperature on the excess molar enthalpy are large. Excess molar
enthalpies are exothermic at all the conditions of temperature and
pressure studied and become extremely exothermic (minimum HEm
values of −3905 and −3755 J mol−1) when low-density supercriti-
cal carbon dioxide is mixed with the liquid DMSO and the resulting
mixture is a liquid or a gaseous and a liquid mixture in equilibrium.
These heat of mixing data are used to establish thermal effects
in SAS experiments. The local temperature increases thus produced
in the precipitation chamber are shown to modify the phase sepa-
ration path and the particle morphology. Therefore, these thermal
effects must be taken into account in SAS design and modeling.
In order to avoid the modiﬁcation of phase behavior for a given
micronization temperature, it may  be recommended to work at a
pressure at least 1 or 1.5 MPa  above the estimated critical pressure
for the binary mixture CO2 + DMSO.
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Supercritical Antisolvent Micronization of Pharmaceuticals 
 
Micronization is the process of reducing the average diameter of a solid material particle. 
Modern methods use supercritical fluids in the micronization process. The most widely 
applied techniques are the SAS method (Supercritical Anti-Solvent), the RESS process (Rapid 
Expansion of Supercritical Solutions), and the PGSS method (Particles from Gas Saturated 
Solutions) that have been previously described (chapter one). In this work we have chosen the 
SAS method to micronize different pharmaceutical compounds. In the first place, a laboratory 
scale SAS apparatus was assembled (chapter three). In the next sections the validation of this 
SAS apparatus is described using a system previously studied in the literature as well as the 
micronization of some pharmaceutical active ingredients. 
 
5.1. Validation of SAS Apparatus: Micronization of Yttrium Acetate 
The micronization of yttrium acetate, YAc, has been chosen to validate our SAS 
equipment. YAc is widely used in the electrotechnical industry as a precursor for high-
temperature superconductors. Reverchon et al. have micronized YAc from yttrium 
acetate/dimethyl sulfoxide (DMSO) mixtures using supercritical CO2 as the antisolvent [1-5]. 
SAS micronization of YAc was performed to improve its properties; submicronic particles act 
as points of nucleation of the pining centers in the high-temperature superconductors. YAc 
micronization experiments performed by Reverchon et al. [1-2] were used as a starting point 
in this work and as a reference for the validation of our equipment. In the first article [1], 
these authors found that the volumetric expansion of the liquid carrier controls the 
morphology of the particles produced by SAS, whereas the solution concentration controls the 
particle size (PS) and particle size distribution (PSD) of the precipitate. Furthermore, YAc 
nanoparticles were successfully produced by SAS, obtaining mean diameters down to 100 
nm.  In the second article [2], they confirmed that SAS micronization is a highly versatile 
process capable of generating particles of various dimensions and morphologies depending on 
the operating conditions. They also demonstrated that it is possible to obtain microparticles of 
YAc with mean diameters from 0.28 to 50 µm by simply changing the operating pressure 
and/or temperature and that the near-critical region can be used to confer larger dimensions 
and different morphologies to precipitated particles. In reference [3] results obtained 
previously at 40 °C and 15.0 MPa are compared. In reference [4] attention is focused on the 
expanded microparticles morphology. Results from previous studies are discussed together 
with those obtained at temperatures of 43 and 65 °C and a pressure of 15.0 MPa, and at a 
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temperature of 60 °C and pressures of 12.0, 12.5 and 13.5 MPa. In the most recent paper [5], 
additional experiments were carried out at 40 °C and several values of pressures for the 
correlation of fluid dynamics with particle morphology. 
 
As previously pointed out, the prerequisites for a successful SAS precipitation are the high 
solubility of the organic solvent in the supercritical carbon dioxide (SC-CO2) as well as the 
low solubility of the solute to be precipitated in SC-CO2. When the solvent has high solubility 
in SC-CO2, its solvent power for the solute reduces faster in the presence of SC-CO2. 
Therefore, supersaturation happens sooner and smaller particles are formed. On other hand, 
the solute must have a very low solubility in SC-CO2 at the working conditions in order to 
avoid the redissolution of the solute by SC-CO2 and be a good candidate for SAS. 
 
The morphology of the particles obtained by SAS is greatly influenced by the phase 
diagram of the system. Working at the one-phase supercritical region usually gives uniform 
particles with a narrow particle size distribution while working at the multiphase region 
results in particle coalescence and non uniform particles. The presence of a solute, third 
component, may or may not modify the binary CO2 + organic solvent system. For example, in 
the case of dextran that interacts with carbon dioxide the pseudo-binary phase diagram, the 
ternary phase diagram at low concentration of the solute, differs to a great extent from the 
binary phase diagram [6]. On the contrary, for ionic solutes such as cefonicid that interact 
weakly with carbon dioxide the ternary phase diagram for the low solution concentration, 
usually employed in SAS, is coincident with the binary one in the CO2-rich region which is 
the region for mixtures involved in SAS. As was explained in the introduction chapter, 
Reverchon et al. used a view cell to confirm this coincidence for the CO2 + DMSO + 
cefonicid system [3]. The same behavior as cefonicid may be expected for the YAc salt. 
 
As was mentioned in chapter four, Andreatta et al. [7] discussed the type of critical locus 
for CO2 + DMSO in the Scott and van Konynenburg classification [8]. According to them, 
this system belongs either to type III or IV in this classification; more data in the lower 
temperature range are required to reach a definitive conclusion. This discussion is however 
irrelevant for the conditions currently used in SAS experiments. To this end, it is enough to 
consider the vapor-liquid critical line and the isothermal vapor-liquid equilibrium (VLE) data 
for CO2 + DMSO shown in Fig. 4.8 of this thesis. Fig 4.8 also shows how the immiscibility 
region becomes larger as the temperature increases. 
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These phase equilibria data for the CO2 + dimethylsulfoxide system were used to 
understand the different morphologies observed in YAc supercritical antisolvent 
micronizations. Taking into account the mixture critical line for the binary system CO2 + 
DMSO, four different sets of experimental conditions have been chosen to validate our SAS 
apparatus. The temperature and pressure values for these experiments are listed in table 5.1. 
 
Table 5.1 Temperature and pressure experimental conditions of the SAS micronization of 
YAc using DMSO. 
 
Conditions Experiment 
T (°C) P (MPa) 
1 40 11 
2 60 14 
3 60 15 
4 60 20 
 
 
The other experimental conditions were 2 % concentration for the YAc solution, 1 
mL/min solution flow rate, 15 g/min CO2 flow rate and drying time required to fill 3 times the 
precipitation chamber. The solution concentration in all the SAS experiments of this thesis is 
expressed as mass of solute per 100 mL of solution. The nozzle diameter was 100 µm in all 
the experiments. These solution and CO2 flow rates lead to a value of 0.96 for the CO2 mole 
fraction in the CO2 + DMSO mixtures formed in the precipitation chamber. 
 
 The materials employed were CO2 (Air Liquide 99.98 mol% pure), DMSO (Fluka, ≥ 99.9 
mol % pure) and yttrium (III) acetate hydrate (Aldrich ≥ 99.9 mol % pure). The experiments 
(1-4) were carried out in the one-phase supercritical region for CO2 + dimethyl sulfoxide 
(DMSO). In particular, experiment (2) was carried out very close to the mixture critical point 
to see the thermal effects in the mixing process between SC-CO2 and DMSO that takes place 
in the SAS precipitation chamber. Fig. 5.1 shows the image of the untreated YAc.  
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Fig. 5.1 Image of untreated YAc. 
 
The SEM images of YAc precipitated in experiments 1-4 are shown in Figs. 5.2 - 5.5. In 
experiments 1, 3 and 4 discrete nanoparticles with a spherical morphology have been 
obtained. In some images particles appear slightly aggregated or connected, which is 
attributed to the incomplete removal of the solvent at the washing step. On the contrary, in 
experiment 2, aggregated particles forming a block have been found. The different 
morphology of the precipitate at these conditions will be explained later. 
 
  
 
Fig. 5.2 SEM images of the YAc precipitated at 40 °C and 11 MPa (Exp. 1). 
 
 
 
Fig. 5.3 SEM images of the YAc precipitated at 60 °C and 14 MPa (Exp. 2). 
Chapter 5 - Supercritical Antisolvent Micronization of Pharmaceuticals   
 
 127 
A slightly decrease in the mean particle size was observed with the increase of the 
pressure. This effect can be seen in Fig. 5.4 and Fig 5.5, where the SEM images of the 
precipitated YAc are shown for the experiments performed at 60 °C and 15 and 20 MPa, 
respectively. 
 
  
 
Fig. 5.4 SEM images of the YAc precipitated at 60 °C and 15 MPa (Exp. 3). 
 
 
  
 
Fig. 5.5 SEM images of the YAc precipitated at 60 °C and 20 MPa (Exp. 4). 
 
Fig. 5.6 shows the mean particle size (PS) and particle size distribution calculated 
following the procedure described in chapter three. As pointed out, it can be observed how 
with increasing pressure the particle size and its standard deviation (SD) decrease and the 
particle size distribution becomes narrower. Particles precipitated in experiment 1 at a lower T 
and P yield larger particles with a wider PSD. Our results will be compared to those obtained 
by Reverchon et al. in 2003 [2] because the conditions of temperature and pressure are the 
same or very close to those used in our study. 
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PS (nm)    SD (nm) 
Exp 1       80  11 
Exp 2       Aggregation 
Exp 3       65  9 
Exp 4       50  5 
 
 
 
 
Fig. 5.6 Probability density as a function of particle size for experiments 1, 3 and 4. 
 
As previously mentioned the other experimental conditions used in this study were: 2 % 
concentration for the YAc solution, 1 mL/min solution flow rate and 15 g/min CO2 flow rate. 
These flow rates lead to a value of 0.96 for the CO2 mole fraction. The obtained powder is 
dried at a time equal to 3 times the time required to completely fill the 500 mL precipitation 
chamber (between 60 and 120 min). All over this study, the nozzle used is always the same 
and it has a diameter of 100 µm. On the other hand, those of Reverchon et al. [2] were: 1.36 
% concentration for the YAc solution, 10 mL/min solution flow rate, 300 g/min CO2 flow 
rate, drying time 90 min for a 500 mL precipitator and nozzle diameter of 60 µm. The much 
larger flow rates used by Reverchon are however not often used in most SAS experiments. 
These flow rates also lead to a value of 0.98 for the CO2 mole fraction in the CO2 + DMSO 
mixtures formed in the precipitation chamber. Tables 5.2a-b show the results obtained in this 
work and those obtained previously by Reverchon et al.  
 
Table 5.2a Results obtained in this study for SAS micronization of YAc. 
Conditions 
Experiment 
T (°C) P (MPa) 
PS (nm) Morphology 
ΔT (°C) 
(x = 0.96) 
1 40 11 80 nanoparticles 3.2 
2 60 14 - aggregated 3.7 
3 60 15 65 nanoparticles 3.8 
4 60 20 50 nanoparticles - 
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Table 5.2b Results obtained by Reverchon et al [2].  
Conditions 
T (°C) P (MPa) 
PS (nm) Morphology 
40 9 400 nano/microparticles 
40 10 80 nanoparticles 
40 11 90 nanoparticles 
40 12 170 nanoparticles 
40 15 100 nanoparticles 
60 14 3000-10000 balloons 
60 16 100-2000 nano + balloons 
 
Our results are in agreement with those obtained by Reverchon et al., although smaller 
particles have been obtained in similar conditions of temperature and pressure. For example, 
at 40 °C and 11 MPa the mean PS obtained by Reverchon et al. [2] is 90 nm but in our case it 
is 80 nm. Therefore, our SAS apparatus may be considered suitable for SAS micronizations.  
 
Moreover, particle morphology is shown to depend on phase equilibrium for CO2 + 
dimethyl sulfoxide. In this work, we have studied the thermal effects in the mixing process 
between SC-CO2 and DMSO that takes place in the SAS precipitation chamber [9]. Mixing 
process may cause a local increase of T in the chamber which also affects phase separation. 
According to the procedure described in chapter four, the temperature increments inside the 
precipitation chamber, ΔT, can be estimated at 0.96 CO2 mole fraction. Values of 3.2, 3.7 and 
3.8 degrees are obtained for experiments 1, 2 and 3, respectively. ΔT can not be estimated for 
experiment 4 due to the lack of experimental excess enthalpy values at 60 °C and 20 MPa. 
The 3.8 degrees increment in experiment 3 at 60 °C brings the P condition closer to the higher 
pressure of the phase boundary at 64 °C. A similar ΔT increment in experiment 2 carried out 
at a lower pressure leads to phase splitting. The P and T conditions for experiment 2 will 
correspond to the two-phase region at 64 °C where aggregated particles are obtained. Fig. 5.7 
shows a scheme of the vapor-liquid equilibrium data at 60 °C and 64 °C, the positions of the 
working conditions and the morphologies of the particles.  
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Fig. 5.7 Particles morphology and phase diagram at 60 °C and 64 °C. Phase boundaries are based on data 
shown in Fig. 4.8. 
 
The local temperature increment at the precipitation chamber is attributed to the mixing of 
the SC-CO2 and DMSO and provokes that exp.2 was performed in the two phase region 
instead of the one phase supercritical region as originally planned. Similarly Reverchon et al. 
[2] obtained at the same temperature and pressure conditions large balloons 3000-10000 nm. 
Although the reason of their unsuccessful micronization was not explained by Reverchon et 
al. [2], we believe that local thermal effect at these conditions could explain it. 
 
Finally, from all the previous, we can say that we have assembled a SAS apparatus that 
can be applied for micronization of a wide category of solutes. This study shows that the 
process arrangement and the apparatus strongly influence the final product properties. The 
binary phase diagram of the binary system CO2 + organic solvent and the heat of mixing 
strongly affect the morphology of the micronized particles.  
 
 
 
(Exp 4) 
(Exp 3) 
(Exp 2) 
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5.2. Micronization of 5-Fluorouracil 
5-Fluorouracil, 5-FU, is commercialized under the brand names Adrucil, Carac, Efudix, 
Efudex and Fluoroplex. It is a pyrimidine analog drug used in the treatment of several types of 
cancer.  
 
5-fluoro-1H-pyrimidine-2,4-dione, IUPAC name of 5-FU 
 
The chemotherapy agent 5-FU has been in used against cancer for about 40 years. It acts 
in several ways, but principally as a thymidylate synthase inhibitor. Interrupting the action of 
this enzyme blocks the synthesis of the pyrimidine thymidine, which is a nucleotide required 
for DNA replication. Thymidylate synthase methylates deoxyuridine monophosphate (dUMP) 
into thymidine monophosphate (dTMP). Administration of 5-FU causes a scarcity in dTMP, 
so rapidly dividing cancerous cells undergo cell death via thymineless death [10]. 
 
5.2.1. Literature Review and Design of Experiments 
Guney and Akgerman have measured the solubilities of 5-fluorouracil in SC-CO2 at 
pressures ranging from 11 to 21 MPa and at temperature values of  35 °C and 55 °C and 
found them to vary from 3.72 x 10-7 to 2.86 x 10-6 in weight fraction [11]. Suleiman et al. 
have measured the solubilities of 5-FU at pressures ranging from 10 to 30 MPa and 
temperatures ranging from 35 to 55 °C and found them to vary from 3.60 x 10-6 to 1.46 x 10-5 
in mole fraction [12]. Furthermore 5-FU is soluble in a variety of solvent such as methanol, 
acetone, dichloromethane, so on, which are highly soluble in SC-CO2. These properties make 
5-FU a good candidate for SAS micronization; carbon dioxide acts as antisolvent. 
 
Kalantarian et al. have recently precipitated 5-FU using SAS from methanol, methanol-
dichloromethane, methanol-acetone, and methanol-ethanol mixtures [13]. The conditions of 
the experiments included pressures of 10 and 15 MPa, temperature of 40 °C, a solution flow 
rate of 1 mL/min, and CO2 flow rate of 20 mL/min. The particles were characterized 
physicochemically before and after the process for their morphology and crystallinity. In spite 
of differences in size, the particles after precipitation were not very different regarding their 
morphology. The resulting particles were of a regular shape, partly spherical, and appeared to 
have a smooth surface. They reported that marked changes in the physicochemical properties 
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of the produced particles were possible by using different solvents or mixture of solvents in 
the supercritical processing of 5-FU. They found that acetone and dichloromethane increase 
the solubility of methanol in SC-CO2 resulting in a reduction of the particle size of the 
precipitated particles, in addition to a change in the morphologic properties of the particles. 
Generally, when a solvent has a higher solubility in SC-CO2; its solvent power reduces faster 
in the presence of SC-CO2. Therefore, supersaturation happens sooner and smaller particles 
are formed. In agreement to this statement, the particles produced from methanol alone had a 
mean size of 2970 nm while the particles produced from methanol-acetone had sizes of 730-
980 nm depending on the amount of acetone. With dichloromethane the particles size reached 
250-440 nm depending on the amount of dichloromethane. Particles exhibit a relatively 
smooth surface and a narrow particle size distribution. 
 
Kalantarian et al. have also used the GAS and SAS methods to co-precipitate 5-FU as a 
hydrophilic antitumor drug and poly lactide-co-glycolide (PLGA) as a biodegradable polymer 
with the aim of forming sustained-release matrices [14]. They used acetone and 
methanol/dichloromethane mixtures. The process conditions were mild and non-aqueous, so 
the hydrophilic drug incorporated in the PLGA had good stability during the process. With 
more 5-FU loading in the produced microparticles, drug release was faster and the amount of 
burst release was greater. The rapid release probably represented the release of drug-loaded 
microparticles with a high ratio of 5-FU and lower polymer molecular weight. Particles with 
4.9% 5-FU and PLGA with high molecular weight showed the slowest drug release. 
 
Chen et al. have successfully prepared 5-FU-SiO2-PLLA drug-polymer microcapsules (< 
0.5 µm) with a core-shell structure in a modified SEDS process, in which an ‘injector’ was 
employed in the particles suspension delivery system [15]. The 5-FU-SiO2 particle suspension 
in a solution of PLLA in dichloromethane and supercritical CO2 were sprayed together 
through the coaxial nozzle into the high-pressure vessel. The supercritical CO2 was used as 
both anti-solvent for its chemical properties and ‘spray enhancer’ by mechanical effect. This 
study demonstrated that the modified SEDS process could be used to produce drug-polymer 
microcapsules with a core-shell structure, high encapsulation efficiency and sustained drug 
release effect. 
 
In view of the results obtained from validating our SAS apparatus and the solubility data 
available for DMSO in SC-CO2, dimethyl sulfoxide was chosen as a solvent for the 
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micronization of 5-FU. The CO2 and DMSO are the same materials used in the micronization 
of YAc. 5-FU was supplied from Sigma-Aldrich (≥ 99 mol % pure). 
 
As mentioned in chapter three, the factors to consider in the SAS process are: the 
concentration of the solution (C), the temperature (T), the pressure (P), the solution flow rate 
(QL), the supercritical CO2 flow rate (QCO2), the drying time (t), and the nozzle diameter (Øn).  
In our study, the drying time and the nozzle diameter are kept constant at 3 times the time 
required to fill the precipitation chamber and 100 µm, respectively.  In order to minimize the 
number of experiments, the fractional factorial design was employed. Among all possible 
fractional factorial design, the design 25-2 was selected. As a result, we generated eight 
different combinations of signs for the five factors as shown in table 5.3. as deeply explained 
in chapter three. 
 
Table 5.3 The Fractional Factorial 25-2 Design. 
Run C (1) T (2) P(3) QL 
(4=12) 
QCO2 
(5=13) 
1 - - - + + 
2 + - - - - 
3 - + - - + 
4 + + - + - 
5 - - + + - 
6 + - + - + 
7 - + + - - 
8 + + + + + 
 
The generated combinations are eight different trails (25, 2, 19, 12, 13, 22, 7 and 32) out 
of the full factorial design at two levels 25 given by Yates order [16]. Thus, the design is a 
fraction of ¼  of the full 25 design. Details above the allied factors and the procedure to 
generate table 5.3 were given in the methodology chapter.  
 
Table 5.4 shows the level identification for CO2 + DMSO + 5-FU system. The low level 
of concentration was set to obtain a sufficient amount of precipitate for subsequent analysis; 
the high level was limited by the saturation of the solution at room temperature. 
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Table 5.4 Level Identification of the Factors. 
Factor Unit Labels Low Level  
 (-) 
High Level  
(+) 
Concentration % C 1 2 
Temperature °C T 40 50 
Pressure MPa P 15 18 
Solution flow rate mL/min QL 1 1.4 
CO2 flow rate (x ≥0.96) g/min QCO2 15 20 
 
 
The two levels of temperature and pressure were chosen mainly on the basis of isothermal 
vapor–liquid equilibrium and critical data for CO2 + DMSO shown in Fig. 4.8, to work in the 
supercritical region. 5-FU may be expected to interact weakly with CO2. Therefore, the binary 
phase diagram for CO2 + DMSO shown in Fig. 4.8 may be used to establish the temperature 
and pressure conditions for SAS experiments. The lower temperature and lower pressure were 
chosen aiming to stay within the one phase supercritical region; the upper values for 
temperature and pressure were chosen based on reducing energy costs and previous studies. 
Flow rate limits were chosen to obtain CO2 mole fractions ≥ 0.96, in the carbon dioxide- rich 
region, considering the limitation of ours SAS apparatus. 
 
The alias structure determines which effects are confounded with each other. MINITAB 
15 SOFTWARE [17] was used to generate the simplified alias structure that is shown in 
tables 5.5. 
Table 5.5 The Simplified Alias Structure. 
Concentration Effect l1 = 1 + 24 + 35 = 1 
Temperature Effect l2  = 2 + 14 = 2 
Pressure Effect l3  = 3 + 15 = 3 
Solution flow rate Effect l4  = 4 + 12 = 4 
Supercritical CO2 flow rate Effect l5  = 5 + 13 = 5 
 
In table 5.3 the effect (contrast) in each column is due to both the main variables (C, T, P, 
QL and QCO2) and the effects of the interactions shown in table 5.5. For screening purposes, 
the interactions between two factors were also considered negligible [18], so the effect value li 
is caused only by the main factor, by other words, concentration for column 1, temperature for 
column 2, and so on. 
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5.2.2. SEM Images. Particle size and Response and Contrast Calculation 
The mean particle size and particle morphology obtained from SEM images were used as 
a response to evaluate the process performance.  
 
Fig. 5.8 shows an optical image of the 5-FU commercial powder and its SEM image. SEM 
images of untreated 5-FU exhibits granulated particles with a mean particle size > 100 µm. 
 
   
 
Fig. 5.8 Images of untreated 5-FU. 
 
SEM images of the 5-FU precipitated are shown next in Figs. 5.9-12. Conditions of the 
precipitation experiments are given in tables 5.3 and 5.4.  All experiments of the design 
matrix were carried out following the same experimental procedure. In every case the 
precipitation was successful and fluffy powders were obtained. SEM images reveled, 
however, that six of the eight experiments (1, 2, 5, 6, 7 and 8) led to a successful 
micronization of 5-fluorouracil. On the other hand, the micronization was unsuccessful for 
runs 3 and 4 were much larger particles of regular shape were obtained. SEM images of 
micronized 5-fluorouracil samples show the formation of elongated particles with a 
distributed mean particle size in range of 216-670 nm and standard deviation within the range 
of 65-220 nm, respectively.  
 
The effect of 5-FU concentration in the liquid solution has been studied at temperatures of 
40 °C and 50 °C and pressures of 15 and 18 MPa. With the exception of the experiment at 50 
°C and 15 MPa, small particles have been obtained at all concentrations.  
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    Run 1        Run 2 
   
 
Fig. 5.9 SEM images of SAS 5-FU obtained at 40 °C, 15 MPa and concentrations of 1 (a) and 2% (b). 
 
Fig. 5.9 compares particles obtained at 40 °C and 15 MPa using two different 
concentrations. Notice that the magnification is lower in the SEM image of run 2, showing 
how larger particles are obtained at the higher concentration. In runs 3 and 4 carried out at 50 
°C and 15 MPa and concentrations of 1 and 2%, respectively, much larger crystals exhibiting 
a thin bar shape are obtained as shown in Fig 5.10.    
  Run 3                Run 4 
              
 
 
Fig. 5.10 SEM images of SAS 5-FU obtained at 50 °C, 15 MPa and concentrations of 1 (a) and 2% (b). 
 
The precipitations performed at 50 °C and 15 MPa were successful but not the 
micronizations and very large particles were obtained at these conditions. The reasons for that 
are not completely understood but it may be attributed to the influence of 5-FU on the phase 
diagram of the CO2 + DMSO binary system which could result in phase splitting. 
  
(a) (b) 
(a) (b) 
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The effect of pressure on the particles morphology was studied at 40 °C and 15 and 18 
MPa. As shown in Fig 5.9 and Fig 5.11 for runs 1, 2, 5 and 6 carried out at 40 °C, for a given 
concentration the particle size decreases as the pressure increases.  
    Run 5                Run 6 
   
 
 
Fig. 5.11 SEM images of SAS 5-FU obtained at 40 °C, 18 MPa and concentrations of 1 (a) and 2% (b). 
  
 
The effect of temperature on the particles morphology was studied at 18 MPa and 40 and 
50 °C. As shown in Fig 5.11 and Fig 5.12 for runs 5, 6, 7 and 8 carried out at 18 MPa, the 
mean particle size decreases as the temperature increases for a given concentration (images 
given at different magnification). 
    Run 7                Run 8 
   
 
 
Fig. 5.12 SEM images of SAS 5-FU obtained at 50 °C, 18 MPa and concentrations of 1 (a) and 2% (b). 
 
SEM images for runs 1, 2, 5-8 show that the particle size increases as the 5-FU 
concentration increases at a given temperature and pressure. However at highest pressure and 
lowest concentration at both 40 and 50 °C, run 5 and 7, the elongated particles start to be 
aggregated and from what look like a porous structure. Particle size distribution at every 
(a) (b) 
(a) (b) 
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condition were obtained from the analysis of the SEM images following the procedure 
described in chapter three and are shown in Fig. 5.13. These data were used as the response to 
evaluate the parameters that affect performance of the SAS process. 
 
Fig. 5.13 Probability density as a function of particle size for 5-FU SAS micronization. 
  
Table 5.6 shows again the fractional factorial design matrix with values for the particle size 
and the standard deviation obtained from the SEM images. 
 
Table 5.6 The Fractional Factorial 25-2 Design with Response and Contrast. 
Response 
Run C (1) T (2) P(3) QL QCO2 Mean PS 
(nm) 
SD 
(nm) 
1 - - - + + 508 170 
2 + - - - - 670 220 
3 - + - - + - - 
4 + + - + - - - 
5 - - + + - 580 180 
6 + - + - + 576 170 
7 - + + - - 216 65 
8 + + + + + 436 130 
 
Mean effect, Contrast,  
PS,nm 94.5 -420.5 157 15 13.5 
SD 28.5 -135.5 39 2.5 2 
 
 
The mean effect, , of each column was calculated using equation (3.44) as it was explained 
in chapter three.  
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Three key factors with major effect on the particle size were identified. In order of 
decreasing importance, these are temperature, pressure and concentration.  
 
As shown in Fig. 5.13, the smallest particle sizes with the narrowest particle distribution 
are obtained in run 7 while the largest particle sizes with a very broad particle distribution are 
obtained in run 2. 
 
Fig. 5.14 shows the effect of the different factors on the particle size. It confirms that 
temperature and pressure have the highest influence in the particle size. The order of 
importance of the factors for particle size and morphology can be summarized in view of their 
mean effect as following  
      T  > P > C >> QL >  QCO2 
 
Fig. 5.14 Effect of the different factors on particles size for 5-FU SAS micronization. 
 
Thermal effects for the conditions of temperature and pressure used are moderate. 
Temperature increases inside the precipitation chamber were calculated using the procedure 
described in chapter four. Values of 1.9 and 2.6 degrees were obtained for experiments at 40 
°C and 15 and 18 MPa, respectively, and values of 3.2 and 2.8 degrees for experiments 
carried out at 50 °C and 15 and 18 MPa, respectively. These moderate increases together with 
the pressure values that are much higher than those shown for the phase boundaries at x = 
0.96 and 40 °C and 50 °C  in Fig. 4.8, exclude the possibility of a phase separation such as 
that described in the YAc micronization at 60 °C  and 14 MPa. 
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Best conditions for the 5-FU micronization were those of run 7: the concentration of the 
solution (C = 1%), the temperature (T = 50 °C), the pressure (P = 18 MPa), the solution flow 
rate (QL = 1 mL/min), the supercritical CO2 flow rate (QCO2 = 15 g/min), the drying time (t = 
3 Volume), and the nozzle diameter (Øn = 100 µm) which result in the smallest mean particle 
size of 216 nm. In comparison to previous report, the particle size and morphology of 5-FU 
precipitated in this work are similar to those obtained by Kalantarian et al. [14]. In their study, 
best results were obtained for particles precipitated from methanol-dichloromethane 50:50 
exhibiting a mean particle size of 248 nm.  
 
5.2.3. Characterization of 5-FU using X-ray Diffraction 
The crystallinity of the precipitated particles has been evaluated using X-ray diffraction 
powder (XRD). Samples were scanned over the range of 10-50 degrees 2θ. Fig 5.15 compares 
the XRD patterns of the untreated and SAS processed 5-FU. 
 
 
 
 
 
 
 
 
Fig. 5.15 XRD patterns of untreated 5-FU and SAS Processed 5-FU obtained at 50 °C and 18 MPa and 
concentrations of 1%. 
 
The XRD pattern of the untreated 5-FU exhibits a very intense peak at 28.7 degree. The 
high intensity of this peak suggests a preferred orientation of the untreated drug at this 
position. On the other hand, the preferred orientation disappeared in the XRD pattern of the 
SAS precipitated 5-FU and that may be attributed to a decrease of crystallinity during SAS 
precipitation of 5-FU from DMSO with respect to the untreated drug. Kalantarian et al. [14] 
observed the preferred orientation in the XRD patterns of both the untreated and the 
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precipitated 5-FU from methanol/dichloromethane. The differences in crystallinity between 
the sample precipitated from DMSO and that obtained by Kalantarian et al. [14] using acetone 
and dichloromethane may be attributed to the difference in polarity of the solvents used in the 
SAS precipitation.  
 
5.3. Micronization of Diflunisal 
Diflunisal is a non-steroidal anti-inflammatory drug (NSAID). It was first sold under the 
brand name Dolobid, marketed by Merck & Co., but generic versions are now widely 
available.  
 
 
2,4-difluoro-4-hydroxybiphenyl-3-carboxylic acid, IUPAC name of diflunisal. 
 
Diflunisal is a salicylic acid derivative used to relieve pain, tenderness, swelling and 
stiffness caused by osteoarthritis (arthritis caused by a breakdown of the lining of the joints) 
and rheumatoid arthritis (arthritis caused by swelling of the lining of the joints). Diflunisal is 
also used to relieve mild to moderate pain from other causes. Like all NSAIDs, diflunisal acts 
by inhibiting the production of prostaglandins, hormones which are involved in inflammation 
and pain [19-21].  
 
A comparison of the pharmacological profile of diflunisal with that of some well-known 
anti-inflammatory agents such as such as aspirin, ibuprofen and indomethacin has shown that 
diflunisal is more potent and less toxic than these drugs [22].  
 
5.3.1. Literature Review and Design of Experiments 
The low solubility of the target substance in supercritical carbon dioxide is essential for the 
development of the supercritical antisolvent precipitation. Coimbra et al. [23] have measured 
the solubility of diflunisal in supercritical CO2 at 308.2, 318.2, and 328.2 K from 9.0 to 25.0 
MPa using a static analytical method. Experimental solubilities were found to be between 
0.54 x 10-6 and 8.07 x 10-6  in terms of diflunisal mole fraction. The obtained experimental 
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solubility data were successfully correlated by the Peng-Robinson cubic EOS and using the 
classical van der Waals mixing rules. Therefore, diflunisal has a very low solubility in 
supercritical carbon dioxide and could be precipitated in principle by SAS. 
 
The wide applications of diflunisal, its low solubility in supercritical carbon dioxide and 
the lack of literature on the SAS micronization of this drug, made diflunisal our next target for 
micronization. In view of the results obtained from the micronization of YAc and 5-FU, 
DMSO was chosen in the first place as a solvent for the micronization of diflunisal. 
Preliminary experiments carried out at conditions similar to those employed in the YAc and 
5-FU SAS experiments showed that DMSO is not a suitable solvent for the SAS 
micronization of diflunisal because of the re-dissolution of the precipitated drug due to the 
high solubility of diflunisal in DMSO.  
 
On the other hand, the phase behavior available for CO2 + acetone [24-29], in addition to 
the excess molar enthalpies of CO2 + acetone mixtures [30] reported in this thesis made 
acetone a good candidate as a solvent for the micronization of diflunisal. Preliminary SAS 
experiments carried out using acetone were successful to precipitate diflunisal. 
 
In this study, the materials employed were:  acetone (Sigma-Aldrich, ≥ 99 mol % pure) and 
diflunisal (Sigma- Aldrich, analytical standard). The CO2 and DMSO are the same materials 
used in the micronization of YAc.  
 
For the choice of the temperature and pressure conditions of the SAS micronization of 
diflunisal, the isothermal vapor-liquid equilibrium (VLE) data of the binary system CO2 + 
acetone have to be taken into account. Fig. 5.16 shows the vapor-liquid equilibrium data for 
this system at 40 and 50 °C. This system presents a type I diagram in the classification of 
Scott and van Konynenburg [8]. Details of the critical locus can be found in Fig. 4 of 
reference [30]. 
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Fig. 5.16 Isothermal vapor–liquid equilibrium  for [CO2(x) + acetone (1-x)] reported by Katayama et al. [24]: 
(□) 40 °C, Day et al. [25] : (○) 40 °C, Adrian and Maurer [26]: (Δ) 40 °C, Bamberger and Maurer [27] : () 50 
°C, Chiu et al. [28] : (◊) 40 °C, and Stievano and Elvassore [29] : (    ) 40 °C; (►) 50 °C. 
 
Table 5.7 shows the temperature, pressure experimental conditions and the estimated 
temperature increments for CO2 + acetone at a temperature of 40 °C and pressures of 9, 12 
and 15 MPa. 
 
Table 5.7 The temperature, pressure and concentration experimental conditions along 
with the temperature increments for SAS micronization of diflunisal from acetone solutions.  
 
Conditions 
Experiment 
T (°C) Conc. (% )  P/ MPa 
ΔT (°C) 
(x = 0.96) 
1 2 9 5.5 
2 2 
3 4 
12 2.0 
4 
40 
4 15 2.2 
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The other experimental conditions were 1 mL/min solution flow rate, 15 g/min CO2 flow 
rate, drying time required to fill 3 times the precipitation chamber. The liquid and CO2 flow 
rates lead to a value of 0.96 for the CO2 mole fraction in the CO2 + acetone mixtures formed 
in the precipitation chamber. 
 
In this thesis, we have studied the thermal effects in the mixing process between SC-CO2 
and acetone that take place in the SAS precipitation chamber [30]. Mixing process may cause 
a local increase in T in the chamber which also affects phase separation. According to the 
procedure described in chapter four the temperature increments inside the precipitation 
chamber, ΔT, can be estimated at 0.96 CO2 mole fraction. Values of 5.5, 2.0, 2.0 and 2.2 are 
obtained for experiments 1, 2, 3 and 4, respectively. Since the P and T conditions are not close 
to the mixture critical point, the 5.5, 2.0 or 2.2 degrees increments have no effect on the phase 
boundaries. Fig. 5.16 indicates that the CO2 + acetone mixtures formed in the precipitation 
chamber at these conditions are indeed supercritical. 
 
5.3.2. SEM Images. Influence of SAS Parameters 
Fig. 5.17 shows the optical and SEM images of the commercial drug.  The untreated 
diflunisal exhibits a high crystallinity.  
 
      
 
Fig. 5.17 Images of untreated diflunisal. 
 
Large thin bars of a crystalline material were observed in the SEM images of the untreated 
drug. SEM images of the SAS precipitated diflunisal in experiments 1-4 are shown in Figs. 
5.18-5.20. In every experiment, similar thin and very long crystalline particles forming 
laminar sticks were observed.  The sticks are bound together like the branches of a tree. The 
width of the sticks ranges from 2-10 µm at all conditions. 
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Fig. 5.18 SEM images of SAS diflunisal obtained at 40 °C, 9 MPa and concentration of 2%. 
 
 
 
   
 
Fig. 5.19 SEM images of SAS diflunisal obtained at 40 °C, 12 MPa and concentration of 2%. 
 
 
SEM images of the SAS precipitated diflunisal at a temperature of 40 °C, pressures 
ranging from 9 to 15 MPa and concentrations of 2 and 4% show that the different conditions 
do not lead to significant changes in the crystallinity of diflunisal. 
 
The effect of pressure on the particles morphology was studied at a temperature of 40 °C 
and pressures of 9 and 12 MPa. As shown in Fig 5.18 and Fig 5.19, the material precipitated 
is very similar in both cases but for a given concentration, the width of the sticks decreases 
slightly as the pressure increases. 
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Fig. 5.20 SEM images of SAS diflunisal obtained at 40 °C, 12 MPa and concentration of 4%. 
 
The effect of the concentration of the solution on the morphology of SAS precipitated 
diflunisal was studied at solution concentrations of 2 % and 4 % at 40 °C and 12 MPa. As 
shown in Fig. 5.19 and Fig. 5.20, the material precipitated in both cases is very similar but 
crystals are slightly wider at the highest concentration. By increasing the pressure up to 15 
MPa at 40 °C and 4 %, slightly thinner bars are observed again as shown in Fig. 5.21. The 
effect of both concentration and pressure on the morphology of the precipitate for this 
compound is very weak. 
 
   
 
Fig. 5.21 Images of SAS diflunisal obtained at 40 °C, 15 MPa and concentration of 4%. 
 
As it was already mentioned in chapter one, SAS can be used to generate an amorphous 
drug by co-precipitation with a polymer such as polyvinylpyrrolidone (PVP). Since diflunisal 
is a crystalline drug, the co-precipitation of diflunisal with PVP is thought to be an effective 
method to improve the amorphousness of the drug. Because of the poor solubility of PVP in 
acetone, a mixture of good and poor polymer solvents was used in the co-precipitation 
process. DCM was chosen to be the good polymer solvent along with acetone as a poor 
polymer solvent and an acetone/DCM mixture (80:20, v/v %) was used. Dichloromethane 
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(Scharlau, ≥ 99.8 mol % pure) was used. The reasons for this solvent mixture will be further 
explained in the 5.4.2. section. 
 
To have a complete understanding for the influence of PVP on the crystallinity of 
diflunisal, a mixture of acetone/DCM (80:20, v/v %), the same mixture used to precipitate 
PVP as will be discussed later, was used to precipitate the drug alone at a temperature of 35 
°C and pressure of 14 MPa. The other experimental conditions were 2% solution 
concentration, 1 mL/min solution flow rate, 20 g/min CO2 flow rate, drying time required to 
fill 3 times the precipitation chamber. The liquid and CO2 flow rates lead to a value of ≥ 0.96 
for the CO2 mole fraction in the mixtures formed in the precipitation chamber. Fig. 5.22 
shows VLE data for the CO2 + DCM system at temperatures close to those used in the SAS 
experiments.  
 
Fig. 5.22 Isothermal vapor–liquid equilibrium and critical data for [CO2(x) + DCM (1-x)] reported by 
Vonderheiden et al. [31] : ( ◊ ) 37.5 °C; ( □ ) 54.5 °C, Gonzalez et al. [32]: ( ♦ ) 38 °C; ( ■ ) 50 °C and Reaves 
et al. [33]: ( x ) critical point; 38.5 °C. 
 
Unfortunately, there is not phase equilibrium data available in the literature for the ternary 
system CO2 + acetone + DCM. Both the binary CO2 + DCM and CO2 + acetone systems 
display a type I diagram [32]. In view of the similarity of phase behavior for the CO2 + DCM 
and CO2 + acetone systems, we can expect the CO2 + acetone + DCM system to behave in a 
similar way to that described in chapter one for the CO2 + hexane + methanol mixtures. At 35 
°C and 14 MPa we can expect temperature increases in the precipitation chamber similar to 
those obtained for CO2 + acetone mixtures. Nevertheless, the mixture formed will be 
supercritical because the P and T conditions are not close to the mixtures critical point.  
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As shown in Fig. 5.23 the SEM images of the precipitated diflunisal from acetone/DCM 
(80:20, v/v) exhibit the same trend observed during the precipitation from acetone alone. A 
bundle of thin bars like branches of a tree is observed.  
 
   
 
Fig. 5.23 SEM images of SAS diflunisal obtained at 35 °C, 14 MPa and concentration of 2%. 
 
SEM images of the SAS precipitated diflunisal from acetone/dichloromethane at 35 °C and 
14 MPa show that there is no change in the morphology of diflunisal in comparison with that 
obtained from acetone alone. This solute does not seem to be very sensitive to the 
precipitation conditions, nor to the solvent during SAS. 
 
5.3.3. Characterization of Diflunisal using X-ray Diffraction and Differential Scanning 
Calorimetry 
Polymorphism is defined as the ability of a molecule to adopt more than one crystalline 
form. This phenomenon occurs widely among organic compounds where several crystal 
packing possibilities exist via variations in intermolecular hydrogen bonding of functional 
groups. Different packing arrangements of organic molecules result in different physical 
properties such as melting point, solubility, hardness, and density. Diflunisal was reported, on 
the basis of powder X-ray data, to have at least four polymorphic crystal forms of which only 
one crystal structure has been solved [34]. Cotton and Hux [35] described the existence of 
three nonsolvated polymorphs. Martínez-Ohárriz et al. [36] reported the existence of a fourth 
form, IV, and gave the experimental conditions for crystallizing each polymorph together 
with their IR spectra and powder X-ray diffraction (XRD) patterns. Briefly, polymorphs I, III, 
and IV of diflunisal were prepared by dissolving with continuous stirring an adequate amount 
of drug in, respectively, chloroform, ethanol, and toluene and warming the solution in a water 
bath to 60 °C. The undissolved drug was filtered off and the resultant saturated solution was 
then cooled in a refrigerator set at 6 °C. The obtained crystals were separated by filtering 
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under reduced pressure and dried over P2O5 at room temperature. For the preparation of form 
II, distilled water was added to the ethanolic or methanolic saturated solution of the drug at 
room temperature to initiate crystallization, and then the solution was allowed to cool. Fig. 
5.24 shows the XRD patterns of the polymorphs of diflunisal. Martínez-Ohárriz et al. [36] 
found that precipitation of diflunisal from the more polar solvent led to the type II polymorph. 
On the other hand, precipitation from the less polar solvent led to type IV polymorph. 
 
Fig. 5.24 X-ray diffraction patterns of the polymorphs of diflunisal, Martínez-Ohárriz et al. [36] 
 
The polymorphism of the precipitated particles and untreated diflunisal has been examined 
using X-ray powder diffraction system. The XRD patterns of the original substance and SAS 
processed diflunisal over the range of 5-50 degrees 2θ are shown in Fig. 5.25. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. 5.25 XRD patterns of untreated and SAS diflunisal obtained at 35 °C, 14 MPa and concentration of 2%. 
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The XRD patterns of the original substance and SAS processed diflunisal are different, 
which means that the polymorphism of diflunisal is changed through the SAS process. 
Confusion exists in the literature regarding the nomenclature and identity of the polymorphic 
forms of diflunisal, but a comparison of the patterns of Fig. 5.25 with the powder diffraction 
data published by Martínez-Ohárriz et al. [36] reveals that the precipitated drug exhibits form 
IV. The XRD pattern for the untreated diflunisal is similar to form II but not actually the same 
suggesting that it is composed of a mixture of polymorphs. The untreated diflunisal is an 
analytical standard material and the history of the recrystallization processes is unknown; this 
could explain why its XRD pattern exhibits a mixture of different polymorphs. 
 
For further characterization of the samples, differential scanning calorimetry (DSC) was 
performed. The thermograms curves of the solids prior and after precipitation are shown in 
Fig. 5.26. The thermal behavior was studied by heating 5 mg of the sample at a scan rate of 5 
°C/min in a covered sample aluminum pan with a hole under nitrogen gas flow, and the 
investigation was carried out over the temperature range -20 to 250 °C.  
 
 
 
Fig. 5.26 DSC thermograms of untreated and SAS processed diflunisal obtained at 35 °C, 14 MPa and 
concentration of 2%. 
 
 
Untreated Diflunisal 
SAS Diflunisal 
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The melting point was measured as the point of intersection between the baseline and the 
linear section of the ascending endothermic curve. The DSC thermograms show that the 
untreated diflunisal has a splitted peak with two melting points at 216.62 and 213.82 °C 
which confirm the presence of more than one polymorph. On the contrary, the SAS diflunisal 
exhibits a single sharp peak at 212.63 °C peak corresponding to the melting point of form IV.  
 
5.3.4. Dissolution Profiles of Diflunisal 
The major objective of scientists in the pharmaceutical industry is to improve the 
bioavailability, stability of the active pharmaceutical ingredients and its convenience to the 
patient. Bioavailability means the rate and extent to which the active substance or therapeutic 
moiety is absorbed from a pharmaceutical form and becomes available at the site of action. 
The bioavailability of an orally administered drug depends on its solubility in aqueous media 
over the pH range of 1.0–7.5 and the rate of mass transfer across biological membranes [37].  
 
Martínez-Ohárriz et al. [36] studied the dissolution properties of the different polymorphic 
forms by determining the intrinsic dissolution rate. They found that the dissolution rates of 
crystalline forms in a phosphate buffer solution of pH 5 are in the sequence: form I > form II 
> form III > form IV.  Rodríguez-Espinosa et al. [38] studied the dissolution profile of 
diflunisal form II in a buffer solution at pH 5. They found that 10 % of the drug was dissolved 
within 1 hour. The dissolved amount increased to 20 % after 2 hours, reaching 30 % at 3 
hours. 
 
The dissolution profile of the diflunisal samples precipitated by SAS was followed by UV-
VIS spectroscopy. The absorption spectrum of diflunisal at 25 mg/L solution in a phosphate 
buffer solution of pH 7.4 is shown in Fig. 5.27. The spectrum shows two broad bands at 275 
and 306 nm which can be related to the two aromatic rings of the molecule.  
 
 
 
 
 
 
 
 
 
 
Fig. 5.27 Ultraviolet absorption spectrum of a 25 mg/L solution of diflunisal in the dissolution medium. 
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According to Brittain et al. [39], the free rotation that would exist in solution about the 
bond connecting the difluorobenzene and salicylate groups leads to energy states associated 
with each aromatic ring. Therefore, the corresponding transitions would be decoupled from 
each other and could be separately observed in the absorption spectrum. 
 
Thus, the band observed at 275 nm is most likely due to absorbance associated with the 
difluorobenzene group, and the band observed at 306 nm would then be associated with 
absorbance in the salicylate group. The most intense band at of 275 nm was then used to 
perform the calibration curve of diflunisal, Fig. 5.28. 
 
Fig. 5.28 Calibration curve of diflunisal performed at 275 nm. 
 
According to the Lambert-Beer law, the absorbance of the solution, A, is linearly related to 
the concentration of the solute obeying the following equation: 
  
                   (5.1) 
 
where a is the absorption coefficient in mg-1 L-1 cm-1, c is the concentration in mg-1 L-1 of the 
solute and l is the path length = 1 cm. 
 
By fitting the absorbance versus concentration to a straight line, the absorption coefficient can 
be determined from the slope and it was found to be 0.0224 mg-1 L-1 cm-1. 
 
Chapter 5 - Supercritical Antisolvent Micronization of Pharmaceuticals   
 
 153 
The dissolution profile of the untreated and SAS processed diflunisal from acetone/DCM 
at 35 °C, 14 MPa and concentration of 2% was studied using the rotating disk method 
described by Nogami et al. [40]. This method presents a constant area during the time scale of 
this experiment and yielded evidence of a zero-order kinetic process. Dissolution tests were 
carried out in a pH 7.4 phosphate buffer medium (0.01 M phosphate buffer). A hydraulic 
press at 5000 kg/cm2 was used to prepare compressed disks in similar fashion to those used 
for IR spectroscopy by the conventional procedure; 100 mg of the diflunisal powder were 
used in each case. Then the compressed tablet was added to 1 L of the buffer solution 
thermostated at 37 °C. A vertical stirrer with 100 rpm speed was used to improve the 
diffusivity of the drug into the solution by generating a continuous fluid motion. Aliquots of 5 
mL were taken up to 480 min at regular time intervals and were analyzed for the drug content 
using a UV/VIS spectrophotometer. The volume of the solution was kept constant by adding 5 
mL of the phosphate buffer solution each time those samples were withdrawn. Dissolution 
profiles are shown in Fig. 5.29. 
 
Fig. 5.29 Dissolution profiles of untreated diflunisal (□) and SAS processed diflunisal (■) obtained at 35 °C, 14 
MPa and concentration of 2%. 
 
The dissolution profile of the untreated and SAS processed diflunisal from acetone/DCM 
obtained at 35 °C, 14 MPa and concentration of 2% is represented in terms of the drug release 
percentage calculated as follows: 
 
Release (%)                       (5.2) 
where Ct is the concentration of the solution at time t and C100% is the concentration of the 
solution at complete dissolution. 
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By applying the Lambert- Beer law given in Eq. (5.1), the release (%) can be easily obtained 
 
Release (%)                                   (5.3)     
where At is the absorbance of the solution at time t, A100% is the absorbance of the solution at 
complete dissolution of the disk. 
  
The drug release (%) of the untreated and SAS processed diflunisal are very close to each 
other especially in the first and last hours. The SAS processed diflunisal exhibited a slightly 
higher dissolution rate compared to untreated drug. Approximately 24 % and 26 % of the 
untreated and the SAS processed drug, respectively, were dissolved within 1 hour and these 
values increased up to 44 % and 48 %, respectively, after 2 hours. The percentage release as a 
function of time exhibits a linear behavior (r > 0.99) for both diflunisal samples in the first 
two hours. This linear tendency was lost with time as a result of partial dissolution of the disk 
losing the zero-order kinetics. Approximately 99 % of the solid material was dissolved in both 
cases after 6 hours. The slight difference in solubility of both materials is most likely due to 
the different polymorphic forms. In the next section the co-precipitation process and its 
influence on the solubility and amorphousness of diflunisal is described in detail. 
 
5.4. Amorphization of Diflunisal by Co-precipitation with Polyvinylpyrrolidone 
In cases where low solubility limits permeability of the crystalline drug, the amorphous 
form may have an advantage in improving dissolution properties. There are a number of 
different methods to generate amorphous drug substances such as solvent deposition [41], co-
grinding [42], melt extrusion [43], spray drying [44], melt quenching [45] and melt adsorption 
[46]. However, some of these applications may be difficult due to the thermal and deposition 
instability of drug during melting, which often poses a major problem [47, 48]. Hancock and 
Parks [49] reported that the experimental solubilities of amorphous solids are at least 2–4 
times greater than their crystalline counterparts.  
 
One of the possible methods to enhance the dissolution properties is the co-precipitation of 
the poorly soluble drug with a water soluble polymer. Polyvinylpyrrolidone polymer, also 
commonly called polyvidone or povidone, is a water-soluble linear polymer made from the 
monomer N-vinylpyrrolidone which is used in large number of pharmaceutical formulations 
including gastrointestinal pharmaceutical preparations. It offers enhancement of dissolution 
rate and bioavailability of drugs with low aqueous solubility. 
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Poly[1-(2-oxo-1-pyrrolidinyl)ethylene], IUPAC name of PVP. 
 
PVP can be purchased with different K-values number (K-10, K-15, K-25, K-30, K-90, K-
360, etc), which is based on viscosity measurements [50]. As mentioned in the introduction, 
polymers with different K-values have different molecular weight and glass transition 
temperature. The influence of two different types of PVP polymer on the physicochemical 
properties of diflunisal was investigated, PVP K-10 of average  = 10,000 and PVP K-30 
of average  = 40,000. 
 
5.4.1. Literature Review  
The possibility of improving the solubility and bioavailability based on the co-precipitation 
of the poorly soluble drug with PVP using supercritical antisolvent technology is very 
attractive and was already discussed in chapter one [37, 51-55]. Lim et al. [51] have 
investigated the feasibility of using supercritical antisolvent co-precipitation process to 
influence the crystallinity or amorphous character of a crystalline non-steroidal anti-
inflammatory drug, indomethacin (IDMC), for solubility enhancement. They were able to co-
precipitate the IDMC with PVP K-360 from acetone/DCM at 85 bar and 35 °C using 
supercritical carbon dioxide as antisolvent. Drug to polymer ratios of 85:15, 50:50 and 20:80 
were used. They revealed that it was technically feasible to generate amorphous indomethacin 
by co-precipitation with minimum 50 wt. % PVP polymer using SAS. Also they demonstrated 
that the amorphousness increases as the PVP content increases. The drug kinetic dissolution 
of the amorphous form of SAS IDMC co-precipitated with PVP has been enhanced as 
compared to its pure crystalline form and physical blends of IDMC-PVP. Spherical particles 
having mean diameters in the nano range were obtained at 20:80 drug to polymer ratio. 
 
Majerik et al. [37] aimed to improve the bioavailability of oxeglitazar, an orally 
administered poorly water soluble active substance used in the treatment of type II diabetes, 
using a SAS process. Oxeglitazar was co-precipitated at 80 bar and 35 °C with various 
polymeric excipients: polyoxyethylene–polyoxypropylene block copolymers (Poloxamer 188 
and 407), polyethylene glycol (PEG 8000) and polyvinylpyrrolidone (PVP K-17) from six 
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different solvents: ethanol, tetrahydrofuran, dichloromethane, chloroform, N-methyl-2-
pyrrolidone, dimethyl sulfoxide and two binary solvent mixtures: ethanol/tetrahydrofuran 
(50:50, v/v %) and ethanol/chloroform (50:50, v/v %). SAS formulations of oxeglitazar–PEG 
8000, Poloxamer 188 and 407 contained acicular drug crystals that were partly embedded in 
polymeric spheres, while experiments with PVP K-17 resulted in quasi amorphous solid 
dispersions with high density. In spite of their morphology, SAS formulations exhibited 
significantly faster dissolution rates compared to those of the raw drug and physical mixtures. 
Similar results were obtained when the co-precipitation of oxeglitazar and Poloxamer 407 was 
performed. More than double amount of the active substance was dissolved after 5 min from 
the Poloxamer 407 and PVP K-17 formulations in comparison with the unprocessed drug. In 
addition, SAS prepared Poloxamer 407 formulation from DCM solution exhibited high 
polymorphic purity and low residual solvent content. 
 
Badens et al. [52] aimed to improve the dissolution kinetics of oxeglitazar using 
supercritical antisolvent and spray-freezing (SF) techniques. In the SF experiments the feed 
solution was injected into liquid nitrogen, a freeze-drying step, through a capillary nozzle 
located just above the surface of the cryogenic medium resulting in precipitation of particles. 
Oxeglitazar was formulated with various excipients, including: Poloxamer 188 and 407, 
polyethylene glycol (PEG) 8000 and polyvinylpyrrolidone (PVP K-17) in a 1:1 weight ratio at 
80 bar and 35 °C. Dichloromethane, chloroform, and a binary co-solvent system of 
chloroform/ethanol (50:50, v/v %) were tested in SAS. In the SF process, tert-butanol was 
used as solvent. SAS and SF processed formulations exhibited enhanced dissolution rates. 
Within 5 min, the amount of dissolved drug varied from 31.6 to 64.3 % for SAS and from 
77.9 to 96.9 % for freeze-dried formulations while only 30.5 % was dissolved from the raw 
drug. However, a part from the oxeglitazar/PVP K-17 solid dispersion prepared by SAS still 
exhibited high crystallinity and particle showed acicular shape. On the contrary, freeze-dried 
formulations consisted of porous spherical particles with high amorphous content (94.2–
100%). 
 
Wu et al. [53] succeeded to prepare solid dispersions of the poorly water-soluble drug 
piroxicam in polyvinylpyrrolidone (PVP K-25) by precipitation with compressed antisolvent 
(PCA) and spray drying techniques. Methylene chloride was used as a solvent and the 
working conditions were 9.65 MPa and 25 °C for PCA. Piroxicam was found amorphously 
dispersed in both solid dispersion systems with a drug to polymer weight ratio of 1:4. 
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Spherical particles having mean diameters of 1- 5 µm were obtained. IR-spectra data indicated 
the formation of hydrogen bonding between the drug and the polymer. Both precipitation 
techniques evaluated led to higher dissolution rates of piroxicam. By comparison, PCA-
processed solid dispersions showed distinctly superior performance. Piroxicam dissolved 
completely within the first 5 min and the dissolution rate within the first 15 min was at least 
20 times faster than that of the raw drug. 
 
Uzun et al. [54] used supercritical fluid gas antisolvent method (GAS) to co-precipitate 
cefuroxime axetil amorphous (CFA, antibiotic) and PVP K-30 for preparing drug–polymer 
composite particles. Solutions of CFA and PVP K-30 in methanol with overall concentrations 
of 50 - 150 mg/mL and drug / polymer ratios of 1/1 - 1/4 were sprayed into the CO2 at 7 – 20  
MPa and 35 - 50 °C with drug + polymer solution injection rates of 0.85 and 2.5 mL/min. 
Spherical particles having mean diameters of 1.88 - 3.97 µm were obtained. Mean particle 
size was not affected significantly with the change of process parameters; it was only affected 
by pressure change. On the other hand, particle size distribution was affected by pressure, 
temperature, drug + polymer solution injection rate and concentration. The drug release rate 
of SAS co-precipitated CFA–PVP (1/1) particles was almost 10 times slower than that of  the 
pure drug alone. However, the drug release percentage increased with increasing the PVP 
content. The drug release rate of SAS co-precipitated particles was faster than that of the pure 
CFA.  
 
Corrigan and Crean [55] successfully prepared micro-crystalline hydrocortisone–PVP 
composites using the supercritical fluid gas antisolvent method. Analysis indicated that 
hydrocortisone–PVP systems were more crystalline than the corresponding systems prepared 
by spray drying. Systems prepared by the GAS method were more similar in physicochemical 
properties to the co-precipitates prepared by conventional solvent evaporation. In addition, 
GAS hydrocortisone–PVP composites had dissolution rates lower than those of the 
corresponding systems prepared by the other processing methods but equivalent to those of 
the physical mixtures. 
 
PVP has a poor solubility in acetone, the first solvent chosen to micronize diflunisal, but it 
is very soluble in ethanol. Preliminary SAS precipitation experiments of polyvinylpyrrolidone 
from ethanol (Panreac, ≥ 99.9 mol % pure) at pressures of 8 and 12 MPa, temperatures of 35 
and 40°C and PVP K-30 solution concentrations of 2% and 5% (CO2 mole fraction ≥ 0.96) 
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were carried out. The SAS precipitation was unsuccessful because of the high solubility of the 
polymer in ethanol which redissolves any precipitated particles.  
 
Gokhale et al. [56] have developed a new SAS process for the formation of polymer 
particles which utilizes a mixture of thermodynamically good and poor polymer solvents and 
enables one to manipulate the particle size and morphology by varying the good-to-poor 
solvent ratio. Experiments were conducted on PVP polymer of molecular weights 1,300,000 
(K-90) and 360,000 (K-60) dissolved in binary mixtures of DCM (a good solvent) and acetone 
(a poor solvent) for micro-nozzles diameters from 10 µm to 127 µm, jet velocities ranging 
from 0.3 m/s to 20 m/s, and CO2 pressures from 79 bar to 120 bar. They found that by 
increasing the acetone content of the acetone /DCM solvent mixtures, the size of the polymer 
particles is reduced from several hundreds to several tens of nanometers and their surface 
rugosity is practically eliminated. Based on these results, a mixture of thermodynamically 
good (DCM) and poor polymer solvents (acetone) was chosen in this thesis as a solvent for 
the SAS precipitation of PVP. To minimize the particle size of the precipitated particles, a 
mixture of acetone/DCM (80:20, v/v %) was used in this study. Gokhale et al. [56] concluded 
that the operation at a chamber pressure slightly above the critical points of CO2 + acetone 
(Fig. 5.16) and CO2 + DCM (Fig. 5.22) binary systems, favors a narrow particle size 
distribution. 
 
5.4.2. Co-precipitation of Diflunisal with PVP K-10. SEM images  
To have a clear image of the influence of PVP on diflunisal, PVP K-10 was precipitated 
alone from acetone/DCM (80:20, v/v %) at 35 °C and 8.5 MPa. PVP K-10 was supplied from 
Fluka. The other experimental conditions were solution concentration of 2 %, 1 mL/min 
solution flow rate, 20 g/min CO2 flow rate, drying time required to fill 3 times the 
precipitation chamber and nozzle diameter of 100 µm. The liquid and CO2 flow rates lead to a 
value of 0.97 for the CO2 mole fraction in mixtures formed in the precipitation chamber.  
SEM images of PVP K-10 thus obtained are shown in Fig. 5.30. SEM images of SAS 
precipitated PVP K-10 reveal that the sample is formed by spherical nanoparticles. 
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temperature and pressure conditions and two different CO2 mole fractions were attempted for 
the co-precipitation of diflunisal with PVP.   
 
Table 5.8 Experimental conditions utilized in the co-precipitation of diflunisal with PVP 
K-10 at a weight ratio of (50:50) from acetone/DCM. 
Exp. 
T  
(°C) 
Conc.  
(%)  
P 
(MPa) 
CO2 flow rates 
(g/min) 
Solution flow rate 
(mL/min) 
Mole 
fraction 
1 35 2 8.5 
2 35 4 8.5 
3 35 4 9 
4 35 4 12 
5 35 2 15 
6 40 2 9 
7 40 4 9 
20 1 0.97 
8 35 4 8 
9 35 4 9 
10 35 4 10 
11 35 4 12 
10 3 0.84 
 
The drying time was the time required to fill 3 times the precipitation chamber and it was 
ranged from (60- 120 min).  
 
Experiments 1, 2, and 3, carried out at 0.97 CO2 mole fraction and a temperature of 35 °C, 
pressure from 8 to 9 MPa and solution concentrations of 2 and 4 %, showed the formation of a 
viscous solution at the bottom of the precipitation chamber. In addition experiment 8, carried 
out at 0.84 CO2 mole fraction and a temperature of 35 °C, pressure of 8 MPa and solution 
concentration of 4 %, showed the same result. These T and P conditions are very close to the 
critical conditions of both CO2 + acetone and CO2 + DCM. The fact that no precipitate was 
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obtained when carrying out the precipitation near the critical points of the CO2 + organic 
solvent binary system may be attributed to the precipitation from a multi-phase region. 
 
In experiment 9, a slight increase in pressure from 8 to 9 MPa with respect to experiment 8 
led to a successful precipitation. Fig. 5.31 shows the SEM images of the SAS precipitated 
diflunisal + PVP K-10 co-precipitate obtained at experiment 9. 
 
   
 
Fig. 5.31 SEM images of diflunisal + PVP K-10 co-precipitate obtained at 35 °C, 9 MPa, concentration of 4% 
and 0.84 CO2 mole fraction (Exp. 9). 
 
The morphology of the co-precipitated particles is completely different in comparison with 
the pure diflunisal and pure PVP precipitated previously. The SEM micrographs of the co-
precipitate exhibit large porous blocks with smaller particles at the surface and in the holes. 
However, working at the same conditions of experiment 9 but at higher CO2 mole fraction of 
0.97 in experiment 3, a viscous solution as that previously mentioned was obtained. The large 
change observed with CO2 concentration in this case may be related to the complicate phase 
diagram of the five-component mixture. 
 
The effect of increasing temperature from 35 to 40 °C was studied in experiments 3 and 7. 
In this case, a very sticky precipitate was formed at 40 °C at the frit and it may be attributed to 
the plasticization of the PVP polymer at higher temperatures. Even after decreasing the 
solution concentration to 2 % at the same conditions (experiment 6) a sticky precipitate was 
observed. 
 
The influence of pressure on the co-precipitated diflunisal + PVP K-10 was studied at a 
temperature of 35 °C and solution concentration of 4 % varying the pressure from 9 to 12 
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MPa at 0.84 CO2 mole fraction (experiments 9, 10 and 11). The co-precipitates obtained at 
these conditions are shown in Fig. 5.31- 5.33. 
 
   
 
Fig. 5.32 SEM images of diflunisal + PVP K-10 co-precipitate obtained at 35 °C, 10 MPa, concentration of 4% 
and 0.84 CO2 mole fraction (Exp. 10). 
 
 
   
 
Fig. 5.33 SEM images of diflunisal + PVP K-10 co-precipitate obtained at 35 °C, 12 MPa, concentration of 4% 
and 0.84 CO2 mole fraction (Exp. 11). 
 
Comparing the SEM micrographs obtained at 10 and 12 MPa with those obtained at 9 MPa 
at the same temperature and mole fraction, the co-precipitates at the higher pressures have a 
more regular morphology with very large spherical particles. Porosity of the particles at these 
conditions however is slightly lower. The size of the spherical balloons obtained decreases 
with increasing the pressure. The mean size of the porous balloons obtained at 10 MPa was 
100 µm while it was 60 µm at 12 MPa.  
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In addition, experiment 4 was carried out at a higher CO2 mole fraction of 0.97 and at the 
same conditions of experiment 11 described previously. Fig. 5.34 shows the diflunisal + PVP 
K-10 co-precipitate obtained. 
 
   
 
Fig. 5.34 SEM images of diflunisal + PVP K-10 co-precipitate obtained at 35 °C, 12 MPa, concentration of 4% 
and 0.97 CO2 mole fraction (Exp. 4). 
 
Spherical balloons were obtained with a slightly smaller mean size of 50 µm with respect 
to those obtained at 0.84 CO2 mole fraction in experiment 11. In view of these results, the 
following experiments were performed at the higher CO2 mole fraction. 
 
As indicated in table 5.8, experiment 5 was carried out at 0.97 CO2 mole fraction, 35 °C, 
15 MPa and solution concentration of 2 %. Fig. 5.35 (a-b) shows the SEM images of 
diflunisal + PVP K-10 co-precipitate obtained at 15 MPa at two different magnifications. 
  
   
   
Fig. 5.35 SEM images of diflunisal + PVP K-10 co-precipitate obtained at 35 °C, 15 MPa, concentration of 2% 
and 0.97 CO2 mole fraction (Exp. 5). 
 
a b 
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By increasing the pressure up to 15 MPa, a fluffy powder was also obtained. However, 
SEM images revealed that the particles precipitated forming a block, Fig. 5.35a. This 
coalescence of particles may be attributed to plasticization of PVP in the CO2 mixture at high 
pressure. The SEM image at a higher magnification, Fig. 5.35b, showed the presence of 
nanoparticles spread on the surface.   
 
Although results of the co-precipitation of diflunisal and PVP K-10 are not very 
encouraging, it is very important to underline that the crystallinity of the diflunisal 
disappeared in the co-precipitate in contrast to that of the pure diflunisal precipitated from the 
same solvent mixture. Therefore, the dissolution rate of the composite material in comparison 
to the raw drug is expected to increase. However, further increase of pressure in the 
precipitation chamber to 15 MPa results in particle coalescence.  
 
5.4.3. Co-precipitation of Diflunisal with PVP K-30. SEM images  
It is well known that the plasticizing effect of CO2 on polymers decreases with increasing 
polymer molecular weight, therefore to avoid particle coalescence we decided to use PVP K-
30 in the co-precipitation. PVP K-30 has a molecular weight 4 times higher than PVP K-10. In 
view of the experimental conditions previously discussed, the temperature of 35 °C, pressure 
of 12 MPa, solution concentration of 4 % and a value of 0.97 CO2 mole fraction were chosen 
to be the starting experimental conditions. Co-precipitation of PVP K-30 and diflunisal was 
carried out at a weight ratio of (50:50) from acetone/DCM (80:20, v/v %). PVP K-30 was 
supplied from Fluka. The experimental conditions are described in table 5.9. Two different 
solution concentrations of 2 and 4% and pressures up to 14 MPa were tested. 
 
Table 5.9 Experimental conditions utilized in the co-precipitation of diflunisal with PVP 
K-30 at a weight ratio of (50:50) from acetone/DCM.  
Exp. 
T  
(°C) 
Conc.  
(%)  
P (MPa) 
CO2 flow rates 
(g/min) 
Solution flow rate 
(mL/min) 
Mole 
fraction 
12 35 4 12 
13 35 2 12 
14 35 2 14 
20 1 0.97 
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The drying time was the time required to fill 3 times the precipitation chamber and it was 
ranged from (50- 60 min).  
 
The influence of the polymer molecular weight in the co-precipitate was studied by 
comparison of experiments 4 and 12. Fig. 5.34 and 5.36 show the SEM images of diflunisal + 
PVP co-precipitate obtained by using PVP K-10 and K-30, respectively. All the other 
experimental conditions are coincident. Much better results were obtained using PVP K-30 
and small nanoparticles were obtained. 
 
   
 
Fig. 5.36 SEM images of diflunisal + PVP K-30 co-precipitate obtained at 35 °C, 12 MPa, concentration of 4% 
and 0.97 CO2 mole fraction (Exp. 12). 
 
As observed previously, the crystallinity of the diflunisal disappeared during the co-
precipitation with PVP K-30 with respect to the SAS precipitated diflunisal from the same 
solvent mixture. SEM micrographs of the diflunisal + PVP K-30 co-precipitate exhibit 
spherical microparticles slightly aggregated. The mean particle size of the diflunisal + PVP K-
30 co-precipitate is at least 5 times smaller than that of the co-precipitate obtained using   PVP 
K-10. The polymer molecular weight was found to have a profound effect on the mean 
particle size. The increase of the polymer molecular weight results in an important decrease in 
the particle size. 
 
SEM images obtained from experiment 13 carried out at a temperature of 35 °C, a pressure 
of 12 MPa, solution concentration of 2 % and a value of 0.97 CO2 mole fraction are shown in 
Fig. 5.37.  
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Fig. 5.37 SEM images of diflunisal + PVP K-30 co-precipitate obtained at 35 °C, 12 MPa, concentration of 2% 
and 0.97 CO2 mole fraction (Exp. 13). 
 
A decrease in solution concentration from 4 to 2 % also resulted in a decrease in the co-
precipitate particle size as shown in Fig. 5.36 and 5.37. A smaller particle size was observed 
in this case in comparison with that obtained in experiment 12.  
 
As mentioned before in many parts of this study, in SAS process, the particle size 
generally decreases with increasing pressure. However, the increase of pressure in the co-
precipitation of diflunisal + PVP K-10 up to 15 MPa resulted in particle coalescence. 
Therefore, a pressure of 14 MPa at the same condition of experiment 13 was tested to see the 
influence of a further increase in pressure on the mean particle size of the drug + PVP K-30 
polymer co-precipitate. SEM images of the diflunisal + PVP K-30 co-precipitate obtained at 
35 °C, 14 MPa, concentration of 2 % and 0.97 CO2 mole fraction are presented in Fig. 5.38. 
 
   
 
 
Fig. 5.38 SEM images of diflunisal + PVP K-30 co-precipitate obtained at 35 °C, 14 MPa, concentration of 2% 
and 0.97 CO2 mole fraction (Exp. 14). 
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At these concentrations spherical particles are also obtained. Particle size is slightly 
smaller than that observed at the lower pressure. The mean particle size of the diflunisal + 
PVP K-30 was found to decrease slightly with increasing the pressure of the precipitation 
chamber up to 14 MPa without coalescence with respect to particles obtained at experiment 
13 and experiment 5. For the larger molecular weight PVP K-30, the effect of the supercritical 
CO2 + solvent mixture into the polymer is not noticeable and as in previous experiments, 
slightly smaller particle are obtained at the highest pressure. 
 
For comparison, PVP K-30 was precipitated alone from acetone/DCM (80:20, v/v %) at a 
temperature of 35 °C, pressure of 14 MPa and solution concentration of 2%. The other 
experimental conditions were 1 mL/min solution flow rate, 20 g/min CO2 flow rate, drying 
time 60 min and nozzle diameter of 100 µm. The liquid and CO2 flow rates lead to a value of 
0.97 for the CO2 mole fraction in mixtures formed in the precipitation chamber.  SEM images 
of PVP K-30 thus obtained are shown in Fig. 5.39. The SAS precipitated PVP K-30 exhibits 
spherical nanoparticles smaller than those obtained for PVP K-10. 
 
 
   
 
Fig. 5.39 SEM images of SAS PVP K-30 obtained at 35 °C, 14 MPa and concentration of 2%. 
 
The mean particle size of the precipitated polymer was 210 nm with standard deviation of 
90 nm. Fig. 5.40 shows the particle size distribution of the precipitated polymer. 
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Fig. 5.40 Probability density of SAS PVP K-30 as a function of particle size. 
 
The influence of the drug: polymer weight ratio on the properties of the diflunisal + PVP 
K-30 co-precipitates from acetone/DCM (80:20, v/v %) was studied at three different drug to 
polymer weight % ratios of 75:25, 50:50 and 25:75 at a temperature of 35 °C, a pressure of 14 
MPa, solution concentration of 2 % and a value of 0.97 CO2 mole fraction. The experimental 
conditions are described in table 5.10.  
 
Table 5.10 Experimental conditions utilized in the co-precipitation of diflunisal with PVP 
K-30 at different drug: polymer ratios from acetone/DCM (80:20, v/v %).  
 
Exp. T (°C) Conc. (%)  
P 
 (MPa) 
Weight 
ratio 
CO2 flow 
rates 
(g/min) 
Solution 
flow rate 
(mL/min) 
Mole 
fraction 
15 35 2 14 75:25 
14 35 2 14 50:50 
16 35 2 14 25:75 
20 1 0.97 
 
The drying time was the time required to fill 3 times the precipitation chamber (close to 60 
min). The co-precipitates obtained at the three different drug: polymer ratios are shown in 
Figs. 5.38, 5.41 and 5.42. 
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Fig. 5.41 SEM images of diflunisal + PVP K-30 co-precipitate obtained at (75:25, drug: polymer wt. %) 
(Exp.15). Other conditions are the same as Exp.14. 
 
 
   
 
Fig. 5.42 SEM images of diflunisal + PVP K-30 co-precipitate obtained at (25:75, drug: polymer wt. %) 
(Exp.16). Other conditions are the same as Exp.14. 
 
The crystallinity of the diflunisal disappeared in the co-precipitate even at the lowest 
polymer content.  The co-precipitate obtained at experiment 15 showed spherical particles 
with mean particle size less than 10 µm that are highly aggregated forming a block. On the 
other hand, the co-precipitate obtained at 25:75, drug: polymer wt. % showed loose spherical 
particles of mean particle size of 460 nm with very little aggregation with respect to those 
obtained at 50:50, drug: polymer wt. %. SEM images presented in Figs. 5.38, 5.41 and 5.42 
demonstrate how the aggregation and the mean particle size decrease with an increase of the 
polymer content. The trend observed is in agreement with that described by Lim et al. [51] for 
the co-precipitation of IDMC with PVP K-360 from acetone/DCM at 85 bar and 35 °C using 
supercritical carbon dioxide as antisolvent at drug to polymer ratios of 85:15, 50:50 and 
20:80.  
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5.4.4. Characterization of Diflunisal-PVP K-30 Co-precipitates  
The diflunisal + PVP K-30 composites obtained from acetone/DCM (80:20, v/v %) at three 
different drug to polymer ratios of 75:25, 50:50 and 25:75 at a temperature of 35 °C, pressure 
of 14 MPa, solution concentration of 2 % and a value of 0.97 CO2 mole fraction (experiments 
14-16) were characterized further using XRD, FTIR and DSC as well as the dissolution 
profile in comparison with the pure drug. 
 
5.4.4.1. Characterization Using X-ray Diffraction  
X-ray powder diffraction was performed for the pure materials and the SAS co-precipitates 
at the three weight ratios obtained from acetone/DCM to investigate the state of the drug 
(amorphous or crystalline). The crystallinity of materials is indicated by the presence of sharp 
peaks that are absent in the case of amorphous state. Samples were scanned over the range of 
5-50 degrees 2θ as shown in Fig 5.43.  
 
 
 
Fig. 5.43 XRD pattern of diflunisal, PVP K-30, and three diflunisal + PVP K-30 composites obtained by SAS at 
35 °C, 14 MPa, concentration of 2% and 0.97 CO2 mole fraction. 
 
XRD patterns show that the SAS processed diflunisal is a crystalline material while the 
SAS precipitated PVP K-30 is an amorphous material.  The crystallinity of the diflunisal 
disappears in the co-precipitate with PVP K-30 in comparison with SAS precipitated 
diflunisal from the same solvent mixture. The amorphousness of the co-precipitates did not 
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change when the PVP K-30 content was increased from 25 % to 75 %. The inhibitory effect 
of the polymer on the crystallinity of the diflunisal may be attributed to the interaction of the 
drug with the PVP polymer resulting in a change in the molecular mobility of the drug, 
ultimately leading to an amorphous form of diflunisal. 
 
5.4.4.2. Characterization Using Infrared Spectroscopy  
The nature and extent of interactions between diflunisal and the PVP K-30 polymeric 
carrier in the solid state are examined by FTIR spectrometer. Mixing of two the components 
at the molecular level will cause changes in the oscillating dipole of the molecules. This will 
manifest itself as changes in the frequency and bandwidth of interacting groups in the 
spectrum. FTIR spectra have been recorded for diflunisal, PVP K-30, and the three diflunisal 
+ PVP K-30 composites obtained at 35 °C and 14 MPa over the range of 4000-450 cm-1 as 
shown in Fig 5.44. For comparison purposes, the FTIR- spectra were expanded in the 2000-
600 cm-1 range. 
 
 
Fig. 5.44 FTIR-spectrum of diflunisal, PVP K-30, and three diflunisal + PVP K-30 composites obtained by SAS 
at 35 °C, 14 MPa, concentration of 2% and 0.97 CO2 mole fraction. 
 
The functional groups in the FTIR-spectrum showed band shifts and broadening compared 
to the spectra of the pure drug and PVP K-30 which may be attributed to the interaction of the 
functional groups. PVP is capable of forming H-bond either through the nitrogen or the 
carbonyl group on the pyrole ring. However, the steric hindrance prevents the lone pair of 
nitrogen to participate in the intermolecular interactions, thus making the carbonyl group 
more favorable for H-bonding [57]. On the other hand, diflunisal is capable of forming H-
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bond either through the fluor, the carbonyl group, the hydroxyl group or carboxylic O-H 
group. 
 
In the region of 4000-2000 cm-1 diflunisal exhibits a band at about 3400–3200 cm-1 due to 
the stretching of the carboxylic O-H group which is subjected to intermolecular hydrogen 
bonding. The aromatic C-H stretch interferes with the O-H band and a broad multiplet peak at 
about 3200–2800 cm-1 is observed. In the same region, the PVP polymer shows two broad 
bands one of them is split, the first centered at 3500 cm-1 and could be attributed to the 
presence of water due to the high hydrophilicity of the polymer, and the second at about 3100-
2900 cm-1 is related to the aliphatic C-H stretch. In the carbonyl frequency region, the drug 
shows a strong band at 1690 cm-1 associated with the CO stretch in the carboxylic group, 
while the polymer gives a broad strong band (1660 cm-1) due to the CO stretch in the cyclic 
amide. The broadening of the band corresponding to the diflunisal carbonyl group (1690 cm-1) 
in the three diflunisal + PVP K-30 composites suggests the formation of intermolecular 
hydrogen bonding between the diflunisal and PVP K-30. In the low-frequency region (1600–
600 cm-1) the bands observed in the three co-precipitates belong to both the polymer and the 
drug, but some bands of diflunisal and the polymer have either disappeared or reduced their 
intensity significantly. For example, the C-H aliphatic bending vibration of the polymer (1260 
cm-1) has almost disappeared; this could be attributed to steric hindrance resulting from the 
interaction between the drug and the PVP through the carbonyl group of the polymer. The C-
F bending vibration of the polymer (1000-900 cm-1) has also reduced its intensity. All these 
results might indicate that a significant change in the total symmetry of the drug molecule in 
the solid polymer matrix has occurred in the co-precipitates. 
 
5.4.4.3. Characterization Using Differential Scanning Calorimetry and 
Thermogravimetric Analysis (TGA) 
In order to get further evidence of the possible interaction of diflunisal with PVP and to 
understand better the structure of the co-precipitates, DSC and TGA studies of SAS co-
precipitated diflunisal + PVP K-30 from acetone/DCM (80:20, v/v %) as well as the pure 
materials were performed from room temperature to 500 °C at a heating rate of 5 °C/min 
using open aluminum crucibles. This study was carried out using a simultaneous DSC and 
TGA device, the so-called SDT apparatus. 
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The DSC thermograms of the pure materials and the three co-precipitates are shown in Fig. 
5.45. Comparison of the DSC diffractograms gives an idea about the crystallinity of the drug 
in composites. The thermal behavior was studied by heating 10 mg of the sample at a scan 
rate of 5 °C/min in an open sample aluminum pan and the investigation was carried out over 
the temperature range 25 to 500 °C.  
 
 
Fig. 5.45 DSC thermograms of diflunisal, PVP K-30, and three diflunisal + PVP K-30 composites obtained by 
SAS at 35 °C, 14 MPa, concentration of 2% and 0.97 CO2 mole fraction. 
 
The DSC thermogram of the pure diflunisal has three peaks. Although diflunisal is not 
hydrophilic, a broad peak appeared at about 50-75 °C which could be attributed to the 
presence of traces of moisture in the housing furnace of the SDT device and working in an 
open aluminum pan. This peak did not appear in the thermogram obtained by the DSC 
apparatus for the same sample, Fig. 5.26. The second one is a very sharp endothermic peak at 
212.46 °C that represents the melting point of the drug. This point was determined using the 
same criteria as that used in the determination of the melting point of the raw drug. The third 
one appears at 270 °C and it is due to the complete decomposition of the drug. On the other 
hand, the thermal behavior of the polymer is that expected for a hygroscopic and amorphous 
substance. An extreme endothermal effect is shown in the 25-75 °C range due to polymer 
dehydration. Then, one could expect to see the glass transition of the PVP polymer as 
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mentioned previously in the introduction chapter. The glass transition temperature of the PVP 
polymer can be estimated using the K-value and it was found for PVP K-30 to be 164 ○C. 
However, the presence of a large amount of water in the polymer hinders the glass transition 
temperature which could not be observed in the DSC. The polymer only showed a second 
peak associated to its decomposition at 415 °C. In addition, the co-precipitates thermograms 
resembled that of the pure polymer; the melting point of the drug at 212 °C is not observed 
which confirms the destruction of the crystalline state of the drug in the solid polymer matrix. 
Furthermore, the hygroscopic property of the amorphous polymer appeared as a highly 
endothermic peak in 25-75 °C. The endothermic effect due to the dehydration of the polymer 
with heating is increased with increasing PVP K-30 content. For the composite materials the 
broad band due to the loss of water also showed a shoulder at 75-125 °C which shifted to a 
higher temperature as the concentration of PVP increased. This may suggests the presence of 
water molecules in the composite material in a different form to that found in PVP and that 
found in pure diflunisal. The three co-precipitates showed two decomposition peaks one 
attributed to the drug and the other one attributed to the polymer. The broadening in the 
decomposition peak of the drug and the polymer could be attributed to the intermolecular 
interaction between diflunisal and PVP K-30. Furthermore, there was a clear shift of the 
decomposition temperature of the drug with increasing the concentration of the polymer at 
higher temperatures which also supports the strong interaction between diflunisal and the PVP 
K-30. 
 
The glass transition temperatures of the pure materials and the drug in the co-precipitate 
obtained at drug to polymer ratio 50:50 were examined using differential scanning 
calorimetry. The thermal behavior was studied by heating 5 mg of the sample at a scan rate of 
5 °C/min in a covered sample aluminum pan with a hole under nitrogen gas flow. The DSC 
thermograms of SAS processed diflunisal, PVP K-30 and co-precipitate are shown in Fig. 
5.46. The investigation was performed in two heating ramps. The first ramp was carried out 
over the temperature range -20 to 125 °C to eliminate the interference of dehydration peak 
then the sample was equilibrated at -20 °C. After that the second heating ramp was started at 
the same heating rate and ended at 250 °C. Fig. 5.46 represents the DSC thermograms of the 
second ramps only.  
 
Glass transition peaks appeared at 99.13 °C and 175.73 °C in the DSC thermograms of the 
the 50:50 co-precipitate and pure polymer, respectively. On the other hand, this peak did not 
appear in the DSC thermogram of the pure drug. The sharp endothermic peak that represents 
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the melting point of the drug did not appear in the DSC thermograms of the 50:50 co-
precipitate; this is a further evidence of the amorphization of diflunisal by co-precipitation 
with PVP K-30. 
 
Fig. 5.46 DSC thermograms of diflunisal, PVP K-30, and 50 diflunisal : 50 PVP K-30 composite obtained by 
SAS at 35 °C, 14 MPa, concentration of 2% and 0.97 CO2 mole fraction. 
 
Thermogravimetric Analysis curves of the pure materials and the three co-precipitates 
were obtained simultaneously with the DSC thermograms at the same working conditions as 
shown in Fig. 5.47. TGA measures the amount and rate of change in the weight of a material 
as a function of temperature or time in a controlled atmosphere. Measurements were carried 
out primarily to determine the composition of the materials and to predict their thermal 
stability at temperatures up to 500 °C. TGA curves of the SAS processed diflunisal and PVP 
K-30 exhibited 2.2 % and 9.4 % weight loss, respectively, in the 25-75 °C range due to the 
dehydration of the pure materials. The decomposition of the pure drug started very early in 
comparison to the decomposition of the polymer. Diflunisal started to decompose at 180 °C 
and almost decomposed at 290°C forming a yellow solid residue while PVP K-30 started to 
decompose at 350 °C and almost decomposed at 460 °C forming a black solid residue. 
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Fig. 5.47 TGA curves of diflunisal, PVP K-30, and three diflunisal + PVP K-30 composites obtained by SAS at 
35 °C, 14 MPa, concentration of 2% and 0.97 CO2 mole fraction. 
 
TGA curves of the three composites showed that the rate of decomposition decreased with 
increasing the polymer content and that the compositions of the SAS co-precipitates were 
close to the feed compositions. TGA curves of the diflunisal + PVP K-30 composites obtained 
at drug to polymer ratios of 75:25, 50:50 and 25:75 showed weight loss of 1.6 %, 2.8 % and 
4.6 %, respectively, in 25-75 °C range due to dehydration of composites. The decomposition 
process of the co-precipitates took place in two steps. The first step started at a temperature 
very close to the starting decomposition temperature of the drug and the second one started 
also very close to that of the polymer. From the weight losses of TGA drug to polymer weight 
ratios of 61.6:38.4, 45.3:54.7 and 25.5:74.5 were obtained. The co-precipitates almost 
decomposed completely at 460 °C forming a black solid residue similar to that of PVP K-30.  
 
The results obtained from XRD, IR, DSC and TGA, indicated that the crystallinity of 
diflunisal disappeared with the co-precipitation process which could be attributed to the 
incorporation of the drug within the polymer at a molecular level. Generally the dissolution 
rate of an amorphous substance is faster than the crystalline one; therefore, the dissolution rate 
of the co-precipitates in comparison to the raw drug is expected to increase.   
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There is an agreement between the results obtained in this study and those given in the 
literature for the influence of the PVP polymer on drug crystallinity. The disappearance of 
drug crystallinity by the co-precipitation with the PVP polymer found in this study was 
previously reported [37, 51-55]. In addition, in this work amorphous diflunisal was generated 
by co-precipitation with only 25 wt. % PVP polymer while 50 wt. % PVP was used to 
generate amorphous drug by Majerik et al. [37], Lim et al. [51], Badens et al. [52] and Uzun 
et al. [54]; 60 wt. % PVP by Corrigan and Crean [55] and 80 wt. % PVP by Wu et al. [53]. As 
to the co-precipitate morphology, our results are better than those reported by Majerik et al. 
[37] and Badens et al. [52], who did not obtained spherical particles. This could be attributed 
to the intermolecular bonding between the PVP polymer and the drug; with increasing the 
intermolecular bonding, the amorphous co-precipitates form at lower PVP content. 
Furthermore, for a given drug to polymer ratio, the mean particle sizes obtained in this study 
are smaller than those obtained by Uzun et al. [54]; Corrigan and Crean [55] and close to that 
obtained by Lim et al. [51] and Wu et al. [53]. 
 
5.4.5. Dissolution Profiles of Co-precipitates 
The dissolution profiles of the diflunisal + PVP K-30 composites obtained at drug to 
polymer ratios of 75:25, 50:50 and 25:75 from acetone/DCM at 35 °C, 14 MPa and 
concentration of 2% were studied. Dissolution tests were carried out following the same 
procedure described in the dissolution experiments of the untreated and SAS processed 
diflunisal. Aliquots of 5 mL were taken at 5 to 90 min at regular time intervals and were 
analyzed using a UV/VIS spectrophotometer. Dissolution profiles are shown in Fig. 5.48.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. 5.48 Dissolution profile of diflunisal + PVP K-30 co-precipitates obtained at 35 °C, 14 MPa and 
concentration of 2% in comparison with the untreated and SAS processed diflunisal dissolution profiles. 
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For comparison purposes, untreated and SAS processed diflunisal profiles are also shown 
here. All the dissolution rates of the diflunisal + PVP K-30 co-precipitates are higher than 
those of the untreated and SAS processed diflunisal. For a given time, the drug release 
increased with increasing PVP K-30 content; the highest dissolution rate was observed in the 
25 diflunisal: 75 PVP K-30 co-precipitate. After 10 min, the percentage drug release  of 
diflunisal + PVP K-30 composites obtained at drug to polymer ratios of 75:25, 50:50 and 
25:75 were approximately 7 %, 15 % and 34 %, respectively, and these values increased up to 
15 %, 27 % and 75 %, respectively, after 20 min.  On the other hand, approximately 4 % and 
4 % of the untreated and the SAS processed drug, respectively, were dissolved within 10 min 
and these values increased up to 8 % and 9 %, respectively, after 20 min. As previously 
mentioned, the linear tendency of the dissolution rate was lost with time as a result of partial 
dissolution of the disk losing the zero-order kinetics. Approximately 75 % of the drug was 
dissolved after 20-30 min for diflunisal + PVP K-30 composites.  Furthermore, approximately 
99 % of the drug was dissolved after 40 min for 25:75 diflunisal + PVP K-30 composite. The 
improvement of the dissolution rate of diflunisal by co-precipitation with PVP K-30 is in 
agreement with the data obtained by Rodríguez-Espinosa et al. [38] for diflunisal + PVP K-30 
co-precipitate obtained by solid dispersion technique. They studied the dissolution kinetics of 
diflunisal form II, drug-polymer physical mixture (70:30 wt %) and three solid dispersions 
obtained by dissolving diflunisal at diflunisal: PVP weight ratios of 80:20, 70:30 and 50:50 as 
shown in Fig. 5.49.  
 
Fig. 5.49 Dissolution profile of diflunisal form II (□), physical mixture 70:30 (▲), co-precipitate 70:30 (○), co-
precipitate 80:20 (■) and co-precipitate 50:50 (●) [38]. 
 
Rodríguez-Espinosa et al. [38] found that the dissolution rates of the co-precipitates were 
faster than those of the physical mixture and the pure drug. The dissolution rate of the co-
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precipitates increased with an increase of the PVP content. However, dissolution rate of the 
co-precipitate obtained at 70:30 drug to polymer ratio was slower than that obtained at 80:20 
drug to polymer ratio. The dissolution rate obtained at 50:50 drug to polymer ratio 
surprisingly high in comparison to the other ratios.  
 
For a given time, the percentage drug release of the co-precipitates obtained by SAS in this 
study are higher than those obtained by Rodríguez-Espinosa et al. [38] using the conventional 
technique for a similar drug to polymer ratio as shown in Fig. 5.48 and Fig. 5.49. However, 
the drug percentage release of the drug to polymer ratio 50:50 obtained in our work is slightly 
lower than the highest value obtained by Rodríguez-Espinosa et al. [38]. 
 
Furthermore, the improvement of the dissolution rate of the pure drug by co-precipitation 
with the PVP water soluble polymer is in agreement with the data reported by Majerik et al. 
[37], Lim et al. [51], Badens et al. [52], Wu et al. [53], Uzun et al. [54] and Corrigan and 
Crean [55]. 
 
Finally, the experiments showed that there are no large changes in the crystallinity of 
diflunisal with the different working conditions. The crystallinity of diflunisal disappeared in 
the co-precipitate with PVP K-10 or PVP K-30 in all studied ratios. The best results were 
obtained from PVP K-30 at 35 °C, 14 MPa, 2% solution concentration and 0.97 CO2 mole 
fraction. The dissolution rate of diflunisal is improved by co-precipitation with the polymer. 
Enhancement of the dissolution rate could be attributed to the inhibition of the drug 
crystallization. This is mostly due to PVP surface adsorption and efficient steric hindrance for 
nucleation and crystal growth [58, 59]. The dissolution rates demonstrate the potential of 
using PVP as a suitable “amorphous inducing and stabilizing” agent for a poorly water-
soluble drug such as diflunisal to improve the bioavailability using SAS process. 
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Summary and Conclusions  
 
This thesis deals with the micronization of solids using supercritical fluids. The reasons for 
this study are twofold: the need for further study of supercritical antisolvent (SAS) processes 
in order to correctly design and scale-up them and the need for further development of 
pharmaceuticals micronizations. The role of excess molar enthalpies in the SAS micronization 
and the SAS micronization of some pharmaceuticals were studied.  
 
Chapter 1. Introduction 
The first part of this work is an introduction about supercritical fluids (SCFs) followed by a 
description of the production of microparticles using SCFs. Next, the fundamentals of 
supercritical antisolvent (SAS) precipitation and its application in the field of pharmaceuticals 
are summarized. 
 
Chapter 2. Objectives This chapter describes the objectives of the thesis. 
 
Chapter 3. Methodology 
The high-pressure isothermal flow calorimeter used to measure the excess molar enthalpies 
( ) for the CO2 + organic solvent systems is described. The calculation of phase equilibria, 
excess enthalpy and critical locus using an equation of state (EOS) is explained. A detailed 
account of the SAS apparatus built in this thesis is given. The design of experiment (DOE) 
strategy and the methods employed for particle characterization are described.  
 
Chapter 4. Thermal Effects in the Supercritical Antisolvent Micronizations 
In the first step, the excess molar enthalpy data for the CO2 + organic solvent systems 
were determined under the conditions of temperature and pressure usually employed in SAS 
micronizations. In a second step, the interaction between the excess enthalpies and phase 
equilibria in the SAS precipitation chamber was elucidated. The solvents acetone (Ac), N,N-
dimethylformamide (DMF), dimethylsulfoxide (DMSO) and ethyl acetate (EA) were studied. 
This part of the thesis has been the subject of four publications which are included in chapter 
four. 
 
The conditions for temperature and pressure were 313.15 and 323.15 K and 9.00, 12.00, 
15.00 and 18.00 MPa as well as 333.15 K and 9.00 and 15.00 MPa. Similar trends for the 
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variation of  with mole fraction, temperature and pressure were observed for all the CO2 + 
organic solvent systems studied. In most cases, mixtures showed very exothermic mixing. 
 minimum values may be as low as –4500 J mol-1. For most conditions of temperature and 
pressure, excess molar enthalpies exhibited this minimum in the CO2 rich region. At certain 
conditions, linear sections in the representation of versus carbon dioxide mole fraction 
were observed due to the appearance of a two phase region in which a gaseous and a liquid 
mixture of fixed composition are at equilibrium. The liquid and the vapor-phase compositions 
are shown to correspond to the x coordinates of the beginning and end of the linear sections. 
The composition values thus obtained were compared with the VLE data from the literature. 
 
The effects of temperature and pressure on  are large. For a given system and mole 
fraction, in general, mixtures become less exothermic as pressure increases or temperature 
decreases. The effect of the nature of the organic solvent depends on the conditions of 
temperature and pressure. For instance, CO2 + EA mixtures are the most exothermic ones at 
the three temperatures studied and 9.00 MPa. However, at the other pressures studied they 
exhibit values intermediate between those observed for the other systems studied. 
 
Excess molar enthalpies for CO2 + Ac, DMF or EA were accurately correlated using the 
Peng-Robinson and Soave-Redlich-Kwong equations of state, and the classical mixing rule 
with two adjustable binary parameters for each temperature. Excess molar enthalpies could 
not be correlated for the CO2 + DMSO system; this could be related to the complex critical 
behavior exhibited by this system. Furthermore, in the case of the CO2 + DMF system, the 
Peng-Robinson and the Soave-Redlich-Kwong EOS were used in conjunction with the 
classical mixing rules to provide a simultaneous and accurate description of vapor-liquid 
equilibrium (VLE) and critical data for the system and to predict excess molar enthalpies. 
Best results were obtained using the Peng-Robinson EOS. 
 
The trends of the excess enthalpies with temperature and pressure were analyzed in terms 
of molecular interactions, phase equilibria, density and critical parameters previously reported 
for CO2 + organic solvent. A literature search was carried out and the available information 
about CO2 + acetone, DMF, DMSO or EA systems was gathered. These systems have been 
the subject of numerous investigations due to their relation to supercritical fluid applications.  
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The excess molar enthalpy is shown to be the sum of two contributions. One contribution 
is associated to changes in molecular interactions due to the disruption of the organic solvent 
liquid structure by carbon dioxide and the formation of complexes among CO2 and the 
organic solvent molecules. The second contribution to  is due to the carbon dioxide 
change of state from that of a gas-like or liquid-like fluid to that of a liquid mixture 
component. These two contributions were referred as the molecular interactions contribution 
and the change-of-state contribution, respectively.  
 
Acetone, DMF, DMSO and EA are unassociated solvents but all of them present high 
dipolar moments and solvent structures dominated by dipole-dipole interactions. On the other 
hand, carbon dioxide does have a relatively large quadrupole moment. The high dipolar 
moments lead to highly structured liquids with relatively high densities. The solvent structure 
is disrupted upon mixing with carbon dioxide leading to an endothermic contribution to . 
Moderately exothermic enthalpies are the result of a balance between the endothermic 
contribution and an exothermic one due to strong organic solvent- CO2 interactions. This is 
the molecular interaction contribution to  that may be expected to change only slightly 
with temperature and pressure.  
 
In order to analyze the change of state contribution to  we need to consider the state 
and densities of the pure components and those of the mixtures formed in the calorimeter. The 
organic solvents are liquid at the conditions of temperature and pressure of the experiments. 
Their density values vary slightly with temperature and pressure. However, the state and 
density of carbon dioxide differ to a great extent from one (P, T) coordinate to another. 
Carbon dioxide is a supercritical fluid that may be either a high-density (liquid-like) fluid or a 
low-density (gas-like) fluid.  
 
The state of the mixtures formed in the calorimeter (liquid, fluid, two-phase) may be 
established by examining the situation of the (P, T) coordinate with respect to the system 
critical locus and taking into account the critical composition and the vapor-liquid equilibrium 
data. The CO2 + acetone, CO2 + DMF and CO2 + EA systems exhibit type I critical behavior 
in the classification of Scott and van Konynenburg; their complete critical locus were 
calculated using the available critical data. The critical behavior of the CO2 + DMSO system 
is more complicate; it belongs either to type III or IV in the Scott and van Konynenburg 
classification.  
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The fluid carbon dioxide mixes with the liquid solvent forming a liquid mixture or the 
gaseous and liquid mixtures in equilibrium. As a consequence of the CO2 change of state, this 
contribution to the excess enthalpy is exothermic and becomes increasingly exothermic when 
low-density CO2 is mixed. This effect is sometimes called the fluid condensation effect. When 
carbon dioxide enters the calorimeter as a liquid-like fluid, the change-of-state contribution to 
 is small and excess molar enthalpy values may be considered mainly the result of the 
molecular interactions contribution to . When carbon dioxide enters the calorimeter as a 
gas-like fluid, the fluid condensation effect is very pronounced and the change-of-state 
contribution to  is extremely exothermic. As a result, the excess molar enthalpy may reach 
values of – 4500 J mol–1.  
 
For a given temperature, pressure and mole fraction the variations due to the organic 
solvent nature observed may be attributed to the type of critical diagram and differences in 
intermolecular interactions in the pure liquid and the mixtures. These differences lead to 
varying values for the molecular interaction contribution to . However, the magnitude of 
the change-of-state contribution can be expected to be similar for the different solvents at a 
given temperature, pressure and mole fraction when no phase equilibria are involved. 
 
Mixtures formed by supercritical CO2 and an organic solvent are involved in several 
supercritical processes other than SAS. The excess enthalpy data reported in this thesis may 
be used to model or optimize these processes. However, the aim of this study was to 
understand the interaction between phase equilibria and excess enthalpies during SAS 
experiments.  
 
As was already pointed out, the phase behavior of the CO2 + organic solvent is one of the 
crucial factors governing the morphology and the mean size of particles obtained in the SAS 
process. The presence of the solute can induce modifications in the phase diagram. This is the 
case of polymers; however, when the solute has little interaction with carbon dioxide the 
ternary phase diagram for the low solute concentrations usually employed in SAS is 
coincident with the binary one in the CO2-rich region which is the region for mixtures 
involved in SAS. Therefore, the mixtures formed in the precipitation chamber may be treated 
as binary CO2 + organic solvent systems. The heat evolved when the supercritical CO2 
dissolves into the organic solution has an important role in the phase behavior. The 
temperature control in the precipitation chamber is not very precise and a local temperature 
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increase may be expected. As a consequence, if the precipitation starts at T and P conditions 
of complete miscibility for the CO2 + organic solvent system, phase splitting may take place 
in a short time. 
 
Since CO2 is fed into the chamber at a flow rate much higher than that of the solution and 
the solute concentration is very low, the contribution to  due to solute interactions may be 
neglected and the thermal effects in SAS experiments can be considered mainly due to the 
formation of CO2 + organic solvent mixtures very rich in carbon dioxide (x ≥ 0.95). Assuming 
an adiabatic process and using the heat capacity of pure CO2, the measured have been 
used to estimate the temperature increments in the precipitation chamber. These estimations 
allowed to explain the unexpected morphology of the precipitates obtained at certain 
conditions. 
 
The enthalpy effect on the phase equilibria has been clearly shown in SAS micronizations 
from the literature using a windowed vessel and DMSO as the polar solvent. By modifying 
the phase equilibria, excess molar enthalpies will influence the particle precipitation 
mechanism. There are other factors that may simultaneously influence the particle 
morphology but the heat evolved upon mixing CO2 and the polar solvent is shown to play an 
important role.  
 
Chapter 5. Supercritical Antisolvent Micronizations of Pharmaceuticals 
• Validation of SAS Apparatus: Micronization of Yttrium Acetate 
The micronization of yttrium acetate (YAc) from dimethylsulfoxide was chosen to 
validate the SAS equipment built at our laboratory. Precipitation experiments were performed 
at temperatures of 40 and 60 °C and pressures ranging from 11 to 20 MPa. Concentration of 
YAc in DMSO was kept constant at 2%. The phase equilibria data for the CO2 + DMSO 
system were used to understand the different morphologies observed in YAc micronizations. 
SEM images of YAc precipitated at condition of complete solubility of CO2 + DMSO showed 
discrete or slightly aggregated nanoparticles with a spherical morphology. On the contrary, 
working in the two phase region resulted in aggregated particles forming a block. A decrease 
in the mean particle size was observed with the increase of the pressure. To establish if the 
precipitation conditions are in the one or two phase region, the phase equilibria and the excess 
enthalpies for CO2 + DMSO should be taken into account as the mixing process may cause a 
local increase in T in the chamber which also affects phase separation. Thus at 60 °C and 14 
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MPa mixing of DMSO and CO2 is highly exothermic and causes a local temperature increase 
of ≈ 4°C leading to phase splitting. Then the P and the new T, 64 °C, conditions will 
correspond to the two-phase region where aggregated particles are obtained.  
 
Our results for the YAc micronization are in agreement with those previosly reported by 
Reverchon et al. This equipment has been used for the micronization of 5-fluorouracil, 
diflunisal, and the co-precipitation of diflunisal with polyvinylpyrrolidone (PVP). 
 
• Micronization of 5-Fluorouracil 
5-Fluorouracil (5-FU) is a pyrimidine analog drug used in the treatment of several types of 
cancer. This compound is soluble in DMSO but has a very low solubility in CO2. Dimethyl 
sulfoxide was chosen as a solvent for the micronization of 5-FU. The factors that could affect 
the SAS process are: the concentration of the solution (C), the temperature (T), the pressure 
(P), the solution flow rate (QL), the supercritical CO2 flow rate (QCO2), the drying time (t), and 
the nozzle diameter (Øn).  In our study, the drying time and the nozzle diameter were kept 
constant at 3 times the time required to fill the precipitation chamber and 100 µm, 
respectively. In order to decrease the number of experiments the DOE methodology was 
applied and the 25-2 fractional factorial design was employed reducing the number of 
experiments to eight. The value of the CO2 mole fraction was ≥ 0.96. The mean particle size 
and particle morphology obtained from SEM images were used as a response to evaluate the 
process performance. 
 
SEM images of untreated 5-FU exhibits granulated particles with a mean particle size > 
100 µm. Precipitation experiments were carried out at 40, 50 °C; 15, 18 MPa; and 
concentrations of 1 or 2 (%). SEM images of the 5-FU precipitated revealed that six of the 
eight experiments (1, 2, 5, 6, 7 and 8) led to a successful micronization of 5-fluorouracil. 
Elongated particles with a distributed mean particle sizes in the range of 216-670 nm were 
obtained. On the other hand, the micronization was unsuccessful for experiments 3 and 4 
where much larger particles of regular shape were obtained.  
 
For a given concentration, the mean particle size decreased as the pressure and the 
temperature increased. The order of importance of the factors for particle size and 
morphology can be summarized in view of their mean effect as follows  
       T  > P > C >> QL >  QCO2 
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Best conditions for the 5-FU micronization were those of experiment 7: C = 1%, T = 50 
°C, P = 18 MPa, QL = 1 mL/min and QCO2 = 15 g/min which resulted in the smallest mean 
particle size of 216 nm.  
 
The crystallinity of the precipitated particles was evaluated using powder X-ray diffraction 
(XRD). The XRD pattern of the untreated 5-FU exhibited a very intense peak at 28.7 degree 
which suggested a preferred orientation of the untreated drug at this position. On the other 
hand, the preferred orientation disappeared in the XRD pattern of the SAS precipitated 5-FU 
and that may be attributed to a decrease of crystallinity during SAS precipitation of 5-FU 
from DMSO with respect to the untreated drug.  
 
• Micronization of Diflunisal 
Diflunisal is a non-steroidal anti-inflammatory drug that is very soluble in DMSO and 
scarcely soluble in CO2. However, preliminary experiments carried out at conditions similar 
to those employed in the YAc and 5-FU SAS experiments showed that DMSO is not a 
suitable solvent for the SAS micronization of diflunisal. On the other hand, SAS experiments 
using acetone were successful. Precipitation experiments were performed at 40 °C; and 9, 12 
and 15 MPa and concentrations of 2 and 4%. Temperature increments inside the precipitation 
chamber, ΔT, were estimated to be up to 5.5 degrees. Since the P and T conditions are not 
close to the mixture critical point, the temperature increment does not lead to phase splitting. 
 
Large thin bars of a crystalline material were observed in the SEM images of the 
commercial diflunisal. In every SAS precipitation SEM images show similar thin and very 
long crystalline particles forming laminar sticks.  The sticks are bound together like the 
branches of a tree. The width of the sticks ranged from 2 to 10 µm at all operating conditions. 
SEM images showed that the different conditions do not lead to significant changes in the 
crystallinity and morphology of diflunisal. Furthermore, SAS precipitation of diflunisal from 
acetone/dichloromethane (DCM) mixture (80:20, v/v %) gave similar results to those obtained 
from acetone alone. Precipitation of pure diflunisal did not seem to be very sensitive to the 
precipitation conditions, nor to the solvent. 
 
Diflunisal was reported to have at least four polymorphic crystal forms. The XRD patterns 
of the original substance and the SAS processed diflunisal were different, indicating that the 
polymorphism of diflunisal is changed through the SAS process. The precipitated drug 
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exhibits form IV. The XRD pattern for the untreated diflunisal suggested that it is composed 
of a mixture of polymorphs. Furthermore, the DSC thermograms showed that the untreated 
diflunisal has a splitted peak with two melting points at 216.62 and 213.82 °C which 
confirmed the presence of more than one polymorph. On the contrary, the SAS diflunisal 
exhibited a single sharp peak at 212.63 °C peak corresponding to the melting point of form 
IV.  
 
• Amorphization of Diflunisal by Co-precipitation with PVP 
The SAS co-precipitation of diflunisal with PVP was thought to be an effective method to 
improve the drug amorphousness. The influence of two different types of PVP polymer on the 
physicochemical properties of diflunisal was investigated. PVP K-10 (  = 10,000) and 
PVP K-30 (  = 40,000) were used. Preliminary SAS precipitation of polyvinylpyrrolidone 
from ethanol at pressures of 8 and 12 MPa, temperatures of 35 and 40°C, and PVP solution 
concentrations of 2% and 5% (CO2 mole fraction ≥ 0.96) were unsuccessful. Because of the 
poor solubility of PVP in acetone, a mixture of good and poor polymer solvents was utilized 
in the co-precipitation process. DCM was chosen to be the good polymer solvent along with 
acetone as a poor polymer solvent and an acetone/DCM mixture (80:20, v/v %) was used.  
 
First, PVP K-10 was precipitated alone from acetone/DCM (80:20, v/v %) at 35 °C, 9 
MPa, a solution concentration of 2% and a value of 0.97 for the CO2 mole fraction. Spherical 
nanoparticles were obtained with 230 nm mean particle size. Diflunisal was then co-
precipitated with PVP K-10 at a drug : polymer weight ratio of (50:50) at 35 and 40 °C, 
pressures ranging from 8 to 15 MPa, solution concentrations of 2 and 4 % and at two different 
CO2 mole fractions of 0.84 and 0.97. At 35 °C, viscous solutions were obtained at pressures 
ranging from 8 to 9 MPa. By increasing temperature slightly to 40 °C, sticky precipitates were 
observed. Working at higher pressures up to 12 MPa at 35 °C resulted in the formation of 
porous spherical balloons, whose size decreased as pressure increased. However, further 
increase of pressure up to 15 MPa resulted in coalescence of particles. Nevertheless, it was 
clear that the crystallinity of the diflunisal disappeared in the co-precipitate in comparison 
with the SAS precipitated diflunisal from the same solvent mixture.  
 
Second, PVP K-30 was used at the same experimental conditions. Much better results were 
obtained which could be attributed to the fact that the plasticizing effect of CO2 on polymers 
decreased with increasing polymer molecular weight. As observed with PVP K-10, the 
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crystallinity of the diflunisal disappeared during the co-precipitation with PVP K-30 with 
respect to the SAS precipitated diflunisal from the same solvent mixture. The mean particle 
size of the diflunisal + PVP K-30 co-precipitate is at least 5 times smaller than that of the co-
precipitate obtained using PVP K-10. The increase of the polymer molecular weight resulted 
in an important decrease in the particle size. 
 
For comparison, PVP K-30 was precipitated alone from acetone/DCM (80:20, v/v %) at 35 
°C, 14 MPa and a solution concentration of 2 %. SEM images exhibited spherical 
nanoparticles with mean particle size of 210 nm. 
 
The influence of the drug: polymer weight ratio on the properties of the diflunisal + PVP 
K-30 co-precipitates from acetone/DCM (80:20, v/v %) was studied at three different drug to 
polymer weight ratios of 75:25, 50:50 and 25:75 at a temperature of 35 °C, a pressure of 14 
MPa, a solution concentration of 2 % and a value of 0.97 for CO2 mole fraction. The 
crystallinity of the diflunisal disappeared in the co-precipitate even with the lowest polymer 
content. The 75:25 co-precipitate consists of spherical particles with mean particle size less 
than 10 µm that are highly aggregated forming a block. On the other hand, the 25:75 co-
precipitate showed loose spherical particles of mean particle size of 460 nm with very little 
aggregation with respect to that obtained at 50:50.  
 
The diflunisal + PVP K-30 composites at the three different drug to polymer ratios were 
characterized further using XRD, FTIR and DSC as well as the dissolution profile in 
comparison with the pure drug. XRD patterns show that the SAS processed diflunisal is a 
crystalline material while the SAS precipitated PVP K-30 is an amorphous material.  The 
crystallinity of the diflunisal disappeared in the co-precipitates. The amorphousness of the co-
precipitates did not change when the PVP K-30 content was increased from 25 % to 75 %. 
The inhibitory effect of the polymer on the crystallinity of the diflunisal may be attributed to 
the interaction of the drug with the PVP resulting in a change in the molecular mobility of the 
drug, ultimately leading to an amorphous form of diflunisal. FTIR-spectrum showed band 
shifts and broadening compared to the spectra of the pure drug and PVP K-30 which may be 
attributed to the interaction of the functional groups. The broadening of the band 
corresponding to the diflunisal carbonyl group (1690 cm-1) in the three co-precipitates 
suggested the formation of intermolecular hydrogen bonding between the diflunisal and PVP 
Chapter 6 - Summary and Conclusions  
 
 194 
K-30. All these results might indicate that a significant change in the total symmetry of the 
drug molecule in the solid polymer matrix has occurred in the co-precipitates. 
 
In order to get further evidence of the interaction of diflunisal with PVP and to understand 
better the structure of the co-precipitates, DSC and TGA studies were performed. In the DSC 
thermogram of the composite materials, a broad band due to the loss of water showed a 
shoulder at 75-125 °C which shifted to a higher temperature as the concentration of the PVP 
increased. This may suggested the presence of water molecules in the composite material in a 
different form to that found in PVP and in pure diflunisal. The three co-precipitates showed 
two decomposition peaks one attributed to the drug and the other one attributed to the 
polymer. Furthermore, there was a clear shift of the decomposition temperature of the drug 
with increasing the concentration of the polymer at higher temperatures which also supported 
the strong interaction between diflunisal and the PVP K-30. TGA curves of the three 
composites showed that the compositions of the SAS co-precipitates were close to the feed 
compositions. In addition, the decomposition process of the co-precipitates took place in two 
steps. The first step started at a temperature very close to the starting decomposition 
temperature of the drug and the second one started also very close to that of the polymer.  
 
 The results obtained from XRD, IR, DSC and TGA, indicated that the crystallinity of the 
diflunisal disappeared with the co-precipitation process which suggests the incorporation of 
the drug within the polymer at a molecular level.  
 
Dissolution tests using the rotating disk method were carried out in a simulated intestinal 
fluid (phosphate buffer pH 7.4) for the pure drug, the untreated drug and the three co-
precipitated materials obtained at drug to polymer ratios of 75:25, 50:50 and 25:75. The 
dissolution profiles were followed by UV-VIS spectroscopy at 275 nm. All the dissolution 
rates of the diflunisal + PVP K-30 co-precipitates were higher than those of the untreated and 
SAS processed diflunisal. For a given time, the drug release increased with increasing PVP K-
30 content; the highest dissolution rate was observed in the 75 % PVP K-30 co-precipitate. 
Approximately 75 % of the drug was dissolved after 20-30 min for diflunisal + PVP K-30 
composites.  
 
The properties of our co-precipitates compare favorably with those of other drug-PVP co-
precipitates obtained by SAS and GAS and with the diflunisal-PVP K-30 physical mixture 
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and solid dispersions reported in the literature. Two key aspects should be underlined: the 
good morphology and small size of the composites obtained in this study, and the faster 
dissolution rates that demonstrate the potential of using PVP as an agent to induce 
amorphousness and stabilization of a poorly water-soluble drug such as diflunisal. 
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Resumena 
A continuación se incluye un resumen de esta tesis en español, a fin de dar cumplimiento 
al artículo 4.3 de la normativa UCM sobre la admisión a trámite de la tesis doctoral. Dicho 
artículo establece que, en el caso de tesis doctorales redactadas en otra lengua como el inglés, 
“se deberá presentar un amplio resumen en español que incluya, al menos, la introducción, 
objetivos, conclusiones y aportaciones fundamentales de la tesis doctoral”.  
Introducción 
 
1.1. Fluidos Supercríticos 
Los fluidos supercríticos (SCFs) son sustancias puras o mezclas a una temperatura y 
presión superiores a sus coordenadas críticas. La densidad es la principal característica 
diferenciadora de un fluido supercrítico; el comportamiento del fluido puede modularse 
pasando desde el de un líquido a alta presión al de un gas a baja presión.  
 
El dióxido de carbono es el fluido supercrítico más utilizado porque no es tóxico, ni 
inflamable y tiene una temperatura y presión crítica moderadas. La Fig. 1.1 muestra el 
diagrama de fases presión-temperatura del dióxido de carbono. En el diagrama se muestran 
las condiciones donde coexisten dos fases junto con áreas donde sólo existe una fase y el 
punto en que el coexisten tres fases, el denominado punto triple. También se muestra la 
presión crítica (Pc) y la temperatura crítica (Tc); la región del fluido supercrítico se extiende 
por encima de Pc y Tc. Si en esta área se reduce la presión o la temperatura la sustancia pasará 
a estar en las regiones de vapor o líquida, respectivamente, sin que haya tenido lugar ningún 
cambio de fase. El dióxido de carbono tiene una temperatura crítica de 304.12 K y una 
presión crítica de 7.37 MPa [2].  
 
La Tabla 1.1 muestra las masas molares y las temperaturas, presiones y densidades críticas 
de varios compuestos utilizados como fluidos supercríticos. Como puede verse, las moléculas 
más ligeras tienden a tener temperaturas críticas más bajas y densidades críticas más altas que 
las moléculas de masa molecular más alta. 
 
a Para evitar duplicidades, las figuras, tablas y referencias bibliográficas citadas en este 
resumen se encuentran en la versión en inglés que constituye el resto de la memoria. 
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Las presiones críticas de la mayor parte de sustancias varían de 3 a 6 MPa. La presencia de 
enlaces de hidrógeno o la polaridad de las moléculas conducen a un aumento de la 
temperatura o presión crítica del compuesto. Aunque en los procesos supercríticos pueden 
emplearse una gran variedad de compuestos, las sustancias más comunes como el dióxido de 
carbono, los hidrocarburos ligeros y el agua son las que han recibido más atención. 
 
1.1.1. Propiedades de los Fluidos Supercríticos 
En la tabla 1.2 se comparan las propiedades de los fluidos supercríticos con las habituales 
de los gases y los líquidos. Las propiedades termofísicas de los SCF incluyen densidades 
similares a las de los líquidos, viscosidades similares a las de los gases y difusividades muy 
superiores a las de los líquidos. 
 
La densidad es un factor muy importante a la hora de determinar la solubilidad de 
diferentes compuestos en un fluido. Un SCF de densidad alta tiene una capacidad como 
disolvente similar a la de los disolventes líquidos. Por otra parte, los SCFs tienen en 
comparación con los líquidos una viscosidad relativamente baja y unos valores de la 
difusividad que les permiten penetrar en las matrices sólidas. Estas propiedades favorecen la 
transferencia de masa de un soluto en el seno de un SCF con respecto al seno de un líquido. 
La transferencia de calor también está favorecida en un SCF porque los SCFs tienen valores 
de la conductividad térmica altos en comparación con los de los gases aunque sean inferiores 
a los de los líquidos. Además, la baja tensión superficial del SCF hace que el fluido pueda 
penetrar en los materiales porosos. 
 
Como resultado de esta combinación de propiedades, los SCFs son sustancias muy 
interesantes para aplicaciones tecnológicas tales como la extracción, el tratamiento y 
fabricación de materiales, la micronización de sólidos y como medios de reacción. La ciencia 
y tecnología de fluidos supercríticos es un área en creciente desarrollo.  
 
Una de las propiedades más importantes es la solubilidad de los diferentes materiales en 
el fluido. Esta solubilidad tiende a aumentar al aumentar la densidad del fluido a temperatura 
constante. En la Fig. 1.2 se muestra como varía la densidad del dióxido de carbono en función 
de la temperatura y la presión. 
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A una temperatura por debajo de la temperatura crítica (T < Tc), como 280 K, al aumentar 
la presión, la densidad del dióxido de carbono gas aumente. Si se aumenta más la presión se 
produce separación de fases o equilibrio líquido-vapor representado por una línea 
discontinua. Si se aumenta la temperatura a 300 K, el CO2 se comprime y condensa en un 
líquido menos denso; si embargo, el equilibrio líquido-vapor persiste. En el punto crítico las 
dos fases se transforman en una fase de fluido supercrítico. A temperaturas inferiores a Tc, se 
requiere un gran aumento de la presión para que la densidad se eleve un poco. Sin embargo, 
en la región supercrítica cerca del punto crítico una pequeña modificación de la presión trae 
consigo un gran cambio en la densidad; así se puede modular la densidad y otra propiedades. 
Un pequeño aumento de presión en el dióxido de carbono a 310 K (T > Tc) causa un gran 
aumento de la densidad de la fase supercrítica. A temperaturas más altas el fluido empieza a 
comportarse como un gas. 
 
Muchos gases a presión son realmente fluidos supercríticos. Por ejemplo, el nitrógeno 
tiene constantes críticas de 126.2 K y 3.4 MPa. Por tanto, el nitrógeno (o el aire comprimido) 
en una botella de gases por encima de esta presión es realmente un fluido supercrítico. A 
temperatura ambiente, se comporta como un gas, similar al CO2 a temperaturas ≥ 400 K.  
 
1.1.2 Diagramas de Fase de Mezclas Formadas por Fluidos Supercríticos 
Se ha definido un fluido supercrítico como una sustancia a una temperatura y presión 
superiores a sus coordenadas críticas. La misma definición es válida para un compuesto puro 
y una mezcla. Generalmente se estudian en primer lugar las mezclas binarias, para pasar a las 
ternarias y mezclas de orden superior. Esta estrategia nos permite usar nuestro conocimiento 
de las mezclas con dos o tres componentes en el estudio de mezclas multicomponentes. 
 
Lejos del punto crítico los diagramas P-x y T-x de una mezcla binaria son fáciles de 
comprender. Sin embargo cuando las condiciones de temperatura o presión se acercan al 
punto crítico de uno de los componentes, se obtienen diagramas de fase como el mostrado en 
la Fig. 1.3 para el sistema CO2 + pentano a 344 K [4].  
 
A la presión de 5 MPa, la intersección de una paralela al eje de abcisas con la curva 
superior proporciona el valor de la fracción molar del CO2 en la fase líquida rica en pentano 
(x1) mientras que la intersección de esta línea con la curva inferior proporciona el valor de la 
fracción molar del CO2 en la fase de vapor rica en CO2 (y1). Estas son las composiciones de 
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las mezclas líquida y vapor en equilibrio a 344 K y 5 MPa. Cada pareja de valores de la 
composición obtenidos así para una presión dada describen posible estados de equilibrio 
líquido-vapor para este sistema. Al aumentar la presión, los valores de x1 e y1 se aproximan. 
A la presión de 9.5 MPa, las dos curvas confluyen, el valor coincidente de x1 e y1 es la 
composición de la mezcla con coordenadas críticas 344 K y 9.5 MPa. Para obtener otras 
coordenadas críticas P, T, x de este sistema es necesario representar diagramas similares a los 
de la Fig. 1.3 a otras temperaturas. El conjunto de coordenadas crítica P, T, x obtenido define 
el denominado locus crítico de este sistema concreto. Por tanto hace falta un diagrama 
tridimensional P-T-x para describir el comportamiento crítico de un sistema binario. La Fig. 
1.4 muestra este diagrama para un sistema como el CO2 + pentano. Este es el comportamiento 
crítico más sencillo. C1 y C2 son los puntos críticos del CO2 y el pentano, respectivamente. 
Las líneas continúas A-C1 y B-C2 representan las curvas de presión de vapor de ambos 
componentes puros. La línea de trazos que conecta C1 y C2 es el locus crítico del sistema CO2 
+ pentano. Las dos superficies que describen la fase líquida y la fase vapor están delimitadas 
por las curvas A-C1, B-C2 y C1-C2. En la Fig. 1.4 también se muestran algunas secciones 
isotermas e isobaras comprendidas entre las superficies de las fases líquida y vapor. Estas 
secciones originan los diagramas bidimensionales P-x y T-x mostrados a la izquierda en la 
Fig. 1.4. La Fig. 1.5 muestra los diagramas P-T a x constante (isopletas) del sistema etano + 
heptano y la proyección del diagrama de fases tridimensional sobre el plano PT.  
 
Generalmente sólo se da la información mostrada en la proyección P-T. Esta proyección 
de la Fig.1.5 también describe el comportamiento del sistema CO2 + pentano. En este caso, 
los puntos del locus próximos a C1 representan coordenadas críticas de mezclas ricas en CO2-
y los puntos próximos a C2 corresponden a mezclas ricas en pentano. Esta representación 
simplificada es la base de la clasificación de Scott y van Konynenburg [5] de los diagramas 
de fase de sistemas binarios mostrada en la Fig. 1.6.  
 
Scott y van Konynenburg demostraron que casi todos los tipos de equilibrios de fase 
binarios conocidos (líquido-vapor, líquido-líquido y gas-gas) pueden predecirse usando la 
ecuación de estado de van der Waals y las reglas de mezcla cuadráticas. Cinco tipos fueron 
generados usando esta ecuación. Para completar la descripción Street [6] añadió el tipo VI 
que es poco frecuente. El comportamiento del sistema se clasifica en uno de estos tipos 
teniendo en cuenta la forma de la línea crítica y la ausencia o presencia de líneas de equilibrio 
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entre tres fases. Mc Hugh y Krukonis [7] describieron con detalles el aspecto y explicación de 
los diagramas P-T-x de estos seis tipos. El sistema CO2 + pentano pertenece al tipo I que está 
caracterizado por una línea crítica continua que conecta los puntos críticos de los 
componentes puros C1 y C2 y la miscibilidad completa en la fase líquida. 
 
En el tipo II los dos componentes no son completamente miscibles y aparece equilibrio 
entre tres fases a temperaturas inferiores a los puntos críticos de ambos componentes. Esto 
sucede en la línea de equilibrio líquido-líquido-vapor (LLV). El punto UCEP indica la 
temperatura consoluta superior para el equilibrio líquido-líquido (L-L) y es comúnmente 
conocido por su acrónimo en inglés (upper critical end point). A presiones superiores a la de 
este punto la fase vapor condensa en una línea de trazos discontinua que representa el 
equilibrio L-L.  
 
Cuando la inmiscibilidad alcanza temperaturas próximas a la temperatura crítica de uno 
de los componentes, el diagrama de fases puede ser tipo III. En este caso la línea crítica tiene 
dos secciones. La sección que comienza en el punto crítico del componente menos volátil 
(C2) se extiende hasta presión alta y puede tener un máximo o un mínimo en la temperatura 
y/o presión. Cuando las temperaturas de esta línea crítica son superiores a la del componente 
2, se la denomina línea crítica gas-gas (b). La otra sección del locus crítico está a 
temperaturas más bajas y conecta el punto crítico del componente más volátil (C1) y el “upper 
critical end point” (UCEP) que delimita la línea de equilibrio de tres fases (LLV). 
 
En los tipos IV y V la línea crítica gas-líquido empieza en C2 y termina en la temperatura 
consoluta inferior o “lower critical end point” representado por LCEP. Este punto delimita la 
línea de equilibrio de tres fases LLV que termina en el “upper critical end point” (UCEP) y 
está conectada al punto crítico del otro componente por la línea crítica VL. En el diagrama 
tipo IV aparece a bajas temperaturas equilibrio líquido-líquido (LL) similar al del diagrama 
tipo II. 
 
Generalmente el diagrama es de tipo I cuando los dos componentes del sistema binario 
tienen una naturaleza química similar. Cuando los componentes difieren el comportamiento 
se complica y aparecen los tipos II, III, etc. [8]. Por ejemplo, en la serie CO2 + alcano, el 
diagrama de fases varía al aumentar la longitud de la cadena. El tipo I lo presentan los 
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sistemas desde CO2 + metano a CO2 + pentano, el tipo II, desde CO2 + octano a CO2 + 
undecano, el tipo III el sistema CO2+ hexadecano y el tipo IV el sistema CO2 + tridecano [9]. 
 
Finalmente, los diagramas de fase tipo VI se observan para algunos sistemas binarios en 
los que uno o ambos componentes presentan asociación por enlace de hidrógeno. En este caso 
hay dos líneas críticas: una línea continua similar a la de los tipos I y II y una línea de 
equilibrio LLV a bajas temperaturas limitada por los puntos UCEP y LCEP. Este LCEP 
distingue al tipo VI del tipo II.  
 
La descripción del equilibrio de fases a alta presión no se limita a fases fluidas. En muchas 
aplicaciones de los SCF está implicada una fase sólida. En esta tesis, se consideran diagramas 
binarios y ternarios sin intervención de fase sólida. Los diagramas con interferencia de una 
fase sólida no se describen para no alargar esta introducción.  
 
El locus crítico de un sistema ternario es una superficie que se extiende entre los locus de 
los tres sistemas binarios relacionados con el ternario. Para sistemas binarios de tipo I esta 
superficie será continua. En otros casos la superficie crítica presentará discontinuidades 
pudiendo hacerse muy complicada. El análisis del locus se puede simplificar si se considera 
al sistema ternario como un conjunto de sistemas pseudobinarios. En la Fig. 1.7 se muestra el 
locus del sistema ternario CO2 + hexano + metanol basado en esta simplificación [10]. Las 
líneas críticas continuas son los locus críticos de los tres sistemas binarios implicados. Los 
símbolos unidos por líneas de trazos son datos críticos obtenidos para mezclas de CO2 y una 
mezcla metanol + hexano de composición fija. En este diagrama el componente 
pseudobinario es la mezcla hexano + metanol. Cada locus pseudobinario (línea de trazos) 
empieza en el componente común CO2 y termina en un punto del locus hexano + metanol. 
Los sistemas CO2 + hexano y CO2 + metanol son tipo I; el sistema metanol + hexano es tipo 
II. 
 
En los procesos SCF estudiados en esta tesis aparecen dos tipos de sistemas ternarios. El 
primer tipo está formado por CO2 como primer componente y dos disolventes orgánicos 
como segundo y tercer componentes; estos sistemas pueden tratarse de modo similar al 
descrito para CO2 + hexano + metanol. En el segundo tipo de sistemas, el primer componente 
es CO2, el segundo componente es un disolvente orgánico y el tercero es un sólido que ha 
sido previamente disuelto en el disolvente orgánico. La naturaleza del sólido es variada: 
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puede tratarse de un fármaco como la cefonicida o a polímero como el dextrano o la 
polivinilpirrolidona. 
 
Reverchon et al. [11] han estudiado el efecto de la cefonicida en el diagrama de fases del 
sistema binario dióxido de carbono + dimetilsulfóxido (DMSO). En la Fig. 1.8 se representa 
el diagrama P-x para este sistema a 60 ºC, junto con los datos experimentales obtenidos en 
presencia de cefonicida.  
 
En este estudio se utilizó una celda de observación visual y se encontró que para 
concentraciones bajas de cefonicida (30 mg/mL) los datos experimentales de equilibrio 
líquido-vapor (VLE) del ternario CO2 + DMSO + cefonicida eran similares a los datos del 
sistema binario CO2 + DMSO. Por otra parte, a concentraciones superiores de cefonicida (50 
mg/mL) los datos de VLE del ternario CO2 + DMSO + cefonicida diferían de los datos 
binarios en la zona pobre en CO2 mientras que en la zona rica en CO2 los datos de VLE del 
sistema ternario eran prácticamente coincidentes con los del binario. Las diferencias entre los 
datos VLE del sistema binario y ternario se reducen al disminuir la concentración del soluto e 
incrementarse la fracción molar de CO2. Generalmente, el punto crítico de la mezcla del 
sistema ternario no coincide con el del sistema binario [11]. Esta coincidencia si se produce 
cuando la cantidad del tercer componente (cefonicida) es pequeña. 
 
Diego et al. [12] utilizaron una celda de observación visual para estudiar el equilibrio de 
fases del sistema CO2 + DMSO + dextrano a presiones en el intervalo de 8-12 MPa y 
temperaturas comprendidas entre 283.69 y 363.66 K. Las medidas se llevaron a cabo con una 
concentración constante de CO2 del 20 % en masa. Se encontró que para concentraciones 
bajas del polímero (0.1 % en masa) no se observaba equilibrio líquido–líquido. Cuando se 
aumentó la concentración de dextrano a 0.85 %, se observaron equilibrios líquido-vapor, 
líquido-líquido y líquido-líquido-vapor. Al aumentar la concentración de dextrano hasta 8 % 
el equilibrio líquido-líquido apareció a una temperatura más baja. Como el dextrano 
interacciona con el CO2 el diagrama de fases pseudobinario, diagrama de fases ternario para 
bajas concentraciones del soluto, difiere mucho del diagrama binario [12]. Para solutos como 
la cefonicida que interaccionan débilmente con el CO2, el diagrama de fases ternario para 
bajas concentraciones de soluto coincide con el binario al menos en la región rica en CO2 
[11].  
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El conocimiento de los diagramas de fase es un factor clave para analizar el 
comportamiento de fases de los sistemas implicados en aplicaciones de los SCFs. Por 
ejemplo, la solubilidad de un sólido o un líquido en un fluido supercrítico en función de la 
presión a una temperatura dada se obtiene de diagramas P-x como el de la Fig. 1.3. Los 
diagramas similares al de la Fig. 1.4 nos ayudarán a encontrar la temperatura y presión crítica 
de una mezcla binaria. A partir de esta información se puede establecer el estado de la mezcla 
(líquido, supercrítico, equilibrio líquido-vapor). En los capítulos siguientes se verá que los 
diagramas de fase son necesarios para entender los fundamentos de los procesos que usan los 
SCF y para optimizar las condiciones de operación de los mismos. Desafortunadamente, 
aunque en la bibliografía existen datos para muchos sistemas binarios formados por un fluido 
supercrítico, los datos para sistemas ternarios y de orden superior son escasos. 
 
1.2. Tecnología basada en los Fluidos Supercríticos 
La naturaleza medioambientalmente benigna de los fluidos supercríticos como el dióxido 
de carbono (SC-CO2) ha hecho que se haya investigado su uso en aplicaciones diversas 
relacionadas con la industria alimentaria, procesos químicos, industrias farmacéutica y textil 
y en la limpieza de componentes valiosos [13-16]. 
 
• Extracción con Fluidos Supercríticos 
La extracción con fluidos supercríticos, conocida por su acrónimo en inglés SFE, se usa 
mucho en industrias como la petroquímica, química y textil y para producir extractos de gran 
calidad a partir de materias primas naturales en la industria alimentaria. La aplicación en la 
industria farmacéutica supone un reto porque sus exigencias de recuperación y 
reproducibilidad son más rigurosas [13]. SFE puede usarse en la etapa de preparación de 
muestras para fines analíticos o en gran escala para eliminar de una matriz un componente no 
deseado (por ejemplo el descafeinado) [17] o para extraer el producto deseado (por ejemplo, 
aceites esenciales) [18]. 
 
• Cromatografía Supercrítica 
La cromatografía supercrítica, conocida por su acrónimo en inglés SFC, es una técnica 
analítica usada para separar los componentes de mezclas complejas con un fluido supercrítico 
(típicamente CO2) como fase móvil. En la SFC la muestra pasa por medio de CO2 a través de 
una columna de separación; la mezcla se separa en bandas debido a la diferente interacción 
entre cada analito y la fase estacionaria de la columna. Al abandonar la columna las bandas 
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un detector las identifica y determina sus cantidades [19]. SFC puede utilizarse para separar 
extractos de alta presión o para purificar mezclas de productos de reacción. También es 
posible concentrar un extracto eliminando impurezas o sub-productos no deseados. Se puede 
purificar un polipéptido separando otros péptidos y componentes obtenidos por fermentación. 
Por ejemplo, la ciclosporina A se puede separar de extractos miceliales purificándola por 
cristalización [20]. 
 
• Fraccionamiento Mediante Fluidos Supercríticos  
El fraccionamiento de los extractos es una herramienta bien conocida que resulta útil para 
mejorar la selectividad de la SFE. A veces no es posible evitar la co-extracción de algunas 
familias de compuestos (con solubilidades diferentes, pero también con diferentes 
transferencias de masa en el material de partida). En estos casos, es posible llevar a cabo  una 
extracción en etapas incrementando la presión para obtener la extracción fraccionada de los 
compuestos solubles presentes en la matriz orgánica ordenados por sus solubilidades 
decrecientes en el disolvente supercrítico. Esta operación permite fraccionar los extractos 
SCF utilizando varios separadores que trabajan en serie a presiones y temperaturas distintas. 
A escala industrial se suele trabajar en modo continuo usando CO2 como disolvente; para 
aumentar su polaridad frecuentemente se añade como cosolvente etanol. El equipo consiste 
fundamentalmente en una columna de fraccionamiento por la que fluyen a contracorriente el 
disolvente supercrítico y el material de partida y secciones de separación. Al contrario que la 
SFE, este proceso es fácil de operar y puede ser automatizado, con lo que requiere poca mano 
de obra y tiene bajo coste de operación [21]. 
 
• Reacciones Químicas 
Los fluidos supercríticos ofrecen como medio de reacción la posibilidad de remplazar en 
las industrias química y farmacéutica a los disolventes orgánicos tradicionales que son 
dañinos para el medioambiente. Simultáneamente el efecto del disolvente en la reacción se 
puede controlar y optimizar mejor. Ello está relacionado con las excepcionales propiedades 
de los SCFs en comparación con las de los líquidos y gases. Los reactivos y el SCF 
frecuentemente forman una sola fase supercrítica. Los SCF comparten muchas de las ventajas 
de las reacciones en fase gaseosa como la miscibilidad con otros gases, baja viscosidad, y 
gran difusividad que mejoran la transferencia de masa y energía y aumentan la velocidad de 
la reacción. Se han investigado muchos tipos de reacciones químicas, como la oxigenación, 
hidrogenación y alquilación [22-23].  
Resumen 
 
 
 
206 
• Procesado de Polímeros 
A veces es difícil producir polímeros con distribuciones de masas moleculares estrechas 
por métodos tradicionales. El parámetro de solubilidad en un fluido supercrítico puede 
variarse cuidadosa y sistemáticamente modificando la temperatura y presión de modo que 
pueden fraccionarse materiales según su masa molecular porque la solubilidad varía con ella 
y con la longitud de cadena. Por tanto se puede someter una mezcla multicomponente a una 
extracción y fraccionamiento selectivo [13]. Además usando SCFs se pueden producir 
espumas poliméricas o impregnar un polímero con un buen control de ambos procesos. 
 
• Recubrimiento y Encapsulado de Partículas  
En aplicaciones farmacéuticas los perfiles de liberación del fármaco son muy importantes. 
La mayor parte de los principios activos son poco solubles en medios acuosos. Por ello en los 
últimos años se ha prestado atención al desarrollo de sistemas poliméricos biodegradables 
para la administración de fármacos con mejores propiedades terapéuticas [24]. Los métodos 
farmacológicos tradicionales para la producción de micropartículas conteniendo una proteína 
como material polimérico suelen emplear un disolvente orgánico que puede inactivar el 
fármaco o dejar residuos del mismo en el producto final. Además no se consigue una gran 
eficiencia en la encapsulación del fármaco [25]. Se pueden usar los fluidos supercríticos para 
recubrir las tabletas y partículas de principios activos con el tamaño adecuado. [26]. 
 
• Micronización de Materiales 
Las partículas de pequeño tamaño con dimensiones de distribución definida son 
importantes en muchas aplicaciones. Por ejemplo, el tamaño de la partícula es un parámetro 
crucial que determina la velocidad de disolución de un fármaco en un fluido biológico y, por 
tanto, tiene un efecto importante en su biodisponibilidad. El diseño de partículas es una de las 
áreas más pujantes entre las aplicaciones de los fluidos supercríticos en las industrias 
farmacéutica, nutracéutica, cosmética y química [26, 27]. En la siguiente sección se examina 
más detalladamente la obtención de partículas usando SCFs y, en particular, la técnica por 
agente antidisolvente supercrítico. 
 
1.3. Producción de Micropartículas usando Fluidos Supercríticos 
La morfología, tamaño y distribución de tamaños de las partículas son propiedades clave 
que deben cumplir ciertos requisitos en conexión con el uso destinado a estos materiales. Las 
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micro y nanopartículas tienen importancia creciente en la producción de materiales cerámicos 
avanzados, colorante, explosivos, catalizadores, materiales para recubrimientos, 
microsensores, polímeros, ingredientes de alimentos y fármacos. Se utilizan varias técnicas 
de micronización convencionales: trituración, precipitación, “spray drying”, “spray freezing” 
y recristalización por evaporación del disolvente o por agente antidisolvente líquido. Esta 
última técnica se basa en utilizar dos disolventes líquidos miscibles entre sí. El soluto a 
micronizar es soluble en el primer disolvente pero no en el segundo. Por tanto la adición del 
segundo disolvente (antidisolvente) induce la formación de una disolución formada por los 
dos líquidos y la sobresaturación y precipitación del soluto. Sin embargo la recristalización 
por evaporación del disolvente o por agente antidisolvente líquido requiere tratamientos 
posteriores complejos para eliminar completamente los residuos de disolvente. Las otras 
técnicas también presentan sus propios inconvenientes. Por ejemplo “spray-drying” suele 
requerir altas temperaturas de trabajo que pueden ocasionar la degradación térmica de 
materiales sensibles como los fármacos. Además todas las técnicas convencionales comparten 
el inconveniente del escaso control del tamaño y la distribución de tamaños, generalmente se 
obtiene un amplio rango de tamaño de partículas [28]. 
 
En los últimos años muchos investigadores han superado con éxito las limitaciones de las 
técnicas convencionales aprovechando las excepcionales propiedades de los fluidos 
supercríticos. El procesado con SCFs en general y con dióxido de carbono en particular tiene 
varias ventajas: la no toxicidad y fácil eliminación del disolvente, temperaturas de trabajo 
moderadas en una atmósfera inerte que evita la degradación del producto y la posibilidad de 
modular las propiedades del fluido modificando al presión y la temperatura, controlando de 
ese modo el tamaño de la partícula y/o su morfología. Jung y Perrut [26] revisaron en 2001 
las técnicas disponibles para el diseño de partículas usando fluidos supercríticos. Dos años 
antes Reverchon [29] había revisado las técnicas basadas en la utilización del CO2 
supercrítico como agente antidisolvente. In 2003 Shariati y Peters [30] actualizaron estas 
revisiones. Mas tarde, otros autores examinaron los avances relativos a distintos tipos de 
materiales: explosivos (Pourmortazavi y Hajimirsadeghi, 2005 [31]); polímeros (Yeo y Kiran, 
2005 [32] y Reverchon et al., 2009 [33]); materiales inorgánicos (Aymonier et al., 2006 [34]); 
materiales biomédicos (Byrappa et al., 2008 [35] y Okamoto y Danjo, 2008 [36]); 
ingredientes alimentarios (Weidner, 2009 [37]). Estas técnicas pueden clasificarse en dos 
grupos; las técnicas no reactivas sólo requieren transformaciones físicas mientras que otras 
técnicas usan el fluido supercrítico como medio (o simultáneamente como disolvente y 
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reactivo) para llevar a cabo una reacción en la que se producen partículas. Se pueden obtener 
micropartículas de un material puro y micropartículas “composite”. Estas últimas son muy 
importantes como fármacos, productos agroquímicos, cosméticos o ingredientes alimentarios; 
se tratará de ellas en la próxima sección. A continuación se describirán brevemente las 
técnicas no reactivas más utilizadas.  
 
1.3.1. Micropartículas “Composite” 
Muchas formulaciones de fármacos, productos agroquímicos o cosméticos consisten en 
una sustancia activa encapsulada o embebida en un material de recubrimiento o soporte que 
les confiere propiedades adicionales. Aunque las micropartículas “composite” tienen 
estructuras muy variadas se las suele clasificar en microesferas y microcápsulas. Las 
micoresferas son partículas con geometría irregular en las que la sustancia activa forma 
agregados o está dispersa a nivel molecular en el seno de la matriz soporte. Las. 
microcápsulas tienen geometría esférica y están formadas por un núcleo de la sustancia activa 
rodeado por un recubrimiento sólido polimérico o proteico. Según su tamaño, las 
micropartículas se clasifican en nano-esferas/cápsulas si son más pequeñas que 1 µm, macro-
esferas/cápsulas si son mayores de 1000 µm y micro-esferas/cápsulas si tienen tamaños 
intermedios. 
 
Gran variedad de materiales como fármacos, enzimas y productos agroquímicos se han 
preparado como microesferas o microcápsulas. El material de soporte o recubrimiento suele 
ser un polímero natural o sintético pero también pueden usarse grasas, azúcares y ceras. 
 
Los materiales “composite” o compuestos presentan varias ventajas. En primer lugar, son 
más fáciles de manejar y de dosificar que las partículas de la sustancia pura. El material 
elegido como soporte o recubrimiento mejora las propiedades de las mismas y depende del 
uso que se vaya a dar al material compuesto. Se usa un soporte biodegradable para la 
liberación controlada del principio activo en el medio (el organismo de un paciente, el suelo 
de un cultivo agrícola, etc.) Si la sustancia activa puede degradarse, el soporte sirve de 
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protección frente a los agentes dañinos. Si la sustancia activa es poco soluble en el medio, el 
soporte facilita su disolución. Este es el caso de numerosos fármacos poco solubles en agua. 
Si el fármaco es poco soluble en su estado cristalino, su presencia en una forma amorfa en el 
material compuesto conduce a ventajas adicionales mejorando su solubilidad, velocidad de 
disolución y biodisponibilidad. 
 
Como ya se ha mencionado existen varias técnicas convencionales para preparar 
materiales compuestos. Cocero et al. [38] han revisado recientemente estos métodos y los 
resultantes de la aplicación de tecnologías supercríticas. Estos últimos han sido objeto de 
numerosas investigaciones en los últimos años; esencialmente son modificaciones de las 
técnicas usadas para obtener partículas puras. Las ventajas ya mencionadas para el procesado 
de materiales puros usando SCFs son aplicables en el caso de materiales compuestos. 
Además los SCFs pueden usarse para modificar las propiedades del soporte (plastificación, 
hinchado o reducción de la temperatura de fusión en el caso de un polímero) o las 
interacciones entre el soporte y la sustancia activa. Estas interacciones no se conocen bien; la 
producción de materiales compuestos todavía es un área de conocimiento empírico.  
 
1.3.2. Expansión Rápida de Disoluciones Supercríticas (RESS)  
Val Kukronis [39] fue el primer científico que aplicó los SCFs en la recristalización de 
materiales sólidos con el objeto de obtener partículas pequeñas con distribuciones estrechas 
de tamaños. La técnica propuesta se denominó “Rapid Expansion of Supercritical Solutions” 
(RESS) y se basa en utilizar el fluido supercrítico como disolvente. El material a micronizar 
se disuelve en el fluido en un extractor (Fig. 1.9). A continuación se produce una 
despresurización rápida por medio de un nebulizador en una cámara de expansión donde la 
nucleación del producto conduce a un material muy disperso. Por medio de RESS pueden 
obtenerse partículas pequeñas con distribuciones estrechas de tamaños a temperaturas 
moderadas.  
 
Turk [40] ha revisado recientemente las publicaciones sobre esta técnica. RESS tiene la 
ventaja de no requerir disolventes orgánicos pero su aplicación está limitada a sólidos con 
una buena solubilidad en dióxido de carbono, que es el fluido más utilizado. La baja 
solubilidad de las moléculas grandes y polares como los fármacos en CO2 limita la aplicación 
de RESS. Si no fuera por esto, RESS sería la técnica a elegir en el diseño de partículas. La 
coprecipitación también es posible pero tanto la sustancia activa como el soporte tienen que 
Resumen 
 
 
 
210 
ser solubles en CO2. Como RESS es un proceso muy rápido, resulta difícil controlar la 
morfología y la carga de los “composites”. Una posibilidad es precipitar el soporte sobre 
partículas previamente formadas de la sustancia activa.  
 
1.3.3. Partículas a partir de Disoluciones (o Suspensiones) -Saturadas de Gas (PGSS) y 
Procesos Afines 
Otra técnica supercrítica para diseñar partículas es la denominada “Particles from Gas-
saturated Solutions (or Suspensions)” (PGSS). En este proceso el fluido supercrítico se 
disuelve en un sustrato líquido o en una disolución del sustrato(s) en un disolvente o en una 
suspensión del sustrato(s) en un disolvente (Fig. 1.10). A continuación la mezcla líquida se 
despresuriza rápidamente por medio de un nebulizador y se forman partículas sólidas o 
gotitas dependiendo del tipo de mezcla y las condiciones. Este proceso se basa en la gran 
solubilidad de los gases comprimidos en líquidos y sólidos como los polímeros en 
comparación con la baja solubilidad de los mismos en la fase a presión. Se forman partículas 
de sustancias que no necesitan ser solubles en el fluido supercrítico. PGSS puede aplicarse a 
suspensiones del sustrato(s) activo en un polímero u otro soporte formándose microesferas 
“composite”.  
 
PGSS también ha sido utilizado para aplicar pinturas u otros recubrimientos como 
adhesivos. En este proceso hay dificultades para obtener partículas submicrónicas y para 
controlar las distribuciones del tamaño de las partículas. La coprecipitación es posible; el 
efecto plastificador y el hinchamiento que acompañan la disolución del CO2 en el polímero 
favorecen la incorporación de la sustancia activa. Sin embargo cuando el soporte se usa en 
fundido, son necesarias temperaturas altas para fundir sustancias como los polímeros 
semicristalinos usados en algunas aplicaciones.  
 
Afín al proceso PGSS es el proceso denominado “Depressurization of an Expanded Liquid 
Organic Solution” (DELOS) propuesto por Ventosa et al. [41]. En él, un gas comprimido en 
un autoclave expande una disolución líquida formada por el soluto a micronizar y un 
disolvente convencional. En este momento, el gas comprimido actúa como cosolvente y no 
como antidisolvente. La disolución expandida o mezcla ternaria del soluto, disolvente y gas 
comprimido se despresuriza reduciendo rápidamente la presión del sistema hasta presión 
atmosférica en una cámara de expansión. La disolución se evapora y su temperatura 
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desciende mucho, se produce una sobresaturación y el soluto precipita en forma de partículas 
pequeñas con una distribución estrecha de tamaños. 
 
1.3.4. Precipitación por Agente Supercrítico Antidisolvente (SAS) 
Krukonis et al. [42] fueron los primeros en proponer el uso del dióxido de carbono como 
agente antidisolvente para inducir la precipitación controlada de solutos a partir de sus 
disoluciones orgánicas. Este enfoque se basa en la baja solubilidad en CO2 de solutos como 
los polímeros o fármacos y la buena miscibilidad del CO2 con muchos disolventes orgánicos. 
Este es el proceso denominado precipitación “supercritical antisolvent” (SAS). Se han 
utilizado distintos dispositivos experimentales y acrónimos: GAS (“gas antisolvent”), PCA 
(“precipitation by compressed antisolvent”), ASES (“aerosol solvent extraction”), SEDS 
(“solution enhanced dispersion by supercritical fluid”) y SAS (“supercritical antisolvent”). El 
acrónimo GAS se suele usar para procesos en discontinuo mientras que SAS describe bien a 
los procesos continuos. Ambos tipos de técnicas se basan en el mismo concepto ilustrado en 
la Fig. 1.11.  
 
El sólido a precipitar se disuelve en un disolvente orgánico y se mezcla con CO2 en la 
cámara de precipitación. Cuando el CO2 supercrítico se disuelve en el disolvente orgánico, el 
líquido experimenta una expansión volumétrica y se convierte en un mal disolvente de soluto 
que precipita en forma de micro y nanopartículas. El tamaño de la partícula se puede modular 
variando los parámetros del proceso como la presión, temperatura, concentración del soluto, 
etc. Los parámetros críticos del CO2 permiten operar a temperaturas moderadas. Además las 
partículas no tienen restos de disolvente y presentan una distribución estrecha de tamaños. 
Desde el punto de vista de la Química Sostenible, SAS tiene el inconveniente de usar 
disolventes orgánicos pero se trabaja a una presión muy inferior a la de RESS. También 
pueden usarse en SAS inhibidores de la aglomeración o modificadores del hábito del cristal. 
Como en RESS, es posible producir “composites” coprecipitando simultáneamente la 
sustancia activa y el soporte o encapsulando partículas formadas previamente. En este caso, 
se prepara una suspensión de las partículas en una disolución del soporte y este se precipita 
por SAS. Si se coprecipitan un fármaco y un excipiente polimérico, se pueden modificar 
fácilmente las proporciones de ambos componentes cambiando sus cantidades relativas en la 
disolución orgánica. 
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1.3.5. Reacciones en Medio Supercrítico con Formación de Partículas 
Las reacciones en medio supercrítico con formación de partículas han recibido bastante 
atención como instrumento para sintetizar partículas de materiales cerámicos u óxidos. Al 
contrario que en los procesos RESS, SAS y PGSS, se utiliza el SCF para llevar a cabo una 
reacción. Por ejemplo, se disuelven lo precursores en el fluido y se les descompone 
térmicamente. Tras la despresurización en CO2, el disolvente vuelve a la fase gaseosa y 
separándose de las partículas que se obtienen finamente divididas. También se puede llevar a 
cabo una reacción sol-gel a alta presión y alta temperatura. En la síntesis hidrotérmica se usa 
un fluido supercrítico simultáneamente como disolvente y reactivo. Para obtener polvos de 
óxidos, los precursores (sales inorgánicas) se disuelven primero en agua y se introduce la 
disolución en un reactor operado en condiciones supercríticas. Por cambios de presión y 
temperatura se modifican las propiedades termodinámicas y de transporte consiguiéndose 
controlar el crecimiento de los cristales, la morfología y el tamaño y la distribución de 
tamaños de las partículas. Esta técnica evita etapas de los procesos convencionales como la 
calcinación pero aún son necesarios el filtrado, lavado y secado. Desafortunadamente, hay 
que enfrentarse a los problemas de corrosión asociados al uso del agua supercrítica. 
 
1.4. Fundamentos de la Precipitación por Agente Supercrítico Antidisolvente (SAS) 
La gran aplicabilidad de SAS ha contribuido a su uso creciente. En los últimos años se han 
micronizado por este método gran variedad de compuestos como explosivos, polímeros, 
fármacos, colorantes, catalizadores y compuestos inorgánicos en general. Por lo que respecta 
a la morfología se han obtenido distintas morfologías para partículas amorfas: nanopartículas 
con diámetros medios en el intervalo 30-200 nm, micropartículas en el intervalo 0,25-20 µm 
y micropartículas expandidas (huecas) con diámetros entre 10 y 200 µm. También se han 
obtenido cristales con distintos hábitos y dimensiones. Debido a estas características, SAS ha 
sido la técnica elegida en esta tesis. 
 
La precipitación SAS incluye varias etapas: 
• Usando una bomba de alta presión se introduce CO2 supercrítico en la cámara de 
precipitación a un flujo constante. Se introduce el disolvente o directamente la 
disolución también a flujo constante alcanzándose el estado estacionario y una 
proporción fluido/disolvente adecuada. La cámara se calienta y se controlan la 
temperatura y la presión. 
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• El fluido se disuelve en la disolución formada por el sólido y un disolvente orgánico 
polar como el dimetilsulfóxido (DMSO) o la N-metil-2-pirrolidona (NMP). Se 
produce la expansión y sobresaturación y comienza la precipitación. El soluto se 
recoge en la cámara de precipitación. 
• Al terminar la precipitación la cámara se lava con el antidisolvente para eliminar el 
disolvente líquido. La mezcla CO2 + disolvente orgánico pasa a la cámara de 
separación donde se recupera el disolvente. 
La expansión volumétrica del disolvente líquido es el resultado de la gran solubilidad del 
fluido supercrítico antidisolvente en la fase líquida. La expansión volumétrica ΔV % 
porcentual se define como  
ΔV % =                                      (1.1) 
donde V (P, T) es el volumen de la fase líquida cargada con el antidisolvente y V0 es el 
volumen de la fase líquida pura a presión atmosférica. 
 
Muchos autores han estudiado las isotermas de expansión volumétrica de los sistemas CO2 
+ disolvente [29, 43], pero también debería tenerse en cuenta el efecto del soluto en la 
expansión volumétrica. Este tipo de estudios son escasos. Reverchon et al. [44] han estudiado 
este efecto en el caso del sistema ternario CO2 + DMSO + dextrano a 30 °C. En la Fig. 1.12 
se muestran las curvas de expansión volumétrica para CO2 + DMSO y CO2 + DMSO + 
dextrano. Los porcentajes de dextrano varían entre 0.05 y 5 %. Su presencia no modifica 
apreciablemente la expansión volumétrica. Los valores de ΔV % para las mezclas ternarias 
siguen la misma isoterma del sistema CO2 + disolvente. Aunque estos datos corresponden a 
una temperatura más baja que la empleada habitualmente en SAS, se pone de manifiesto que 
para las bajas concentraciones de soluto utilizadas en esta técnica la expansión volumétrica 
puede describirse usando datos binarios.  
 
El éxito de la micronización SAS, y la morfología, tamaño y distribución de tamaños de 
las partículas dependen de un gran número de parámetros del proceso: temperatura, presión, 
concentración, elección del disolvente, modo de inyección del antidisolvente, etc. Estos 
parámetros influyen simultáneamente en el equilibrio de fases a alta presión, la 
hidrodinámica, la transferencia de masa y la formación y crecimiento de las partículas. Para 
comprender el proceso SAS deben tenerse en cuenta todos estos factores y las interacciones 
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entre ellos. Los estudios experimentales suelen explorar distintas combinaciones de los 
parámetros del proceso seleccionando sus valores óptimos después de un trabajo 
considerable. A veces se sigue una estrategia de diseño de experimentos para minimizar el 
número de micronizaciones. A partir de este tipo de estudios es difícil obtener conclusiones 
generales o reunir la información necesaria para el escalado requerido en aplicaciones 
comerciales. Por ello muchos autores han llevado a cabo estudios, tanto teóricos como 
experimentales, encaminados a establecer los fundamentos y mecanismos de la precipitación 
SAS. Para poder establecer estos mecanismos han de tenerse en cuenta interacciones entre el 
equilibrio de fases a alta presión, las variaciones de la tensión superficial, la dinámica del 
chorro, la transferencia de masa, y la nucleación y crecimiento de las partículas. Una revisión 
detallada de todas estas contribuciones está fuera del alcance de esta introducción. 
 
Los profesores Ernesto Reverchon y María José Cocero, y sus grupos de las universidades 
de Salerno (Italia) y Valladolid (España), han contribuido extraordinariamente en los estudios 
experimentales y en el análisis de los mecanismos de precipitación SAS. Martín y Cocero 
[45] revisaron en 2008 las contribuciones sobre los fundamentos y mecanismos de SAS 
prestando atención a la mecánica de fluidos, las propiedades termodinámicas y de transporte, 
la transferencia de masa y la formación y crecimiento de las partículas. Como mostraron 
Reverchon, Brauer y sus colaboradores usando técnicas de difusión de luz y láser [46, 47], los 
mecanismos son el resultado de las influencias mutuas entre estos fenómenos. En dos trabajos 
publicados recientemente, De Marco y Reverchon [48, 49] resumieron estas contribuciones y 
las conclusiones más importantes. 
 
Algunos autores intentaron explicar los mecanismos de SAS partiendo del análisis de 
dinámica de fluidos en la inyección de la disolución en el antidisolvente a presión. Lengsfeld 
et al. [50] indicaron que cuando el disolvente y el antidisolvente son totalmente miscibles la 
mezcla en el chorro es similar a la de un gas gracias a la desaparición de la tensión superficial 
dinámica asociada a la formación de una disolución supercrítica. Más tarde, Dukhin et al. 
[51], Sarkari et al. [52], Badens et al. [53], Gokhale et al. [54] y Obrzut et al. [55] estudiaron 
la atomización del chorro en gases a presión. Se observaron dos tiempos característicos: un 
tiempo de relajación τ y un tiempo de ruptura “break-up” del chorro t. Si t < τ, existe una 
interfase entre el líquido y la fase fluida, y el “break-up” del chorro predomina transformando 
el chorro líquido en gotitas. Si τ < t, cerca del orificio del nebulizador persiste un chorro corto 
y se produce una mezcla del chorro tipo gas. Dukhin et al. propusieron un mecanismo de 
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tensión interfacial dinámica (DIT) producido por gradientes de entalpía e introdujeron un 
nuevo modo DIT no isotermo que contribuía a la estabilidad del chorro cuando la mezcla era 
exotérmica. Debenedetti y Werling [56, 57] introdujeron modelos matemáticos de 
transferencia de masa. Baldyga et al. [58] y Martín y Cocero [59] propusieron modelos para 
el proceso de precipitación por encima y por debajo del punto crítico de la mezcla CO2 + 
disolvente (MCP; “mixture critical point”). 
 
En concordancia con la descripción de los diferentes mecanismos de mecánica de fluidos, 
Reverchon et al. [60] encontraron que cuando se trabajaba a presiones por encima del MCP, 
los parámetros que influían en la mezcla del chorro, como el diseño del nebulizador y cámara 
de precipitación, o el número de Reynolds en el nebulizador, no tenían un efecto apreciable 
en la precipitación. Esto indica que, en estas condiciones, la mezcla entre la disolución y el 
CO2 es más rápida que la precipitación, y por tanto los parámetros de mezcla no pueden 
influir en la misma. Sin embargo a presiones por debajo del MCP, estos parámetros tienen 
una gran influencia. Además en estas condiciones se observó un cambio en la morfología de 
la partículas, a veces las partículas se aglomeraban formando esferas huecas, lo que podría 
indicar que la atomización y precipitación tienen lugar por formación de gotitas. Se estableció 
una correlación entre las dimensiones de las partículas y la posición de las coordenadas 
presión y temperatura del proceso en el diagrama VLE del sistema CO2 + disolvente. A 
presiones bastante superiores al MCP se obtenían nanopartículas [11, 61, 62] y un poco por 
encima del MCP, micropartículas [63] coexistiendo a veces las nanopartículas y las 
micropartículas. La uniformidad de los productos empeora cuando las condiciones de 
precipitación se acercan al locus crítico. En la región de vapor se forman micropartículas 
agregadas e irregulares y en la región líquido-vapor se forman “clusters” esféricos o 
aglomerados densos. Los estudios de Chang et al. [61] demuestran la relación entre la 
morfología de las partículas de α-chymotrypsina precipitadas a partir de sus disoluciones en 
DMSO y el equilibrio de fases del sistema CO2 + DMSO. Sus resultados se resumen en la 
Fig. 1.13. 
 
Se ha propuesto una interpretación de los resultados obtenidos a varias presiones [46, 48, 
63] mostrando que el cambio de nanopartículas a micropartículas se debe a que compiten el 
“break-up” del chorro de líquido inyectado en el cámara de precipitación y la mezcla tipo gas. 
Cuando domina el primer proceso, se forman gotitas de líquido que producen partículas 
micrométricas; cuando domina el segundo, se forman nanopartículas por precipitación en la 
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fase fluida. La competición entre estos dos procesos puede explicarse teniendo en cuenta sus 
tiempos característicos: cuando el tiempo para el “break-up” del chorro es inferior al tiempo 
necesario para que desaparezca la tensión superficial dinámica se forman gotitas, en el caso 
opuesto domina la mezcla tipo gas [46, 63, 64]. Las nanopartículas se diferencian de las 
micropartículas en su diámetro y en su morfología esférica irregular debido a la precipitación 
gas-sólido en ausencia de tensión superficial. De Marco y Reverchon [47] también mostraron 
que estos mecanismos de precipitación pueden modularse cambiando la presión, la 
temperatura o la concentración del soluto, así se puede seleccionar el rango de tamaños 
requerido. 
 
Los mecanismos son distintos cuando el compuesto precipita en forma cristalina [48]: en 
este caso hay dos posibilidades. Cuando el secado de las gotas va seguido de una cinética de 
cristalización rápida, los cristales tienen predominantemente forma esférica. Cuando la 
precipitación tiene lugar en una fase líquida expandida se obtienen cristales de diversos 
hábitos y dimensiones dependiendo de las interacciones con el disolvente utilizado.  
 
Puesto que el equilibrio de fases es uno de los factores cruciales en la morfología y tamaño 
medio de las partículas obtenidas en el proceso SAS, se ha dedicado mucha atención en los 
últimos años al equilibrio de fases de las mezclas binarias formadas por el CO2 y los 
disolventes orgánicos usados en SAS. En presencia de solutos como los polímeros el 
diagrama de fases se modifica; desafortunadamente los datos para sistemas ternarios 
incluyendo el soluto son escasos. Sin embargo, cuando el soluto interacciona débilmente con 
el CO2, el diagrama de fases ternario coincide con el binario para las bajas concentraciones de 
soluto utilizadas en SAS en la región rica en CO2, que es la región de las mezclas formadas 
ene este proceso. Por ejemplo, este es el caso del sistema CO2 + DMSO + cefonicida 
mencionado en la sección 1.1.2. Por tanto, en muchos casos, las mezclas formadas en la 
cámara de precipitación pueden tratarse como sistemas binarios CO2 + disolvente orgánico. 
Las propiedades volumétricas, densidades y parámetros críticos de este tipo de sistemas 
también han sido objeto de numerosos trabajos. Sin embargo no se ha prestado atención, con 
la excepción del trabajo de Dukhin [51], al calor liberado cuando el CO2 se disuelve en el 
disolvente orgánico. Este calor de mezcla (entalpía de exceso) puede ser muy alto. Por tanto 
los efectos térmicos durante este proceso pueden influir en la separación de fases y deben 
tenerse en cuenta para entender mejor las micronizaciones SAS. La contribución debida a las 
interacciones del soluto puede despreciarse: los efectos térmicos pueden estudiarse midiendo 
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las entalpías de exceso de las mezclas CO2 + disolvente orgánico formadas en la cámara de 
precipitación SAS. 
 
Midiendo las entalpías de exceso del CO2 y la N-metil-2-pirrolidona en las condiciones de 
presión y temperatura usadas en SAS, nuestro grupo ha mostrado en un estudio previo [65] 
que los efectos térmicos tienen un papel importante en SAS y parecen estar relacionados con 
la coalescencia no deseada de partículas de antibiótico obtenidas usando NMP. Las 
condiciones de temperatura y presión para la coalescencia coinciden con las de valores más 
exotérmicos de la entalpía de exceso. Se requiere un estudio sistemático de las entalpías de 
exceso de las mezclas CO2 + disolvente orgánico y micronizaciones paralelas para dilucidar 
el efecto de la temperatura y la presión y las interacciones entre el equilibrio de fases y el 
calor liberado cuando se mezclan el fluido y la disolución. El calor de mezcla del CO2 
supercrítico y metanol o etanol ya se ha medido [66-68]. Sin embargo, esta magnitud no se 
conoce para los disolventes más utilizados en SAS como el DMSO y la acetona.  
 
1.5. Aplicación de Precipitación por Agente Supercrítico Antidisolvente en el Desarrollo 
de Fármacos 
La aplicación de SAS en el desarrollo de fármacos es un área de investigación muy activa 
[33, 35, 36]. En el caso de sustancias puras, SAS proporciona un buen control del tamaño y la 
morfología. Se han producido cristales, nanopartículas y micropartículas que mejoran la 
administración de los fármacos. Todos los estudios mencionados en la sección anterior 
pueden aplicarse en este caso. 
 
La formación of micropartículas “composite” no se conoce tan bien [33, 38]. En la 
precipitación sobre una suspensión de partículas, las partículas actúan como núcleos para la 
precipitación del polímero y por aglomeración se forma una matriz polimérica de partículas 
encapsuladas. Este método es especialmente adecuado para materiales orgánicos insolubles 
como las proteínas. Para fármacos solubles en disolventes orgánicos se prefiere la 
coprecipitación. La precipitación de nanopartículas no conduce a coprecipitación debido al 
mecanismo gas-partícula que gobierna el proceso. Las micropartículas “composite” polímero-
fármaco se forman por eliminación del disolvente en las gotitas de líquido. Este proceso es 
más complicado que el de los fármacos puros. Aparecen nuevos parámetros como la masa de 
polímero o la proporción polímero-fármaco. 
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Al contrario de la micronización de materiales puros, la coprecipitación no está bien 
estudiada. Como destacaron Reverchon et al. [33], aunque en muchos casos se haya usado el 
polímero poli-L-láctico (PLLA), no se ha llevado a cabo ninguna investigación sistemática, 
sobre la influencia de los parámetros SAS en las propiedades del material compuesto. Es 
necesario estudiar las interacciones polímero-fármaco para saber que se puede esperar si el 
mismo polímero se combina con un fármaco distinto. 
La selección del material soporte o de recubrimiento es crucial. Debe reunir varios 
requisitos: biocompatibilidad, no toxicidad, conservación de las propiedades y la actividad 
del fármaco y afinidad con el mismo. Gracias a esta afinidad, el fármaco se incluye en el 
soporte en estado amorfo. El material del soporte o de recubrimiento debe ser también fácil 
procesable mediante SAS. La incorporación del fármaco en su estado amorfo hace que las 
partículas compuestas sean más pequeñas que las del material puro precipitado en las mismas 
condiciones. Esta es otra ventaja a añadir a las mejoras de la solubilidad, velocidad de 
disolución y biodisponibilidad del fármaco amorfo.  
 
Se han usado varios polímeros en la coprecipitación SAS además de PLLA: 
polietilenglicol (PEG), polivinilpirrolidona (PVP), el copolímero lactida glicolida (PLGA), 
ácido poli-DL-láctico (PLA), eudragit. En esta tesis se ha elegido PVP porque esta lactama 
polimérica es uno de los principales aditivos en las formulaciones farmacéuticas. Usando 
PVP se mejora la velocidad de disolución y biodisponibilidad de fármacos poco solubles. 
 
Poli[1-(2-oxo-1-pirrolidinil)etileno], nombre IUPAC del PVP. 
El incremento de la velocidad de disolución se debe a la inhibición de la cristalización 
gracias principalmente al efecto plastificante del PVP y su adsorción superficial e 
impedimento estérico para la nucleación y crecimiento del cristal [69-70]. Además el PVP es 
un polímero sintético soluble en agua y lineal, capaz de disolverse en gran número de 
disolventes orgánicos. Chadha et al. [71] recopilaron las propiedades del PVP y las técnicas 
analíticas empleadas para caracterizar los sistemas fármaco-PVP en estado sólido o líquido. 
Dependiendo de las condiciones de polimerización, el PVP puede preparase en gran variedad 
de masas moleculares expresadas mediante los valores del parámetro K. 
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K-valor =  
                               (1.2) 
donde Z es la viscosidad del PVP a la concentración C relativa al agua. 
 
Las masas moleculares promedio en número ( ), promedio en masa ( ) y promedio 
viscoso ( ) pueden obtenerse a partir de las siguientes expresiones: 
 
 = 24* K2,  = 15* K2.3,  = 22.22 (K + 0.0075 K2)1.65               (1.3) 
  
La temperatura de transición vítrea (Tg) del PVP lineal aumenta al aumentar la masa 
molecular y puede calcularse según la ecuación: 
 
Tg [○C] = 175 - (9685/K2)                         (1.4) 
 
Recientemente, el PVP se ha usado en el proceso SAS como soporte o excipiente de varios 
fármacos. Lim et al. [72] obtuvieron micropartículas “composite” de indometacina por 
coprecipitación con PVP K-90. La indometacina es un fármaco cristalino antinflamatorio. 
Uzun et al. [73] también obtuvieron micropartículas “composite” formadas por el antibiótico 
axetil cefuroxima y PVP K-30. Badens y colaboradores [74, 75] prepararon dispersiones 
sólidas de oxeglitazar en PVP K-17. Este es un fármaco nuevo usado en el tratamiento de la 
diabetes tipo II. Wu et al. [76] obtuvieron micropartículas “composite” formadas por 
piroxicam y PVP K-25 por PCA. También se han usado procesos afines a SAS. Corrigan y 
Crean [77] prepararon micropartículas “composite” de hidrocortisona-PVP mediante GAS. 
En la mayor parte de los casos se obtuvieron buenas morfologías y mejoras en las velocidades 
de disolución. 
 
El PVP interacciona con la molécula del fármaco por fuerzas electrostáticas (ion-ion, ion-
dipolo, dipolo-dipolo), fuerzas de van der Waals y enlaces de hidrógeno. Varias técnicas 
fisicoquímicas proporcionan información sobre las interacciones. La difracción de Rayos X 
(XRD), calorimetría diferencial de barrido (DSC) y espectroscopia infrarroja (IR) son las más 
usadas. XRD da información sobre los cambios en la cristalinidad y forma polimorfa como 
consecuencia de SAS. DSC puede usarse para establece las temperaturas de transición vítrea. 
IR se usa para detectar el enlace de hidrógeno entre el fármaco y el PVP por medio del 
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nitrógeno o el grupo carbonilo del anillo del pirrol. La microscopia electrónica de barrido da 
información sobre las morfologías del fármaco puro, el PVP y los materiales compuestos. La 
solubilidad y velocidad de disolución de la combinación o “composite” fármaco-PVP son 
también clave. Se llevan a cabo tests de disolución en un fluido intestinal simulado (pH = 7.4) 
y se comparan los resultados con los obtenidos para el fármaco puro. 
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Objetivos 
 
Esta tesis estudia la micronización de compuestos utilizando fluidos supercríticos. Entre 
las diferentes técnicas posibles se eligió el método SAS por las propiedades excepcionales de 
los materiales micronizados utilizando dióxido de carbono supercrítico como agente 
antidisolvente. 
 
La motivación de este estudio es doble y se basa en la necesidad de profundizar en el 
estudio de los procesos SAS para poder diseñarlos y escalarlos correctamente, y en la 
necesidad de desarrollar micronizaciones de formulaciones farmacéuticas. 
 
Nuestro estudio preliminar sobre los efectos térmicos en la precipitación SAS de 
antibióticos usando NMP como disolvente se ha extendido obteniendo datos de calores de 
mezcla (entalpías de exceso) de los sistemas CO2 + disolvente orgánico utilizados más 
frecuentemente en estas micronizaciones. Se ha dilucidado la interacción entre las entalpías 
de exceso y el equilibrio de fases en la cámara de precipitación SAS. Se han llevado a cabo 
micronizaciones de fármacos usando estos disolventes y CO2 como agente antidisolvente, y 
se han estudiado los parámetros SAS prestando especial atención a las condiciones de presión 
y temperatura, el equilibrio de fases y el calor desprendido al mezclarse el fluido supercrítico 
y la disolución. Se han obtenido micro y nanopartículas de dos fármacos puros y 
micropartículas compuestas de uno de ellos.  
 
Los objetivos específicos de esta tesis fueron: 
 
1. Medida de los Datos de Entalpía de Exceso de los Sistemas CO2 + Disolvente 
Orgánico 
Las entalpías de exceso se midieron usando un calorímetro de flujo isotermo capaz de 
operar a alta presión disponible en nuestro laboratorio. Se utilizaron las condiciones de 
presión y temperatura habituales en las micronizaciones SAS. Como estos datos ya estaban 
disponibles para N-metil-2-pirrolidona, etanol y metanol, se han estudiado los disolventes 
dimetilsulfóxido (DMSO), acetona, N,N-dimetilformamida (DMF) y acetato de etilo (EA). 
Los datos de entalpías de exceso se correlacionaron usando ecuaciones de estado. 
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2. Estudio del Equilibrio de Fases a Alta Presión de los Sistemas CO2 + Disolvente 
Orgánico. Interacción entre el Equilibrio de Fases y las Entalpías de Exceso durante los 
Experimentos SAS 
En la bibliografía pueden encontrarse datos del equilibrio de fases isotermo (VLE) y las 
constantes críticas de los sistemas CO2 + disolvente orgánico estudiadas en esta tesis. 
Generalmente los datos de constantes críticas son escasos. Para cada sistema se llevó a cabo 
una recopilación bibliográfica. En caso necesario, el locus crítico y los datos de VLE se 
predijeron o calcularon utilizando ecuaciones de estado. Basándose en el conjunto de datos 
obtenidos en los objetivos 1 y 2, se discutió el comportamiento termodinámico de las mezclas 
formadas en la cámara de precipitación SAS y la influencia de los efectos térmicos en el 
equilibrio de fases y la morfología de las partículas.  
 
3. Construcción de un Dispositivo SAS 
Se construyó en nuestro laboratorio un aparato SAS que fue validado micronizando 
acetato de itrio con DMSO como disolvente. Esta micronización está bien descrita en la 
bibliografía. 
 
4. Micronización de Fármacos 
Se llevaron a cabo experimentos de micronización para determinar las condiciones 
óptimas de estos procesos teniendo en cuenta los requisitos de tamaño y morfología de las 
partículas. Se utilizó una estrategia de diseño de experimentos para minimizar el número de 
los mismos. Se estudió la relación entre las condiciones de presión y temperatura, el 
equilibrio de fases y la entalpía de exceso. Se establecieron las condiciones óptimas de 
precipitación. Después de una revisión de la bibliografía se eligieron los fármacos a 
micronizar: el 5-fluorouracilo, ampliamente utilizado en el tratamiento de distintos tipos de 
cánceres, y el diflunisal, un derivado del ácido salicílico con actividad analgésica y 
antiinflamatoria. Ambos fármacos son poco solubles en CO2. El 5-fluorouracilo ha sido 
micronizado previamente usando metanol o mezclas de metanol con otros disolventes. El 
diflunisal no se ha micronizado usando una técnica supercrítica. Las partículas obtenidas se 
estudiaron por microscopia electrónica de barrido (SEM) estableciéndose el tamaño y la 
distribución de tamaños. La cristalinidad y forma polimórfica de los fármacos obtenidos por 
SAS se determinó usando difracción de rayos X. 
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5. Co-precipitación de Fármacos y PVP 
Se coprecipitó diflunisal usando PVP K-15 y K-30 como medio. Para elegir el disolvente 
puro o mezcla se tuvieron en cuenta las solubilidades del fármaco puro y del PVP y se 
establecieron las condiciones óptimas de precipitación. Se probaron distintas proporciones del 
fármaco y el polímero. Las micropartículas se estudiaron usando SEM, XRD, espectroscopia 
infrarroja (IR), calorimetría diferencial de barrido (DSC), y análisis termogravimétrico 
(TGA). Se estableció la solubilidad y la velocidad de disolución del material compuesto 
diflunisal-PVP y se estudiaron las interacciones entre ambos componentes. También se llevó 
a cabo una comparación sistemática con otros materiales compuestos fármaco-PVP obtenidos 
previamente por SAS. 
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Resumen y Conclusiones  
 
En esta tesis se estudia la micronización de sólidos usando fluidos supercríticos partiendo 
de una doble motivación: la necesidad de profundizar en el estudio de los procesos SAS para 
poder diseñarlos y llevar a cabo su escalado y la necesidad de desarrollar las micronizaciones 
de fármacos. Se examina el papel de las entalpías molares de exceso en las micronizaciones 
SAS y se aborda la micronización de fármacos.  
 
Capítulo 1. Introducción 
La primera parte de este trabajo es una introducción acerca de los fluidos supercríticos 
seguida de una descripción de la producción de micropartículas usando los SCFs. A 
continuación se revisan los fundamentos de la precipitación SAS y su aplicación en 
farmacología. En las páginas precedentes de este resumen puede encontrarse una versión 
española completa del capítulo. 
 
Capítulo 2. Objetivos 
En este capítulo se describen los objetivos de esta tesis. En las páginas precedentes de este 
resumen puede encontrarse una versión española completa del mismo. 
 
Capítulo 3. Metodología 
Se describe el calorímetro de flujo isotermo de alta presión utilizado para medir las 
entalpías molares de exceso, , de los sistemas CO2 + disolvente orgánico. Se explica la 
metodología de los cálculos del equilibrio de fases, las entalpías de exceso y el locus crítico 
usando ecuaciones de estado. Se describen con detalle el aparato SAS construido en esta 
tesis, la estrategia para el diseño de experimentos y los métodos usados para caracterizar las 
partículas.  
 
Capítulo 4. Efectos Térmicos en las Micronizaciones por Agente Antidisolvente 
Supercrítico 
En una primera etapa se midieron las entalpías molares de exceso, , de los sistemas 
CO2 + disolvente orgánico bajo las condiciones de presión y temperatura utilizadas en las 
micronizaciones SAS. En una segunda etapa se estudió la interacción entre las entalpías de 
exceso y el equilibrio de fases en la cámara de precipitación SAS para los disolventes acetona 
Resumen 
 
 
 
225 
(ac), N,N-dimetilformamida (DMF), dimetilsulfóxido (DMSO) y acetato de etilo (EA). Esta 
parte de la tesis ha sido objeto de cuatro publicaciones que se incluyen en este capítulo.  
 
Las condiciones de temperatura y presión fueron 313.15 y 323.15 K y 9.00, 12.00, 15.00 
y 18.00 MPa, así como 333.15 K y 9.00 y 15.00 MPa. Para los sistemas estudiados se 
observaron tendencias similares en la variación de  con la fracción molar, la temperatura 
y la presión. La mayor parte de los procesos de mezcla fueron muy exotérmicos.  alcanzó 
valores mínimos de –4500 J mol-1. Para casi todas las condiciones de temperatura y presión, 
las entalpías molares de exceso presentan este mínimo en la región rica en CO2. En algunas 
condiciones, al representar frente a la fracción molar del CO2, se observaron secciones 
lineales debidas a la existencia de una región de dos fases en la que están en equilibrio una 
mezcla líquida y una mezcla gaseosa de composiciones dadas. Se puede demostrar que las 
composiciones de estas dos fases se corresponden con los valores de la coordenada x al 
comienzo y al final de la sección lineal. Los valores de las composiciones así obtenidos se 
compararon con los datos de VLE de la bibliografía. 
 
La temperatura y la presión tienen un gran efecto sobre . Para cada sistema, a una 
fracción molar dada, en general, las mezclas se hacen menos exotérmicas al aumentar la 
presión y disminuir la temperatura. El effecto de la naturaleza del disolvente orgánico 
depende de las condiciones de temperatura y presión. Por ejemplo, las mezclas CO2 + EA son 
las más exotérmicas a las tres temperaturas y 9.00 MPa. Sin embargo, a las otras presiones 
estudiadas, presentan valores intermedios entre los observados para los otros sistemas. 
 
Las entalpías molares de exceso de CO2 + Ac, DMF o EA se correlacionaron con 
precisión usando las ecuaciones de estado de Peng-Robinson y Soave-Redlich-Kwong, junto 
con la regla de mezcla clásica con dos parámetros binarios ajustables para cada temperatura. 
Esta correlación no se pudo llevar a cabo para el sistema CO2 + DMSO; el motivo puede ser 
el comportamiento crítico más complejo de este sistema. Además, en el caso del CO2 + DMF, 
se describieron simultáneamente el equilibrio líquido-vapor y el locus crítico usando las EOS 
de Peng-Robinson y Soave-Redlich-Kwong, junto con la regla de mezcla clásica, y se 
predijeron las entalpías molares de exceso. La ecuación de Peng-Robinson proporcionó unos 
resultados mejores. 
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Las variaciones de la entalpías molares de exceso con la presión y la temperatura se 
analizaron teniendo en cuenta las interacciones moleculares y los datos de equilibrio de fases, 
densidad y paramétros críticos existentes en la bibliografía para los sistemas CO2 + disolvente 
orgánico. Se llevó a cabo una recopilación bibliográfica para CO2 + acetona, DMF, DMSO o 
EA. Estos sistemas han sido objeto de numerosas investigaciones debido a su implicación en 
las aplicaciones de los SCFs.  
 
La entalpía molar de exceso resulta de la suma de dos contribuciones. Una de ellas es 
debida a los cambios en las interacciones moleculares causadas por la alteración de la 
estructura del disolvente orgánico líquido y la formación de complejos entre el CO2 y las 
moléculas del disolvente orgánico. La segunda contribución a se debe al cambio de 
estado del CO2 desde el de un fluido similar a un gas o similar a un líquido hasta el de 
componente de la mezcla binaria. Designaremos a estas dos contribuciones respectivamente 
como contribución de interacciones moleculares y contribución de cambio de estado.  
 
La acetona, la DMF, el DMSO y el EA son disolventes que no están asociados pero tienen 
todos ellos momentos dipolares grandes y presentan estructuras dominadas por las 
interacciones dipolo-dipolo. Por otro lado el CO2 tiene un momento cuadrupolar 
relativamente grande. Estos valores de los momentos dipolares hacen que los disolventes sean 
líquidos muy estructurados con densidades relativamente grandes. La estructura del 
disolvente se altera al mezclarse con el dióxido de carbono y aparece una contribución 
endotérmica a . Esta contribución se combina con otra contribución exotérmica debida a 
las fuertes interacciones entre el CO2 y el disolvente orgánico resultando valores de la 
entalpía moderadamente exotérmicos: esta es la contribución de interacciones moleculares a 
, contribución que puede esperarse que sólo cambie ligeramente al modificar la 
temperatura y la presión.  
 
Para analizar la contribución de cambio de estado a  se necesita tener en cuenta el 
estado y las densidades de los dos componentes puros y las mezclas formadas en el 
calorímetro. Los disolventes orgánicos son líquidos en las condiciones de temperatura y 
presión de los experimentos. Sus densidades varían muy poco con la temperatura y presión. 
Sin embargo, el estado y la densidad del dióxido de carbono difieren mucho de unas 
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coordenadas (P, T) a otras. El dióxido de carbon es un fluido supercrítico que puede parecerse 
a un líquido cuando su densidad es grande, o a un gas cuando su densidad es pequeña.  
 
El estado de las mezclas formadas en el calorímetro (líquido, fluido, dos-fases) puede 
establecerse examinando la situación de la coordenada (P, T) con respecto al locus crítico y 
teniendo en cuenta la composición crítica y los datos de VLE. Los sistemas CO2 + acetona, 
CO2 + DMF y CO2 + EA son del tipo I en la clasificación de Scott y van Konynenburg; sus 
locus críticos completos se han calculado teniendo en cuenta los datos existentes. El 
comportamiento crítico del sistema CO2 + DMSO es más complejo; puede tratarse de un tipo 
III o IV en esta clasificación.  
 
El dióxido de carbono fluido se mezcla con el disolvente líquido formando una mezcla 
líquida o una mezcla gaseosa y otra líquida en equilibrio. Como consecuencia del cambio de 
estado del CO2, esta contribución a  es exotérmica y se hace aún más exotérmica cuando 
se mezcla CO2 de baja densidad. Este efecto se denomina a veces “efecto de la condensación 
del fluido”. Cuando el dióxido de carbono entra en el calorímetro en un estado similar al de 
un líquido, la contribución de cambio de estado a  es pequeña y las entalpías molares de 
exceso pueden considerarse principalmente debidas a la contribución de interacciones 
moleculares a . Cuando el dióxido de carbono entra en el calorímetro en un estado similar 
al de un gas, el efecto de la condensación del fluido es muy grande y la contribución de 
cambio de estado a  es muy exotérmica. En consecuencia, la entalpía molar de exceso 
alcanza valores de – 4500 J mol–1.  
 
Para una temperatura, presión y fracción molar dadas las variaciones debidas a la 
naturaleza del disolvente orgánico pueden atribuirse al tipo de diagrama crítico y a las 
diferentes interacciones moleculares en el líquido puro y las mezclas. Estas diferencias hacen 
variar la contribución de interacciones moleculares a . Sin embargo, la magnitud de la 
contribución de cambio de estado puede esperarse que sea similar para los distintos 
disolventes si se fija la temperatura, presión y fracción molar y no hay equilibrio de fases. 
 
Las mezclas formadas por CO2 y un disolvente orgánico están implicadas en muchos 
procesos supercríticos además de SAS. Los datos de entalpías de exceso medidos en esta tesis 
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pueden usarse para modelar u optimizar estos procesos. En esta tesis el objetivo es examinar 
su interacción con el equilibrio de fases en el marco de los experimentos SAS.  
 
Como ya se ha señalado el equilibrio de fases CO2 + disolvente orgánico es uno de los 
factores cruciales que controlan la morfología y el tamaño medio de las partículas en el 
proceso SAS. La presencia del soluto puede modificar el diagrama de fases como en el caso 
de los polímeros. Sin embargo cuando el soluto interacciona débilmente con el dióxido de 
carbono, para las bajas concentraciones de soluto usadas en SAS, el diagrama de fases 
ternario coincide con el binario en la zona rica en CO2, que es la zona de las mezclas 
formadas en SAS. Por tanto, estas mezclas pueden tratarse como sistemas binarios CO2 + 
disolvente orgánico. El calor liberado al disolverse el CO2 supercrítico en la disolución 
orgánica tiene un papel importante en el equilibrio de fases. El control de temperatura en la 
cámara de precipitación no es muy preciso y puede producirse un aumento local de 
temperatura. Por ello, si la precipitación comienza en condiciones de T y P de miscibilidad 
completa para el sistema CO2 + disolvente orgánico, en un corto tiempo puede producirse la 
separación de fases. 
 
Puesto que el CO2 se introduce en la cámara a un flujo mucho mayor que el de la 
disolución y como la concentración del soluto en la misma es pequeña, la contribución a  
debida a las interacciones del soluto puede despreciarse y se puede considerar que los efectos 
térmicos en SAS se deben a la formación de mezclas CO2 + disolvente orgánico muy ricas en 
CO2 (x ≥ 0.95). Suponiendo un proceso adiabático y utilizando la capacidad calorífica del 
CO2, pueden usarse los valores de  para estimar el incremento de temperatura en la 
cámara de precipitación. Estas estimaciones permiten explicar las morfologías de precipitados 
observadas que no eran de esperar en las condiciones de operación. 
 
El efecto de la entalpía en el equilibrio de fase se ha mostrado para micronizaciones con 
DMSO como disolvente descritas en la bibliografía, que han sido llevadas a cabo en una 
cámara provista de ventana. Al modificarse el equilibrio de fases se modifica el mecanismo 
de precipitación de partículas cambia. Hay otros factores que influyen simultáneamente en la 
morfología de las partículas, pero el calor liberado al mezclarse el CO2 y el disolvente polar 
tiene un importante papel.  
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Capítulo 5. Micronizaciones SAS de Fármacos 
• Validación del aparato SAS: Micronización del Acetato de Itrio 
Se eligió la micronización del YAc a partir de disoluciones de DMSO para validar el 
equipo SAS construido en nuestro laboratorio. Los experimentos se llevaron a cabo a 
temperaturas de 40 y 60 °C y presiones entre 11 y 20 MPa. La concentración del YAc se 
mantuvo constante en 2%. La morfología de las partículas se estudió teniendo en cuenta el 
equilibrio de fases del sistema CO2 + DMSO. Las imagines SEM del YAc precipitado en 
condiciones de solubilidad completa del CO2 + DMSO muestran nanopartículas esféricas 
discretas o ligeramente agregadas. Por el contrario al trabajar en la zona de dos fases las 
partículas se agregan formado un bloque. El tamaño medio de las partículas disminuye al 
aumentar la presión. Para establecer si las condiciones de precipitación corresponden a una o 
dos fases se tuvo en cuenta, además del equilibrio de fases, las entalpías de exceso de CO2 + 
DMSO, puesto que el proceso de mezcla puede producir un incremento de T en la cámara que 
afecta al equilibrio de fases. Así a 60 °C y 14 MPa la mezcla del DMSO y el CO2 es muy 
exotérmica y el incremento de temperatura estimado (≈ 4°C) produce separación de fases. 
Las condiciones de P y la nueva T, 64 °C, corresponden a la zona de dos fases donde se 
obtienen partículas agregadas.  
 
Estos resultados están de acuerdo con los obtenidos por Reverchon et al. Este equipo SAS 
se usó para micronizar 5-fluorouracilo, diflunisal y para coprecipitar diflunisal y PVP. 
 
• Micronización del 5-Fluorouracilo 
El 5-Fluorouracilo (5-FU) es un fármaco de la familia de la pirimidina utilizado en el 
tratamiento de varios tipos de cáncer, soluble en DMSO y con una solubilidad baja en CO2. 
Se eligió DMSO como disolvente. Los factores que influyen en el proceso SAS son: la 
concentración de la disolución (C), la temperatura (T), la presión (P), el flujo de la disolución 
(QL), el flujo del CO2 (QCO2), el tiempo de secado (t), y el diámetro del nebulizador (Øn). En 
esta tesis el tiempo de secado (3 veces el tiempo necesario para llenar la cámara) y el 
diámetro del nebulizador (100 µm) se mantuvieron constantes. Para disminuir el número de 
experimentos se aplicó una metodología DOE y se utilizó el diseño 25-2 fraccional factorial 
reduciéndose el número de experimentos a ocho. El valor de la fracción molar del CO2 fué ≥ 
0.96. Como respuesta se usaron el tamaño medio de las partículas y su morfología evaluadas 
a partir de las imágenes SEM. 
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Las imágenes SEM del 5-FU no tratado muestran partículas granuladas con un tamaño 
medio > 100 µm. Los experimentos SAS se llevaron a cabo a 40, 50 °C; 15, 18 MPa; y 
concentraciones de 1 o 2 (%). Las imágenes SEM del 5-FU precipitado indican que seis de 
los ocho experimentos (1, 2, 5, 6, 7 y 8) conducen a una micronización del 5-fluorouracilo. Se 
obtienen partículas elongadas con tamaños medios en el intervalo 216-670 nm. En los 
experimentos 3 y 4 no se produjo la micronización obteniéndose partículas mucho mayores.  
 
Para una concentración dada, el tamaño medio de las partículas disminuyó al aumentar la 
temperatura y la presión. El orden de importancia encontrado para los factores que influyen 
en el tamaño medio de las partículas y su morfología fue   
       T  > P > C >> QL >  QCO2 
 
Las mejores condiciones para al micronización del 5-FU fueron las del experimento 7: C = 
1%, T = 50 °C, P = 180 MPa, QL = 1 mL/min, QCO2 = 15 g/min, condiciones que condujeron 
al mejor tamaño medio de partícula, 216 nm.  
 
La cristalinidad de las partículas se estudió por XRD. Para el 5-FU aparece un pico muy 
intenso a 28.7 grados que sugiere una orientación preferencial en esta posición. Esta 
orientación preferencial desaparece en el 5-FU precipitado por SAS, lo que indica una 
disminución de la cristalinidad.  
 
• Micronización del Diflunisal 
El diflunisal es un fármaco antiinflamatorio no esteroideo muy soluble en DMSO y poco 
soluble en CO2. Sin embargo, experimentos preliminares llevados a cabo en condiciones 
similares a las de los experimentos SAS del YAc y del 5-FU mostraron que el DMSO no era 
un disolvente adecuado. Sin embargo, si tuvieron éxito los experimentos SAS con acetona. 
Estos experimentos se llevaron a cabo a 40 °C; 9, 12 y 15 MPa, y concentraciones del 2 y el 
4%. Se estimó que los incrementos de temperatura dentro de la cámara de precipitación, ΔT, 
podían ser de hasta 5.5 grados. Como las condiciones de P y T no estaban próximas al MCP, 
estos incrementos de temperatura no pueden producir separación de fases. 
 
Las imágenes SEM del diflunisal no tratado muestran barras grandes y delgadas de un 
material cristalino. En las del material precipitado por SAS se observan barras cristalinas 
delgadas y largas, unidas entre sí como si se tratase de las ramas de un árbol. La anchura de 
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las barras varió entre 2 y 10 µm. Las imágenes SEM indican que la cristalinidad y la 
morfología apenas cambian al variar las condiciones de precipitación. Resultados similares se 
obtuvieron al precipitar el diflunisal a partir de us disoluciones en acetona/diclorometano 
(DCM) (80:20, v/v %). La precipitación del diflunisal puro no parece modificarse ni con las 
condiciones ni con el disolvente utilizados. 
 
Se han encontrado hasta cuatro formas polimórficas del diflunisal cristalino. Los 
difractogramas XRD del diflunisal no tratado y del procesado por SAS son distintos, 
indicando que el polimorfismo del diflunisal se ha modificado en el proceso the SAS. El 
fármaco precipitado exhibe la forma IV. El difractograma del diflunisal no tratado sugiere la 
mezcla de dos polimorfos. Esto se confirma por los termogramas DSC que muestran un pico 
dividido con dos puntos de fusión a 216.62 y 213.82 °C para el diflunisal no tratado y un solo 
pico para el diflunisal obtenido por SAS a 212.63 °C, que corresponde al punto de fusión de 
la forma IV.  
 
• Amorfización del Diflunisal por Coprecipitación con PVP 
Se consideró que la coprecipitación SAS del diflunisal con PVP era un método efectivo 
para incorporar el fármaco en estado amorfo. Se investigó la influencia de dos tipos del 
polímero en las propiedades físico-químicas del diflunisal usándose PVP K-10 (  = 
10,000) y PVP K-30 (  = 40,000). La precipitación SAS de PVP utilizando etanol a las 
presiones de 8 y 12 MPa, temperaturas de 35 y 40 °C y concentraciones del 2% y 5% 
(fracción molar de CO2 ≥ 0.96) no tuvo éxito. Como el PVP es poco soluble en acetona, se 
usó una mezcla de un buen y un mal disolvente del polímero. Se eligió DCM como buen 
disolvente y acetona como malo, usándose la mezcla acetona/DCM (80:20, v/v %).  
 
En primer lugar se precipitó, PVP K-10 con acetona/DCM (80:20, v/v %) a una 
temperatura de 35 °C, presión de 9 MPa, concentración del 2% y un valor de 0.97 para la 
fracción molar del CO2, obteniéndose partículas esféricas con un tamaño medio de 230 nm. A 
continuación se coprecipitó el diflunisal con PVP K-10 para una proporción fármaco: 
polímero en masa de (50:50) a 35 y 40 °C, presiones en el intervalo de 8 a 15 MPa, 
concentración del 2 y 4% y dos diferentes fracciones molares del CO2, 0.84 y 0.97. A 35 °C y 
presiones entre 8 y 9 MPa se obtuvieron disoluciones viscosas que se transformaron en 
precipitados pegajosos al aumentar la temperatura hasta 40 °C. Aumentando la presión hasta 
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12 MPa a 35 °C se obtuvieron globos esféricos con tamaño decreciente al aumentar la 
presión, pero al aumentarla hasta 15 MPa aparecía coalescencia de las partículas. Sin 
embargo, estaba claro que la cristalinidad del diflunisal desaparecía en el coprecipitado en 
comparación con el diflunisal puro obtenido por SAS a partir de la misma mezcla de 
disolventes.  
 
En segundo lugar, se usó PVP K-30 en las mismas condiciones experimentales 
obteniéndose unos resultados mucho mejores. Esto puede atribuirse al efecto plastificante del. 
CO2 sobre los polímeros que disminuye al aumentar la masa molecular. Al igual que en el 
caso del PVP K-10, la cristalinidad del diflunisal desapareció durante la coprecipitación con 
respecto al diflunisal puro obtenido por SAS a partir de la misma mezcla de disolventes. El 
tamaño medio del coprecipitado diflunisal + PVP K-30 es 5 veces más pequeño que el 
obtenido con PVP K-10. El aumento de la masa molecular trajo consigo una reducción 
importante del tamaño de las partículas. 
 
Para comparar se precipitó PVP K-30 solo usando acetona/DCM (80:20, v/v %) a 35 °C, 
14 MPa y concentración de 2 %. Las imágenes SEM muestran nanopartículas esféricas con 
tamaños medios de 210 nm. 
 
Para estudiar la influencia de la proporción fármaco: polímero en los coprecipitados de  
diflunisal + PVP K-30 usando acetona/DCM (80:20, v/v %) se eligieron las proporciones en 
masa 75:25, 50:50 y 25:75, la temperatura de 35 °C, la presión de 14 MPa, la concentración 
del 2 % y un valor de 0.97 para la fracción molar del CO2. La cristalinidad del diflunisal 
desapareció incluso en el coprecipitado con menos cantidad de polímero. El coprecipitado 
con proporción 75:25 está formado por partículas esféricas con tamaños medios inferiores a 
10 µm que están muy agregadas formando bloques. El coprecipitado con proporción 25:75 
está formado por partículas sueltas con tamaño medio de 460 nm y muy poca agregación en 
comparación con el de proporción 50:50.  
 
Los coprecipitados diflunisal + PVP K-30 con proporciones en masa 75:25, 50:50 y 25:75 
se caracterizaron por XRD, FTIR y DSC, estudiándose también su velocidad de disolución en 
comparación con la del fármaco puro. Los difractogramas XRD muestran que el diflunisal 
procesado por SAS es un material cristalino mientras que el PVP K-30 procesado por SAS es 
un material amorfo. La cristalinidad del diflunisal desapareció en los coprecipitados sin que 
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se observe variación en su amorfización cuando se aumenta el contenido del PVP K-30 del 25 
% al 75 %. El efecto inhibidor de la cristalinidad del diflunisal causado por el polímero puede 
atribuirse a la interacción del fármaco con el PVP, que produce un cambio en la movilidad 
molecular del mismo, resultando una forma amorfa del diflunisal. El espectro FTIR muestra 
ensanchamientos y desplazamientos de bandas con respecto a los espectros del fármaco puro 
y del PVP K-30 que pueden atribuirse a interacciones de los grupos funcionales. El 
ensanchamiento de la banda correspondiente al grupo carbonilo del diflunisal (1690 cm-1) en 
los tres coprecipitados indica la formación de un enlace de hidrógeno intermolecular entre el 
diflunisal y el PVP K-30. Todos estos resultados apuntan a un cambio importante en la 
simetría total de la molécula del fármaco en la matriz polimérica sólida del coprecipitado. 
 
Para investigar mejor la interacción del diflunisal con el PVP y para comprender mejor la 
estructura de los coprecipitados se hicieron estudios de DSC y TGA. En los termogramas 
DSC de los materiales “composite” aparece una banda ancha debida a la pérdida de agua con 
un hombro a 75-125 °C que se desplaza a temperaturas más altas al aumentar la 
concentración del PVP. Esto puede deberse a la presencia de moléculas de agua en el material 
“composite” en una forma distinta a la del PVP y la del diflunisal puros. Los tres 
coprecipitados muestran dos picos de descomposición atribuidos respectivamente al polímero 
y al fármaco. Además hay un desplazamiento claro de la temperatura de descomposición del 
fármaco al aumentar la concentración del polímero a temperaturas altas que también apoya la 
interacción fuerte entre el diflunisal y el PVP K-30. Las curvas TGA de los tres 
coprecipitados muestran que las composiciones de los mismos están próximas a las 
composiciones de partida. La descomposición de los tres coprecipitados tiene lugar en dos 
etapas. La primera etapa comienza a una temperatura muy próxima a la temperatura de 
descomposición del fármaco y la segunda etapa comienza a una temperatura muy próxima a 
la temperatura de descomposición del polímero.  
 
The resultados obtenidos por XRD, IR, DSC y TGA indican que la cristalinidad del 
diflunisal desapareció en el proceso de coprecipitation sugiriendo que el fármaco se incorpora 
en el seno del polímero a nivel molecular.  
 
Se llevaron a cabo pruebas de disolución usando el método del disco rotatorio en un fluido 
intestinal simulado (tampón de fosfato de pH 7.4) para el fármaco puro, tratado y sin tratar, y 
para los tres coprecipitados obtenidos con las proporciones en masa fármaco: polímero de 
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75:25, 50:50 y 25:75. Los perfiles de disolución se siguieron por espectroscopia UV-VIS a 
275 nm. Todas las velocidades de disolución de los coprecipitados diflunisal + PVP K-30 
fueron superiores a las del diflunisal puro, tratado y sin tratar. A un tiempo dado, la liberación 
del fármaco aumentó al aumentar el contenido de PVP K-30; la velocidad de disolución más 
alta se observó para el coprecipitado con 75 % de PVP K-30. Para los “composite” diflunisal 
+ PVP K-30 aproximadamente el 75 % del fármaco se disolvió transcurridos 20-30 min.  
 
Las propiedades de nuestros coprecipitados son semejantes o mejores que las de otros 
coprecipitados fármaco-PVP obtenidos por SAS y GAS y las de la mezcla física y las 
dispersiones sólidas diflunisal-PVP K-30 descritas en la bibliografía. Deben subrayarse dos 
aspectos clave: la buena morfología y pequeño tamaño de los “composites” obtenidos en este 
estudio, y las velocidades de disolución más rápidas que demuestran el potencial del PVP 
como agente para la amorfización y estabilización de un fármaco poco soluble en agua como 
el diflunisal. 
 
	  
